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Drugs in Oral Fluid – An evaluation of the release of cocaine and cocaine derivatives 
from oral drug depots into oral fluid 
ABSTRACT 
Oral fluid (OF) drug testing has been implemented in several countries including the 
UK  for the screening and confirmatory analysis of drugs of abuse (Wille et al. 2009, Chu 
et al. 2012, Vindenes et al. 2012, UK Goverment 2014). OF testing offers advantages of 
being non-invasive, less infectious, less likely of being adulterated and simplified 
collection of samples compared to other matrices such as blood. However, there are still 
some concerns about the interpretation of the results from OF drug testing related to 
variation in the concentration of drugs and/or metabolites in OF in comparison with 
blood. The considerably higher concentrations of some drugs in OF than their respective 
concentrations in blood could be explained by the release of drugs from oral drug depots 
into OF (Huestis and Cone 2004). 
The work described in this thesis aimed at enhancing the existing knowledge on the 
release of cocaine and cocaine related compounds from oral drug depots into OF and 
evaluating alternative techniques for the detection of drugs in OF and biological tissues. 
To accomplish this, the kinetics of release of cocaine and cocaine derivatives were 
investigated using an in-vivo and an in-vitro model. The in-vivo study evaluated the 
release of cocaine and derivatives from drug depots into OF by measuring the 
concentration of these analytes in collected OF samples from human participants that 
ingested or swirled a cup of coca tea. The in-vitro model evaluated the release using an 
adapted test system for studying the transport of drugs across biological membranes, 
Franz diffusion cells, applied on porcine oral tissue and synthetic oral fluid. Classical and 
alternative techniques such as liquid chromatography and Raman spectroscopy were 
evaluated for the analysis of cocaine and cocaine derivatives in OF and porcine oral 
tissue. 
The research offered new insights into the present knowledge on the release of cocaine 
and derivatives from drug depots into OF and presented an alternative non-invasive 
technique for analysing cocaine in OF and tissues. The findings of the research have also 
contributed to the interpretation of results from OF drug testing. The in-vivo release of 
drugs from drug depots showed differences in release profiles and windows of detection 
for cocaine, BZE, EME and AEME following the consumption of coca tea. Windows of 
detection varied between analytes and indicated that the concentration of drugs in OF was 
the contribution of the release of drugs from drug depots and the systemic circulation. 
The in-vitro release of drugs indicated that analytes were released into OF at different 
rates depending on the physicochemical characteristics of the molecules. Alternative 
techniques for analysing cocaine in biological matrices included the use of Raman 
microscopy which could detect cocaine at nanogram levels. The present research is 
beneficial to regulatory agencies in regard to the analysis of cocaine, the windows of 
detection, the false positives obtained following ingestion of coca tea and alternative 
techniques for on-side OF drug testing. 
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1.1 INTRODUCTION  
Oral fluid (OF) drug testing has been applied to workplace drug-testing programs, 
driving under the influence of drugs (DUID), drug-treatment settings and the prison 
service to detect drugs of abuse (Drummer 2006, Chiappin et al. 2007, Bosker and Huestis 
2009, Osselton 2012, Vindenes et al. 2012). Drugs in OF have similar detection times to 
those found in blood, for instance, drug detection in OF could indicate recent use and the 
effect that the drug might have on the donor at the time the OF sample was collected.  
OF offers a convenient and practical matrix for the screening and confirmatory 
analysis of drugs of abuse (Mali et al. 2011). The preference in use of OF over traditional 
matrices for drug testing (such as urine or blood) relies on its numerous advantages, which 
include: (1) Simplified collection of samples, as OF can be collected by non-trained 
personnel including the donor. (2) It is a non-invasive procedure and acquisition of 
samples is painless. (3) Oral secretion is considered to be less infectious than blood 
samples, e.g. in the case of HIV-positive samples, where manipulation of OF samples is 
considerably safer. (4) OF samples are less likely to be adulterated or substituted. (5) 
Transport and storage conditions of OF samples are less strict compared with blood 
samples (preservatives, temperature and time of storage). (6) There is a decrease in the 
cost of transport, storage and trained personnel required to supervise and collect the 
samples when OF is used in comparison with other matrices such as blood and urine. 
(Kato et al. 1993, Moore and Lewis 2003, Toennes et al. 2005, Drummer 2006, Bosker 
and Huestis 2009). 
Although OF offers a number of advantages over other matrices, OF drug testing has 
its limitations with regard to the high concentration of drugs that can be found in collected 
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samples, which are reflected in large variations of OF to blood ratios (also described as 
saliva to plasma ratios S/P). This variation makes it difficult to interpret the results from 
OF testing and currently impossible to assess impairment from this matrix (Wolff et al. 
2017). Considerably higher concentrations of drugs in OF than their respective 
concentrations in the circulating blood have been reported by various authors (Osselton 
2002, Huestis and Cone 2004, Bosker and Huestis 2009, Gjerde et al. 2010, Vindenes et 
al. 2012). Originally excretion of drugs into OF was supported by the hypothesis of drugs 
passing from the blood to the OF based on the drug’s pKa as stated by Henderson-
Hasselbalch equation (Haeckel and Hänecke 1996, Kidwell et al. 1998, Spiehler 2011). 
However, the increased drug concentrations found in OF samples are not entirely 
explained by this hypothesis.  
Huestis and Cone (2004) suggested that drugs can be classified into those that enter 
OF by passive diffusion from the systemic circulation and those that enter OF from depots 
formed in mouth tissues. Drugs absorbed in the oral cavity should be predominately 
hydrophobic, but they also need to have some hydrophilicity in order to be excreted into 
the systemic circulation or into the OF. If the drug is exceptionally hydrophobic, there 
would be a tendency for the drug to be retained in the hydrophobic components of the 
mucosal tissue (cell membranes) and not reach the OF or systemic circulation (Pather et 
al. 2008). Drugs that are found at higher concentrations than expected from their S/P ratio 
(theoretical value based on the Henderson-Hasselbach equation) would generally be 
excreted into OF from depots in the oral tissues (Spiehler and Cooper 2008). Furthermore, 
drugs that are orally abused through smoking (crack cocaine), sublingual absorption 
(fentanyl or buprenorphine), consumed as liquid preparation (methadone, morphine or 
coca tea) or nasal insufflation (cocaine) could create substantial oral tissue depots and 
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therefore have elevated S/P ratios following administration (Huestis and Cone 2004, 
Spiehler and Cooper 2008). 
Studies on the kinetics of drugs in oral tissue and OF could contribute to the 
understanding of the release of drug from drug depots into OF and its potential effect on 
OF drug testing (Huestis and Cone 2004, Drummer 2006, Spiehler and Cooper 2008, 
Reichardt 2014). The experiments undertaken in this PhD thesis were conducted to 
increase our understanding of the release of drugs from oral drug depots into OF. 
As previously mention, a drug needs to have specific physicochemical characteristics 
in order to diffuse and cross the buccal mucosa (Madhav et al. 2009, Steffansen et al. 
2010, Bartlett and van der Voort Maarschalk 2012). Drugs that have predominant 
lipophilicity such as cocaine have been detected in OF at considerably higher 
concentrations than their respective concentrations in the circulating blood. These 
lipophilic drugs are more likely to form drug depots in the oral cavity (Pather et al. 2008, 
Reichardt 2014), which could consequently increase their concentration in OF (Spiehler 
and Cooper 2008). Cocaine is one of the most abused drugs worldwide (Cognard et al. 
2006, UNODC 2017) and the second most widely used drug of abuse in the UK and 
Europe (EMCDDA 2017). Thus, cocaine was selected as the principal compound for the 
study of the release of drugs from drug depots into OF for this research. 
1.2 COCAINE 
Cocaine also named benzoyl-methyl-ecgonine and coca base are consumed as 
recreational drug and are natural products extracted from the coca plant (Penny et al. 
2009, Biondich and Joslin 2015). The coca plant is a South American plant from the 
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family Erythroxylaceae original of the Andes area. This plant genus has approximately 
260 species, from which predominant species are the Erythroxylum coca and 
Erythroxylum novogratense (Plowman 1979, Biondich and Joslin 2015). 
Studies on the coca plant have demonstrated that coca leaves from Bolivia, Colombia 
and Peru contain higher amounts of cocaine compared with other coca leaves from 
different countries (Moore et al. 1994, Jenkins et al. 1996, Casale et al. 2014). Cocaine 
concentrations by weight of coca leaf has been reported at 0.5-1.5% (Jenkins et al. 1996, 
Penny et al. 2009). In order to extract some of the active principles and obtain certain 
effects, the coca leaves are chewed, drunk as an infusion/tea or chemically extracted to 
obtain cocaine. Coca leaves are traditionally consumed in the Andes, to alleviate hunger, 
thirst, tiredness and to lessen the symptomatic relief of acute mountain sickness (AMS).  
On the street, cocaine can be found as a coca paste, hydrochloride salt (cocaine 
hydrochloride) or as a base (cocaine base or crack-cocaine). Coca paste is the raw product 
resulting from the first process of extraction of the cocaine from the coca leaves. It is 
obtained from the maceration of coca leaves with sulfuric acid and other chemical 
products, e.g. alkaline organic solvents and ammonia. The result of this extraction 
contains approximately 40-85% of cocaine sulphate and is subsequently used in the 
elaboration of cocaine hydrochloride. The cocaine hydrochloride is the free base of 
cocaine and is commonly administered via nasal insufflation or intravenously. The 
cocaine base (crack-cocaine) is the product of mixing cocaine hydrochloride with a basic 
solution such as ammonia. When crack-cocaine is dissolved in ether, it can be volatised 
and subsequently inhaled by heating the solution at high temperatures (80 ºC) using 
propane lighters. Crack-cocaine is commonly presented as solid blocks (crystals) of 125-
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300 mg with colour varying from yellow to pale rose or white and is administered via 
smoke (Egred and Davis 2005). 
1.2.1 Cocaine Chemical Properties and Mechanism of Action 
Cocaine (Figure 1.1) is a white crystalline compound with a bitter taste. It is soluble 
in water and reacts with acids to form salts, e.g. cocaine hydrochloride. Cocaine forms 
part of the tropane alkaloid group, having tropane as a fundamental core. Albert Niemann 
was the first person that reported the extraction of cocaine from coca leaves in 1859. 
Although cocaine can also be synthesised from the reaction of Ecgonine (ECG) and 
benzoic acid, as ECG forms esters when reacting with alcohols and acids through its OH 
group (Figure 1.1). The cyclic structure of ECG allows COC to generate isomers, from 
which L-cocaine is the most important alkaloid of coca leaf. Cocaine (molecular weight 
of 303.35 g/mol) is a weak base (pKa = 8.6), highly protein bond (approximately 90%) 
with a melting point of 98ºC (Moffat et al. 2011). 
 
Figure 1.1 Synthesis of cocaine from ecgonine and benzoic acid. 
Cocaine is a highly addictive stimulant with high toxicity (Gjerde et al. 2014). Cocaine 
passes through the blood-brain barrier (BBB) to reach the central nervous system (CNS), 
where it acts as a sympathomimetic agent, inhibiting specifically the monoamine 
transporters of the presynaptic membrane. In this way, the reuptake (type I) of certain 
Ecgonine Benzoic acid Cocaine 
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neurotransmitters such as dopamine, noradrenaline, serotonin and norepinephrine is 
inhibited, facilitating their accumulation in the synaptic cleft. The increased 
bioavailability of dopamine (the result of the inhibition of the reuptake type I) produces 
the feeling of euphoria and dependency when cocaine is consumed. The excess of 
noradrenaline generated by the consumption of cocaine is responsible for the majority of 
pharmacological effects and the acute complications (increased blood pressure, pupil 
dilatation, sudation and tremor). The inhibition of the reuptake of serotonin produces 
changes in its bioavailability, which is reflected in the decrease of 3-methoxy-4-
hydroxyphenylglycol (MHPG) and 5-hydroxyindoleacetic acid (5-HIAA) metabolites. 
These processes affect the catecholaminergic and serotonergic neurotransmission, which 
are the basis of the mechanism of action of dependency. Norepinephrine, on the other 
hand, is the responsible for the changes in the vascular system: vasoconstriction and flow 
rate decrease. Furthermore, cocaine consumption leads to the increase in the 
concentration of excitatory amino acids (glutamate), which is responsible for 
hyperthermia and convulsions (Lizasoain et al. 2002, Ministerio de Sanidad y Consumo 
2007).  
1.2.2 Oral Administration of Cocaine  
Cocaine from the coca leaves can be orally administered by chewing coca leaves or 
drinking the infusion of coca leaves (Biondich and Joslin 2015). Cocaine (cocaine 
hydrochloride), coca base and coca paste can be administered by different routes 
including drinking, snorting or smoked (Caballero and Alarcon 2000). Cone (2012) 
reported that the principal rout of exposure of cocaine is via smoke (63%) followed by 
nasal insufflation (32%) and intravenous injection (3%). Coca base (crack-cocaine) or 
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coca paste can also be administered by smoking or mixing the coca paste or coca base 
with other substances such as tobacco or cannabis.  
Although the oral cavity is principally exposed to cocaine when is orally administered, 
nasal insufflation of cocaine hydrochloride or inhalation of the vapours produced by the 
burning of “crack” can also contaminate the oral cavity (Spiehler and Cooper 2008). The 
particles of cocaine present in the vapours or gases can pass through the nasal turbinate 
in the nasal cavity with help of the cilia (hair-like structures), which line the mucous 
membrane of the nasal cavity. The cilia move the particles trapped in the mucous and 
drain them into the oral cavity (Beule 2010). 
1.2.3 Pharmacokinetics of Cocaine  
1.2.3.1 Absorption 
The absorption of cocaine following the insufflation of cocaine hydrochloride and the 
smoking of cocaine base was reported to be rapid, as mean plasma concentrations were 
obtained immediately after administration (Cone et al. 1994). Jenkins et al. (2002) 
confirmed the rapid absorption of cocaine by reporting mean peak plasma concentrations 
two minutes after smoking 40 mg of cocaine base. Zhang et al. (2012) reported that 
cocaine is well absorbed following nasal insufflation and that its absorption could be very 
rapid as psychostimulatory CNS effects are rapidly produced. Similarly, pharmacokinetic 
studies have demonstrated that oral cocaine is well absorbed from the gastrointestinal 
tract as cocaine is detected in plasma within 30 minutes of oral administration (Wilkinson 
et al. 1980). 
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Comparable results were reported by Coe et al (2018), who reported that after oral 
administration cocaine was rapidly absorbed and detected in plasma within 30 minutes. 
Coe also reported the oral bioavailability of cocaine (fraction of oral cocaine that reaches 
the systemic circulation) at 0.32 (100 mg oral dose) and 0.45 (200 mg oral dose) with 
range 0.15-0.93. These values were similar to those reported by other authors (0.2-0.6) 
that retrospectively calculated the bioavailability of cocaine from data across different 
groups of participants who received acute doses following oral or intravenous 
administration (Mayersohn and Perrier 1978, Wilkinson et al. 1980). 
1.2.3.2 Distribution of cocaine in tissue 
Several reports have demonstrated that cocaine accumulates in the body and transports 
across biological tissues (e.g. liver and muscle from human or pig)  (Chow et al. 1985, 
Spiehler and Reed 1985, Poklis et al. 1987, Jeffcoat et al. 1989, Laizure et al. 2003, 
Othman et al. 2007, Moffat et al. 2011, Rees 2011). The volume of distribution (Vd) for 
cocaine were reported to range between 1 and 3 L/Kg (Moffat et al. 2011). However, little 
has been reported concerning the accumulation and permeability of cocaine into tissues 
with non-keratinised epithelia such as nasal/buccal mucosa or epithelial cell models (Bhat 
et al. 2001, Zhang et al. 2012, Clemons et al. 2014). Zhang et al. (2012) reported that the 
transport across nasal mucosa (ranged 0.2-1.0 µg/min/cm2) was similar to the olfactory 
mucosa (range 0.2-0.9 µg/min/cm2) for concentrations ranging 1-5 mM and that 
permeability across these tissues was dose-dependent. 
Similar studies using epithelial cells (colonic T-84 monolayers) showed that cocaine 
transport increased linearly across these cells with the increase in cocaine concentration 
(100-800 ng) and that this relation did not change when the time of exposure increased 
from 30 to 60 minutes (Bhat et al. 2001). The rate of transport (apparent permeability 
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Papp) of cocaine across an artificial membrane of poly(vinylidene-fluoride) PVDF coated 
with a lipid solution (method used to mimic biological membranes such as BBB or oral 
mucosa) was reported at 3.66x10-3 cm/s (Clemons et al. 2014).  
Different concentrations of cocaine were reported to accumulate in body tissues after 
administration of lethal dosages of cocaine suggesting that the transport of cocaine across 
tissues is more rapid in tissues with high blood flow, e.g. heart, liver and brain than in 
tissues with less blood supply (Poklis et al. 1987, Furnari et al. 2002, Rees 2011, 
Brajković et al. 2016). Poklis et al. 1987 reported high concentrations of cocaine from 
five related fatalities (five individuals) in kidney, brain, skeletal muscle and spleen 
(kidney: 39.4 ng/mL, brain: 35.3 ng/mL, skeletal muscle: 28.0 ng/mL, spleen:  26.0 
ng/mL) than in adipose tissue, heart and liver (2.4 ng/mL, 5.7 ng/mL and 10.0 ng/mL 
respectively). Furnari et al. (2002) reported higher concentration of cocaine (based on the 
analysis of one individual) in bile than, brain, cardiac muscle and thigh muscle, with 
higher concentration of cocaine in the bile than in the cardiac muscle and thigh muscle 
(Furnari et al. 2002). Brajković et al. (2016) reported high concentrations of cocaine 
(based on one participant) in kidney and liver (21.2-24.9 µg/mL) in comparison with brain 
(18.9 mg/Kg), heart (9.2 µg/mL), intestine (6.1 µg/mL) and stomach (4.6 µg/mL).  
1.2.3.3 Metabolism 
The metabolism of cocaine is shown in Figure 1.2. Cocaine is metabolised through 
four pathways: (1) the enzymatic hydrolysis into ecgonine methyl ester (EME) and 
benzoylecgonine (BZE), which are pharmacologically inactive. BZE is formed from 
spontaneous hydrolysis by the hepatic carboxylesterase. The carboxylesterase hCE-1 
causes the hydrolysis of cocaine to BZE by demethylation (Fleming et al. 1990, Pindel et 
al. 1997). (2) the hydrolysis of the benzoyl group by the action of hepatic and plasmatic 
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esterases (carboxylesterase hCE-2) to form EME (Pindel et al. 1997). (3) the production 
of EME via serum butyrylcholineterase (BchE) and (iv) the demethylation of cocaine to 
form norcocaine (NC) by the action of cytochrome (CYP) 450. NC is further metabolised 
by the CYP-450 enzyme to form N-hydroxynorcocaine. Further oxidative metabolism 
produce minor metabolites: m-hydroxycocaine, p-ydroxycocaine n-benzoylecgonine, m-
hydroxybenzoylecgonine and p-hydroxybenzoylecgonine (Coe et al. 2018). 
Cocaine can spontaneously hydrolyse into BZE and EME in-vitro and in-vivo at 
physiological temperature and pH at a rate of 4.8% (in vitro) of total cocaine per hour 
(Baselt et al. 1993, Warner and Norman 2000). 
Other cocaine derivatives such as anhydroecgonine methyl ester (AEME) and 
cocaethylene (CE) are formed after administration of cocaine or crack cocaine. AEME is 
formed after crack cocaine consumption and is product of the thermal degradation of 
cocaine (Kintz et al. 1997). AEME is further metabolised (enzymatic hydrolysis) into 
anhydroecgonine. In the presence of alcohol, carboxylesterase (hCE1) reacts with cocaine 
to form CE via in vivo transesterification, where the methyl ester group is replaced with 
an ethyl group (Lewis et al. 2004).  CE is pharmacologically active, and its activity is 
similar to that of cocaine (Laizure et al. 2003). It has been reported that concentrations of 
CE are considerably higher when alcohol has previously been consumed, thus increasing 
the risk of overdoses. (Laizure et al. 2003, Ministerio de Sanidad y Consumo 2007). 
C
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1.2.3.4 Excretion 
Cocaine is excreted from the body by different routes such as urine, sweat and OF 
(Jufer et al. 2000, 2006, Allen 2011). Cone et al. (1998) reported that 39% (intravenous), 
30% (insufflation) and 16% (smoking) of a dose of cocaine was excreted in the urine 
within 24 hours. Cocaine and BZE were detected in sweat after two to four hours and up 
to 24 hours following intravenous administration of 2.1 mg/Kg cocaine hydrochloride 
(Kacinko et al. 2005). Cocaine and its major metabolite (BZE) were detected in OF above 
a concentration of 8 ng/mL (cut-off level) for up to four to eight hours after consumption 
of 25 mg (intravenous), 32 mg (intranasal) or 42 mg (smoked) of cocaine (Anizan and 
Huestis 2014). The cut-off concentration refers to the minimum concentration at which a 
drug (or its metabolites) must be present in a sample for the result to be considered 
positive (Allen 2011, EWDTS 2015, Alere Toxicology 2018). In OF the elimination half-
life (t1/2) of cocaine was reported as 30 minutes following intravenous administration of 
15 and 40 mg cocaine (Anizan and Huestis 2014).  
A different study reported that after increasing the dose from 75 mg to 150 mg cocaine 
(subcutaneous administration) the time of last detection of cocaine and BZE increased 
from 11.5 to 32 hours for cocaine and from 17 to 47 hours for BZE respectively (cut-off 
levels of 2.5 ng/mL for cocaine and BZE) (Scheidweiler et al. 2010). These results 
indicated that the time at which a drug can be detected above its cut-off level (i.e. 
detection window) changes with the dosage and route of administration. The increase on 
detection window of cocaine in OF was also reported by different authors after giving a 
maximum cumulative dose of 2 g (5 doses of 25 mg per day over a period of 16 days) to 
human volunteers.  The detection times in this study increased up to 21 and 50 hours for 
cocaine and BZE respectively (8 ng/mL cut-off) (Strano-Rossi et al. 2010). Jufer et al. 
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(2006) reported mean detection times of 85 and 93 hours for cocaine and BZE 
respectively, following chronic cocaine administration.  
1.3 ORAL FLUID 
The term OF is used to describe the fluid from the oral cavity that can be sampled, 
which contains a mixture of saliva and other constituents present in the mouth including 
(1) microbial organisms, e.g. oral bacteria, viruses, fungi; (2) cells from the oral mucosa;
(3) blood and blood derivatives; (4) extrinsic substances derived from food; (5) other
fluids, e.g. bronchial and nasal secretions (Table 1.1) (Kaufman and Lamster 2002, 
Spiehler and Cooper 2008).  
Table 1.1 Components of oral fluid (Osselton 2012). 
Salivary 
Glands 
Microbes Cells 
Extrinsic 
substances 
Blood Other fluids 
Water Bacteria Epithelial Food 
Micro-
bleeding 
Gingival fluid 
Proteins Viruses From food Toothpaste Serum 
Bronchial 
mucus 
Electrolytes Fungi Tobacco Cells Nasal mucus 
Other organics - - - - - 
The secretion of saliva is primarily controlled by three pairs of salivary glands that are 
located in mouth and throat: The parotid gland (glandular parotis), sublingual gland 
(glandular sublingualis) and submandibular gland (glandular submandibularis) (Hand 
and Frank 2014). An illustration of the major salivary glands is shown in Figure 1.3. 
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Figure 1.3 Major salivary glands with ducts that produce saliva and excrete it in the oral cavity 
(Biology dictionary 2019). 
Saliva is also secreted by many minor salivary glands present in the oral cavity, e.g. 
hard and soft palates, labia and tongue. Approximately 450 – 1000 minor salivary glands 
are present in the oral cavity and are considered to have an exocrine function (Guzzo et 
al. 2010). Minor salivary glands contribute to less than 10% of total saliva, whereas major 
salivary glands are responsible for more than 90% of total saliva (Eliasson et al. 1996, 
Yoshizawa et al. 2013). The parotid gland is the largest of the major salivary glands and 
produces approximately 65% of the total saliva (Eliasson et al. 1996, Ferguson 1999, 
Hand et al. 1999, Yoshizawa et al. 2013). 
Human saliva is a hypotonic biological fluid with clear, heterogeneous and slightly 
acidic characteristics (pH 6.0 – 7.0). It is comprised of water (99%), proteins (0.3%) and 
inorganic substances such as electrolytes (0.2%) (Yoshizawa et al. 2013). Electrolytes 
and proteins can be found at different concentrations in the saliva depending on the 
velocity at which the saliva passes through the ducts (Figure 1.3). Thus, higher flow rates 
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result in a reduced exchange of electrolytes. Changes in the content of analytes 
(electrolytes and proteins) and volume of saliva can be influenced by the nervous system 
and external factors such as (1) time of day, (2) gustatory and olfactory stimulus, (3) 
mechanical stimulus, (4) pain, (5) pregnancy, (6) hormone changes such as the 
menopause, (7) medications and (8) stress (Forde et al. 2006, Chiappin et al. 2007). Some 
proteins have an essential role as antibacterial and antifungal agents (e.g. lysozyme, 
lactoferrin, mucins), and some are important in the digestive process, e.g. α-amylase, 
lipase, DNase and RNase (Aps and Martens 2005).  
Functions of the saliva include aiding the processes of digestion, ingestion, tasting and 
lubrication of oral tissues. Saliva also acts as a protective barrier against pathogenic 
agents. On average, individual salivation can vary from 0.3 to 0.7 mL of saliva per minute 
(Lenander-Lumikari et al. 1998, Ferguson 1999, Wu et al. 2008), thus producing 
approximately 1.0 - 1.5 L per day (Yoshizawa et al. 2013). Buffering properties of saliva 
rise with the high concentrations of bicarbonate in stimulated saliva. Under these 
conditions, the parotid gland decreases the production of saliva significantly (sublingual 
and submandibular glands are responsible for the production of saliva) resulting in a small 
volume of saliva, which is more viscous, protein-rich and can stabilise the pH of the 
surrounding saliva (Kaufman and Lamster 2002, Almståhl and Wikström 2003). 
Buffering capacity in unstimulated saliva is important for the lubrication of tissue within 
the oral cavity (Aps and Martens 2005, Forde et al. 2006, Chiappin et al. 2007). 
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Salivary glands are highly permeable and are enveloped by capillaries (Figure 1.4). 
These capillaries allow free transport of substances such as electrolytes and proteins into 
the secretory cells also called acinus cells (Guzzo et al. 2010). The primary function of 
the acinus cells is the excretion of fluids including the saliva into the oral cavity through 
the intercalated, striated and excretory ducts (Gómez de Ferraris and Campos 2002, Aps 
and Martens 2005). 
 
Figure 1.4 Mechanism of transport of electrolytes and proteins from the blood into salivary 
gland ducts. (a) Ultrafiltration, (b) active transport or passive diffusion, (c) simple filtration, (d) 
transepithelial movement of water along NaCl gradient via chanel proteins, (e) creation of 
hypotonic salivary solution via ductal Na+ reabsorption, (f) acinal cell membrane, (g) cell 
membrane pore, (h) intercellular space, (i) acinar cell (Forde et al. 2006, p.45). Ó Quintessence 
Publishing Company Inc, Chicago. 
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1.4 HISTOLOGY OF THE ORAL MUCOSA 
OF testing is conducted by the collection of OF from the oral cavity (Wolff et al. 2013). 
The lining of the oral cavity is the oral mucosa, the area of which (197 - 241 cm2) accounts 
for approximately 80% of the total mouth cavity area, which includes the cheek and the 
tongue as depicted in Figure 1.5 (Naumova et al. 2013). The remaining 20% of the oral 
cavity correspond to the teeth. The primary role of the oral mucosa is to protect the 
underlying tissue from mechanical damage and to allow or prevent the absorption and 
excretion of exogenous substances such are drugs (Squier and Kremer 2001). 
 
Figure 1.5 Mucosal regions in the oral cavity (Head and Neck Cancer Guide 2018). © Jill 
Gregory, Head & Neck Cancer Guide. 
The structure of the oral mucosa, which includes the cheek and tongue is composed of 
a stratified epithelium which is separated from the underlying connective tissue (lamina 
propria) by a basement membrane (~1-2 µm thickness) (Nicolazzo and Finnin 2008). The 
epithelium comprises tightly packed epithelial cells whereas the lamina propria consists 
of fibroblasts, connective tissue, small blood vessels (capillaries), inflammatory cells 
(macrophages) and extracellular matrix (ECM) that aids in the fast transportation and 
clearance of absorbed molecules (Sonis 2004).  In many regions (e.g. cheeks) a layer of 
Dorsum of the tongue 
Buccal mucosa or cheek 
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connective tissue (containing the major blood vessels and nerves) separates the oral 
mucosa from underlying bone or muscle as illustrated on the left side of Figure 1.6. 
  
Figure 1.6 Left: Components and layers of the oral mucosa. The stratified epithelium is 
separated from the underlying connective tissue (lamina propria) by a basement membrane. The 
lamina propria and submucosa contain small blood vessels, macrophages and extracellular matrix 
(ECM) that aids in the transportation and clearance of absorbed molecules (Bhusnure et al. 2017, 
p.120). Right: The epithelium can be keratinised or non-keratinised depending on the region of 
the oral cavity (Vibhooti and Preeti 2018, p.2). 
The epithelium of oral mucosa varies within regions in the oral cavity as shown in the 
right side of Figure 1.6: (1) A non-keratinised epithelium in the lining mucosa, e.g. cheek 
(comprising 60%). (2) A keratinised epithelium is found in the masticatory mucosa 
(comprising 25% of the oral mucosa). (3) Both keratinised and non-keratinised regions 
(specialised mucosa)  are found in the dorsum of the tongue (comprising 15%) as shown 
in Figure 1.5 (Squier 1991, Sohi et al. 2010). Keratinized epithelium refers to an outer 
layer of skin which contains multiple layers of dead cells at the surface. In contrast, the 
non-keratinized cells are nucleated and alive. 
In the cheek and under the surface of the tongue, the non-keratinized human buccal 
epithelium has 20-40 cell layers with thickness of 450-600 µm (Nielsen 2002). The 
Non-Keratinised 
(Cheek) 
Keratinised 
(Dorsum of the tongue) 
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distinct layers of the non-keratinized human epithelium are (1) Mucus layer formed of 
salivary layer of approximately 70 – 100 µm. (2) Superficial layer: well defined flat cells 
that comprises 20 – 30% of the epithelium. (3) Intermediate cell layer: flattened cells, 
with thick plasma membrane and lipophilic intercellular substance excreted from the 
membrane coating granules (MCG). (4) Prickle cell layer: large cells with occurrence of 
MCG. (5) Basal cell layer: columnar cells anchored to the mechanical supportive basal 
lamina by hemidesmosomes. (6) Basal lamina: which is approximately 1 µm thick and 
separates the epithelium from the connective tissue (lamina propria) (Nicolazzo and 
Finnin 2008).  
In the dorsum of the tongue the keratinized epithelium is composed of distinct layers: 
(1) stratum corneum: is the surface layer, formed of 10-25 rows of dead keratinocytes 
embedded in a lipid matrix and has a thickness of 10 – 50 µm. (2) stratum granulosum 
formed of flattened cells containing keratohyalin granules. (3) Stratum spinosum 
composed of several rows of larger spherical prickle cells. (4) The basal layer or stratum 
basale formed of a layer of cuboidal cells adjacent to the basal lamina. Both basal and 
stratum spinosum constitute 50 – 75 % of the thickness of the epithelium (Nicolazzo and 
Finnin 2008). 
1.5 TRANSPORT OF DRUGS ACROSS THE ORAL MUCOSA  
Oral mucosal membranes act as an efficient semi-permeable barrier system allowing 
diffusion of drugs, water, small molecules (electrolytes) from the systemic circulation or 
muscle tissue into the OF and vice-versa. Factors such as the amount of drug, degree of 
the drug's ionisation (pKa), pH, size of the drug molecule, relative lipid solubility, 
mucosal contact time and vascularisation of the mucosal tissues controls the amount of 
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drug absorbed into and transported across the oral mucosa into the systemic circulation 
or OF (Madhav et al. 2009). 
The different layers of the oral mucosa (hydrophilic mucus, keratinised layers if 
applicable, densely packed epithelial cell layers, basement membrane and hydrophilic 
connective tissue) place a barrier in the transport of drugs. It was observed that the top 
epithelial layer of thickness 200 μm is a major rate-limiting factor in transport kinetics of 
drugs (Kulkarni et al. 2010, Sohi et al. 2010). The impact of the mucus and basement 
layer in the transport of drugs across the oral mucosa is not well understood and may be 
minor compared to the inherent barrier of the epithelium (Nicolazzo and Finnin 2008). 
The transport of drugs within regions of the oral cavity varies significantly and is 
inversely proportional to keratinisation and thickness of tissue, e.g. molecules are most 
permeable in the buccal than the palate surfaces or the dorsum of the tongue (Figure 1.5). 
The higher permeability in the buccal mucosa (cheek) has been attributed to the absence 
of organised lipid lamellae in the intercellular spaces and the polar nature of its lipids 
composition (such as polar phospholipids and cholesterol esters) compared with 
keratinised epithelia (Nicolazzo and Finnin 2008).   
The primary mechanism involved across the buccal mucosa is the paracellular route 
(through the spaces between the cells) by passive diffusion (Fickian diffusion) in 
accordance with the pH partition hypothesis (Zhang et al. 2002). Although, other 
transcellular mechanisms can be involved by carrier-mediated diffusion, active transport 
or others like endocytosis (Nicolazzo and Finnin 2008). For example, drugs such as 
penicillin, hormones and steroids are actively excreted through the acinus cells and ducts 
into the saliva (Spiehler and Cooper 2008). The passive diffusion is dependent on the 
physicochemical properties of the molecule (diffusion coefficient and partition 
coefficient). Hence, drugs require being: (1) lipophilic, (2) neutral and (3) protein free 
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binding in order to pass through cellular membranes. Thus, only the non-binding fraction 
of non-ionised drugs from the plasma is detected in OF (Sohi et al. 2010, Jones 2015).  
1.6 TRANSFER OF DRUGS BETWEEN PLASMA AND ORAL FLUID 
Drugs that are absorbed through the oral mucosa membranes have direct access to the 
systemic circulation and the OF. The relationship between the concentration of drugs in 
saliva and plasma was described by Rasmussen as per Equation 1. This equation was 
derived from the Henderson-Hasselbach equation (Equation 2) (Haeckel and Hänecke 
1996). Equation 1 demonstrates that at equilibrium, the saliva to plasma ratio (S/P) is 
dependent on: (1) The concentration of drug in saliva (S). (2) The concentration of drug 
in plasma (P). (3) The dissociation constant for basic drugs (pKb) or acidic drugs (pKa). 
(4) The pH of the saliva (pHs). (5) The pH of the plasma (pHp) and (6) the fraction of 
drug bounded to saliva (fs) and plasma proteins (fp). 
Equation 1. Rasmussen Equation for the saliva to plasma ratio. 
Acidic drugs:    
!" = [%&%'()*+,)-.)][%&%'1)*),)-+2] 3)3+ 								     Basic drugs:    !" = [%&%'1)-5,)*+2][%&%'1)-5,)*)2] 3)3+         
S/P: Saliva to plasma ratio; S: Concentration of drug in saliva; P: Concentration of drug in plasma; pKb: 
basic drugs; pKa: Dissociation constant for acidic drugs; pHs: The pH of the saliva. pHp: pH of the plasma; 
fs: Fraction of bounded drug to saliva; fp: Fraction of bounded drug to plasma proteins. 
The Henderson-Hasselbach equation (Equation 2 - left) describes the pH as a measure 
of acidity in a chemical system using pKa, where the pH is dependent on the pKa and their 
concentration of acid [HA] and conjugate base [A-]. An alternative form of this equation 
using the pKa is given by the Heylman-Lardinois equation (Equation 2 - right), where [B] 
and [BH+] are the concentration of the base and its conjugate acid respectively. 
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Equation 2. Henderson-Hasselbach and Heylman-Lardinois equations. Acid:				;< = ;=> + @AB [C,][DC] Basic:						;H< = ;=I + @AB [JDK][J]
pKa: Dissociation constant for acidic drugs; [HA] Concentration of acid [A-]: Concentration of conjugate 
base; [B]: Concentration of base; [BH+]: Concentration of conjugate acid. 
1.7 ELEVATED ORAL FLUID TO BLOOD DRUG RATIOS 
In general, the concentration of drugs in OF are higher than corresponding 
concentrations in plasma (Forde et al. 2006). Elevated S/P ratios (>100 fold) have been 
reported for cocaine after smoking 40 mg cocaine base, with concentrations of cocaine 
ranging 15,852-50,480 ng/mL in saliva and 46-291 ng/mL in plasma after smoking 
(Jenkins et al. 1995). Fiorentin et al. (2017) reported mean cocaine concentration in OF 
(39 ± 70 ng/mL) five times higher than in plasma (8.2 ± 18 ng/mL) from 124 
cocaine/crack users. Similarly, Scheidweiler et al. (2010) reported median values of 
cocaine maximum concentration in OF (1092; 406-3006 ng/mL) four times higher than 
in plasma (305; 109-434 ng/mL). 
Furthermore, cocaine has been reported at high concentrations (ranging 1.3-3.1 
µg/mL) in OF following oral administration after doses of 25-150 mg (Kato et al. 1993, 
Kidwell et al. 1998, Bosker and Huestis 2009). Concentrations in the range of 0.4-2490 
ng/mL cocaine and 0.4-12100 ng/mL BZE in OF were reported after chronic 
administration of cocaine (Cone 2012). Data from the Forensic Science Service showed 
mean cocaine concentrations of 1191 ng/mL (33-3537 ng/mL) in OF (Osselton et al. 
2001). These concentrations were significantly higher than the concentration that can be 
found in blood following cocaine drug overdose (1.1-98.1 μg/mL) (Karch et al. 1998, 
Fineschi et al. 2002). 
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At the lower pH of normal saliva (pH = 6.7), which is slightly acidic, many of the 
illicit drugs including cocaine will be ionised and leading to ion trapping in the OF (Allen 
2011). This ion trapping occurs because of the decreased diffusion into blood resulting 
from ionisation of the molecule (DePriest et al. 2015). Since saliva presents a pH lower 
than the plasma, the S/P ratio for acidic drugs (pKa < 5.5) or highly bound molecules is 
generally inferior to one. Neutral molecules (pKa 5.5-8.5) have a S/P ratio near to 1.0 that 
does not vary with the salivary flow rate. Basic drugs and drugs that do not bind highly 
to proteins are ionised at saliva pH and are ion trapped in the OF producing S/P ratios 
greater than 1.0 (Spiehler and Cooper 2008).  
For drugs with pKa between 5.5 and 8, the S/P ratio may vary depending on the flow 
rate of saliva and therefore its pH (Schramm et al. 1992). The pH of saliva has been 
proved to be inversely proportional to the saliva flow (Dawes and Jenkins 1964). When 
the flow is low, sodium is less absorbed by the salivary ducts and so an accumulation of 
sodium produces an increase in the salivary pH. Hence, unstimulated saliva has higher 
pH, reaching values of up to pH 8. An example of the variation of S/P ratio with the 
salivary flow was reported for cocaine, with S/P ratios ranging between 3.0-9.0 when the 
salivary pH varied between 5.0-7.8 following intravenous (IV) dosages of 25 mg (Kato 
et al. 1993). The S/P ratio might also be influenced by the route of consumption, for 
example, snorting or smoking of drugs such as cocaine would lead to buccal 
contamination and therefore much higher S/P ratios (Allen 2011). 
1.8 DRUG DEPOTS 
Huestis and Cone (2004) initially suggested that drugs that are found at higher 
concentration in OF are excreted into the OF from drug depots in the oral tissues. This 
hypotesis was then supported by other authors (Drummer 2006, Spiehler and Cooper 
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2008). In 2014, Reichardt proved this hypothesis by showing (immunohistochemical 
staining) that drugs such as cocaine and heroin could accumulate into porcine tongue 
tissue following exposure to the drug in solution or simulated smoking, thus, confirming 
the formation of drug depots in oral tissues. 
Reichardt’s study showed that the staining in the porcine tongue tissue increased with 
the increase in drug exposure (Figure 1.7). The amount of cocaine/heroine deposited in 
the tissue that is proportional to the strength of the staining was subsequently confirmed 
by quantitative analysis of the tongue tissue using liquid chromatography coupled to mass 
spectrometry (LC-MS). The results of the quantitative analysis showed that cocaine 
concentration increased from 6-25 ng/mL (100 ng/mL dose) to 55-274 ng/mL (10,000 
ng/mL dose), confirming the relation between the dose exposed and the amount of drug 
depot formed in the porcine tongue tissue. Comparison between the staining obtained 
following cocaine and heroin, showed that staining following heroin exposure was more 
intense than cocaine exposure. Therefore, indicating that there was a higher amount of 
heroin deposited into the tongue tissue than cocaine, which could be explained by the 
higher lipophilicity of heroin in relation to cocaine. 
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Figure 1.7 Immunohistochemical staining for cocaine and heroin in porcine tongue tissue 
following exposure of 100-10000 ng/mL of the drug. Images at magnification x65 (Reichardt 
2014, p 183-188). 
The results reported by Reichardt also included a study on the release of drugs from 
tongue tissue, where tongues were exposed to either 100 ng/mL or 1000 ng/mL of cocaine 
or heroin and then washed for 1 hour, 6 hours, 24 hours or 48 hours in artificial saliva 
with continuous mechanical stirring. The outcome of this study showed that cocaine was 
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detected for up to 24 hours post-exposure whereas morphine was detected for up to 48 
hours post exposure. These results indicated that cocaine and heroin were being released 
from drug depots into OF over time (Figure 1.8) and could interfere with the interpretation 
of drug concentrations in OF when investigating S/P ratios (Reichardt 2014). 
 
Figure 1.8 Cumulative amount of cocaine and morphine in OF following the interaction to 
porcine tongue tissue exposed to 1000 ng cocaine or heroin. The graph was plotted based on data 
reported by Reichardt (2014). 
1.9 MODELS EMPLOYED TO ASSESS DRUG DIFFUSION 
Study on the diffusion of drugs through biological membranes is commonly conducted 
by the use of in vivo and/or in vitro models, although mathematical models are also used 
(Bolger et al. 2002). While in vivo models are more appropriate for assessing the 
bioavailability of a drug, in vitro models are more commonly used for preclinical 
compound screening, elucidation of the mechanism of transport across the oral mucosa 
and assessment of compound permeability (Nicolazzo and Finnin 2008). 
1.9.1 In vivo models to assess diffusion of drugs 
One of the in vivo methods used to evaluate the absorption of drugs in the buccal 
mucosa is the test of Beckett and Triggs (Beckett and Triggs 1967). In this test, a known 
volume of a drug solution is introduced into the oral cavity, swirled around for a specific 
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period of time and then expel it. The expelled solution is finally analysed to determine 
how much drug was absorbed in the mucosa. The advantages of this test are the time of 
the study and the use of single participants, although kinetic profiles cannot be obtained. 
Beckett and Triggs test was then modified by various authors. Dearden and Tomlinson 
(1971) introduced a factor that corrects for the production of OF (Dearden and Tomlinson 
1971). Tucker (1988) modified the test by collecting samples of the swirled solution from 
the oral cavity every few minutes without removing the whole solution. Thus, allowing 
the study of the absorption kinetics on a single participant (Tucker 1988). Additionally, 
other authors have reported the addition of marker compounds to the swirling solution, 
such as phenol red, to account for salivary dilution and accidental swallowing of the 
solution (Nicolazzo and Finnin 2008). 
Other in vivo methods used to determine the absorption and diffusion of drugs into the 
oral cavity include the use of perfusion systems, which can be attached to the oral tissues 
of both animals and humans (Tsai 2003, Tunblad et al. 2004, Bansal and Ajay 2012). This 
method consists of perfusing a specific amount of drug through the cell. The amount of 
drug disappearing from the perfusate accounts for the amount of drug absorbed by the 
tissue. Quantification of the drug in either OF or plasma has also been included in this 
method to evaluate the diffusion of drugs such as nicotine through the oral mucosa 
(Adrian et al. 2006). 
1.9.2 In vitro models to assess diffusion of drugs 
In vitro methods commonly involve the use of diffusion cells fitted with suitable 
membranes, e.g. porcine skin, that operate under atmospheric conditions. These models 
are often used to determine the kinetics of a drug across a specific tissue and to evaluate 
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the barrier nature of a particular biological tissue (Nicolazzo and Finnin 2008). In vitro 
models are commonly used instead of in vivo models because (1) they can offer 
comparative diffusion results (Nicolazzo and Finnin 2008, Castro et al. 2016). (2) 
Variables such as temperature, pH and drug concentration can be easily controlled. (3)  
In cases where human tissue is not available, animal models can be used instead, which 
reduces cost and ethical considerations (Patel et al. 2012). 
The most common diffusion cells are the Franz-type diffusion cells (Figure 1.9) 
(Nicolazzo and Finnin 2008, Bartosova and Bajgar 2012, Castro et al. 2016). These cells 
are normally used to assess in vitro transport of compounds across the buccal mucosa 
(Ceschel et al. 2002). In this system, the buccal mucosa is placed in between two 
chambers, and buffer solutions with and without the addition of a test compound are 
added to the chambers. The amount of compound that has permeated the tissue over time 
is measured by analysing samples periodically collected from the chambers (Bartosova 
and Bajgar 2012). 
Figure 1.9 Franz type diffusion cell. (Bartosova and Bajgar 2012, p.4673) 
In the Franz cell system, a donor solution containing the drug is applied to the apical 
surface of the membrane to initiate the absorption of the drug. The receptor compartment 
is filled with a receiver solution suitable for the study (such as PBS) that does not induce 
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any alteration to the barrier properties of the membrane (Bartosova and Bajgar 2012, 
Castro et al. 2016). The receiver solution should be maintain at 37 °C in order to mimic 
in vivo skin surface temperature (Nielsen 2002). Additionally, it should not exceed 10% 
of the donor concentration in the receiver solution (saturation should be avoided) as this 
maintains a concentration gradient between the donor and receiver solution (Bartosova 
and Bajgar 2012). To aid the maintenance of sink conditions throughout the experiment, 
stirring of the receiver solution is employed (Brodin et al. 2010). 
Ideally, human buccal (cheek) mucosa should be used to study buccal diffusion in 
vitro, however, lack of availability of human tissue, as well as national and international 
ethical considerations make the use of human tissue difficult. Instead, cell culture models 
and animals have been employed to mimic the skin barrier properties (Shrestha et al. 
2015). Porcine buccal tissue is often preferred as an alternative to the human buccal 
mucosa for in vitro studies (Nielsen 2002) (apart of primates) because of its similarities 
in non-keratinised buccal epithelium and biochemical properties (Gray and Yardley, 
1975; Jacobi et al., 2007). Prove of this is the similarities between the diameter of the 
external epithelial layer and values of permeability for water between pig buccal mucosa 
(thickness: 772 ± 150 µm; permeability: 634 ± 60 cm/min) and human buccal mucosa 
(580 ± 00 µm; permeability: 579 ± 22 cm/min ), which were reported to be very similar 
(Squier et al. 1996). Based on these results and many others, it has been recommended 
that permeability across buccal mucosa be conducted using porcine buccal mucosa 
(Nicolazzo and Finnin 2008). 
Checks of the integrity of the buccal mucosa are commonly conducted during diffusion 
or permeability studies to guarantee that no damage to the membrane took place during 
the transport, preservation or after permeability studies (Pather et al. 2008). Several 
studies have been reported on the use of biological media and/or temperature conditions 
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for the preservation of tissue and its biological bioavailability. It has been reported that 
porcine buccal mucosa retained its integrity when stored with a preservative (Phosphate 
buffer saline PBS pH7, Kreb's bicarbonate ringer solution, HEPES buffer or HBSS – 
Hank’s balanced salt solution) at 4 °C for 24 hours (Kulkarni et al. 2010). Furthermore, 
the buccal mucosa can also be stored for a more extended time at -20 °C following 
sectioning of the tissue without losing its integrity (Michaud and Foran 2011). 
Regulatory authorities such as The Food and Drug Administration (FDA) Guidance 
2000 have proposed guidelines for the determination of in vivo and in vitro permeability 
of drugs (specifically for the gastrointestinal tract). These guidelines suggest that excised 
human or animal tissue be used and that for the purpose of permeability evaluation viable 
or non-viable tissues would be suitable (van der Bijl and van Eyk 2003). 
When drugs are being evaluated, the amount of drug applied in the donor compartment 
should be (1) an infinite dose (i.e. > 10 mg.cm2), typically used when analysing the 
fundamental permeation behaviour of a test molecule or (2) a finite dose (i.e. 2 - 10 
μg.cm2) typically used to mimic the application of a topical dose (Howes et al. 1996). The 
kinetic permeation or diffusion profile is obtained by sampling the receiver fluid at 
defined time points and quantifying the amount of drug in the receiver fluid using accurate 
and sensitive methods, such as high performance liquid chromatography (HPLC) (Castro 
et al. 2016). 
1.9.3 Mathematical models 
The passive transport of molecules across a biological barrier can be described by 
mathematical models, e.g. zero and first order models. These mathematical modelling can 
be fitted on experimental data to determine physical parameters, such as the drug 
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diffusion coefficient (Dash et al. 2010). The release of molecules in solutions and 
molecular transport across biological barriers can follow different release patterns 
(Brodin et al. 2010). These patterns can be described by the release of drugs at a slow 
zero or first order rate or the release of an initial high amount of drug followed by a slow 
release of zero or first order.  
Generally, the transport of molecules across a biological barrier is a multifactorial 
process, however, a simplified model has been proposed to help understand the transport 
process (Barry, 1983). The main mechanism involved in the transfer of molecules across 
the oral mucosa was described by Fick’s first law in 1855 (Fick 1855, 1995). Fick’s law 
proposes the concept that a solute will move from a region of high concentration to a 
region of low concentration across a concentration gradient and can be described by the 
Equation 1.3.  
L = MCN = O ∆QR     (Equation 1.3) 
Fick’s equation relates the flux (J) in stationary state to an amount of compound (Q) 
that is transported across a barrier with area (A), over a period of time (t) with a constant 
concentration gradient (DC), a diffusion coefficient in the barrier (D) and a path length 
(h). This model assumes that the barrier is a pseudo-homogeneous membrane, which 
characteristics do not change during the compound transfer process. The slow transport 
across the oral mucosa or release of drug (from the mucosa) can be represented by 
different equations: 
1.9.3.1 Zero-order model 
This model describes the slow transport/release of drugs independent of the initial drug 
concentration. In Equation 1.4, Q is the amount of drug transported/released in time (t), 
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Q0 is the initial amount of drug being transported/released and K0 is the zero-order 
transport/release constant expressed in units of concentration time (µg/cm2/h). The 
constant K can be obtained from experimental data by plotting the cumulative amount of 
drug transported/released versus time (cm/h). 
SN = =NT + S'	     (Equation 1.4) 
1.9.3.2 First order model 
This model describes the slow transport/release of drugs and the absorption and/or 
elimination of some drugs (Dash et al. 2010) that is directly proportional to the drug 
concentration embedded in the matrix. In Equation 1.5 and 1.6, C is the amount of drug 
transported/released in time t, C0 is the initial concentration of drug and K is the first-
order transport/release constant expressed in units time (h-1). The constant K can be 
obtained from experimental data by plotting the log cumulative amount of drug 
transported/released vs. time. 
UQUN = −=W or @ABX = @ABX' − YZ[.]']  (Equation 1.5 and 1.6) 
1.9.3.3 Higuchi model 
This model describes drug transport/release as a diffusion process based on the Fick’s 
law and describes the diffusion in terms of the thermodynamic activity of the permeant 
compound (Higuchi 1961). When it is assumed that the concentration of a compound on 
the basolateral side is insignificant compared to the concentration in the matrix or apical 
side (sink conditions), the maximum rate of diffusion per unit time (Jmax) is proportional 
to the thermodynamic activity of the compound and not its concentration (Equation 1.7). 
L^ _` = O !aR     (Equation 1.7) 
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In Equation 1.7, D is the diffusion coefficient of the compound, Ss is the maximum 
solubility of the compound and h is the barrier thickness. According to this equation, the 
flux of a compound from saturated conditions is constant, regardless of the saturated 
concentration in a given vehicle because all saturated solutions have a thermodynamic 
activity of one (Bronaugh and Maibach, 1989). Higuchi’s model assumes that mass 
transfer occurs under sink conditions, the drug diffusivity is constant, drug diffusion takes 
place only in one direction  and the application vehicle does not affect the barrier (Higuchi 
1961). The Higuchi model equation is given by: 
bN = S = c − =Wdefg (2X − iXj)XjT   (Equation 1.8) 
Q is the amount of drug released in time t per unit area A, C is the drug initial 
concentration, Cs is the drug solubility in the matrix media and D is the diffusivity of the 
drug molecules (diffusion coefficient) in the matrix substance, d is the porosity of the 
matrix and t the tortuosity (Tortuosity is defined as the dimensions of radius and 
branching of the pores and canals in the matrix) (Costa and Sousa Lobo 2001). A 
simplification of Higuchi’s model is given by Equation 1.9. In this equation, KH is the 
Higuchi dissolution constant (Higuchi, 1961). The constant K can be obtained from 
experimental data by plotting the cumulative amount of drug released vs. square root of 
time. 
bN = S = =D√T      (Equation 1.9) 
1.9.3.4 Korsmeyer-Peppas model 
This model can be used as a decision parameter between the Higuchi and zero order 
models (Ciurba et al. 2014). Although this model is generally used to analyse the release 
of dosage forms, when the release mechanism is not well known or when more than one 
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type of release take place (Steffansen et al. 2010). This model assumes that the 
transport/release occurs in a one-dimensional way, the calculation of n is based on the 
portion of the release curve where Mt/M∞<0.6 and the system width–thickness or length–
thickness relation be at least 10. The release mechanism is a function of the diffusion 
exponent n, where values of n = 0.5 suggests a Fickian diffusion (elimination rate as a 
function of time t-0.5). Values between 0.5 < n < 1.0 supports an anomalous non-Fickian 
transport (elimination rate as a function of time tn-1). For n = 1.0, the release mechanism 
is represented by a case-II, zero order model (elimination rate is independent of 
time)(Costa and Sousa Lobo 2001).  
lZlm = >Tn (Equation 1.10) 
1.9.3.5 Quantitative Structure Property Relationship (QSPR) models 
The Quantitative Structure Property Relationship (QSPR) models are used to 
determine the release coefficient (kp) using algorithms derived from the molecule’s 
octanol-water partition coefficients and molecular weight (Flynn 1990). The most 
commonly used QSPR model is the one developed by Potts and Guy (1992). This model 
correlates the log permeability coefficient (log kp) with the log partition coefficient of the 
drug in octanol water (logPoct/w) and its molecular weight (MW). 
log rs = −6.3 + 0.71 log yzWN/| − 0.0061}~;  with R2 = 0.67 and n = 93    (Equation 1.11) 
1.10 MECHANISM OF RELEASE OF DRUGS FROM ORAL TISSUE INTO 
ORAL FLUID 
The mechanism of the release of cocaine or other drugs from oral tissues into OF still 
unknown but it could be similar to the mechanism of action of drugs crossing the blood-
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brain barrier (BBB). The similarities are based on the fact that drug molecules need to 
successfully pass across the hydrophobic BBB into the hydrophilic central nervous 
system to exert a pharmacological function (Johnston et al. 2016). In order to detect 
cocaine in OF the molecules need to cross barriers such as the oral mucosa. However, the 
high hydrophobicity of molecules such as cocaine could make the drug be sequestered by 
the lipophilic bed in the oral membranes and not reach the hydrophilic OF. As a result, 
cocaine molecules must somehow partition between the lipophilic (e.g. mucosa) and 
hydrophilic (aqueous OF) medium in order to be released into the OF. 
Studies developed on the transport of molecules such as cocaine across the BBB have 
been developed to understand how small lipophilic molecules cross the BBB (Geldenhuys 
et al. 2012, Johnston et al. 2016). These studies suggested that the transport of molecules 
across biological membranes depend on the structure and the hydration of the molecule. 
The results reported by Johnson et al. (2016) suggested that (1) cocaine can adopt a 
complex ring structure, where the rings would include water molecules, which help confer 
lipophilicity to the cocaine molecule. (2) Cocaine is highly lipophilic even when it is 
protonated. (3) Cocaine is still readily water-soluble in a more closed conformation and 
(4) Cocaine can easily achieve both lipophilicity and hydrophilicity simultaneously 
without having to adopt a different conformation in either physical regime or having to 
go through a protonation-deprotonation reaction to effectively permeate the BBB. Based 
on Johnson’s study, the association of water with the hydrogen bonds in cocaine could 
add diffusion across the BBB and therefore the oral mucosa. 
1.11 RAMAN SPECTROSCOPY 
Raman spectroscopy is a vibrational spectroscopic (inelastic scattering) technique 
being used as novel approach for screening of drugs of abuse in biological matrices such 
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as OF and tissue (Dronova et al. 2016, Wolff et al. 2017). In Raman scattering, the 
molecule retains some of the energy of the scattered photon, which results in nuclear 
movement in the intramolecular atoms. The scattered photon is then released with a 
slightly changed energy, and therefore wavelength. Each chemical bond requires a unique 
energy to vibrate, thus a fingerprint can be built up of the chemicals present in the sample 
by collecting the scattered photons with varying wavelengths. Raman spectroscopy 
provides detailed information on specific constituents (such as drugs) within a complex 
biological matrix, e.g. OF and tissues (Williams and Sebastine 2005, Farquharson et al. 
2011, Dana et al. 2015). 
Raman analysis offers advantages over other analytical techniques such as LC-MS or 
immunohistochemistry: (1) it is a non-invasive, non-destructive technique where (2) 
minimal sample preparation is required. (3) There is no need for toxic chemicals or direct 
exposure to the sample. (4) It has high chemical specificity; therefore, molecular 
information can be obtained without the need of chemical staining or labelling. (6) Raman 
spectra can be collected in few minutes. (7) Raman spectroscopy in combination with 
microscopy is very powerful for imaging biological samples, e.g. individual cells. (8) In 
combination with visible or near-infrared light it reduces the absorption of water, 
therefore analysis of biofluids and tissue can be obtained at near-physiological conditions. 
(9) Raman spectroscopy can take advantage of the advanced optical fibres, miniaturised 
lasers and other photonic devices. For this reason, there are hand-held and portable 
instruments in the market which allow measurements to be taken in real time (Movasaghi 
et al. 2007, Fernandes de Oliveira et al. 2012, Radzol et al. 2012, Sharma et al. 2012, 
Kong et al. 2015). 
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1.11.1 SERS - Surface Enhanced Raman Spectroscopy 
Surface Enhanced Raman Spectroscopy (SERS) has been developed to enhance the 
Raman signal for up to 1013 – 1015 times and overcome the majority of drawbacks of 
conventional Raman spectroscopy such as low sensitivity (Feng 2015). SERS 
enhancement occurs when a molecule is in close proximity to a metal nanoparticle (NP) 
or metallic surface with plasmonic properties (able to form a dipole that produces 
oscillation of free electrons). The enhancement of the Raman signal occurs when two 
theoretical processes take place: (1) An electromagnetic enhancement where an 
interaction between the incoming radiation and the plasmon resonance produce an 
enhancement in the local electric field. (2) A chemical enhancement where a bond is 
formed between the metallic surface and the molecule under examination that increases 
the molecular polarizability, giving an enhancement in the signal (Sharma et al. 2012). 
In SERS analysis, the detection process is identical to normal Raman analysis 
following excitation of the plasmon resonance and generation of the SERS signal. A long-
pass filter is used to absorb or reflect any Rayleigh scattering while allowing for 
transmission of the Raman signal, and a spectrograph and detector are used to image 
Raman spectra across a wide spectral region.  
In the last decade, the development of new substrates (NPs with plasmonic properties) 
has increased. The most common substrates used in SERS analysis are gold (Au) and 
silver (Ag) NPs, which can vary in structure (plasmon resonances and a range of average 
enhancement factors) and SERS activity (Sharma et al. 2012, He et al. 2017). The 
development of NPs with plasmonic properties is very important to obtain reproducible 
and robust results, and a whole area of research (nanotechnology) focuses on the synthesis 
and development of these NPs. Synthesis of NPs can be either chemical or physical: 
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Chemical synthesis takes place by the reduction of metal salts, micro-emulsions, thermal 
decomposition and electrochemical synthesis; whereas physical methods include pulsed 
laser ablation, chemical vapour deposition, microwave irradiation, supercritical fluids and 
gamma radiation amongst others (Herrera et al. 2013). 
Identification of analytes in liquid or solid matrices, including drugs in biological 
matrices have been reported using SERS substrates (Farquharson et al. 2011, Salehi et al. 
2013, Barnett and Rathmell 2015, Dana et al. 2015, Wrona et al. 2015, Yang et al. 2015). 
After complexation with SERS substrate samples containing cocaine were detected in the 
range of 2 ng/mL to 10 µg/mL (Farquharson et al. 2011; Dana et al. 2015; Feng 2015). 
In this case, the substrates used were silver, gold or a mixture of silver and gold NPs 
obtained by precipitation of silver (I) oxide, reduction of silver nitrate to silver ions or 
seed growth of silver and/or gold (Table 1.2). 
Table 1.2 Summary of methods reported for the analysis of cocaine in OF by SERS. 
Drug Method 
LLD 
(ng/mL) 
Volume of 
specimen 
(uL) 
Excitation 
wavelength 
(nm) Reference 
Cocaine/BZE 
SERSa 50 -c 785 Farquharson et al. 2011 
SERSa 125 1000 785 Dana et al. 2015 
SERS 29 50 - Yang et al. 2015 
SERSa 39,000 - - 
(Barnett and Rathmell 
2015) 
COC: Cocaine; BZE: Benzoylecgonine; SERS: Surface Enhanced Raman Spectroscopy. a: Handheld Raman 
spectroscopy; c: Unavailable information; LLD: Low limit of detection. 
1.11.1.1 Silver substrates synthesised via chemical deposition 
This substrate has been used for the analysis of liquid and solid state samples and 
therefore can be used for the analysis of cocaine in OF and tissue samples (Wrona et al. 
2015, 2017). Examples of this are the analysis of butylated hydroxyl-anisole (BHA) in 
edible and essential oils (LOD 5% BHA in oil) (Wrona et al. 2015) and assessment of the 
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oxidation degree of oxo-biodegradable plastics (Wrona et al. 2017). SERS analysis was 
conducted by applying test solution on the surface of the NPs or depositing the NPs 
directly on the surface of the solid sample.  
Silver substrates can be obtained using the Tollens reagent, this reagent uses silver 
and hydroxide ions that react to form a precipitate of silver (I) oxide, which can further 
form the diamine silver (I) ion 2[Ag(NH3)2]+ known as silver mirror. The reaction of this 
silver mirror can be seen clearly from the equations below: 
2cB&(>) + 2H<Ä(>) ⇌ cB[H(Ç) + <[H(@)                                            (Equation 1.12) 
cB[H(Ç) + 4Ñ<](>) + <[H(@) ⇌ 2[cB(Ñ<])[]&(>) + 2H<Ä(>)      (Equation 1.13) 
1.11.1.2 Silver substrates synthesised via hydroxylamine reduction 
Reports have shown that cocaine can be detected in OF at concentrations of 20-50 
ng/mL using silver colloids (silver NPs in solution), which are the most commonly used 
substrates in SERS analysis (Farquharson et al. 2011; Dana et al. 2015). 
There are numerous methods for the synthesis of these substrates, which differ in the 
time of reaction, temperature, reducing agent, aggregating agent and stabilizers. From 
these, the synthesis of silver NPs by the method of hydroxylamine hydrochloride 
reduction (using sodium chloride NaCl as an agglomeration agent) has proven to offer 
NPs with higher SERS activity than other types of synthetic pathways and aggregation 
agents (Feng 2015). This method also offers the advantage of producing silver NPs at 
room temperature and under atmospheric conditions. The hydroxylamine reduction 
method has been proved to generate small mono-dispersive particles with high SERS 
activity and it has previously been used in the analysis of proteins in OF (Feng 2015). 
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1.11.1.3 Bimetallic substrates synthesised via seed growth 
Core-shell bimetallic silver and gold (Ag-Au) particles have been used for SERS 
analysis because of their composition, size and unique optical properties involving 
surface plasmon resonance (Mohammad et al. 2010, Wang et al. 2015). Wang et al. 
(2015) reported the detection of a small molecule Rhodamine B (MW: 479) at 
concentrations as low as 2 ng/mL in food products, using a portable Raman 
spectrophotometer and optimised Au-core/Ag-shell NPs. As the authors stated, the 
optimised Au-core/Ag-shell NPs could be used as a sensitive SERS substrate to detect 
trace species (Wang et al. 2015). Thus, offering the possibility of detecting drugs such as 
cocaine in OF and oral tissue at biological concentrations. 
The synthesis of this substrate involved the use of IP6, which is a non-toxic reagent 
that can chelate with metal ions to form stable NPs. Initially, gold seeds are formed by 
the interaction of inositol hexaphosphate (IP6) with gold ions, then silver ions are added 
to the gold seeds to create a homogeneous cover over the core of the gold seed. The 
mechanism under which the Ag-Au core-shell is obtained has not yet been described 
(Wang et al. 2015). 
1.11.1.4 Magnetic Substrates 
Metallic NPs can be obtained by diverse number of methods, such as those described 
above, where particle size and electric properties can be controlled. Aggregation of these 
NPs is essential to produce hot-spots and therefore gain SERS activity. Most methods use 
aggregation agents (chemical methods) to control the aggregation of the NPS. 
Nonetheless, there are reports on the synthesis of paramagnetic metallic NPs where 
aggregation can be controlled by the use of a magnet (Yang et al. 2015). 
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Applications of this magnetic NPs as SERS substrate include the analysis of trace 
pesticide residues at femtomolar levels using portable Raman spectrometry and the 
detection of drugs (cotinine and benzoylecgonine) from saliva and fingerprints at LOD 
of 18 ng/mL for cotinine and 29 ng/mL for BZE (Yang et al. 2014, 2015). The detection 
of low concentrations of analytes using magnetic NPs suggested that this NPs could be 
used for the detection of cocaine from OF and tongue tissue. 
The synthesis of these magnetic NPs was described by Yang et al. (2014; 2015) and 
is shown in Figure 1.10. Initially, the iron (III) oxide (Fe3O4) network is prepared by co-
precipitating the oxide with the help of IP6; then the gold NPs are prepared by the 
reduction of chloroauric acid (HAuCl4) with sodium citrate. The resulting structure of the 
substrate is attributed to the presence of the IP6 and its role of binding and capturing the 
two different NPs. 
 
Figure 1.10 Diagram of the fabrication process of S1, from Yang et al. (2014, p.1327). Ó 
Wiley-VCH Verlag GmbH & Co. KGaA. 
1.11.1.5 Paper based SERS substrates 
Paper based SERS substrates have been prepared by different methods, including 
thermal inkjet printer and dripping (Fierro-Mercado et al. 2012, He et al. 2017). These 
methods involved the synthesis of gold NPs via chemical reduction (Lee and Meisel 
1982). These substrates have the advantage of flexibility, conformability, efficient uptake 
and absorption of liquid media on the surface of the substrate (Nguyen et al. 2016, 
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Mosier-Boss 2017). This type of inkjet printing substrates do not need to be prepared in 
bulk and can be stored for a prolonged period of time (Yu and White 2013). Paper based 
SERS substrates (inject method) have also been described as substrates that can be 
obtained in almost any environment with easy fabrication procedures which reduce the 
cost of the substrate. The advantages that this substrate offers makes it a good candidate 
for its use in drug testing as the cost of analysis could be reduced significantly compared 
with other SERS substrates. 
Applications of paper-based SERS substrates include the detection of methotrexate 
(MTX) in human serum and buffered solution of bovine serum albumin (BSA-PBS) at 
therapeutic levels (of 1.0 × 10−7 M to 3.0 × 10−4 M). The results of these studies showed 
good linearity when using BSA-PBS (R2= 0.95± 0.02) and poor linearity when analysing 
human serum (R2 = 0.57 ± 0.08) (Fornasaro et al. 2016, Jaworska et al. 2016). Similarly, 
heroine was successfully detected using paper substrates from solutions of IR780 dye 
(solution in acetonitrile). The results of this study revealed LOD of 25 ng of heroin on 
0.5 µg of IR780 (Yu and White 2013). The LOD reported on these applications suggested 
that the analysis of cocaine in SOF could be achieved using this type of substrates. 
1.11.1.6 Silica-based SERS substrate 
Most of the methods that have been described for the preparation of silica-based SERS 
substrates involve the depositions of NPs by different techniques: (1) Nanolithography, 
(2) metal film over nanostructures fabrications, (3) sputtering and (4) Laser ablation (Han
et al. 2009, Fierro-Mercado et al. 2012, Nguyen et al. 2016). Silica-based substrates offer 
advantages such as chemical stability, excellent adherence, high enhancement factors, 
signal homogeneity, ruggedness, simplicity in preparation and uniform nanostructures 
that are highly reproducible (Nguyen et al. 2016, Mosier-Boss 2017). Immobilization of 
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silver or gold NPs on the surface of the silica particles results in controlled aggregation 
of the NPs which produces large enhancements in the Raman signal of adsorbed 
molecules. However, the time consumed in the fabrication of this kind of substrates is 
long and skilled procedures are required, making this substrate not cost effective. 
Applications on the use of silica-based substrates have been reported for the detection 
and quantitation of anticancer drugs (sunitinib, paclitaxel, irinotecan and a metabolite of 
irinotecan SN-38) and cocaine at therapeutic concentrations. Detection of cocaine in 
distilled water was obtained at LOD of 50 ng/mL. The three drugs (Sunitinib, irinotecan 
and SN-38) were detected at LOD of 18-26, 60-70 and 20-50 ng/mL respectively. 
Linearity was evaluated at a range of 102-103 ng/mL paclitaxel (a metabolite of 
irinotecan), and doxorubicin. Other applications have reported the detection of anthracene 
and pyrene at LODs of 1.4 and 8 ng/mL, respectively (Mosier-Boss 2017). Melamine 
(adulterant added to food products to increase their apparent protein content) was detected 
at LOD of 1 ng/mL (Wang et al. 2014). Similarly to paper base, the silica base substrates 
suggested that the analysis of cocaine in SOF and tissue could be achieved using this type 
of substrates. 
1.11.2 Raman Instrumentation 
The characteristics of the Raman instrumentation plays an important role in the 
sensitivity of the method (Kiselev et al. 2016). During Raman and SERS analysis the 
sample is exposed to an excitation source, this source should be able to efficiently excite 
the molecule of study and the metallic NPs of the substrate. It has been theoretically 
reported that a maximum enhancement occurs when the laser is tuned to the peak of the 
plasmon resonance of the substrate (Sharma et al. 2012, Schlücker 2014). However, 
experimentally it has been shown that maximum enhancement factors are found when the 
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laser wavelength is shifted to lower wavelengths (blue wavelength of the plasmon 
resonance) on both the excitation and emission parts of the Raman process. The maximum 
signal is therefore found when the plasmon frequency is tuned to be slightly red-shifted 
from the laser wavelength (Sharma et al. 2012). 
Lasers are the excitation source in Raman instrumentation (Koljenović et al. 2007). 
Lasers beams are highly monochromatic, usually with a small diameter that can be further 
reduced by using lens systems to focus on small samples (~1 mm3). In the case of Raman 
microscopy the diameter of the beam can be as small as 2 μm (Turrell and Corset 1996). 
The power of the laser can be controlled by the use of different type of laser such as gas 
lasers (Argon Ar+, Krypton Kr+, Helium-Neon He-Ne) or solid-state lasers such as 
Neodymium –YAG (1064 nm). Diode lasers can be obtained at a specific wavelength in 
the blue or the infrared regions (Turrell and Corset 1996, Thomson 2002, Gnyba et al. 
2011, Trapping and Sorting 2015). 
In the current Raman spectrometers, the detection of the Raman signal is conducted 
by Charge Coupled Devices (CCDs) (Ali and Edwards 2010). The development of 
compact, low-power laser sources, optical components have resulted in the manufacture 
of handheld and portable Raman spectrometers that are now available from several 
manufacturers. This new developments allow the measurement of sample in field (in-situ) 
for real-time chemical detection (Manoharan et al. 1996). Furthermore, stand-off 
detection by SERS can be possible with Raman microscopes and optical fibre probes. 
  
Chapter 1 – General Introduction 
 46 
1.12 THESIS RATIONALE 
The initial concept of drug transport or release into OF was based on a philosophy that 
drugs present in the blood could pass through the cell membranes of the salivary glands 
across a concentration gradient, the extent of which would be determined by the drug’s 
lipid solubility and pKa value. Whilst this theory holds for many medicinal drugs orally 
administered, some authors have demonstrated that for cocaine, which is commonly 
consumed via nasal insufflation or smoking, the S/P ratios are higher than 1.0 and 
detection times are significantly longer than would be expected using pharmacokinetic 
models (Osselton et al. 2001, Huestis and Cone 2004). This lead to the proposition that 
cocaine could form depots in the mouth tissues following exposure and could 
subsequently be released from the tissue over time, thus increasing the concentration of 
cocaine in OF and its time of detection. 
This research investigated cocaine absorption and excretion from oral/buccal tissues 
by the use of a modified human kinetic study (in vivo study) and in vitro release studies 
to evaluate the impact of drug depots in the concentration of drugs in OF. Previous in vivo 
studies demonstrated that following ingestion of coca tea, cocaine and BZE were detected 
in OF at concentration above the cut-off level (8 ng/mL) (EWDTS 2015) for up to one 
hour (Reichardt 2014). However, release profiles and windows of detection were not 
evaluated in the study. Reichardt’s study also revealed a number of unexplained artefacts 
relating to the random detection of cocaine derivatives (AEME, EME, NC and CE) in OF 
collected after the consumption of coca tea. The analysis of OF samples containing 
cocaine and cocaine derivatives collected over a prolonged period of time (four hours) 
following ingestion or swirling of a cup of coca tea could allow the determination of 
detection windows as well as release profiles using an in vivo safe model. Additionally, 
it could help to understand the unexpected artefacts reported by Reichardt (2014) and 
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confirm the presence of other cocaine derivatives in OF following the consumption of 
coca tea. Furthermore, any differences in the release of cocaine/cocaine derivatives 
(cocaine metabolites and related products such as AEME) from ingestion of coca tea and 
exposure of the tea to the oral cavity could help evaluate the impact of the contamination 
of the oral cavity and the release of drugs from drug depots in OF drug testing. 
The use of coca tea in in vivo studies allowed the evaluation of the release of cocaine 
and cocaine derivatives into OF safely and with reduced ethical considerations. Coca tea 
contains small quantities of cocaine derivatives such that at high altitude it eases breathing 
and reduces the symptoms of altitude sickness. Coca tea does not produce any form of 
“high” or intoxication and is significantly less likely to affect an individual than the social 
use of alcohol (Jenkins et al. 1996). 
In order to confirm the results of the in vivo study and evaluate the kinetics of release 
of cocaine and cocaine derivatives a modified in vitro model using Franz diffusion cells 
was used. This was achieved by measuring the release of cocaine and AEME into 
synthetic oral fluid (SOF) across porcine buccal mucosa. By mimicking the in vivo 
process, where drugs such as cocaine are initially absorbed into the oral mucosa following 
oral exposure (dose) and then released into OF, it is possible to monitor the release profile 
as well as the permeability of the buccal mucosa. The use of in vitro permeability or 
diffusion studies has been widely used to determine the barrier nature as well as 
evaluating the kinetics of the tissue and/or the drug in use (Nicolazzo and Finnin 2008). 
In vitro models are commonly used instead of in vivo models because of the reduced cost 
and because they offer comparative diffusion results (Nicolazzo and Finnin 2008, Castro 
et al. 2016). 
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The evaluation of the kinetics of cocaine and cocaine derivatives in oral tissue using 
the modified in vitro model could contribute to the understanding of the transport of 
cocaine from drug depots formed in oral tissues into OF. Furthermore, it could contribute 
to the kinetics of cocaine across oral mucosa as only few authors have reported the 
accumulation and permeability of cocaine into tissues with non-keratinised epithelia such 
as nasal or epithelial cell models (Bhat et al. 2001, Zhang et al. 2012, Clemons et al. 
2014). Zhang et al. (2012) reported that the transport across nasal mucosa (ranged 0.2-
1.0 µg/min/cm2) was similar to the olfactory mucosa (range 0.2-0.9 µg/min/cm2) for 
concentrations ranging 1-5 mM and that permeability across these tissues was dose-
dependent.  
Since the high percentage of tissue in the oral cavity is composed of lining mucosa and 
drugs are more permeable through the non-keratinised epithelium, it was evident that 
buccal (cheek) mucosa should be used for the development of in vitro diffusion studies. 
However, confirmation of the presence of drug depots has only been reported on porcine 
tongue tissue (Reichardt 2014). Because of the physiology of the dorsum of the tongue, 
i.e. keratinised epithelium and decreased permeability compared with the lining mucosa, 
it can be assumed that formation of drug depots is limited in the dorsum of the tongue 
than in the lining mucosa. From the lining mucosa, the buccal mucosa offers a relatively 
immobile surface for ensuring controlled release systems (Madhav et al. 2009) and drug 
depots could be more likely to be formed in this tissue. While the sublingual tissue (part 
of the lining mucosa) has non-keratinised epithelium and its high permeability allows 
rapid transport of drugs into the systemic circulation, its high blood flow, constant saliva 
washing and tongue activity, could make difficult for drugs to reside in this tissue. In 
these studies, SOF was used instead of neat (authentic) OF because of the large volumes 
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of neat OF required. In research, SOF is commonly used to overcome limitations of the 
low volume of neat OF required in in vitro studies (Anizan et al. 2015). 
In order to monitor the release of cocaine from oral tissues into SOF in real time, 
Raman spectroscopy was evaluated. Raman spectroscopy and more specifically SERS, 
could offer the possibility of detecting drugs in both OF and tissue in a shorter period of 
time with minimal to no sample pre-treatment and at concentrations below accepted cut-
off levels (cocaine cut-off 8 ng/mL in OF) (EWDTS 2015). Although this technique has 
been used in therapeutic drug monitoring, its implementation in OF drug testing is still 
novel. Studies on the application of Raman spectroscopy could contribute to its 
importance as an alternative technique for OF drug testing, as its use could significantly 
reduce the cost and time of analysis. Detection and quantification of drugs in OF and 
tissue are commonly conducted by conventional techniques such as LC-MS. However, 
these techniques are time-consuming and monitoring of the release of drugs from oral 
tissue into OF cannot be achieved in real time. 
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1.13 AIM AND OBJECTIVES 
1.13.1 AIMS 
This research aimed to enhance our knowledge on the absorption and subsequent 
release of drugs from oral drug depots into oral fluid and to contribute to the interpretation 
of drug concentration in oral fluid. It also aimed to evaluate alternative techniques for the 
detection of drugs in oral fluid and oral tissues.  
The study proposed to test the following hypotheses: 
1. Raman spectroscopy could be implemented in the detection and quantification 
of cocaine in OF and oral tissue and allow the monitoring of the release of drugs 
from drug depots in oral tissue into oral fluid in real time. 
2. Oral exposure to coca tea could aid in the understanding of oral contamination 
and elimination of cocaine and its metabolites from formed oral drug depots into 
oral fluid, on an ethically in vivo safe model. 
3. In vitro diffusion studies could be used to determine the kinetics of release of 
drugs from drug depots in oral tissues. 
1.13.2 OBJECTIVES 
The proposed objectives of this research are related to the measurement and 
understanding of the phenomenon of the release of drugs from drug depots in oral tissues 
and their effect on the analysis of drugs from oral fluid.  
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1. To evaluate the use of Surface Enhancement Raman Spectroscopy (SERS) in
the detection and quantification of cocaine in synthetic oral fluid and porcine
oral tissue using homemade substrates.
2. To assess the use of portable Raman spectroscopy and Raman microscopy for
the detection and quantification of cocaine in synthetic oral fluid and porcine
oral tissue.
3. To develop and validate LC-MS quantitative methods for the analysis of cocaine
and derivatives in oral fluid, synthetic oral fluid and porcine oral tissue.
4. To evaluate the stability of cocaine and derivatives in buffered oral fluid,
synthetic oral fluid and porcine oral tissue under different storage conditions.
5. To investigate the elimination profile and time of detection window of cocaine
and its metabolites in collected oral fluid samples following ingestion or swirling
of a cup of coca tea.
6. To identify the factors involved in the release of drugs (cocaine and
anhydroecgonine methyl ester) from oral tissues using and in vitro model that
could measure the release of drugs from drug depots into oral fluid.
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2.1 INTRODUCTION 
Detection and quantification of drugs in oral fluid (OF) and tissues are commonly 
conducted by analytical techniques such as gas/liquid chromatography couplet to mass 
spectrometry (GC-MS or LC-MS). These techniques, however, are time-consuming as 
sample preparation procedures are generally required to increase the sensitivity and 
robustness of the GC/LC-MS method. In comparison, Raman spectroscopy offers the 
possibility to detect drugs in both OF and tissue in a shorter period of time (few minutes) 
with minimal to no sample pre-treatment (Section 1.11). Furthermore, Surface Enhanced 
Raman Spectroscopy (SERS) may have a potential to allow the detection of drugs such 
as cocaine at physiological concentrations.  
In human OF samples, cocaine can be detected at concentrations as high as 3 μg/mL 
following smoke of crack-cocaine (Kato et al. 1993; Cone 2012) and up to 9 μg/mL 
following immediate drinking of a cup of coca tea (Reichardt 2014). In in vitro studies 
cocaine was detected in synthetic oral fluid (SOF) at concentrations of 0.42-1.3 μg/mL 
and at 0.08-0.87 μg/mL in tissue homogenates following exposure to the smoke of 200 
mg crack-cocaine (Reichardt 2014). Although cocaine can be detected at concentrations 
of up to 9 μg/mL in human OF samples and up to 1.3 μg/mL in SOF from in vitro studies, 
any OF samples at concentration above 8 ng/mL would also give a positive result 
(EWDTS 2015). 
After complexation with SERS substrate, drugs were detected in biological and non-
biological samples at concentrations in the range of 2 ng/mL to 10 µg/mL (Farquharson 
et al. 2011; Dana et al. 2015; Feng 2015). Which implies that cocaine could be detected 
in OF at concentrations below the cut off concentration of 8 ng/mL. The substrates used 
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in the studies that allowed the detection of drugs at concentrations below the cut-off 
concentration for cocaine were silver, gold or a mixture of silver and gold nanoparticles 
(NPs) obtained by the following procedures: the formation of diamine silver ions, 
reduction of silver nitrate to silver ions or seed growth of silver and/or gold NPs. 
Furthermore, the substrates used were applied on liquid and solid samples and therefore 
had the potential to be used for the analysis of drugs in SOF and porcine tongue tissue 
samples. 
Wrona et al. reported that diamine silver ions formed via Tollens reagent (Equation 
1.13) were used in the analysis of analytes in liquid and solid state such as edible oils 
(2015) and plastics (2017). Similarly, silver NPs synthesised by the method of 
hydroxylamine hydrochloride reduction (Feng 2015) produce a liquid substrate that could 
be applied on SOF and tissue samples. This synthesis has proven to generate small mono-
dispersive NPs that can be used to detect cocaine in OF at concentrations of 20-50 ng/mL 
(Farquharson et al. 2011; Dana et al. 2015). Core-shell bimetallic silver and gold (Ag-
Au) particles and magnetic NPs could also be used to enhance the Raman signal for the 
detection of cocaine in OF and tissue. Limits of detection (LOD) of 2 ng/mL for 
Rhodamine B (MW: 479) in food products were reported using the Ag-Au particles and 
a portable Raman spectrophotometer (Wang et al. 2015). Magnetic NPs were used for the 
analysis of cotinine and benzoylecgonine from saliva and fingerprints at LOD of 18 
ng/mL for cotinine and 29 ng/mL for benzoylecgonine (BZE) (Yang et al. 2014, 2015). 
In this chapter, Raman spectroscopy and more specifically SERS was evaluated as an 
alternative technique to LC-MS for the analysis of cocaine in SOF and porcine tongue 
tissue. Raman analysis could confirm the formation of drug depots in porcine tongue 
tissue and furthermore could speed the process of the monitoring of the release of drugs 
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from drug depots into OF. In order to evaluate the SERS technique four different 
substrates with different morphologies were synthesised and characterised. Substrate 
characterisation was essential to determine the activity of the substrates. Although in this 
work there was no intent to develop the plasmonic properties of the SERS substrates, this 
study faced the challenge of producing sensitive SERS substrates that could be applied to 
both liquid and solid biological samples for the detection of cocaine at physiological 
concentrations.  
2.1.1 AIM AND OBJECTIVES 
2.1.1.1 Aim: 
The aim of this chapter was to evaluate the use of Raman spectroscopy in the detection 
and quantification of cocaine in OF and oral tissue using substrates synthesised in the 
laboratory, i.e. homemade substrates. 
2.1.1.2 Objectives: 
• Synthesise SERS substrates that can enhance the Raman signal of cocaine for the 
detection of cocaine in synthetic oral fluid and porcine tongue tissue.  
• Characterise the synthesised substrates in order to determine their SERS 
properties. 
• Evaluate the synthesised substrates for the detection and quantification of cocaine 
in synthetic oral fluid and porcine tongue tissue using handheld Raman 
spectroscopy.  
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2.2 METHODS 
2.2.1 Materials 
Crack cocaine was provided by TICTAC Communications, St Georges Medical 
School, University of London. 
Porcine tongues were purchased from The Village Butcher, Kingsclere. Porcine 
tongue tissue was used due to its physiological and anatomical similarities to human 
tongue tissue (Simon and Maibach 2000). 
Ascorbic acid (C6H8O6), ammonia solution (35%), clearene, chloroauric acid 
trihydrate (HAuCl4·3H2O), cocaine hydrochloride, ethanol analytical grade, 
hydroxylamine hydrochloride (HONH2·HCl), inositol hexaphosphate (IP6), iron (II) 
chloride (FeCl2), iron (III) chloride (FeCl3), silver nitrate (AgNO3), sodium chloride 
(NaCl), sodium hydroxide (NaOH), sodium-potassium tartrate tetrahydrate 
(KNaC4H4O6·4H2O), tri-sodium citrate (Na3C8H2O7), were purchased from Sigma 
Aldrich (Dorset, UK). Clearene solvent was purchased from Leica Biosystems (Munich, 
Germany). 
2.2.2 Instrumentation 
Ultraviolet-visible (UV-Vis) measurements were performed using a Varian Cary 50 
Probe UV-Vis spectrophotometer with a xenon flash lamp and dual silicon diode detector. 
The instrument was run with the Scan application of CaryWinUV software and set up to 
measure absorbance in dual beam mode, with a range of 200 - 800 nm. The analysis was 
conducted by the researcher at Bournemouth University. 
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Scanning Electron Microscopy (SEM) images were obtained using a JEOL scanning 
electron microscope; model JSM-6010 Plus/LV with InTouchScope software. Gold 
coating was obtained using a Quorum Q150R ES Sputter Coater. The analysis was 
conducted by the researcher at Bournemouth University. 
Transmission Electron Microscopy (TEM) images were obtained using a JEOL 
transmission electron microscope; model JEM 1400Plus. Images were recorded and 
processed using a Gatan Orius camera and Gatan Microscopy Suite Digital Micrograph 
Software version 2.11.1404.0. The analysis was conducted by the researcher in 
collaboration with Hospital Fundación Santa Fe de Bogotá (Bogotá – Colombia). 
Sectioning of tissue at thickness 2-5 mm was conducted using a Brunel bench 
microtome and a section razor (Brunel microscopes Ltd., Chippenham – UK). Thickness 
of 0.02 mm were obtained using a Brunel YD rotary microtome (Brunel microscopes 
Ltd., Chippenham – UK) at an angle of 35°. 
Raman measurements were performed using the Rigaku First Guard handheld Raman 
spectrometer equipped with 532 nm laser power, 60 mW laser output power and charge 
coupled device (CCD) detector. Raman spectra were collected over the wavenumber 
range of 250-3000 cm-1 and spectral resolution of 10 cm-1. Each spectrum was the sum of 
three scans, such that each scan was exposed for 14 seconds. The analysis was conducted 
by the researcher at Bournemouth University. 
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2.2.3 Synthesis of SERS substrates 
In order to develop the SERS analysis, four different substrates were synthesised for 
their use in the detection of cocaine in SOF and tongue tissue. Substrates consisted of 
silver and/or gold colloids (Table 2.1). The substrates were not commercially available. 
Table 2.1 Details of gold and silver substrates. 
Substrate Substrate Name Substrate base Synthesis Method Reference 
S1 Deposition Silver CD (Wrona et al. 2015) 
S2 Reduction Silver CR (Feng 2015) 
S3 Silver-Gold Silver and gold CR (Wang et al. 2015) 
S4 Magnetic Silver CR (Yang et al. 2015) 
CD: Chemical deposition, CR: Chemical reduction, S1: Substrate 1, S2: Substrate 2, S3: Substrate 3hemical 
deposition, S4: Substrate 4. 
2.2.3.1 Synthesis of Substrate 1 
Substrate 1 (S1) was made based on the methodology described by Wrona et al. 
(2015). The synthesis involved the chemical reduction of an aqueous solution of silver 
nitrate using a reducing agent of sodium-potassium tartrate in alkaline conditions (pH 12). 
S1 was generated by deposition of silver nanoparticles (NPs) on a glass surface after 
mixing Solutions 1 and 2 (see below) in a 1:1 ratio. The silver NPs were deposited on 
cover glasses (Borosilicate glass, 22x40 mm) that were previously washed with ethanol 
and dried under a stream of nitrogen. 
Solution 1: Ammonia solution (35%) was added drop by drop to a 14 mL silver nitrate 
solution (62 mg/mL), the initial addition of ammonia solution produced a chocolate-
coloured precipitate that then disappeared. An extra 1 mL of silver nitrate solution was 
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added to obtain a turbid solution. The final solution was diluted to a final volume of 100 
mL with ultrapure water and stored in an amber glass bottle to be protected from light. 
Solution 2: Potassium sodium tartrate (0.19 g) was added to 100 mL of boiling 
ultrapure water. Then 20 mL of aqueous silver nitrate (110 mg/mL) was slowly added 
with vigorous stirring using a magnetic stirrer. The solution was left to boil for 10 min 
and then allowed to cool on standing at room temperature. The solution obtained was 
filtered with a Millex-HA Millipore filter (membrane diameter: 33 mm, pore size: 0.45 
μm) and kept protected from light. 
2.2.3.2 Synthesis of Substrate 2 
Substrate 2 (S2) was prepared based on the method described by Feng et al. (2015). 
The silver NPs were obtained by the reduction of silver nitrate by hydroxylamine 
hydrochloride. Initially, 9 mL of 0.1M sodium hydroxide was added to 10 mL of 0.06M 
hydroxylamine hydrochloride to adjust the hydroxylamine solution at pH of 12. This 
solution was then rapidly added to a 180 mL of 0.1mM silver nitrate. The appearance of 
the resulting solution was milky-grey. The final solution was stored in an amber glass 
bottle. 
Before SERS analysis, the colloidal solution (200 mL) was centrifuged for 30 min at 
10,000 rpm and 140 mL of the supernatant was eliminated to concentrate the substrate. 
Aqueous 0.4M sodium chloride (1.2 mL) was added to the substrate (final concentration 
of 8mM) to aggregate the NPs. 
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2.2.3.3 Synthesis of Substrate 3 
Substrate 3 (S3) was prepared based on the method described by Wang et al. (2015). 
To obtain the core-shell NPs (S3), an initial 5 mL of 0.001M IP6 was added to 100 mL of 
0.025mM chloroauric acid and then heated to boiling using a hot plate. Then 1 mL of 
0.04M tri-sodium citrate was added at a rate of 0.1 mL/min while stirring vigorously using 
a magnetic stirrer to obtain a solution of iron oxide (Fe3O4) NPs. A mixture of 80 mL of 
1.3mM silver nitrate solution and 1 mL of the previously prepared Fe3O4 solution were 
then mixed while stirring at room temperature. Then 5 mL of 0.1M acetic acid was added 
drop wise while stirring. The substrate was obtained after 10 min.  
2.2.3.4 Synthesis of Substrate 4 
The magnetic Substrate 4 (S4) was prepared based on the method described by Yang 
et al. (2014). The fabrication procedure of S4 involved two steps, which included the 
preparation of the iron (III) oxide (Fe3O4) network and the preparation of gold NPs by the 
reduction of chloroauric acid (HAuCl4) with sodium citrate. S4 was synthesised at 
atmospheric pressure. 
Preparation of the Fe3O4 network: Solution 1 was obtained by adding 5 mL of 
0.001M IP6 to 150 mL of ultrapure water. This solution was heated to boiling with 
vigorous stirring using a hot plate and a magnetic stirrer. Solution 2 was obtained by 
mixing 0.318 g of iron (III) chloride and 0.130 g of iron (II) chloride in ultrapure water. 
5 mL of Solution 2 was added to the boiling Solution 1 to obtain Solution 3 and then 
allowed to stir for one hour. After 1 hour of stirring, 1.2 mL of 0.4 M sodium hydroxide 
was added drop by drop into Solution 3 to obtain Solution 4. After 30 minutes of stirring 
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5 mL of 0.001M IP6 was added to Solution 4 and the final solution was stirred for another 
30 minutes. The final solution contained black-brown magnetic NPs (Fe3O4 network) that 
were collected using a magnet. The Fe3O4 network was rinsed with ultrapure water seven 
times to remove the excess of reagents. 
Addition of gold NPs to the Fe3O4 network: The magnetic Fe3O4 network was 
dispersed in 150 mL of ultrapure water and then heated to boiling with strong stirring. 
Then 5 mL of chloroauric acid 0.03 M was added and the solution was refluxed for 15 
minutes. After 15 minutes of refluxing, 10 mL of sodium citrate 0.04 M was added rapidly 
into the boiling solution and refluxed for 45 minutes. The colour of the mixture changed 
from black-brown to reddish brown. The reaction mixture was allowed to cool on 
standing at room temperature and the resulting NPs (S4) were collected by a magnet and 
washed seven times with ultrapure water. 
2.2.4 Substrate Characterisation 
Characterisation of NPs with SERS properties can be achieved by measuring the 
resonance absorbance of the plasmoid in the visible region of the absorption spectra, 
which is obtained by UV-Vis spectrometry (Cañamares et al. 2005). Characterisation by 
this technique was only conducted for S2, S3 and S4. S1 could not be characterised by 
UV-Vis because of its solid state. Additionally, the morphology of the NPs was obtained 
by electron microscopy (Table 2.2) using SEM and TEM techniques, which are the most 
common techniques used for the measurement of particle size and plasmon identification  
(Desai et al. 2012, Williams 2015). 
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Table 2.2 Substrates characterisation methods. 
Substrate Name of substrate 
Characterisation 
technique  
S1 Deposition SEM 
S2 Reduction UV-Vis, TEM 
S3 Silver-Gold UV-Vis, TEM 
S4 Magnetic UV-Vis, TEM 
S1: Substrate 1, S2: Substrate 2, S3: Substrate 3, S4: Substrate 4, SEM: Scanning electron microscopy, TEM: 
Transmission electron microscopy, UV-Vis: Ultraviolet-Visible. 
2.2.4.1 UV-Vis spectroscopy 
UV-Vis spectra of S3, S3 and S4 were obtained by diluting 300 μL of the substrate in 
ultrapure water to a final volume of 1 mL. Samples were measured using disposable semi-
micro 1.5 mL polymethyl methacrylate (PMMA) Cuvettes at room temperature. Spectra 
of S1 could not be obtained because of its solid state. UV-Vis spectra were collected on 
day 0, 3, 7 and 19 in order to monitor the particle size of NPs. An increase in particle size 
was an indication of poor stability (Larmour et al. 2012). 
2.2.4.2 Scanning Electron Microscopy (SEM) 
S1 was initially gold coated to a final thickness of 5nm. SEM images were then 
obtained with a JEOL scanning electron microscope at 20 kV using the option of 
Secondary Electron in high vacuum mode. Particle size measurements and count were 
acquired using ImageJ software version d 1.47. 
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2.2.4.3 Transmission Electron Microscopy (TEM) 
S2, S3 and S4 were initially washed seven times with ultra-pure water to clean the 
NPs and eliminate any excess of reagents left from the synthesis. The NPs were re-
suspended in water and subsequently deposited on cupper grids of 400 mesh (Agar 
Scientific) using a capillary. Samples were protected from light at all times.  
TEM images were obtained at different magnifications (range 20,000x – 30,000x) 
using a JEOL transmission electron microscope. Particle size measurements and count 
were acquired using ImageJ software version d 1.47. 
2.2.5 Synthetic Oral fluid preparation 
SOF was prepared using the Cozart Biosciences protocol (2008) “Production of 
Synthetic Saliva” (Appendix A). 
2.2.6 Exposure of porcine tongue to crack-cocaine 
Exposure of tongue tissue was conducted following the procedure described by 
Reichardt (2014). The porcine tongue was suspended in a smoking chamber and exposed 
to the smoke generated by burning 200 mg crack cocaine (Figure 2.1). The smoking 
chamber was connected to a vacuum pump that created an airflow of 0.5 m/s. The latter 
conditions were made in order to achieve sufficient suction to mimic normal smoking 
conditions. The crack cocaine was heated using a Bunsen burner and exposure to cocaine 
continued until smoking ceased. After exposure to cocaine smoke, the tongues were 
washed seven times with SOF to remove any excess of cocaine from the surface of the 
tongue. 
Chapter 2 - Evaluation of homemade SERS substrates and handheld Raman spectroscopy for the 
analysis of cocaine in synthetic oral fluid and porcine oral tissue 
65 
Figure 2.1 Exposure of tongue tissue to 200 mg crack cocaine. 
2.2.7 Oral fluid sample preparation 
Samples of SOF with and without cocaine (control SOF) were prepared by serial 
dilutions from a stock solution (10 mg/mL cocaine hydrochloride in ethanol). The final 
concentrations of cocaine in the SOF samples were 0.1, 0.2, 0.4, 0.6, 0.8 and 1 mg/mL. 
2.2.8 Tissue sample preparation 
Cross sections of control tissue and tissue containing cocaine were cut from 1.5 cm 
above the tip of the tongue. Tissue sections at 5, 2 and 0.02 mm were obtained by two 
different cutting methods (bench microtome and rotary microtome cutting respectively) 
to determine the best working thickness of the sample. 
2.2.8.1  Bench Microtome cutting 
Initially, control and exposed tongue tissue were frozen at -20 °C. A total of 12 samples 
were subsequently cut from frozen using a Brunel bench microtome and a sectioning razor 
at thickness of 5 and 2 mm. 
Porcine tongue 
Tongue suspended at 5 cm from 
200 mg crack cocaine 
Bunsen burner 
Chamber under vacuum 
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2.2.8.2 Rotary Microtome cutting 
Tissue samples with dimensions of 50 x 50 x 50 mm were fixed in 10% formalin 
solution for 48 hours and embedded into paraffin wax prior to sectioning. Tissue sections 
were cut using a Brunel rotary microtome. Tissue sections were floated into a 30°C water 
bath in order to reduce shrinking and creasing of the tissue. Floated tissues were picked 
up using microscope slides. The slides were then heated at 37 °C for 48 hours. Finally, 
tissues were de-waxed using clearene solvent and rehydrated using five solutions with 
decreasing amounts of alcohol in water (70, 50, 30, 10 and 0 % v/v). 
2.2.9 Analysis of Oral Fluid Samples - Acquisition of Raman spectra 
Samples of control SOF and SOF containing cocaine were analysed using the Rigaku 
532 nm handheld Raman instrument with and without the addition of SERS substrates. 
Raman spectra were obtained by directly exposing the samples to the laser beam. 
SERS spectra were obtained by measuring the scattering of the samples mixed with 
substrate. Six replicates were collected for each experiment. The optimal number of 
replicates was calculated based on the intraclass coefficient (ICC) (Saha et al. 2012) of a 
preliminary data set from 23 samples at three concentrations (200, 500 and 1000 mg/mL 
cocaine in SOF). The ICC was calculated based on the Equation 2.1. The ICC was >0.90 
for all concentrations for 3 and 6 replicates with ICC ranging 0.93 to 0.98. Comparison 
between the spectra obtained with the matrix (SOF and porcine tissue) and matrix 
containing cocaine was used to evaluate the presence of cocaine. Cocaine was confirmed 
by the presence of the peak at 1000 cm-1 in all samples. 
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!""	$%	&'()	$%	'm'	replicates	=	 678977:	;<=><:?7(678977:	;<=><:?7ABCDECF	GHICHFJKL ) (Equation 2.1) 
The between variance is the inherent sample heterogeneity or variability (pooled across the 
three concentrations) and within variance is the within-sample variability. When ICC is close to 
1, the reliability increases and when ICC = 1 there is no sample variability. 
2.2.9.1 Method Optimisation 
The following parameters were evaluated: (1) Concentration of sample required to 
obtain Raman signal. (2) Optimal amount of sample mixed with the substrate. (3) Optimal 
time of interaction between the substrate and the samples, i.e. sample/substrate ratio. (4) 
Concentration range including limit of detection (LOD) of cocaine in SOF and linearity. 
(5) Accuracy and precision, and (6) matrix effect. Some of the parameters evaluated
(accuracy, precision, linearity and range) are part of the criteria recommended for the 
validation of quantitative Raman methods described by the United States Pharmacopeia 
(USP 2011). The other parameters (sample to substrate ratio and time of interaction) were 
evaluated based on different times/ratios observed in the literature. Because of low 
sensitivity obtained with some of the substrates (S1 and S4), some of the parameters could 
not been evaluated. 
The sample to substrate ratio was evaluated on six sets of samples at ratios of 1:1, 
1:2, 1:4, 1:6, 1:8 and 1:10 sample to substrate. The time of interaction between the 
sample and the substrate was evaluated in three set of samples at 5, 30 and 60 minutes. 
The LOD was determined as the lowest concentration at which a three-to-one signal-to-
noise ratio (S/N) could be obtained. The S/N was based on the peak height from the 
baseline noise. The linearity of the method for cocaine in SOF was evaluated over a 
concentration range of 0.1-1 mg/mL using six standards. The regression line was 
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calculated by the method of least squares and expressed by the correlation coefficient 
(R2), linearity was assessed by F-test and visual evaluation of residual plots. 
Intra-day and inter-day precision and accuracy of the method was determined at a low 
(0.1 mg/mL), medium (0.4 mg/mL) and high (1 mg/mL) concentration. Intra-day 
precision was calculated using six (n = 6) sets of samples obtained on the same day at 
each concentration level and expressed as a percentage relative standard deviation (RSD). 
Inter-day precision was evaluated at each concentration level on three different days (n 
= 3) and expressed as a percentage of RSD. An acceptable value of ±20% of the reference 
value was used for intra-day and inter day precision (USP 2011). Accuracy was 
calculated by dividing the mean measured concentration at each level (n = 6) by the 
theoretical spiked concentration and expressed as a percentage of the theoretical spiked 
concentration. Accuracy was reported as acceptable if the measured concentration was 
±20% of the theoretical value. The matrix effect which is the effect of SOF constituents 
in the detection of cocaine was assessed by comparing the Raman intensity of cocaine 
when SOF had been diluted with water at dilutions factor of 1.5, 2, 3, 4, 6, 9, 17 and 34 
(n = 8). 
2.2.10 Analysis of Tissue Samples - Acquisition of Raman spectra 
SERS analysis using S1, was conducted by depositing the NPs on the surface of the 
tissue. Analysis using S2-4, was conducted by depositing 200 μL of substrate on the 
surface of the tissue using a pipette and allowed to dry at room temperature. 
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2.2.11 Spectral pre-treatment and treatment 
All spectra were dark background corrected using the inbuilt Micro 20/20 software 
from the First Guard Raman instrument. Comparison between spectra was conducted by 
setting the baseline in the proximities of the cocaine Raman peak (1000 cm-1) to zero. 
Statistical analysis was conducted using the software ~IBM SPSS Version 23. Kruskal-
Wallis Test H test was used for comparison of groups. Results with 2-tailed ps < 0.05 
were considered significant. 
2.3 RESULTS AND DISCUSSION 
2.3.1 Characterisation of SERS substrates 
2.3.1.1 Characterisation of Substrate 1 
 The synthesis of S1 resulted in homogeneous depositions on the glass base. The SEM 
images (Figure 2.2-S1) showed the aggregation of the NPs and indicated that hot-spots 
could be formed. Hot-spots are regions where the electromagnetic camp is intensified 
because of the proximity of the plasmonic surfaces.  
The morphology and particle size of S1 were similar to those reported in the literature 
(particle size ranging 80-230 nm) (Wrona et al. 2015, 2017). Spherical particles with 
distribution sizes between 70-210 nm were seen in the micrographs of the synthesised 
substrate. Average particle size for S1 was 110 ± 20 nm.  
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2.3.1.2 Characterisation of Substrate 2 
Figure 2.3 illustrates the characteristic plamonic resonance at 413 nm obtained for the 
hydroxylamine substrate S2 using UV-Vis spectrometry. The band at 413 nm indicated 
the presence of mono-disperse NPs of approximately 30 nm particle size (Agnihotri et al. 
2014). A decrease in maximum absorption at longer wavelengths seen in the following 
days of the synthesis (Figure 2.3) indicated that S1 was conformed of heterogeneous 
particles with various particle sizes (Mie 1908; Agnihotri et al. 2014). Mie (1908) theory 
explains, that the position of maximum extinctions is directly related to the size of the 
NPs and the broadening of the peak (width at half maximum (FWHM) of a peak). Hence, 
the decrease in UV-Vis band intensity also suggested the possible oxidation of NPs and 
loss of SERS activity, i.e. the decrease in stability of the substrate. 
Figure 2.3 UV-Vis spectra (Varian Cary 50) of S2. Spectra collected at times 0, 3, 7 and 19 
days. 
These results contradicted the results presented by Feng et al. (2015), which stated 
that the silver NPs obtained using their methodology were stable for up to four months, 
since the particle size increased and varied with time of storage. The increase and 
variation in particle size implied that S2 was not stable, therefore this substrate (S2) was 
synthesised prior to each SERS analysis to ensure the use of small mono-disperse NPs. 
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Spherical particles with an average size of 50 ± 26 nm and distribution in particle size 
from 20-120 nm were observed in the TEM micrographs (Figure 2.5-S2). The histogram 
in Figure 2.7-S2 indicates that there was a maximum percentage of NPs in the range 
between 30-50 nm. Aggregation of silver NPs were seen in all images, even though the 
samples were sonicated several times during the TEM sample preparation. This 
aggregation inferred the possibility of hot-spot formation and therefore the high activity 
of the substrate. 
2.3.1.3 Characterisation of Substrate 3 
Figure 2.4 illustrates the characteristic plasmonic resonance of S3 at 412 nm. This 
resonance was more characteristic of silver NPs than gold NPS, which was attributed to 
the higher amount of silver NPs in the complex. The absorbance of silver NPs has been 
reported at approximately 400 nm, whereas gold NPs absorb at around 550 nm (Herrera 
et al. 2013). The silver to gold molar ratio used for the synthesis of this substrate was 
36:1. Only one band was present in the UV-Vis spectra indicating that the silver NPs 
homogeneously covered the core of the gold seed. A small variation (< 0.5%) on the 
maximum absorption was seen in the following days, which indicated that the S3 was 
very stable. 
Figure 2.4 UV-Vis spectrum (Varian Cary 50) of S3. 
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TEM images, on the other hand, showed that S3 was composed of spherical particles 
with average size of 22 ± 4 nm (Figure 2.2-S3). The histogram illustrated in Figure 2.2-
S3 indicated that there was a maximum percentage of NPs in the range between 20–25 
nm. 
Although all of the particles had a spherical shape, there were marked differences in 
the colour and characteristics of the NPs. The morphology obtained for S3 was compared 
with the morphology reported by Wang et al. (2015) to confirm the core-shell 
morphology. Three primary particle types were observed with a substantial fraction of 
the NPs having a core-shell structure: (1) Particles with a homogeneous dark colour (thick 
shell) indicated the inadequate amount of gold seeds used in the synthesis. (2) Particles 
with empty shells. (3) Particles with core-shell morphology. 
Aggregation of Ag-Au NPs was observed in all micrographs, even though samples 
were sonicated several times during TEM preparation. This aggregation inferred the 
possibility of hot-spot formation and therefore the high activity of the substrate which 
could increase the LOD of cocaine in SOF samples. 
2.3.1.4 Characterisation of Substrate 4 
Synthesis of the Fe3O4 network was achieved under atmospheric conditions. This 
solution had a characteristic dark brown colour and the particles were aggregated by a 
magnet. Figure 2.5 illustrates the solutions’ colour and the magnetic response of both the 
Fe3O4 network and the final magnetic S4. These initial results indicated that synthesis of 
the Fe3O4 network was successful. Furthermore, synthesis of the magnetic NPs led to a 
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dark red coloured solution , characteristic of the magnetic NPs (Yang et al. 2015) with 
magnetic properties. 
   
Figure 2.5 Photograph of S4 before (A) and after (B) magnetic separation by an external 
magnet. 
The characterisation by UV-vis for S4 was not conclusive because no characteristic 
absorption was seen in the spectra (Figure 2.6). These results were attributed to the small 
percentage (32%) of gold NPs in the substrate. 
 
Figure 2.6 UV-Vis spectrum (Varian Cary 50) of S4. 
Spherical particles were observed for S4 in the TEM images with mean particle size 
of 13 ± 3 nm and range of 10-15 nm for the majority of the magnetic NPs (Figure 2.2–
S4). 
The micrographs showed (1) clear particles (IP6), (2) clear particles with dark spots 
(Fe3O4) and (3) dark particles (Au) some of which were also embedded into the clear 
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particles. The morphology of S4 and the morphology reported by Yang et al. (2015) 
showed similarities in the shape and colour of the NPs. However, a higher amount of gold 
particles was seen in comparison to the embedded Fe3O4. The particle size obtained for 
the NPs (13 nm) were similar to those reported for the magnetic substrate (10-11 nm) 
(Yang et al. 2015). 
2.3.2 SERS analysis of synthetic oral fluid and tissue samples. 
This section presents the SERS results of the detection of cocaine from SOF and 
tongue tissue samples using the four substrates described previously. Characterisation of 
the substrates (section 2.2.4) showed that all substrates could have plasmonic properties 
and therefore be able to enhance the Raman signal of cocaine significantly.  
The initial Raman analysis of solutions of cocaine in SOF at a concentration of 10 
mg/mL was unsuccessful and no Raman signal was obtained, for this reason, SERS 
analysis was evaluated. A higher limit of detection of 1 mg/mL cocaine in SOF was set 
for SERS analysis. This concentration was chosen as 100 times the maximum theoretical 
concentrations of cocaine in OF that could be obtained from in vitro and in vivo studies 
(< 0.008 mg/mL cocaine in OF). Samples at concentrations equal or above 1 mg/mL 
cocaine in SOF that did not show a visible signal after enhancement with SERS substrates 
were not further evaluated. 
2.3.2.1 Analysis of synthetic oral fluid and tissue samples using Substrate 1 
None of the SERS spectra of either SOF or tongue tissue using S1 showed any of the 
characteristic peaks of cocaine (Farquharson et al. 2011, Yang et al. 2015), which 
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indicated that cocaine could not be detected in these samples using S1 (Figure 2.7). 
Different volumes of SOF with high concentrations of cocaine (range 1-10 mg/mL) were 
evaluated unsuccessfully. Farquharson et al. (2011) and Yang et al. (2015) reported 
Raman scattering at approximately 872, 999, 1026, 1273, 1597 and 1716 cm-1 for the 
presence of cocaine (Farquharson et al. 2011, Yang et al. 2015). Figure 2.7 illustrates the 
different SERS spectra obtained for S1 (control), S1 mixed with a solution of cocaine in 
ethanol (10 mg/mL) and S1 deposited on the surface of the tissue. 
   
 
Figure 2.7 SERS spectra (Handheld Raman 532 nm, Rigaku) of Substrate 1 (blue color), 
Substrate 1 mixed with cocaine in ethanol at 10 mg/mL (Red colour) and S1deposited on the 
surface of tongue tissue containing cocaine. 
Deposition of S1 on the surface of the tissue was very challenging because S1 needed 
to be synthesised on the surface of the tissue. The deposition procedure led to uneven 
deposition of particles, which varied between tissue samples. Spectra from tissue 
containing cocaine showed some scattering at wavenumbers of 1455, 1518, 1752 1915 
cm-1. These peaks were assigned to the scattering of proteins (CH2, C=C) inherent of the 
tissue. However, no peaks could be assigned to the scattering of cocaine in the tissue. 
Since cocaine in SOF could not be detected at concentrations below 10 mg/mL, it was 
assumed that no enhancement would be obtained from tissue samples containing cocaine 
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using S1. Concentration of cocaine in tissue were reported in the range of 25-870 ng/mL 
(Reichardt 2014). 
2.3.2.2 Analysis of synthetic oral fluid and tissue samples using Substrate 2 
Raman spectra of control SOF, SOF containing cocaine, methanol, S2 substrate with 
methanol and S2 with cocaine in ethanol (10 mg/mL) were obtained to determine 
characteristic peaks from the scattering of these samples. 
No peaks were seen when control SOF, SOF containing cocaine and S2 were analysed 
independently. This indicated that any scattering from the mixture of S2 with solutions 
of control SOF and SOF containing cocaine would be the result of the scattering of 
cocaine and/or SOF. Comparison of Raman spectra of the control SOF and cocaine in 
SOF resulted in evident differences in band positions and intensities (Figure 2.8). The 
spectrum of the SOF did not show any characteristic peaks for cocaine. The solution of 
cocaine in SOF, exhibited a predominant band at 1704 cm-1 (C=O stretching), which was 
assigned to the tropine ring stretch, the symmetric and asymmetric phenyl ring breathing 
modes, the C-phenyl stretch, the trigonal phenyl ring breathing mode, and the ester 
carbonyl stretch of the phenyl ester ring. The band at 1605 cm-1 (C=C amide I) was 
assigned to proteins present in the SOF from which scattering is enhanced by the presence 
of the cocaine. The band at 1605 cm-1 (C=C) was assigned to the trigonal mode of the 
phenyl ring. The bands at 1359, 1273 and 1173 cm-1 (CH2) were assigned to the tropine 
ring and/or protein and aliphatic amino acids present in the OF and the scattering at 1000 
cm-1 is characteristic of cocaine’s asymmetric stretch of the phenyl ring.
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Figure 2.8. Raman spectra (Handheld Raman 532 nm, Rigaku) of control SOF (         ) and 
cocaine in SOF (         ) at 1 mg/mL using Substrate 2. 
2.3.2.2.1 SOF sample to Substrate 2 ratio 
The sample to substrate ratio was evaluated because the enhancement of Raman 
scattering is determined by the interaction between the analyte and the hot-spots in the 
NPs. Figure 2.9 illustrates the difference in scattering at a wavenumber of 1000 cm-1 for 
cocaine in SOF at 1 mg/mL, when samples were mixed in different proportions with the 
substrate (ratios analysed were 1:1, 1:2, 1:4, 1:6, 1:8 and 1:10). 
 
Figure 2.9 Box and whisker plot of the effect of SOF sample to substrate ratio on the 
intensity of Raman signal for the analysis of cocaine in SOF. Sample to Substrate 2 ratios of 
1:1, 1:2, 1:4, 1:6, 1:8 and 1:10. Samples at concentration of 1 mg/mL cocaine in SOF. Time 
of interaction of 30 min. The box represents the interquartile range with the median. The 
whiskers extend to the 10th and 90th percentiles. 
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A Kruskal-Wallis H test showed that there was a significant statistical difference in 
Raman scattering between the different sample to substrate ratios, H(5) = 12.42, p = 0.03. 
Although, when performing post hoc tests (Mann-Whitney and Bonferroni) to determine 
which sample to substrate ratio was different, no significant statistical difference was 
observed within the samples (p = 0.2 – 1). A Jonckheere’s test revealed a significant trend 
in the data: the median Raman intensity increased with an increase in the amount of 
substrate, J = 80, z = 3.37, r = 0.87.  
In addition to statistical analysis, it was observed that at bigger ratios (1:10), the peaks 
were more resolved that at lower ratios (1:1). A ratio of one to ten was kept during the 
development of this study. This observation could be related to the increase in the number 
of NPs and therefore, the probability of the cocaine to get adsorbed on the NPs. It could 
also be related to a decrease in noise from the surrounding cocaine particles being 
adsorbed on neighbours NPs, this because at bigger ratios the adsorbed cocaine molecules 
are more distant from one another.  
Higher concentrations of NPs were not evaluated (sample to substrate ratios >10) as 
an over-agglomeration of the NPs could occur. Consequently, reducing the number of 
hot-spots and available surfaces for the analyte to be adsorbed. However further studies 
need to be conducted to confirm the decrease of SERS activity when using higher sample 
to substrate ratios  
2.3.2.2.2 Time of interaction between SOF samples and Substrate 2 
The interaction between samples of SOF (1 mg/mL) containing cocaine and S2 was 
evaluated at three different time periods (5 min, 30 min and 1 hour) to determine whether 
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SERS enhancement was time dependent. An increase in the time of interaction between 
the sample and the substrate could lead to an increase in the probability of deposition of 
cocaine molecules on the substrate’s surface, i.e. more cocaine molecules could be 
enhanced by the NPs’ plasmoid. 
Figure 2.10 illustrates the difference in Raman scattering (peak at 1000 cm-1) from a 
sample of 1 mg/mL cocaine in SOF when Raman spectra were collected at 5, 30 and 60 
minutes after interaction with the substrate. The results showed an increase in scattering 
when samples of SOF containing cocaine were left in contact with the substrate for a 
longer period of time.  
 
Figure 2.10 Effect of time of interaction between Substrate 2 and SOF samples containing 
cocaine (1 mg/mL) on the intensity of Raman signal for the analysis of cocaine in SOF. 
Raman spectra collected using the Rigaku handheld Raman 532 nm. 
The results obtained showed that SERS enhancement was proportional to the time of 
interaction between the SERS substrate and the sample, thus indicating that there was a 
higher probability that cocaine molecules interacted with the electromagnetic field of the 
hot-spots over time. The intensity of the Raman signal of samples analysed after 5 and 30 
minutes were 39% and 71% of the Raman signal of the samples analysed after one hour 
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of interaction. Since the difference in the intensity of Raman signal between the 
interaction at 30 minutes and one hour was less than 50%, it was decided that 30 minutes 
of interaction was an appropriate time to allow for the adsorption of cocaine on the surface 
of the NPs (S2). All SOF and tongue tissue samples were subsequently evaluated after 30 
minutes of the mixture with the substrate.  
2.3.2.2.3 Limit of Detection 
The SERS spectra collected for the analysis of linearity and LOD were collected using 
an increased exposure time (14 seconds rather than 4) in order to be able to obtain more 
sensitive results. The time of exposure is related to the time that the laser hits the sample, 
which increases the amount of Raman spectra that are recorded and accumulated to one 
spectrum. Hence, the intensity of the Raman signal (sensitivity) was proportional to the 
amount of spectra accumulated. 
LOD in this study was 0.1 mg/mL cocaine in SOF. Comparison between the LOD 
presented in this section and previously reported values (Farquharson et al. 2011; Dana 
et al. 2015) indicated that a sample pre-treatment should be conducted in order to obtain 
lower LOD of cocaine in SOF. Farquharson et al. (2011) and Dana et al (2015) reported 
LOD ranging 25-50 ng/mL for the detection of cocaine, which were achieved after solid 
phase extraction (SPE). Dana et al. (2015) reported that un-extracted samples of cocaine 
in OF at 10 µg/mL or below only produced a background spectrum. 
As mentioned above, SOF influenced the sensitivity of the results; therefore, it can be 
assumed that lower limits of detection could have been obtained if a sample pre-treatment 
(like SPE) had been conducted. However, sample pre-treatment was not considered in 
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this study as the aim of the research was to evaluate the direct analysis of cocaine in SOF 
with no sample pre-treatment. 
2.3.2.2.4 Linearity 
Three regression lines with mean concentrations of cocaine in SOF were obtained for 
a concentration range of 0.1-1.0 mg/mL in SOF using six concentration points: (1) y = 
77.12x – 19527; R2 = 0.954, (2) y = 84.270x + 18372; R2 = 0.837 and (3) y = 66.002x + 
32253; R2 = 0.797. Mean values were calculated based on a minimum of three replicates 
at each concentration point. Calibration lines and residual plots are shown in Figure 2.11. 
Random scattering of the residuals were observed with all values falling within the 
corresponding values of  ± t(0.95 np-2), which indicated a linear correlation. The F-test (a = 
0.5%) indicated that the data was homoscedastic and therefore the variance around the 
regression line was uniform (p < 0.05). The F-test and the residual plot confirmed the 
linear regression of the model. 
  
Chapter 2 - Evaluation of homemade SERS substrates and handheld Raman spectroscopy for the 
analysis of cocaine in synthetic oral fluid and porcine oral tissue 
83 
Figure 2.11 SERS calibration lines and residual plots for cocaine in OF using Subsrate 2. 
Data represents mean values (n>3). Doted lines (-) represents ±t(0.95, np-2). 
2.3.2.2.5 Accuracy and precision 
Intra-day precision data are summarised in Table 2.3. The intra-day precision values 
were > 25% for the low (0.1 mg/mL) concentration, which was above the acceptable value 
of ± 20% (USP 2011). Precision values were < 11% for the medium (0.4 mg/mL) and 
high (1 mg/mL) concentrations. Intra-day accuracy was also above the acceptable value 
of ± 20% (USP 2011) and varied between concentrations and analysis. In general, inter-
day accuracy was higher than 40% and ranged from 47-140%. 
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Table 2.3 Intra-day and inter-day data for analysis of cocaine in SOF using Substrate 2. 
Analysis conducted using a Rigaku 532 nm handheld Raman spectrometer.  
  Concentration (µg/mL) 
1000 (H) 400 (M) 100 (L) 
Intra-day 1-1 
(n = 6) 
Mean 91457 73027 23077 
 SD 10153   8308 15055 
 SE   4145   4796   8692 
 %RSD       11       11      65 
 Accuracy (%)       89     140      86 
     
Intra-day 1-2 Mean 94918 59609 18148 
(n = 6) SD   8549   6513   4468 
 SE   3823   3760   3159 
 %RSD        9       11       25 
 Accuracy (%)      97     102       47 
     
Intra-day 2 Mean 40696 20929 2455 
(n = 6) SD     832  1324  115 
 SE     588    936    81 
 %RSD         2        6      5 
 Accuracy (%)      97    133   94 
     
Inter-day  Mean 75690 51188 14560 
(n = 3) SD 30355 27050 10769 
 SE 17526 15618   6218 
 %RSD      40       53       74 
SD: Standard deviation, SE: Standard error, %RSD: Percentage relative standard deviation. H: High concentration, 
M: Medium concentration and L: Low concentration. 
 
The inter-day precision for cocaine in OF was higher than 40% and above the 
acceptable value (± 20%) Inter-day precision values were 40, 53 and 74% for the high, 
medium and low concentrations respectively. 
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2.3.2.2.6 Matrix effect in SERS analysis 
Matrix effect is the effect on an analytical method caused by all other components of 
the sample except the specific compound to be quantified (Semeraglia 2002). This effect 
was evaluated to determine the interference of SOF in the analysis of cocaine by SERS. 
Most SERS suppliers suggest the pre-treatment of OF samples by extracting the analyte 
of interest and eliminating any other interferent substances in order to lower the LOD of 
the method. Since there is no clear evidence of interference of the SOF in the analysis of 
drugs by SERS, an evaluation of the dilution factor and therefore the matrix effect of the 
sample was conducted. Few discussions were reported by Dana et al. (2015) describing 
the differences in limits of detection for the detection of cocaine before and after sample 
pre-treatment, i.e. elimination of the interference of OF from the sample. However, no 
discussion on the effect of the OF in the Raman scattering of compounds (e.g. cocaine) 
was given. 
When SOF samples were diluted with water and samples were prepared to a final 
concentration of 1 mg/mL of cocaine, the Raman intensity of the cocaine peak 
(Wavenumber at 1000 cm-1) increased linearly to a maximum of 59 % of the initial value 
(dilution factor of 1:34) (see Figure 2.12). These results confirmed that the matrix affects 
the final response of the analyte, i.e. the presence of SOF in the sample interferes with 
the scattering of cocaine. The results also suggested that samples of SOF containing 
cocaine or any drug should be diluted in order to increase the sensitivity of the SERS 
analysis.  
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Figure 2.12 The effect of SOF on the intensity of the Raman signal for the analysis of cocaine 
using Substrates 2. Dilution factors of 1.5, 2, 3, 4, 6, 9, 17 and 34 were evaluated using water 
as diluent. Samples were at a concentration of 1 mg/mL of cocaine. The Substrate 2 to sample 
ratio was 10:1 in OF. Time of interaction was 30 min. Correlation coefficient R2 = 0.98 (y = 
483x + 2248). 
The interference of SOF in the SERS analysis could be attributed to a competition 
between the SOF constituent molecules and the cocaine molecules to be adsorbed onto 
the surface of the NPs. As the number of molecules from the components of the SOF 
increases, the molecules of drug (cocaine) have less chance to be adsorbed onto the NPs, 
thus decreasing the scattering of the cocaine molecules.  
While the matrix effect of the SOF was confirmed and the dilution of the samples 
suggest an increase the sensitivity of the SERS analysis, it is important to note that larger 
dilutions are a disadvantage because limits of detection will need to be increased to detect 
such diluted samples.  
2.3.2.2.7 Analysis of tissue containing cocaine 
Despite of the Raman scattering enhancement obtained for the analysis of cocaine in 
SOF samples sing S2, no Raman scattering of cocaine from tongue tissue samples was 
obtained using this substrate. Conditions such as: (1) sample to substrate ratios, (2) 
instrument conditions, (3) physical state of the substrate (liquid and dry substrate) and (4) 
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physical state of the sample (fresh tissue and dry tissue), were evaluated to decrease the 
fluorescence from molecules in the tissue and obtain Raman scattering unsuccessfully. 
No scattering was obtained for cocaine and/or any of the components of the tissue such 
as proteins and lipids.  
2.3.2.3 Analysis of synthetic oral fluid and tissue samples using Substrate 3 
Initially, a solution of control SOF and S3 in a ratio 1:1 was evaluated to determine 
any interferent peaks. Following the control spectra, the SERS spectra of cocaine in SOF 
was obtained at concentration of 1 mg/mL to evaluate the enhancement of the Raman 
signal when using S3 (Figure 2.13). A time of interaction of 30 minutes was used based 
on the results from S2. This time was allowed to provide enough time for the molecules 
of cocaine to be adsorbed onto the substrate’s surface. 
Figure 2.13 SERS spectra (Handheld Raman 532 nm, Rigaku) for control SOF (  )and 
1 mg/mL cocaine in SOF (         ) using Substrate 3. Sample to substrate ratio was 1:1. 
The spectra of control SOF and SOF containing cocaine (Figure 2.13) showed the same 
predominant bands as those obtained with S2 (Figure 2.8): 1704 cm-1 (C=O stretching) 
from the tropine ring stretch, the symmetric and asymmetric phenyl ring, the trigonal 
phenyl ring breathing mode, and the ester carbonyl stretch. The band at 1605 cm-1 (C=C 
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amide I) was assigned to proteins present in the SOF. The band at 1605 cm-1 (C=C) 
assigned to the trigonal mode of the phenyl ring. The bands at 1359, 1273 and 1173 cm-1 
(CH2) were assigned to the tropine ring and/or protein and aliphatic amino acids present 
in the SOF and the scattering at 1001 cm-1 characteristic of cocaine asymmetric stretch of 
the phenyl ring. 
2.3.2.3.1 SOF Sample to Substrate 3 ratio 
Figure 2.14 illustrates the change in scattering at wavenumber of 1001 cm-1 for cocaine 
in SOF at 1 mg/mL when samples were mixed in different proportions with the substrate 
S3 (ratios analysed were 1:1, 2:1, 4:1, 6:1, 8:1 and 10:1). 
 
Figure 2.14 Box and whisker plot of the effect of SOF sample to substrate ratio on the 
intensity of Raman signal for the analysis of cocaine in SOF. Sample to Substrate 3 ratios of 
1:1, 1:2, 1:4, 1:6, 1:8 and 1:10. Samples at concentration of 1 mg/mL cocaine in SOF. Time 
of interaction of 30 min. The box represents the interquartile range with the median. The 
whiskers extend to the 10th and 90th percentiles. 
A Kruskal-Wallis H test showed that there were statistical significant differences in 
Raman scattering between the sample to substrate ratios, H(5) = 14.85, p = 0.01. It 
appeared that intensity of the Raman signal was significantly different (following port 
hoc tests Mann-Whitney and Bonferroni) for ratios 1:1 and 1:6 (p = 0.04) only. Because 
most (93%) asymptotic significance values were > 0.05 it was concluded that there were 
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no differences between most sample to substrate ratios. A Jonckheere’s test revealed that 
the intensity of Raman signals was the same across all ratios, J = 62, z = -0.42, r = -0.11. 
Additional to statistical analysis, no differences were seen following visual analysis on 
peak shape and signal to noise. Hence, experiments were undertaken using sample to 
substrate ratio of 1:1. 
2.3.2.3.2 Limit of detection 
The LOD of cocaine in SOF using S3 had a value of 1 mg/mL and was obtained with 
an increased exposure time (14 seconds) in order to obtain more sensitive results. The 
LOD obtained for cocaine in SOF using S3 was considerable higher (5x105 times) than 
the LOD reported by Wang et al. (2015) for the analysis of Rhodamine B in water (2 
ng/mL). These remarkable differences in sensitivity of S3 could have been the result of 
unsuccessful synthesis of this substrate (S3) and the effect that SOF had on SERS analysis 
as was mentioned above. 
A comparison between the LOD obtained for the detection of cocaine in SOF using 
S2 (0.1 mg/mL) and S3 (1 mg/mL) showed that the SERS activity of S3 was considerably 
lower than the S2. The SERS scattering of cocaine using S2 was four times the scattering 
of that for cocaine using S3 at the same concentration of cocaine in SOF (1 mg/mL). This 
result could be attributed to a decrease in hot-spots of the S2. The fact that the particle 
size of S3 (22 ± 4 nm) was lower than for S2 (50 ± 26 nm), indicated that the core-shell 
could have affected the electromagnetic cloud (hot-spot formation) and therefore the 
SERS activity of the S3. 
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2.3.2.3.3 Linearity, accuracy and precision 
Linearity, accuracy and precision were not evaluated with this substrate because the 
LOD was ³ 1 mg/mL cocaine in SOF 
2.3.2.3.4 Analysis of tissue containing cocaine 
No studies were conducted on the tongue tissue using S3 because SERS enhancement 
was not observed at concentrations below 1 mg/mL cocaine in SOF. It was concluded 
that if cocaine at 1 mg/mL in SOF produced low enhancement when analysed with S3, 
no enhancement would be obtained from tissue containing cocaine (cocaine 
concentrations in homogenate tissue ranged between 25–870 ng/mL) (Reichardt 2014). 
2.3.2.4 Analysis of synthetic oral fluid and tissue samples using Substrate 4 
The mixture of S4 (magnetic NPs) with the highest concentration of cocaine solution 
(10 mg/mL cocaine in ethanol), resulted in no visible differences in colour or magnetic 
properties of S4. The agglomeration of magnetic NPs was achieved by the use of a 
magnet. This observation indicated that agglomeration of NPs and therefore formation of 
hot-spots were not affected by the presence of cocaine and/or ethanol. Figure 2.15 shows 
the representative SERS spectra of S4 with ethanol and cocaine in ethanol at a 
concentration of 10 mg/mL. No Raman scattering was obtained for S4 mixed with 
ethanol, therefore any scattering at Wavenumber of 1000 cm-1 was further attributed to 
the presence of cocaine. 
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Figure 2.15 SERS spectra (Handheld Raman 532 nm, Rigaku) for ethanol (  ) and 10 
mg/mL cocaine in ethanol (           ) using Substrate 4. Sample to substrate ratio of 1:1. 
SERS Spectra of cocaine in methanol (Figure 2.15) showed the characteristic 
scattering of cocaine tropine ring stretch, symmetric and asymmetric phenyl ring 
breathing modes, C-phenyl stretch, trigonal phenyl ring breathing mode and ester 
carbonyl stretch (870, 1008, 1042, 1265, 1448 and 1600 cm-1). There were evident 
changes in frequency compared with the reported bands for cocaine (872, 999, 1026, 
1273, 1597 and 17116 cm-1) (Farquharson et al. 2011). These changes could be attributed 
to the extent to which each vibrational mode interacted with the surface and plasmon (hot-
spots) of the magnetic substrate. 
Detection of cocaine in SOF samples containing cocaine could not be obtained from 
the highest standard of cocaine in SOF (1mg/mL); therefore, it was determined that the 
LOD for the analysis of cocaine using S4 was 10 mg/mL. This LOD was 107 times higher 
than that reported by Yang et al. (2014, 2015), where the LOD for benzoylecgonine in 
OF was reported at 29 ng/mL. These enormous differences could be attributed to the 
quality of the synthesised particles and therefore to the synthesis procedure. During the 
preparation of the Substrate 4, it was noted that many details on the conditions under 
which each step of the synthesis was performed were omitted in the publication. Even 
though the physical characteristics of the magnetic substrate matched those described by 
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Wang et al. (2014; 2015), e.g. the reddish colour and magnetic effect, the activity of the 
obtained SERS substrate was not achieved. 
Evaluation of linearity, sample to substrate ratio and matrix effect was not conducted 
for the analysis of cocaine in SOF using S4 because of the high LOD obtained. 
2.3.2.4.1 Analysis of tissue containing cocaine 
No studies were performed on the tongue tissue because SERS enhancement was not 
observed at concentrations below 10 mg/mL of cocaine. It was concluded that if a low 
enhancement was produced when analysing a concentration of cocaine at 10 mg/mL, no 
enhancement would be obtained from the tissue containing cocaine (cocaine 
concentrations in tissue range 25-870 ng/mL) (Reichardt 2014). 
The application of SERS in drug detection has a number of limitations, including the 
dependency on the morphology, optical and electromagnetic properties of the substrate 
in use. Enhancement of the resonance of the NPs depends upon the adsorption of the 
analyte to the surface of the substrate. Reproducing the analysis is problematic because 
of the difficulty of having an equal number of NPs and consequently hot-spots formed 
each time, and differences in these factors may lead to changes in the intensity of the 
scattering at specific concentrations of analyte. Finally, and not related to the SERS 
substrate, the sensitivity of the Raman instrumentation and the limit of detection can add 
further limitations. 
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2.4 CONCLUSIONS 
The synthesis of four different SERS substrates (S1 to S4) was achieved through 
various routes: chemical deposition, reduction and seed growth. These four substrates 
were subsequently used in the SERS analysis of cocaine in SOF and porcine tongue tissue. 
The synthesised substrates were silver and gold-based substrates, which are the most 
common metallic NPs used as SERS substrates. Selection of the synthesis procedures was 
based on reported LOD values for these substrates, as well as the feasibility of the 
synthetic procedure. 
Characterisation of all four synthesised substrates indicated that synthesis of silver 
and/or gold NPs were successful. Low differences were seen (< 29%) when the particle 
sizes were compared with the reported values for each synthesised substrate. The mean 
particle size for the S1 (110 ± 20) were within the range of the reported value (155 ± 
75)(Wrona et al. 2015). Average particle size for S2 was 50 ± 26 nm compared with the 
reported 35 ± 5 nm (Feng 2015). However, the major percentage of S2 ranged 30-50 nm. 
Particle size for S3 was 22 ± 4 compared with the reported 25 nm (Wang et al. 2015) and 
13 ± 3 nm compared with the reported 11.7 ± 2.7 nm for S4 (Yang et al. 2015). In addition 
to the particle size, physical characteristics such as appearance, i.e. morphology of the 
particles, colour of the final substrate and magnetic properties (S4 only) indicated that all 
substrates were successfully synthesised. From the above, it was concluded that all 
substrates could form hot-spots and therefore enhance the Raman signal of drugs in OF 
and tongue tissue. 
SERS spectra of cocaine in SOF were successfully collected at the LOD of 0.1 mg/mL 
and 1 mg/mL using S2 and S3 respectively. A LOD of 10 mg/mL cocaine in ethanol was 
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obtained with S4. No spectra were obtained for solutions of cocaine in SOF or ethanol 
when using the S1. Data from this chapter showed that silver NPs obtained by 
hydroxylamine reduction (S2) had the highest SERS activity when compared with the 
other substrates. 
The quantitative SERS analysis concluded that cocaine could only be detected at levels 
above 100 μg/mL in SOF using S2 using a handheld Raman spectrometer with 532 nm 
laser exposure. Even though the LOD was highly increased by the use of this substrate 
(104), this method (LOD) would not allow the detection of cocaine in real OF samples as 
concentration of cocaine in OF range 0-8.6 μg/mL (Kato et al. 1993, Cone 2012, 
Reichardt 2014). Likewise, it would not allow the in vitro monitoring of the release of 
cocaine from oral drug depots (tissue) into SOF, where maximum concentration of 
cocaine in tissue or SOF are expected to range 5-8 μg/mL. Although linear regression was 
obtained for the method using S2 (Mean R2 = 0.863), the results obtained demonstrated 
that accuracy (> 25 %) and precision (< 40 %) were below the values recommended by 
the Unite States Pharmacopeia for the validation of Raman spectroscopic methods (USP 
2011). Future analysis using more sensitive Raman instrumentation is recommended to 
increase the sensitivity, precision and accuracy of this method. 
Analysis of tongue tissue using S1, S3 and S4, was not conducted because of the high 
values of LOD obtained from the SOF sample analysis with each of these substrates. 
Analysis of tissue using S2 did not show any visible bands from either cocaine or tissue 
constituents (proteins, lipids, etc.). Therefore, it can be concluded that cocaine cannot be 
detected using any of the SERS substrates described in this chapter and the Rigaku First 
Guard handheld Raman spectrometer. 
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Chapter 3   
EVALUATION OF COMMERCIAL SERS SUBSTRATES 
FOR THE DETECTION OF COCAINE IN SYNTHETIC 
ORAL FLUID AND PORCINE ORAL TISSUE USING 
PORTABLE RAMAN SPECTROSCOPY AND RAMAN 
MICROSCOPY  
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3.1 INTRODUCTION 
In latest years, various research groups and manufacturers have made a great effort in 
improving Raman instrumentation and developing Surface Enhanced Raman 
Spectrometry (SERS) substrates for applications in drug testing (Farquharson et al. 2011, 
Dana et al. 2015, Yang et al. 2015). The vast majority of these SERS substrates has been 
developed by originally synthesising silver and/or gold nanoparticles (NPs) in the form 
of colloidal metal suspensions, i.e. metal NPs in suspension such as those described in 
Section 2.2.3 (e.g. synthesis of silver NPS via hydroxylamine reduction) (Feng 2015, 
Wang et al. 2015, Yang et al. 2015). 
The results presented in Chapter 2 indicated that SERS substrates obtained via 
hydroxylamine reduction could be used for the detection and quantification of cocaine in 
synthetic oral fluid (SOF) at limits of detection (LOD) of 100 µg/mL. However, this LOD 
did not provide the required sensitivity for the analysis of cocaine in SOF or tissue at 
physiological levels (0-9µg/mL) without the use of sample pre-treatment. 
In order to produce hot-spots and increase the SERS activity of a substrate, an effective 
aggregation of the NPs need to be achieved, i.e. NPs should be near to one another. Recent 
publications have proved that SERS substrates can be fabricated with more controlled 
aggregation of the NPs by using more elaborate procedures such as the immobilisation of 
metallic NPs on solid surfaces (paper or silica). Some of the common techniques used to 
immobilise NPs include the deposition or inject printing, the in situ growth (synthesis of 
NPs directly on solid surfaces) or the lithographic techniques (Sharma et al. 2012, Mosier-
Boss 2017). These procedures have the advantage of producing commercial SERS 
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substrates of high quality at an affordable cost, which could benefit the implementation 
of the Raman technique in drug testing programs (Thomson 2002, Radzol et al. 2012). 
Additional to the activity of the SERS substrates, the characteristics of the Raman 
instrumentation plays an important role in the sensitivity of the method (Kiselev et al. 
2016). The selection of the correct excitation laser, the power of the laser and 
improvement of the optics allow more sensitive Raman measurements (Section 1.11). 
Raman spectrometers can be coupled to a microscope to enable depth analysis of a sample 
as the incident excitation laser can be focus on the sample and the scattered light can be 
collected more accurately. Laboratory based Raman microscopes offer significant 
advantages over portable and handheld Raman spectroscopes because of the improved 
optics and detectors, which result on an increased sensitivity of the analysis (Turrell and 
Corset 1996). Raman microscopy has been used for the analysis of molecules (proteins, 
pharmacologically relevant molecules and vitamins) in biological matrices for medical 
diagnosis (Kiselev et al. 2016). Some examples on the application of Raman microscopy 
in the analysis of drugs in biological tissues are: (1) the label-free imaging of erlotinib 
distribution and metabolism in colon cancer cells (El-Mashtoly et al. 2014), and (2) the 
use of Raman microscopy in imaging of omega-3 fatty acids and saturated lipids in living 
cells (Freudiger et al. 2008). 
This chapter describes the use of two commercial SERS substrates for the detection of 
cocaine in SOF and their comparison to the use of a homemade substrate (silver NPs 
obtained by the hydroxylamine reduction, Chapter 2) using a portable Raman 
spectrometer. This analysis was developed to decrease the LOD of cocaine in SOF 
obtained with homemade substrates (described in Chapter 2) and handheld Raman 
spectroscopy. As was previously mentioned, commercial substrates are commonly 
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prepared by complex and accurate techniques that could have NPs with an increased 
number of hot-spots and therefore which could provide more sensitive methods. An 
evaluation of the sensitivity of the analysis and the quantification of cocaine in SOF was 
also conducted. 
Additional to the analysis of cocaine using portable Raman spectrometry, Raman 
microscopy was used to increase the sensitivity of the Raman detection and to evaluate 
further the presence of cocaine in porcine tongue tissue. Even though, portable Raman 
instruments can easily be used by unskilled individuals and offer the advantage of 
allowing the analysis of samples on site without the need to transport the samples to the 
laboratory, portable instruments are not as accurate and sensitive as laboratory-based 
instruments. 
3.1.1 AIM AND OBJECTIVES 
 Aim: 
The aim of this chapter was to evaluate the use of commercial SERS substrates using 
portable Raman spectroscopy and the use of Raman microscopy for the detection of 
cocaine in porcine tongue tissue. 
 Objectives: 
• Assess the use of commercial SERS substrates in the detection and quantification 
of cocaine in SOF using portable Raman spectrometer  
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• Compare the response of Raman signal obtained with commercial SERS 
substrates with the response obtained using a home-made SERS substrate in the 
detection of cocaine in SOF. 
• Evaluate the use of Raman microscopy for the detection of cocaine from porcine 
tongue tissue. 
3.2 METHODS 
3.2.1 Materials 
The reagents used to synthesise the silver substrate were purchased as described in 
Section 2.2. 
Crack cocaine was provided by John Ramsey, TICTAC Communications, St Georges 
Medical School, University of London. Cocaine hydrochloride was purchased from 
Sigma-Aldrich (Pool, UK). Internal standard cocaine-d3 was purchased from LTG 
Standards. Bis-(trimethylsilyl)-trifluoroacetamine (BSTFA) + 1% trimethylchlorosilane 
(TMCS) and b-glucuronidase, Type H-1 (from Helix pomatia) were purchased from 
Sigma-Aldrich. Ammonia solution (33%), hydrochloric acid (37%) and phosphate buffer 
(1.0M, pH 6.0) were purchased from Fisher Scientific (Loughborough, UK). TELOSâ 
SPE cartridges (3 mL volume) with 130 mg H-CX sorbent were purchased from Kinesis 
(Cambridgeshire, UK). 
Porcine tongues were purchased from LFB Meats, Bournemouth, UK. 
Test sticks gold substrates (Thermo Scientific) were purchased from Hamamatsu. Tac 
PackTM-P substrates (Paper strips) were donated by BWTek. 
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TELOSâ SPE cartridges (3 ML volume) with 130 mg H-CX sorbent were purchased 
from Kinesis (Cambridgeshire, UK). 
3.2.2 Instrumentation 
Portable Raman spectrometer iRaman Plus (B&W Tek, UK) with a fibre optic probe 
coupled to a video microscope and a charge coupled device (CCD) detector. The 
spectrometer was equipped with 785 nm laser power, >320 mW (420 mW max) laser 
output power and laser control of 0 to 100%. The camera had an effective pixel size of 
14 µm x -0.9 mm and magnification objectives of 10x, 20x, 40x and 100x; this was used 
to focus the laser beam on the sample. Raman spectra were collected over the 
wavenumber range of 200-3200 cm-1 and spectral resolution of 2.4 cm-1. Each spectrum 
was the sum of a minimum of three scans. Data collection was conducted by the 
researcher at Bournemouth University. 
Raman Microscopy measurements were performed using a DXRTM dispersive Raman 
microscope (Thermo Scientific, UK) equipped with 534 nm and 780 nm laser power and 
a charge coupled device (CCD) detector. The slit aperture and spot size used were 50 μm 
and 2.1 um respectively. Raman spectra were collected over the wavenumber range of 
200-2000 cm-1 and spectral resolution of 5 cm-1. Data collection was conducted in 
collaboration with Thermo Fisher Scientific at Thermo Fisher Scientific, Hemel 
Hempstead – UK. 
Quantification by gas chromatography couplet to mass spectrometry (GC-MS) was 
conducted using a Varian 2200 Gas Chromatographer coupled with a Varian Saturn 200 
ion-trap detector (Agilent Technologies, Stockport, UK). Chromatographic separation 
was conducted using a BPX5 fused silica capillary column (30 m x 0.25 mm i.d. 0.25 
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µm) with 5% phenyl – 95% methyl-polysiloxane stationary phase (SGE Analytical 
Science, Ringwood, Australia). Helium was used as carrier gas at flow rate 1.0 mL/min. 
Data collection was conducted by the researcher at Bournemouth University. 
3.2.3 Synthetic oral fluid sample preparation 
SOF was prepared using the Cozart Biosciences protocol (2008) “Production of 
Synthetic Saliva” (Appendix A). 
Samples of SOF with cocaine and without cocaine (control SOF) were used. Samples 
of SOF containing cocaine were prepared by serial dilutions of a stock solution (20 
mg/mL cocaine hydrochloride in ethanol). The final concentration of the test samples was 
0.1, 0.5, 1, 5, 10 and 20 mg/mL of cocaine hydrochloride in SOF. 
3.2.4 Tissue sample preparation 
Details on the exposure of tongue tissue to crack cocaine and tissue sample preparation 
were outlined in section 2.2.8 Sections of porcine tongue tissue with thickness at 0.02 
mm, 2 mm and 5 mm containing cocaine were analysed using the Thermo Scientific DXR 
Raman microscope. 
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3.2.5 Analysis of synthetic oral fluid samples - Acquisition of Raman spectra using 
portable Raman spectroscopy 
Test samples of control SOF and SOF containing cocaine (range 0.1-20 mg/mL) were 
analysed using the iRaman Plus portable Raman instrument with and without the use of 
SERS substrates. 
In order to develop the SERS analysis, three different substrates (S2, S5 and S6)1 were 
assessed for their use in the detection of cocaine in SOF. The substrates used in this 
chapter were either silver or gold NPs (Table 3.1). The synthesis and characterisation of 
S2 were described in sections 2.2.3 and 2.2.4 respectively. Substrates S5 and S6 are 
commercially available and were donated by B&WTek and Thermo Fisher Scientific 
respectively. 
Table 3.1 Details of gold and silver substrates used for the detection of cocaine using the 
portable iRaman Plus 785 nm spectrometer. 
Substrate Substrate name 
Substrate 
base 
Physical 
state Description Supplier 
S2 Hydroxylamine Silver Liquid NPs in suspension Homemade 
S5 Paper Gold Solid NPs deposited on paper B&W Tek 
S6 Silicon Gold Solid NPs deposited on silicon pieces 
Thermo 
Scientific 
Homemade: substrate synthesised in the laboratory at BU, NPs: Nanoparticles, S2: Substrate 2, S5: Substrate 5 and 
S6: Substrate 6. 
Raman spectra were collected by directly exposing the samples to the laser beam. 
SERS spectra were obtained by measuring the scattering of the samples with the 
respective substrate: (1) S2 was used by mixing the test samples with the substrate in a 
                                               
1 The use of substrates S1 and S3 were described in Chapter 2.  
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1:10 ratio and analysed following a time of interaction of 30 min. (2) S5 was used by 
immersing the substrate into the corresponding sample. The sample measurements were 
conducted after five minutes, when the paper was dry. (3) S6 was used by directly 
applying a drop of the test sample on the surface of the substrate and sample 
measurements were collected after five minutes, when the sample was dried. Raman 
spectra were collected at various exposure times of the substrates to the laser beam (1-20 
s), laser power percentage (20-100%) and number of scans (4-8) (Table 3.2).  
Table 3.2 Conditions used to analyse cocaine in SOF using SERS and iRaman Plus 785 nm 
spectrometer. 
Substrate Substrate name 
Substrate 
base 
Laser 
exposure 
(%) 
Laser 
exposure 
(mW) 
Exposure 
time (s) 
 Number 
of Scans 
S2 Hydroxylamine Silver 100 320 20 8 
S5 Paper Gold 20 64 1 4 
S6 Silicon Gold 100 320 10 8 
Laser Exposure: Approximate values, s: seconds, S2: Substrate 2, S5: Substrate 5, S6: Substrate 6, mW: milliwatt, 
%: percentage. 
Raman spectra of SOF samples using S2 were collected using the fibre optic probe 
(spot size of ~100 µm). Raman spectra using S5 and S6 were obtained using the fibre 
optic adapted to an optical microscope. Magnification objectives of 10x, 20x 40x and 
100x (spot size of 210, 105, 52 and 21 µm respectively) were evaluated using S5 and SOF 
containing cocaine at 20 mg/mL to determine the highest Raman signal. Analysis of 
cocaine using S6 was conducted applying the same optimised magnification objective as 
for S5. 
Samples of tongue tissue containing cocaine could not be evaluated with these 
substrates because of the nature of the substrates, i.e. S5 and S6 could not be applied on 
or mixed with tissue samples. 
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A minimum of three replicates were collected for each analysis using S2 and six 
replicates using S5 and S6. The optimal number of replicates was calculated based on the 
intraclass coefficient (ICC) (Saha et al. 2012) of a preliminary data set (n = 26) at three 
concentrations (0.1, 1 and 10 mg/mL cocaine in SOF) and the Equation 2.1. ICC values 
higher than 0.95 were obtained for all concentrations using 3 and 6 replicates (ICC ranged 
0.95 to 0.98). 
 Method optimisation  
The following parameters were evaluated: (1) limit of detection (LOD) of cocaine in 
SOF, (2) linearity, (3) accuracy and precision. These parameters are part of the criteria 
recommended for the validation of quantitative Raman methods described by the United 
States Pharmacopeia (USP 2011). 
The LOD was determined as the lowest concentration at which a three-to-one signal-
to-noise ratio (S/N) could be obtained. The S/N was based on the peak height from the 
baseline noise. The linearity of the method for cocaine in SOF was evaluated over a 
concentration range of 0.1-20 mg/mL using six standards. The regression line was 
calculated by the method of least squares and expressed by the correlation coefficient 
(R2), linearity was assessed by F-test and visual evaluation of residual plots.  
Intra-day and inter-day precision and accuracy of the method was determined at a low 
(0.1 mg/mL), medium (0.5 mg/mL) and high (5 mg/mL) concentration. Intra-day 
precision was calculated using six (n = 6) sets of samples obtained on the same day at 
each concentration level and expressed as a percentage relative standard deviation (RSD). 
Inter-day precision was evaluated at each concentration level on three different days (n 
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= 3) and expressed as a percentage of RSD. An acceptable value of ± 20% of the reference 
value was used for intra-day and inter day precision (USP 2011). Accuracy was 
calculated by dividing the mean measured concentration at each level (n = 6) by the 
theoretical spiked concentration and expressed as a percentage of the theoretical spiked 
concentration. Accuracy was reported as acceptable if the measured concentration was ± 
20% of the theoretical value.  
3.2.6 Analysis of tissue samples - Acquisition of Raman spectra using Raman 
microscopy 
Samples of control porcine tissue and porcine tissue containing cocaine were analysed 
using the DXRTM Raman microscope without the use of SERS substrates. Two excitation 
wavelengths of 532 nm and 785 nm were used for the analysis. Conditions of Raman 
spectroscopic measurements at 534 nm and 780 nm laser power are summarised in Table 
3.3. 
Table 3.3 Conditions used to analyse cocaine in porcine tongue tissue using the DXRTM 
Raman microscopy with excitation wavelength 532 nm and 785 nm. 
Excitation 
wavelength 
(nm) 
Tongue Tissue Parameters 
Tissue Section of tissue Mode 
Laser 
Power 
(mW) 
Exposure 
Time (s) 
Objective 
(x) 
Number 
of Scans 
532 
Control 
1 1 
10 5 2 6 2 1 
3 1 
With 
cocaine 
1 1 
10 4 15 6 2 1 
3 1 
785 
Control 1 1 24 20 3 6 
With 
cocaine 
1 1 24 30 2 6 
2 1 24 30 2 6 2 
3 1 24 6 10 6 2 
Control: Tissue without cocaine. With cocaine: tissue containing cocaine. x: Objective magnification. 
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Low magnification objectives were used for the analysis of porcine tongue tissue 
(532nm laser: 2x and 785 nm laser: 15x). These magnifications allowed the collection of 
spectra from the tissue as a whole and not the analysis of individual cells. Spectra were 
collected at three different sides of the sectioned tissue (Figure 3.1). Changes in 
concentration were assessed by measuring the intensity of the band at 1002 cm-1 at the 
various sections of the tongue. 
 
Figure 3.1 Illustration of the transverse cross-section of tongue tissue showing the sections 
analysed. Centre (1), off-centre (2) and edge (3). 
3.2.7 Spectral data processing 
All spectra were dark background corrected using the inbuilt software from the 
iRaman Plus instrument. Comparison between spectra was conducted by setting the 
baseline in the proximities of the cocaine Raman peak (1000 cm-1) to zero. All spectra 
collected with the DXRTM dispersive Raman microscope were pre-processed to remove 
artefacts caused by background fluorescence and intensity fluctuations using a 
background subtraction method (polynomial 6th degree) from the OMNIC software. Band 
intensity at 1000 cm-1 of cocaine was used for qualitative analysis. Statistical analysis 
was conducted using the software ~IBM SPSS Version 23. Kruskal-Wallis Test H test 
was used for comparison of groups. Results with 2-tailed ps < 0.05 were considered 
significant. 
1 3 2 
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3.2.8 GC-MS Analysis 
The amount of cocaine in porcine tissue exposed to crack cocaine was confirmed by 
GC-MS. Sample extraction and quantification by GC-MS was conducted using the 
method described by Rees et al. (2012). In summary, 1 mL of homogenised tissue was 
extracted using SPE cartridges equilibrated and conditioned with 2 mL methanol and 2 
mL 0.1M Phosphate buffer (pH 6.0). Cartridges were washed with 2 mL deionised water, 
2 mL 0.1 M HCl and 3 mL methanol. Samples were eluted using 2 mL of fresh dichloro-
methane/isopropanol/ammonium hydroxide (80:17:3 v/v/v) and subsequently dried under 
a stream of nitrogen (£ 40 °C). Dried samples were reconstituted in 25 µL ethyl acetate 
and 25 µL BSTFA and heated for 20 min at 70°C.  
Extracted samples were injected into the GC-MS instrument using 2 µL injection 
volume. A temperature gradient was run for a total run time of 16 min: an initial 
temperature of 130 °C was held for 1 min, then the temperature was ramped to 240 at a 
rate of 30 °C/min and held for 4 min, then ramped to 260 °C at 15 °C/min and held for 2 
min, then ramped to 300 °C at 60 °C/min and held for 3.33 min. The ion-trap was operated 
in multiple reaction monitoring (MRM) with total ion current of 10,000 and excitation 
amplitude of 52.5 V. Precursor ion was 182 m/z for cocaine and 185 m/z for cocaine-d3, 
quantification ion was 150 m/z for cocaine and 153 m/z for cocaine-d3. The method had 
a limit of quantification (LOQ) of 5 ng/g, a linear range 0.01- 1.0 mg/0.5 Kg tissue and 
calibration line equation y = 0.006x + 0.00008 with regression coefficient R2 = 0.999. 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Portable Raman spectroscopy - Analysis of synthetic oral fluid samples 
The substrates employed in this chapter were selected based on their availability and 
differences in physical characteristics. S2 contained NPs in suspension. S2 and S6, on the 
other hand, were solid substrates with magnetic NPs deposited on different surfaces 
(paper and silicon respectively). Because of their physical differences, diverse parameters 
were required. 
Optimised values of exposure time and laser power were described in Table 3.2. These 
values were optimised to obtain the highest signal without saturating the detector and/or 
damaging the sample or substrate. Larger exposure times were required for cocaine 
analysis using S2 (20 seconds) compared with S2 (1 second) and S6 (10 seconds). This 
extended exposure time for S2 was attributed to the increased amount of energy that is 
required to excite NPs in suspension (Mosier-Boss 2017). The silver NPs or groups of 
aggregated silver NPs in suspension, were more separated or spatially dispersed from one 
another compared to S2 or S6. The NPs in S2 and S6 were deposited in a smaller surface 
area than S2. S6 for the contrary was analysed at low laser power and exposure time due 
to the chemical nature of this substrate (cellulose fibres) (Mosier-Boss 2017). During the 
development of this study, it was observed that application of laser power with energies 
above 80 mW resulted in the substrate’s destruction. 
Detection of control SOF and cocaine in SOF using the iRaman Plus 785 nm was only 
achieved with the use of SERS substrates (Figure 3.2 B-C). The Raman spectrum of 
cocaine hydrochloride (> 98.5% purity) was obtained and used for comparison, and it is 
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illustrated in Figure 3.2-A.  The spectra of control SOF and SOF containing cocaine (20 
mg/mL) with and without the use of SERS substrates (B-I) is also illustrated in this figure. 
 
Figure 3.2 Raman spectra of (A) cocaine hydrochloride, (B) SOF, (C) SOF containing cocaine 
(20 mg/mL), (D) SOF using S2, (E) SOF containing cocaine (20 mg/mL) using S2, (F) SOF  using 
S5, (G) SOF containing cocaine (20 mg/mL) using S5, (H) SOF using S6 and (I) SOF containing 
cocaine (20 mg/mL) using S6. Spectra obtained with iRaman and 785 nm laser. The boxes 
indicate the principal peaks of cocaine. 
A 
B 
C 
D 
E 
F 
I 
H 
G 
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 Analysis of SOF samples using Substrate 2 
SERS spectra of SOF and SOF containing cocaine (20 mg/mL) using S2 were analysed 
and compared with the spectrum of cocaine hydrochloride (Figure 3.2 A) to determine 
characteristic peaks from the scattering of the samples. Comparison of Raman spectra of 
control SOF (Figure 3.2 D) and SOF containing cocaine (Figure 3.2 E) resulted in distinct 
differences in band positions and intensities. A very weak scattering was seen for SOF 
with S2. Minor peaks at 637-689, 728 and 914 cm-1 (-C-C- stretch) were assigned to 
proteins present in the SOF. The bands at 1192 and 1207 cm-1 (CH2) were assigned to 
protein and aliphatic amino acids and the bands at1450, 1540-1589 cm-1 (C=C amide I) 
to proteins present in the SOF. 
SOF containing cocaine (20 mg/mL), showed more visible bands than the control SOF. 
Bands at 522, 617-687, 775 cm-1 (-C-C- stretch) were assigned to proteins present in the 
SOF, the band at 887 cm-1 (-C-C- stretch) was assigned to the tropine ring. The scattering 
at 1000 cm-1 was characteristic of the asymmetric stretch of the phenyl ring from the 
cocaine. Bands at 1121 and 1215 cm-1 (CH2) were assigned to the tropine ring and/or 
protein and aliphatic amino acids present in the SOF. The bands at 1554, 1596 cm-1 (C=C 
amide I) were from proteins found in the SOF which scattering was enhanced by the 
presence of the cocaine and the trigonal mode of the phenyl ring. The band at 1716 cm-1 
(C=O stretching) was assigned to the tropine ring stretch, the symmetric and asymmetric 
phenyl ring breathing modes, the C-phenyl stretch, the trigonal phenyl ring breathing 
mode, and the ester carbonyl stretch. Appendix B shows the identification and functional 
group assignment for the peaks obtained with the iRaman 785 nm. 
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Among all bands observed in the test samples containing cocaine, the band at 1000 
cm-1 was chosen for the quantification of cocaine because of the highest intensity and 
lack of interference with the response from SOF. 
3.3.1.1.1 Method optimisation 
SERS response for the analysis of cocaine in SOF at concentrations ranging 0.1-20 
mg/mL is shown in Table 3.4. Mean SERS response and standard deviation were 
calculated based on three different measurements at each concentration point (0.1, 0.5, 1, 
5, 10 and 20 mg/mL). Coefficients of variation for the SERS response were below 20% 
within the range of concentrations. 
Table 3.4 Descriptive statistics of the analysis of cocaine in SOF using S2 and iRaman Plus. 
Cocaine in 
SOF (mg/mL) 
Mean 
 (n=3) SD %RSD Min
 Max 
(Arbitrary Units) 
0.1 163 19.4 12 145 184 
0.5 350 27.9 8.0 323 378 
1.0 581 56.6 9.7 548 647 
5.0 1211 48.7 4.0 1166 1263 
10.0 1044 88.0 8.4 962 1137 
20.0 1779 228 13 1571 2070 
Mean: mean value of relative intensity of cocaine in SOF using S2. Min: Minimum value of relative intensity, Max: 
Maximum value of relative intensity, n: number of measurements, SD: standard deviation, %RSD: Percentage of 
relative standard deviation. SOF: Synthetic oral fluid.  
The LOD in this study was 0.1 mg/mL cocaine in SOF using S2. This LOD was equal 
to the LOD obtained using a handheld Raman spectrometer (Chapter 2).  
The calibration curve and residual plot (range 0.1-20 mg/mL) obtained for the 
quantification of cocaine in OF using S2 is shown in Figure 3.3. Figure 3.3 shows that 
there was a logarithmic relation between the increase in SERS response of cocaine with 
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the increase in concentration of cocaine in SOF. The residual plot shows a non-random 
pattern in the residuals, which confirmed the non-linearity of the model.  
  
Figure 3.3 SERS calibration curve and residual plot for cocaine in SOF in a range of 0.1-20 
mg/mL using S2. (Data represents mean values (n=3). Doted lines (-) represents ±t(0.95, np-2). Data 
collected at Raman shift 1000 cm-1using iRaman Plus 785 nm. Error bars represent the standard 
deviation of the data. 
In order to linearise the curve, the square of the SERS response was plotted against the 
cocaine concentration in SOF. Figure 3.4 illustrates the linear regression for the data after 
some outliers were removed. A regression line with mean response values of cocaine in 
SOF was obtained for a concentration range of 0.1-20.0 mg/mL in SOF using six 
concentration points: (1) y = 133665x – 143783; R2 = 0.905. Mean values were calculated 
based on a minimum of three replicates at each concentration point. Calibration lines and 
residual plots are shown in Figure 3.4. No random scattering of the residuals were 
observed with all values falling within the corresponding values of  ±t(0.95 np-2), which 
indicated the lack of linear correlation. The F-test (a= 0.5%) indicated that the data was 
heterocedastic and therefore the variance around the regression line was not uniform (p > 
0.05). The F-test and the residual plot confirmed the non-linear regression of the model. 
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Figure 3.4 SERS calibration curve and residual plot for the square of the SERS response of 
cocaine in SOF in a range of 0.1-20 mg/mL using S2. (Data represents mean values (n>3). Doted 
lines (-) represents ±t(0.95, np-2). Data collected at Raman shift 1000 cm-1using iRaman Plus 785 nm. 
The SERS response of cocaine obtained using S2 could be explained by the fact that 
the number of hot-spots present in the substrate were saturated and therefore the excess 
of cocaine molecules could not be enhanced by the NPs (Herrera et al. 2013, Schlücker 
2014).  
Accuracy and precision were not evaluated for S2 as the linearity of the model could 
not be confirmed. 
 Analysis of SOF samples using Substrate 5 
Comparison of Raman spectra of control SOF (Figure 3.2 F) and SOF containing 
cocaine (20 mg/mL) using S5 (Figure 3.2 G) resulted in evident differences in band 
positions and intensities. Minimal scattering was seen for SOF with S5. Minor bands at 
617 and 727 cm-1 (-C-C- stretch) were assigned to the aromatic ring from proteins present 
in the SOF. The bands at 1123 and 1221 cm-1 (CH2) were assigned to protein and aliphatic 
amino acids and the bands at 1474, 1569 cm-1 (C=C amide I) to proteins present in the 
SOF. 
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Test samples of cocaine in SOF (20 mg/mL), on the other hand, showed more visible 
bands than the control SOF. Scattering at 522, 617, 717 cm-1 (-C-C- stretch) were 
assigned to proteins present in the SOF, the band at 887 cm-1 (-C-C- stretch) was assigned 
to the tropine ring. The scattering at 1000 cm-1 was characteristic of cocaine (asymmetric 
stretch of the phenyl ring). Bands at 1141 and 1247 cm-1 (CH2) were assigned to the 
tropine ring and/or protein and aliphatic amino acids present in the SOF. The 1478 and 
1571 cm-1 (C=C) bands were from proteins found in the SOF which scattering is enhanced 
by the presence of the cocaine and the trigonal mode of the phenyl ring respectively. And 
the band at 1716 cm-1 (C=O stretching) was assigned to the tropine ring stretch, the 
symmetric and asymmetric phenyl ring breathing modes, the C-phenyl stretch, the 
trigonal phenyl ring breathing mode, and the ester carbonyl stretch. Summary of 
identification and functional group assignment for S5 can be seen in Appendix B. 
3.3.1.2.1 Method optimisation  
Initially an evaluation of the magnification was conducted to obtain the higher SERS 
signal. A Kruskal-Wallis H Test showed that there was not a significant statistical 
difference in Raman scattering between the evaluated magnification objectives 10x, 20x, 
40x and 100x (H(3) = 6.33, p = 0.096) (Figure 3.5). Although, Jonckheere’s test revealed 
a significant trend in the data: as the number of objective magnification increased, the 
median of the Raman intensity decreased, J = 27.5, z = -2.12, r = -0.51. The intensity of 
the Raman signal acquired with low magnification objectives (10x and 20x) was 48% 
stronger (comparison of median values) than that of higher magnification (40x and 100x). 
These differences could be attributed to the larger amount of Raman photons being 
collected. Median values for the intensity of Raman spectra with the 10x and 20x showed 
differences of 6%. Thus, a low magnification objective of 20x was preferred. At low 
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magnifications, a smaller laser energy density was delivered to the surface of the sample 
and a larger surface area was covered. 
 
Figure 3.5 Box and whisker plot of the effect of magnification objectives on the intensity of 
Raman signal for the analysis of cocaine in SOF. Magnification objectives 10x, 20x, 40x and 
100x. Samples at concentration of 20 mg/mL cocaine in SOF using S5. Time of interaction of 30 
min. The box represents the interquartile range with the median. The whiskers extend to the 10th 
and 90th percentiles. 
SERS response for the analysis of cocaine in SOF at concentrations ranging 0.1-20 
mg/mL is shown in Table 3.5. Mean SERS response and standard deviation were 
calculated based on a minimum of 11 spectra per concentration point. The % RSD values 
were above 20% for all the concentrations. 
Table 3.5 Descriptive statistics of the analysis of cocaine in SOF using S5 and iRaman Plus. 
Cocaine in 
SOF (mg/mL) 
Raman intensity (Arbitrary Units) 
Mean  
(n > 10) SD %RSD Min Max 
0.10 189.7 49.3 26.0 105.7 256.9 
0.50 459.8 182.0 39.6 154.8 905.3 
1.00 526.2 299.5 56.9 123.0 1151.5 
5.00 993.4 252.2 25.4 589.1 1496.8 
10.00 1540.6 695.9 45.2 596.2 2692.4 
20.00 510.0 248.1 48.6 356.9 1314.5 
Mean: mean value of relative intensity for cocaine in SOF using S5. Min: minimum value of relative intensity, 
Max: maximum value of relative intensity, n: number of measurements, SD: standard deviation, %RSD: percentage of 
relative standard deviation. SOF: Synthetic oral fluid.  
The Figure 3.6 illustrates the SERS response of test samples against the concentration 
of cocaine in SOF using S5. This figure shows that the response of cocaine increased with 
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the increase of cocaine concentration up to a concentration of 10 mg/mL, then there was 
a decrease in the SERS scattering at a concentration of 20 mg/mL. Hence, the calibration 
curve showed a non-linear relation between the SERS response and the cocaine 
concentration in the SOF samples, which was confirmed by the residual plot (showing a 
u shape). This response could be attributed to a saturation of the hot-spots present in the 
substrate by the molecules of cocaine and SOF constituents, e.g. proteins and salts 
(Herrera et al. 2013, Schlücker 2014) at concentrations higher than 10 mg/mL. It could 
also be attributed to a subsequent suppression of the signal due to the excess of 
surrounding molecules being absorbed by the paper and on the surface of the NPs (Desai 
et al. 2012, Schlücker 2014). 
    
Figure 3.6 SERS calibration curve and residual plot for the SERS response of cocaine in SOF 
in a range of 0.1-20 mg/mL using S5. (Data represents mean values (n = 6). Doted lines (-) 
represents ±t(0.95, np-2). Data collected at Raman shift 1000 cm-1using iRaman Plus 785 nm. Error 
bars represent the standard deviation of the data. 
In order to linearise the curve, the samples at concentration 20 mg/mL were excluded. 
Figure 3.7 illustrates the calibration curve and residual plot for the range 0.1-10 mg/mL 
cocaine in SOF. A linear regression was obtained using five concentration points: (1) y = 
194.82x – 217.71; R2 = 0.955. Mean values were calculated based on a minimum of six 
replicates at each concentration point. Random scattering of the residuals were observed 
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with all values falling within the corresponding values of  ±t(0.95 np-2), which indicated a 
linear correlation. The F-test (a= 0.5%) indicated that the data was homoscedastic and 
therefore the variance around the regression line was uniform (p < 0.05). The F-test and 
the residual plot confirmed the linear regression of the model. 
  
Figure 3.7 SERS calibration curve and residual plot for the square of the SERS response of 
cocaine in SOF in a range of 0.1-10 mg/mL using S5. (Data represents mean values (n=6). Doted 
lines (-) represents ±t(0.95, np-2). Data collected at Raman shift 1000 cm-1using iRaman Plus 785 nm. 
Error bars represent the standard deviation of the data. 
The LOD achieved in this study was 0.1 mg/mL cocaine in SOF, which is the same 
value obtained with Substrate 2. 
Intra-day precision data are summarised in Table 3.6. The intra-day precision values 
were > 33% for the low (0.1 mg/mL) medium (0.5 mg/mL) and high (5 mg/mL) 
concentration. This values were above the acceptable value of ± 20 % recommended by 
the United States Pharmacopeia (USP 2011). Similarly, the inter-day precision for 
cocaine in SOF was above the acceptable value for the low (24%) and middle (43%) 
concentrations. The intra-day precision at the high concentration was acceptable, with 
%RSD of 14%. Intra-day accuracy varied between concentrations and analysis. In 
general, inter-day accuracy ranged from 79-429%. 
y = 187.55x + 272.99
R² = 0.9576
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Table 3.6 Intra-day and inter-day data for analysis of cocaine in SOF using S5. Analysis 
conducted using a the iRaman Plus 785 nm spectrometer. 
  Concentration (mg/mL) 
0.1 0.5 5 
Intra-day 1 
(n = 6) 
Mean  0.31 1.17 3.66 
SD 0.30 0.70 1.20 
SE 0.17 0.35 0.49 
% RSD 97.07 59.91 32.73 
     
Intra-day 2 
(n = 6) 
Mean 0.47 0.49 3.20 
SD 0.31 0.34 1.32 
SE 0.18 0.14 0.76 
%RSD 65.51 68.52 41.35 
     
Intra-day 3 
(n = 6) 
Mean 0.51 1.28 4.22 
SD 0.25 0.48 1.50 
SE 0.11 0.21 0.53 
%RSD 48.37 37.16 35.53 
     
Inter-day 
(n = 3) 
Mean 0.43 0.98 3.69 
SD 0.11 0.42 0.51 
SE 6.07 24.46 29.35 
%RSD 24.49 43.24 13.77 
 Accuracy 429.27 195.94 73.86 
n: Number of samples, OF: Oral fluid, SD: standard deviation, SE: Standard error, %RSD: Percentage of relative 
standard deviation.  
Overall, the variability of the SERS response in the test samples was higher than 20%. 
These differences were attributed to: (1) The section of the paper analysed (number of 
hot-spots present in the area). (2) The differences in the surfaces of the substrates due to 
the deposition method, e.g. variability in the homogeneity of the NPs. (3) The 
chromatographic effect obtained when using paper. Paper has a capillary effect that 
allows the separation of substances (Yu and White 2013). The components of a test 
sample, e.g. cocaine and proteins, can travel across the paper at a different rate and 
through various sections of the paper; which could lead to differences in the number 
molecules absorbed on the surface of the NPs and hence to the resulted SERS scattering. 
(4) Inaccuracy from the Raman instrumentation, e.g. objective and detector. (5) The lack 
of an internal/external standard in the analysis, which could account for any variability in 
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surface enhancement and/or instrumental parameters, e.g. laser power, sample alignment 
(Loren et al. 2004). 
Comparison between Substrate 2 and 5 indicated that Substrate 2 had lower variability 
in the measurements. Substrate 2 presented %RSD values below 20% for all 
concentrations evaluated whereas Substrate 5 presented values above 20% (4-13% and 
26-57% respectively). The linear range obtained for substrate 2 (0.1-20 mg/mL cocaine 
in SOF) was higher than for Substrate 5 (0.1-10 mg/mL cocaine in SOF), although 
Substrate 5 presented better correlation coefficient (R2 = 0.90 and 0.96 respectively).  
 Analysis of SOF samples using Substrate 6 
SERS spectra of test samples with and without cocaine using Substrate 6 (Figure 3.2 
H-I) were analysed and compared with the spectrum of cocaine (Figure 3.2A) to 
determine characteristic peaks from the scattering of the samples. Comparison of Raman 
spectra of control SOF (Figure 3.2 H) and cocaine in SOF (Figure 3.2 I) resulted in 
apparent differences in band position and intensities. No scattering was seen for control 
SOF with substrate 6. Test samples containing cocaine (20 mg/mL) showed more visible 
bands than the control SOF. Bands at 613, 790 cm-1 (-C-C- stretch) were assigned to 
proteins present in the SOF, the band at 895 cm-1 (-C-C- stretch) was assigned to the 
tropine ring. The scattering at 1000 cm-1 was characteristic of asymmetric cocaine stretch 
of the phenyl ring. Bands at 1164 and 1258 cm-1 (CH2) were assigned to the tropine ring 
and/or protein and aliphatic amino acids found in the SOF. The 1445 and 1554 cm-1 (C=C) 
bands were from proteins present in the SOF which scattering is enhanced by the presence 
of the cocaine and the trigonal mode of the phenyl ring respectively. Summary of 
identification and functional group assignment for S6 can be seen in Appendix B. 
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3.3.1.3.1 Method optimisation  
As for substrate 2 and 5, the band at 1000 cm-1 presented the highest Raman intensity 
and therefore it was chosen for the quantification of cocaine. Quantitative analysis was 
conducted using a minimum of six spectra per concentration point (71 SERS spectra in 
total). Table 3.7 shows the mean values of relative intensity along with standard deviation, 
%RSD and minimum and maximum values.  
Table 3.7 Descriptive statistics of the analysis of cocaine in SOF using Substrate 6 and iRaman 
Plus 785 nm. 
Cocaine in 
SOF (mg/mL) 
Raman intensity (Arbitrary Units) 
Mean  
(n = 6) SD %RSD Min
 Max 
0 32 11.8 36.5 16 82 
0.1 112 70 62.3 48 279 
0.5 577 94 16.3 411 710 
1.0 583 56 9.6 519 666 
5.0 479 120 25.0 257 687 
10.0 248 116 46.5 166 489 
20.0 296 131 44.3 178 569 
Mean: mean value of relative intensity for cocaine in SOF using S6. Min: Minimum value of relative intensity, 
Max: Maximum value of relative intensity, mg: Milligrams, mL: millilitres, n: Number of measurements, SOF: 
Synthetic oral fluid, SD: standard deviation, %RSD: Percentage of relative standard deviation.  
The calibration curve for cocaine was evaluated over a concentration range of 0.1 – 20 
mg/mL in SOF. The Figure 3.8 illustrates the SERS response of test samples using S6 
against the concentration of cocaine in SOF and its residual plot. This figure shows an 
increase in the response of cocaine with the increase of cocaine concentration up to a 
concentration of 1 mg/mL. At concentrations of 5 mg/mL and above, a decrease in the 
response was observed (17-57%). The residual plot showed a scattering of the data within 
two standard deviation and a similar shape as the observed in the calibration curve. The 
obtained SERS response suggested that there was a saturation of the hot-spots present in 
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the substrate by the molecules of cocaine and SOF constituents, e.g. proteins and salts 
(Herrera et al. 2013, Schlücker 2014). The subsequent suppression of the signal was 
attributed to the excess of surrounding molecules from the SOF being absorbed on the 
surface of the NPs (Desai et al. 2012, Schlücker 2014). 
    
Figure 3.8 SERS calibration curve and residual plot for the SERS response of cocaine in SOF 
in a range of 0.1-20 mg/mL using S6. (Data represents mean values (n = 6). Doted lines (-) 
represents ±t(0.95, np-2). Data collected at Raman shift 1000 cm-1using iRaman Plus 785 nm. Error 
bars represent the standard deviation of the data. 
Since a possible saturation of the hot-spots in the S6 substrate occurred at 
concentrations higher than 1 mg/mL, it was not possible to evaluate the linear regression 
of the model in the range 0.1-1 mg/mL. The USP suggest the use of six standards for the 
evaluation of linearity, therefore a larger number of standards need to be evaluated (USP 
2011).  
The LOD of this study was obtained at 0.1 mg/mL cocaine in SOF. The precision and 
accuracy of the method could not be evaluated because of the lack of standards available 
to confirm the linearity of the method (range 0.1-1 mg/mL).  
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The variability of the data (%RSD) obtained with Substrate 6 was higher than for 
Substrate 2 (Substrate 2: 4-13% and Substrate 6: 11-100%). Comparison between 
Substrate 5 and 6 showed no significant differences at concentrations 0.1 to 5 mg/mL 
(H(3) = 3.00, p = 3.92). However, at higher concentrations (10 and 20 mg/mL) Substrate 
6 presented grater variability (> 93%) than the Substrate 5 (45-49%).  
The potential linear range obtained for Substrate 6 (0.1-1 mg/mL cocaine in SOF) was 
shorted than Substrate 2 and Substrate 5 (0.1-20 mg/mL and 0.1-10 mg/mL cocaine in 
SOF respectively). The differences between linear range and correlation coefficients were 
attributed to the number of hotspots present in each of the substrates (Mosier-Boss 2017). 
Overall, Substrate 6 presented less variability in the results (< 20%) and Substrate 5 better 
linearity (R2 = 0.96). The LOD, on the other hand, was the same for all substrates (0.1 
mg/mL cocaine SOF). 
Although detection and quantification of cocaine in SOF were obtained, the LOD 
obtained did not allow the detection of cocaine at physiological levels (< 3 µg/mL cocaine 
in SOF) or its use in in vitro studies. The concentration of cocaine in SOF and porcine 
tongue tissue has been reported to be in the range of  5-8 μg/mL at maximum (Cone 2012, 
Reichardt 2014). 
The increase in sensitivity of SERS methods can be achieved by conducting a solid 
phase extraction (SPE) before the SERS analysis (Barnett and Rathmell 2015). However, 
SPE was not evaluated in this chapter because the time spent in the extraction procedure 
increases significantly the analysis, which contradicted the objectives of this research. 
The extraction procedure used in this chapter (a modified version of the methodology 
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described by Rees et al. (2012)) for the analysis of SOF samples containing cocaine based 
on can take up to four hours. 
3.3.2 Raman microscopy - Analysis of tissue samples 
Additionally to SERS analysis, i.e. use of NPs, the response of the Raman signal could 
be enhanced by the use of more sensitive Raman instruments (Miljković et al. 2010). 
Raman spectroscopy coupled with microscopy offered several advantages over handheld 
and portable devices because of the improvements in the design of the instrumentation 
(sources, optics, detectors, software). Raman microscopy has been used in the analysis of 
analytes at physiological levels in several biological tissues including lungs, breast, 
cornea, brain, oral tissue (Movasaghi et al. 2007, Freudiger et al. 2008, Matthäus et al. 
2008, Kiselev et al. 2016).  
 Influence of excitation wavelength 
The analysis in the Vis-Raman and NIR-Vis-Raman (excitation wavelength 532 and 
785 nm respectively) demonstrated that cocaine could be detected using both excitation 
wavelengths. Figure 3.9 shows representative spectra of tissue containing cocaine 
analysed by Raman microscopy using excitation wavelengths 532 nm and 780 nm. This 
figure shows that bands in the VIS-Raman produced significant strengthening of the 
scattering than the bands in the NIR-Vis-Raman. Tongue constituents (carotenoids, haem 
from protein, lipids, cocaine) were more visible with the lower energy laser. These 
differences in scattering were attributed to the enhanced Raman scattering of intrinsic 
tissue chromophores like carotenoids, which have broad absorption at a maximum of 480 
nm (Movasaghi et al. 2007). Resonance enhancement may occur when the incident 
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radiation is near the frequency of the electronic transition of tissue chromophores, which 
results in an enhancement (via coupling of electronic and vibrational transitions) of the 
intensity of inherently weak Raman bands (Synytsya et al. 2014). 
 
Figure 3.9 Raman spectra of tissue containing cocaine using excitation wavelengths 532 nm 
and 780 nm. Spectra collected with a Thermo Scientific DXR Raman microscope from section 1 
of exposed tongue tissue. 
The enhancement of the Raman scattering obtained with the excitation wavelength 
532 nm could also be attributed to the increase in irradiated energy. This is because 532 
nm excitation wavelength has higher energy than the wavelength at 780 nm and Raman 
scattering is proportional to the incident energy (Synytsya et al. 2014). The contribution 
from the incident energy was not considered significant in this study, as the time of 
exposure and magnification of the objective were optimised before collecting the Raman 
spectra at both excitation wavelengths (532 and 780 nm). 
Excitation at longer wavelengths (785 cm) is frequently used for measurements of 
fresh tissues due to the relatively low background obtained. However, excitations at 
shorter wavelengths (532 cm) increase signal intensity. Unwanted auto-fluorescence and 
sample damage are often the main disadvantages when analysing biological tissue with 
shorter wavelengths. In order to obtain good spectra without sample damage a longer 
0
400
800
1200
1600
200 600 1000 1400 1800
R
am
an
 In
te
ns
ity
  
(A
rb
itr
ar
y 
U
ni
ts
)
Wavenumber  (cm-1)
780 nm
532 nm
Chapter 3 - Evaluation of commercial SERS substrates for the detection of cocaine in synthetic 
oral fluid and porcine oral tissue using portable Raman spectroscopy and Raman microscopy 
 
 125 
scanning time was used with the excitation wavelength 785 nm (20-30 s) compared with 
the 532 nm (4-5 s). Under these conditions the morphology of tongue tissue remained 
intact, no visible changes or signs of laser damaging was observed after laser exposure. 
 Analysis of tissue samples 
Test samples of tissue at a thickness of 0.02 mm showed very weak scattering with no 
visible bands. Tissues at 2 and 5 mm, on the other hand, showed visible bands. Hence, 
only the samples at a thickness of 2 mm were used for further analysis.  
The chemical composition of tongue tissue comprised a distinct number of small and 
large molecules: amino acids, carbohydrates associated with surface epithelium, collagen 
component of the epithelium, globulins, lipids or muscles and proteins among others 
(Hand and Frank 2014). Vibrational frequencies related to different functional groups and 
back bond chains like proteins, nucleic acids and saccharides usually overlap specific 
functional groups of a particular molecule in the tissue, thus making it difficult to get 
accurate frequency assignments. 
Comparison of Raman spectra of control tissue and tissue containing cocaine resulted 
in evident differences in band positions and intensities, with spectra obtained with the 
excitation laser 532 nm showing more resolved and intense bands. Figure 3.10 illustrates 
the Raman scattering of cocaine hydrochloride (> 98% purity), control tissue and tissue 
containing cocaine obtained with the excitation laser 532 nm. The control tissue presented 
minimal bands: the band at 1298 cm-1 was assigned to (CH2) from protein and lipids, the 
band at 1439 cm-1 was assigned to collagen content in lipids, the bands at 1638 and 1655 
cm-1 were assigned to (C=C amide I) from proteins and lipids and 1744 cm-1 to (C=O 
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stretching) from lipids. On the other hand, samples of tissue containing cocaine presented 
shifted bands at 748, 1309, 1442, 1644 and 1709 cm-1 (CH2) that were assigned to protein 
and aliphatic amino acids. These bands are characteristic of chromophores such as 
collagen, myoglobin (Mb), tryptophan, etc. The presence of scattering at Raman shift of 
1003 cm-1 was assigned to the scattering of the tropine aromatic ring from the cocaine 
molecule. Thus, identifying cocaine in exposed tissue only. Summary of the identification 
and functional group assignment for the peaks obtained with the DXR Raman microscope 
using excitation laser 532 nm and 785 nm can be found in Appendix B. 
 
Figure 3.10 Raman spectra of cocaine hydrochloride, control tissue and tissue containing 
cocaine. Spectra obtained with a Thermo Scientific DRX Raman microscope and excitation 
wavelength 532 nm.  
Although changes in the intensity and band position could be attributed to the effect 
that cocaine exerts in the scatter of nearest-neighbour molecules in the sample, 
differences in objectives (2-15x) could also have contributed to these changes (Turrell 
and Corset 1996). Differences in magnification objectives affected the laser energy 
density and therefore the Raman scattering of the sample (Sheena Mary et al. 2012, 
Schlücker 2014). 
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The analysis using the excitation laser 785 nm also showed differences in band 
position and intensity between the samples of control tissue and tissue containing cocaine 
(Figure 3.11): Control tissue presented weak bands: The band at 1122 cm-1 was assigned 
to amides present in the collagen, amino acids and proteins; the band at 1294 cm-1 was 
assigned to (CH2) from protein and lipids, the band at 1439 cm-1 was assigned to collagen 
content in lipids, and the band at 1657 cm-1 was assigned to (C=C amide I) from proteins 
and lipids. Figure 3.11 illustrates the Raman scattering of cocaine hydrochloride (> 98% 
purity), control tissue and tissue containing cocaine obtained with the excitation laser 785 
nm. 
 
 
Figure 3.11 Raman spectra of control cocaine (A), control tissue (B) and tissue containing 
cocaine (C). Spectra obtained with a Thermo Scientific DRX Raman microscope and excitation 
wavelength 785 nm. 
Tissue containing cocaine (Figure 3.11), on the other hand, presented fewer bands 
characteristic of chromophores such as collagen and myoglobin (Mb). The bands at 1340 
and 1450 were assigned to collagen content in lipids, and the band at 1657 cm-1 was 
assigned to (C=C amide I) from proteins and lipids. A small band at 1003 cm-1 was 
assigned to the cocaine asymmetric stretch of the phenyl ring and therefore the presence 
of cocaine in tongue tissue. 
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 Identification of drug depots  
Variability in scattering from the tissue samples containing cocaine at the different 
sections of the tongue tissue is illustrated in Figure 3.12. Differences in band intensity 
(cocaine concentration) were seen in NIR-Vis-Raman and Vis-Raman. Analysis with the 
excitation wavelengths 532 nm showed a decrease in the scattering from the outside-in 
of the tissue (section 1 to 3, Figure 3.1). The scattering in section 2 was 8% lower than in 
section 1 and the scattering in section 3 was 14% lower than in section 2. Analysis 
conducted with the excitation wavelengths 780 nm, on the other hand, showed a different 
tendency.  Changes in scattering intensity for section 2 was 21% higher than section 1 
and section 3 was 2% lower than section 2. 
 
Figure 3.12 Differences in Raman scattering for test samples of tissue containing cocaine at 
three different sections of the tongue tissue. Spectra obtained with a Thermo Scientific DRX 
Raman microscope and excitation wavelength 532nm and 785 nm. Error bars indicate the 
standard deviation of the data. 
Quantitative analysis by GC-MS of the amount of cocaine present in the tissue at the 
specific sections (section 1, 2 and 3) showed an increase in concentration from sections 
1, 2 and 3: Section 1: 7.8 ng/g, Section 2: 24.2 ng/g and Section 3:154.1 ng/g of tissue. 
These results indicated that the concentration of cocaine in tissue containing cocaine 
decreased from the outside-in of the tissue. The trend obtained by GC-MS (i.e. increase 
in concentration from Section 1 to 3) was in agreement with the trend obtained using the 
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exposure laser 532 nm (Figure 3.12) and the results presented by Reichardt (2014), who 
reported that concentration of cocaine in exposed tongue tissue varied at various regions 
of the tissue and that concentration of cocaine decrease from the outside-in within the 
tissue. 
During the development of this study, differences in scattering were seen within the 
same section (Section 1, 2 or 3). Scattering obtained at different positions in the same 
section differed of up to 15%. The fact that the position of the beam was not recorded 
when Raman analysis was conducted could have influenced the response obtained from 
the sample, thus explaining the variability in the response seen in Figure 3.10. The 
differences in Raman scattering could also be attributed to: (1) The response from a 
different kind of tissue, e.g. connective tissue and muscle could change based on the 
position of the incident light. (2) The response could be from a spot located in the 
proximities of the neighbour section, i.e. a spot in section 1 close to section 2. (3) The 
overlapping of spectral signature from different analytes, e.g. suppression of cocaine 
signal by the scattering of tissue constituents. 
Changes in cocaine concentration (Raman scattering) were also assessed based on the 
colour seen in the optical images of the tissue’s surface. When sections of same colour 
were analysed, differences in band intensity of up to 5% were found, which indicated that 
colour discrimination could not be used to identify regions with higher or lower drug 
concentration. It is important to note that at specific positions within the tissue sample 
containing cocaine, the Raman scattering corresponded to the fingerprint of control tissue, 
whereas some other areas included the scattering of the cocaine deposited in the tissue. 
The fact that cocaine was observed in different sides of the tissue and at different 
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concentrations suggested that cocaine could be specifically located within the tissue 
following exposure to the drug. 
3.4 CONCLUSIONS 
Three different SERS substrates were evaluated, for their use in the SERS analysis of 
cocaine in SOF (S2, S5 and S6). One homemade silver substrate and two commercial 
gold substrates. Selection of the substrates was based on the physical characteristics of 
the substrate. SERS spectra were successfully collected with all substrates for the 
detection of cocaine in SOF. The analysis indicated that cocaine could be detected at a 
LOD of 0.1 mg/mL using any of the substrates.  
Quantitative analysis was possible using calibration lines within the range of 0.1-20 
mg/mL for S2 (R2 = 0.90) and 0.1-10 mg/mL for S5 (R2 = 0.96). However, the preliminary 
results indicated that the precision (14-97%) and accuracy (73-429%) of the method using 
S5 were outside the acceptable values of ± 20% (USP 2011). The accuracy and precision 
of the method using S2 and S6 could not be evaluated because of the lack of linearity. 
Thus, a full validation (evaluation of linearity, precision, accuracy, LOD, limit of 
quantification, etc.) is required in order to fully evaluate the SERS methods. 
The results of the analysis of cocaine in SOF using portable Raman spectroscopy 
proved that cocaine could be detected at levels above 0.1 mg/mL in SOF using S2, S5 or 
S6. However, the enhancement by these substrates (104) would not allow the detection of 
cocaine in real OF samples or its use in in-vitro studies (detection of cocaine in SOF). 
Levels of cocaine range between 5-8 μg/mL at maximum in OF (Cone 2012, Reichardt 
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2014). Therefore, a more sensitive Raman instrument or a different analytical technique 
should be used to obtain lower LOD.  
Although all substrates allowed the detection of cocaine in SOF at LOD od 0.1 mg/mL, 
S2 was the substrate that provided less variability in the SERS results. Furthermore, the 
use of this substrate offered the advantage of more economic analysis compared with the 
commercial substrates, as a large volume of the substrate can be synthesised with few 
reagents and at atmospheric conditions.  
The results presented in this chapter also concluded that cocaine in porcine tongue 
tissue (7-154 ng/mL) could not be detected using any of the SERS substrates and the 
portable iRaman spectroscope. Enhancement of the Raman signal using S5 and S6 could 
not be achieved due to the physical nature of the substrates (these substrates could not be 
mixed or applied on the surface of the tissue). Even though S2 could be applied on the 
surface of the tissue, the detection of cocaine in the tissue would not be achieved, as 
concentrations of cocaine in tissue are below the LOD of this substrate. 
Raman spectroscopy coupled with microscopy provided molecular level information, 
enabling the investigation of drugs in porcine oral tissue. The results presented in this 
chapter showed that cocaine could be detected in different sections of tissue exposed to 
crack cocaine, using NIR-Vis-Raman and Vis Raman analysis (785 and 532 nm laser 
respectively). The optimal conditions for detection of cocaine in tongue tissue using the 
Thermo Scientific DXR Raman microscope were: excitation wavelength 532 nm and 
laser power 15 mW. Optimisation of parameters as the excitation wavelength was 
fundamental for the collection of good Raman scattering. 
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Evident spectral differences were seen between the tissue samples analysed in the 
NIR-Vis-Raman and Vis-Raman region. The bands of principal biochemical components 
(proteins, lipids, nucleic acids, etc.) predominated in the NIR-Vis-Raman spectra, while 
bands of intrinsic tissue chromophores (carotenoids, haeme) prevailed in the Vis-Raman 
spectra. This difference was attributed to resonance enhancement from the higher energy 
applied. Differences in Raman scattering were also visible at different positions of the 
tongue. These results indicated that cocaine was absorbed/deposited in specific areas 
within the tissue, thus supporting the idea of formed drug depots. 
The results above mentioned indicated the presence of drug depots in tissue exposed 
to cocaine. However, further evaluation of the presence of drug depots could not be 
performed due to limitations on the availability of instrumentation. Mapping of cocaine 
could identify the areas where cocaine is located in tissue samples exposed to the drug 
and hence confirm the preliminary results obtained in this PhD thesis and the 
immunohistochemical results reported by Reichardt (2014). 
Because of limitations with the availability of the Raman microscope, it was not 
possible to evaluate the detection of cocaine in SOF. However, based on the results 
obtained for the detection of cocaine in porcine tissue containing cocaine it can be 
suggested that a cocaine could be detected at physiological concentrations in SOF. 
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4.1 INTRODUCTION 
The detection and quantification of cocaine (COC) and cocaine derivatives1 in 
buffered oral fluid (BOF), synthetic oral fluid (SOF) and porcine oral mucosa tissue was 
required for the assessment of the release of drugs from drug depots formed in oral tissue 
into oral fluid (OF). The results presented in Chapter 2 and 3 demonstrated that the 
detection and quantification of cocaine by handheld and portable Raman spectroscopy 
could not be achieved for cocaine in SOF at physiological concentrations (LOD: 0.1 
mg/mL for cocaine in SOF). However, it demonstrated that detection of cocaine in oral 
tissue could be achieved by Raman microscopy at nanogram levels. Although Raman 
microscopy could be used for the detection of cocaine and cocaine derivatives at 
physiological concentrations, it was not possible to confirm its detection and subsequent 
quantification in OF. 
A wide range of concentrations of cocaine can be found in OF and oral tissue samples 
following consumption of cocaine: concentrations in the range of 0.42-1.3 μg/mL and 
0.080-0.870 μg/mL cocaine were reported in SOF and homogenised tongue tissue 
respectively following exposure to the smoke of 200 mg crack cocaine (Reichardt 2014). 
Furthermore, concentrations of cocaine in OF ranging 0.014-8.6 μg/mL were reported 
following immediate drinking of a cup of coca tea (Reichardt 2014). In addition to 
Reichardt’s studies, other authors have reported concentrations of cocaine in OF ranging 
                                               
1 Metabolites and other products such as anhydroecgonine methyl ester AEME (Section 1.2.3.3) 
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0-3 μg/mL following oral administration (chronic cocaine administration) (Kato et al. 
1993; Cone 2012). 
This chapter describes the development and validation of two LC-MS methods for the 
analysis of cocaine and cocaine derivatives in three different biological matrices: BOF, 
SOF and porcine oral mucosa samples. Liquid chromatography coupled to mass 
spectrometry (LC-MS) was selected for the quantitation of cocaine and cocaine 
derivatives in BOF, SOF and oral tissue because of its high sensitivity, selectivity and 
reliability (Drummer 2006, Bosker and Huestis 2009). Solid phase extraction (SPE) was 
conducted prior to the LC-MS analysis to eliminate interferents from the biological 
matrices, reduce the matrix effect and increase the selectivity and sensitivity of the LC-
MS method (Valente et al. 2010, Rees et al. 2012). 
These methods were subsequently used to evaluate the release of drugs from drug 
depots into OF using an in vivo (Chapter 6) and in vitro model (Chapter 7). 
Anhydroecgonine methyl ester (AEME), benzoylecgonine (BZE) and cocaine (COC) 
were evaluated in SOF and porcine oral mucosa as these analytes are the more likely to 
be encountered when cocaine or crack cocaine have been orally consumed (Kintz et al. 
1997). BZE is the primary degradation product of cocaine (Jufer et al. 2006) and AEME 
is the pyrolysis product of cocaine (Lewis et al. 2004). 
For the analysis of BOF the following analytes were analysed: COC, AEME, BZE, 
ecgonine methyl ester (EME), cocaethylene (CE) and nor-cocaine (NC). The metabolites 
EME, BZE and NC were included to the SOF method, to evaluate any degradation of 
cocaine. CE was also included in this method because this metabolite could potentially 
be present in collected OF, e.g. in cases where the participant had ingested alcohol 
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previously to the study. AEME, on the other hand, was evaluated as preliminary studies 
demonstrated that AEME could be an intrinsic analyte from the coca leaves. Hence, it 
could form drug depots in the oral cavity and its monitoring can aid in the understanding 
of release of drugs from drug depots. 
4.1.1 AIM AND OBJECTIVES 
4.1.1.1 Aim: 
This chapter aimed to develop quantitative LC-MS methods for the analysis of cocaine 
and cocaine derivatives in SOF, BOF and porcine oral tissue. 
4.1.1.2 Objectives: 
• To develop and validate an LC-MS method for the quantitation of AEME, BZE 
and cocaine in SOF using a single quadrupole LC-MS instrument. 
• To develop and validate an LC-MS method for the quantitation of AEME, BZE 
and cocaine in porcine oral tissue using a single quadrupole LC-MS instrument. 
• To develop and validate a method for the quantitation of AEME, BZE, EME, CE, 
NC and cocaine in buffered OF (BOF) using a triple quadrupole LC-MS/MS 
instrument. 
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4.2 METHODS 
4.2.1 Materials 
The analytical standards used for the analysis on SOF and tissue: AEME and BZE 
were purchased from LGC Standards (Teddington, UK). Cocaine hydrochloride 10 mg 
(purity 99.9%) was purchased from Sigma-Aldrich (Pool, UK). Deuterated internal 
standards AEME-d3, BZEd3 and COC-d3 were purchased at concentrations of 1 mg/mL 
in acetonitrile from LGC Standards (Teddington, UK). 
The analytical standards used for the analysis of BOF: AEME, BZE, COC, CE, EME 
and NC were purchased at concentrations of 1 mg/mL in acetonitrile from Cerilliant, 
Sigma-Aldrich (Dorset, UK). Deuterated AEME-d3, BZE-d3, COC-d3 and CE-d3 were 
purchased at concentrations of 1 mg/mL in acetonitrile from Lipomed, Kinesis Ltd. 
(Cambridgeshire, UK). 
Acetonitrile LC-MS grade, ammonia solution (33%), anhydrous disodium hydrogen 
orthophosphate, dichloromethane, hydrochloric acid (37%), isopropanol LC-MS grade, 
methanol LC-MS grade and potassium dihydrogen orthophosphate were purchased from 
Fisher Scientific (Loughborough, UK). Formic acid was purchased from VWR 
(Leicestershire, UK). Ammonium tartrate and sodium hydroxide were purchased from 
Sigma Aldrich (Dorset, UK). 
TELOS® H-CX 130 mg 3 mL mixed-mode SPE columns were purchased from 
Kinesis (Cambridgeshire, UK). Oasis® mixed-mode cation exchange (MCX) micro 
elution plates (Waters, Manchester, UK) were donated by AlereTM Toxicology. 
Concateno Certus Oral Fluid collection devices were donated by AlereTM Toxicology. 
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Porcine cheeks were purchased from L F B Meats, Bournemouth, UK. 
4.2.2 Instrumentation 
SOF and porcine oral tissue analysis was conducted using an Agilent 1200 Infinity 
Series LC system coupled to an Agilent Singe Quadrupole 6120 series MS system 
(Agilent Technologies, Waldbronn, Germany). The analysis was conducted using the 
electrospray ionisation source (ESI) set on positive mode. Capillary voltage was set to 
4000V. Corona current was set to 4 µA. Nitrogen was used as the nebuliser gas (40 psi) 
heated to 200°C and drying gas flow at 11 L/min heated to 250°C.  The instrument was 
operated in selected ion monitoring (SIM) mode. Chromatographic separation was 
achieved using a C18 stationary phase (column Poroshell 120 EC-C18 4.6 x 100 mm, 2.7 
µm) maintained at 40°C. A column filter (in-line filter, 0.2 µm, Waters, UK) was used in 
front of the analytical column. Separation was achieved using gradient elution as will be 
discuss later in this chapter. The ChemStation software (Version A.02.) was used for 
system control and data acquisition. Quantitative analysis was conducted using the 
Quantitative Analysis MassHunter Workstation software (Version B.07.01). The analysis 
was conducted by the researcher at Bournemouth University. 
BOF analysis samples was conducted using a LC-MS/MS system comprising of a 
Waters Xevo TQ MS (tandem quadrupole mass spectrometer) coupled to a Waters 
Acquity UPLC® system. The Analytes were separated on an Acquity UPLCTM BEH 
C18 column (130Å, 1.7µm, 1mm x 100mm) (Waters, Manchester, UK). Positive ESI was 
used and all analyses were performed in multiple reaction monitoring (MRM) mode with 
at least one transition (and maximum of three target ions) for each analyte. The capillary 
voltage was set to 4500V and desolvation temperature was 450 °C. Desolvation and cone 
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gas flow were 900 L/h and 50 L/h respectively. Separation was achieved using gradient 
elution as will be discuss later in this chapter. The MassLynx software (Version V4.1 
SCN950) was used for system control, data acquisition and quantitative analysis. The 
analysis was conducted by the researcher at Alere Toxicology (Abingdon, UK). 
4.2.3 Synthetic oral fluid preparation 
Synthetic oral fluid was prepared using the Cozart biosciences protocol (2008) 
“Production of Synthetic Saliva” (Appendix A). 
4.2.4 Tissue preparation 
To prepare the oral tissue homogenates, pieces of the tissue were finely cut using 
surgical scissors. The sectioned tissue was subsequently weighted and a solution of 0.1M 
phosphate buffer saline (PBS) (pH 6) was added at a weight three times that of the tissue 
weight. The tissue was homogenised using a PowerGen 125 homogeniser (Fisher 
Scientific) at 20,000 rpm until the sample was smooth and homogeneous. Homogenised 
tissue was then centrifuged at 30,000 rpm for 15 minutes and the supernatant layer was 
removed with a manual pipette and stored at -20°C for further use. 
4.2.5 Collection of control human oral fluid 
Samples of control human OF were collected from five human volunteers (male and 
female with age range 25-35) using the Concateno Certus® collection devices. OF was 
collected following manufacturer recommendations and under the ethical approval 
granted by Bournemouth University.  
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The collection device comprises of an absorbent pad attached to a handle that has an 
indicator incorporated, and a collection tube that contains a buffer (Figure 4.1). The 
indicator turns blue when 1 mL of OF has been collected. To collect the samples, each 
participant put the Certus device(s) in the oral cavity between the inner side of the cheek 
and the teeth until the indicator(s) turned blue. The pad was subsequently inserted into 
the respectively labelled tube (part of the collection device) which contained a buffer. 
After the collection, all devices were stored at room temperature for 24 hours. A pool of 
buffered OF (BOF) was subsequently obtained. 
Figure 4.1 AlereTM Concateno Certus oral fluid device. 
4.2.6 Solution preparation - Synthetic oral fluid and porcine oral tissue 
4.2.6.1 Stock and working solutions 
Initially, six stock solutions (A1, A2, A3, B1, B2, A3 and B3) containing AEME, BZE 
and cocaine were prepared at 1(A1/B1), 10 (A2/B2) and 100 (A3/A3) µg/mL in methanol 
from individual 1 mg/mL stock solutions (as purchased). The set A was used to prepare 
Absorbent Pad 
Tube containing buffer 
Volume indicator 
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the working solutions (5, 10, 50 and 100, 500 and 1000 ng/mL) and the set B was used to 
prepare the quality control (QC) standards (20, 250 and 800 ng/mL). The stock solutions 
were stored at -20 °C for up to three months and replaced as and when needed. Nine 
working solution mixtures were prepared in deionised water from the stock solutions. 
4.2.6.2 Calibration and QC solutions 
Calibration standards were prepared each day by fortifying 0.9 mL of drug-free SOF 
or homogenised tissue with the appropriate volume of working solution (100 µL), as 
outlined in Table 4.1. 
Table 4.1 Preparation of calibration and QC solutions for the analysis of cocaine and cocaine 
derivatives in SOF and porcine oral mucosa. 
 Level 
Working 
solution 
(ng/mL) 
Volume of 
working 
solution (µL) 
Final volume 
SOF/Tissue 
(µL) 
Calibrator/QC 
final 
concentration 
(ng/mL) 
Calibrator 
1       5 100 1000 0.5 
2     10 100 1000 1 
3    50 100 1000 5 
4   100 100 1000 10 
5   500 100 1000 50 
6 1000 100 1000 100 
      
QC 
1     20 100 1000 2 
2  200 100 1000 20 
3  800 100 1000 80 
QC: Quality control; SOF: Synthetic oral fluid; Tissue: Homogenised porcine oral mucosa 
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4.2.6.3 Internal Standard working solution 
The internal standard (IS) solution was prepared in methanol containing all deuterated 
analytes (AEME-d3, BZE-d3, COC-d3) at a concentration of 200 ng/mL to give a final 
concentration of 10 ng/mL in the final samples.  
4.2.6.4 Sample preparation 
A 50 µL of the internal standard working solution was added to all tubes containing 
calibrators, QCs or samples (SOF or tissue) to obtain a final concentration of 10 ng/mL. 
All tubes were then vortexed for 30 seconds and transferred to clean SPE cartridges. 
4.2.6.5 Blank samples 
Control (drug-free) SOF or homogenate tissue was fortified with IS working solution 
and used as blanks. Blank matrix samples were used to monitor any carryover and to 
ensure that batch contamination had not occurred. For recovery determination, standard 
solutions were prepared at the same nominal concentration as QCs in methanol 
4.2.7 Solution preparation - Buffered oral fluid 
4.2.7.1 Stock and working solutions 
Initially, two sets of stock solutions (A/B) were prepared. One set was used to prepare 
the working solutions and the second set to prepare the QC standards.  Stock solution A 
was prepared at 20 µg/mL and B was prepared at 10 µg/mL from each analyte (AEME, 
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EME, BZE, COC, CE and NC) in acetonitrile from individual 1 mg/mL stock solutions 
(as purchased). Working solutions were prepared at concentrations of 10, 20, 200, 1000, 
2500 and 5000 ng/mL. QC standards were prepared at concentrations of 15, 400 and 4000 
ng/mL. The stock solutions were stored at -20 °C for up to one year and replaced as and 
when necessary. 
4.2.7.2 Calibration and QC solutions preparation 
Calibration standards were prepared by fortifying 380 µL of drug-free BOF with the 
appropriate volume of working solution (20 µL), as outlined in Table 4.2. The calibration 
standard solutions had a final concentration of 0.5, 1, 10, 50, 125 and 250 ng/mL. 
Table 4.2 Preparation of calibration and QC solutions for the analysis of AEME, BZE, COC, 
CE, EME and NC. 
 Level 
Working 
solution 
(ng/mL) 
Volume of 
Working 
Solution (µL) 
Final Volume 
BOF (µL) 
Final 
concentration 
(ng/mL) 
Calibrator 
1     10 20 400       0.5 
2     20 20 400     1 
3   200 20 400   10 
4 1000 20 400   50 
5 2500 20 400 125 
6 5000 20 400  250 
      
QC 
1      15 20 400          0.75 
2    400 20 400             20 
3  4000 20 400           200 
BOF: Buffered oral fluid. QC: Quality control.  
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4.2.7.3 Internal Standard working solution 
A mixed internal standard working internal standard solution was prepared in 
acetonitrile containing all deuterated analytes at a concentration of 4 µg/mL to give a final 
concentration of 20 ng/mL. 
4.2.7.4 Sample preparation 
IS working solution (20 µL) was added to all tubes containing calibrators, QCs or 
samples to obtain a final concentration of 20 ng/mL. Then, 200 µL of 0.1M HCl was 
added to all tubes. All tubes were vortexed for 30 seconds and transferred to clean SPE 
cartridges. 
4.2.7.5 Blank samples 
Control (drug-free) BOF was fortified with IS working solution and used as blanks. 
Then 200 µL of 0.1M HCl was added. For recovery determination, standard solutions 
were prepared at the same nominal concentration as QCs in methanol. 
4.2.8 Solid phase extraction - Synthetic oral fluid and porcine oral tissue 
SOF or tissue samples were extracted using a modification of the method described by 
Rees et al. (2012). The derivatisation of analytes was removed from Rees’ method as this 
was not required for the analysis by LC-MS. TELOSÒ SPE cartridges were equilibrated 
and conditioned with successive washes of 2 mL methanol and 2 mL 0.1 M PBS (pH 
6.0). Cartridges were then loaded with 1 mL of sample (calibrator, QC, blank, SOF 
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sample or tissue sample). Columns were washed with 2 mL deionised water, 2 mL 0.1 M 
hydrochloric acid and 3 mL methanol. Analytes were eluted using 2 mL of a freshly made 
solution of dichloromethane/isopropanol/ammonium hydroxide (80:17:3 v/v/v) solution. 
The excess of elution solvent was then evaporated to dryness using a gentle stream of 
nitrogen (£ 30°C). Dried samples were reconstituted using 50 µL mobile phase A 
(aqueous solution of 10 mM ammonium formate and 0.1% formic acid).  
The recovery of the SPE method was calculated using the average of three replicates 
at all QC levels and the Equation 4.1. Fresh unextracted standards were analysed 
alongside these samples. 
𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦	(%) = 	 -./0	12./	3/456	7842/94.:-./0	12./	3/456	;<.842/94.: 𝑥100           (Equation 4.1) 
4.2.9 Solid phase extraction - Buffered oral fluid samples 
BOF samples were extracted using OasisÒ MCX cartridges. These cartridges were 
available at Alere Toxicology and are routinely used for the analysis of drugs of abuse in 
OF. Different extraction conditions were evaluated with the OasisÒ MCX cartridges in 
order to obtain the highest recovery of analytes. Optimisation was conducted using a low, 
medium and high concentration (0.75, 20 and 200 ng/mL). Table 4.3 shows the conditions 
evaluated for the SPE procedure. OasisÒ MCX cartridges were equilibrated and 
conditioned with successive washes of 200 µL conditioning solution 1 (CSl) and 200 µL 
conditioning solution 2 (CS2). All samples were then loaded with 400 µL of sample 
(calibrator, QC, blank or BOF sample) mixed with 200 µL loading solution (LS). 
Columns were subsequently washed with 200 µL washing solution 1 (WS1) and 200 µL 
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washing solution 2 (WS2). Analytes were eluted using 50 µL elution solvent (ES). 
Following extraction of analytes, 100 µL of aqueous solution of 0.1% formic acid was 
added to all dwells.  
Table 4.3 SPE methods evaluated for the detection of cocaine and cocaine derivatives in BOF. 
Method 
SPE steps 
Conditioning Loading Wash Elution 
CS1 
(200 µL) 
CS2 
(200 µL) 
LS 
(200 µL) 
WS1 
(200 µL) 
WS2 
(200 µL) 
ES1 
(200 µL) 
ES2 
(200 µL) 
1 MeOH HCl HCl:MeOH (50:50) HCl 
H2O:ACN 
(70:30) ACN 
MeOH:NH4 
(97:3) 
2 MeOH HCl HCl:MeOH (50:50) HCl 
H2O:MeOH 
(70:30) ACN 
MeOH:NH4 
(97:3) 
3 MeOH HCl HCl HCl H2O:MeOH (70:30) - 
MeOH:NH4 
(97:3) 
4 MeOH HCl PBS (pH6) PBS (pH6) H2O:MeOH (70:30) - 
MeOH:NH4 
(97:3) 
5 MeOH HCl HCl:MeOH (50:50) HCl 
H2O:ACN 
(70:30) - 
MeOH:NH4 
(97:3) 
6 MeOH HCl HCl HCl MeOH - MeOH:NH4 (97:3) 
7 MeOH HCl HCl HCl MeOH - MeOH:NH4 (98:2) 
8 MeOH HCl PBS (pH6) PBS (pH6) MeOH - MeOH:NH4 (97:3) 
9 MeOH HCl PBS (pH6) PBS (pH6) MeOH - MeOH:NH4 (98:2) 
ACN: Acetonitrile, NH4: Ammonia solution, HCl: 0.1M Hydrochloric acid, CS1-2: Conditioning step 1-2, ES1-2: 
Elution step 1-2, LS: loading step, MeOH: Methanol, PBS: 1.0M Phosphate buffer solution pH 6, SPE: Solid phase 
extraction and WS1-2: Washing step 1-2. 
The recovery for each SPE method was calculated using the average of three replicates 
at all QC levels and the Equation 4.1. Fresh unextracted standards were analysed 
alongside these samples. 
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4.2.10 LC-MS conditions - Method optimisation for synthetic oral fluid and porcine 
oral tissue. 
Chromatographic separation was conducted using an adapted version of a previously 
reported method (Mack and Long 2010). The LC and MS parameters were altered several 
times to ensure chromatographic separation and optimum detection. The separation was 
achieved using aqueous 10 mM ammonium formate with 0.01% formic acid as mobile 
phase A and acetonitrile as mobile phase B. With flow rate 1mL/min and column 
temperature of 40 °C. The gradient was programmed from 7% B to 18% B over 1.5 min, 
then to 50% B over 2 min, then to 95% B over 0.5 min, then held for 1 min. The system 
was then returned to its original conditions and the column was re-equilibrated at 7% B 
for 3 min. The total chromatographic cycle time was 8 minutes. Chromatography was 
fitted to obtain retention factor k > 1 and resolution Rs > 2 for all analytes The samples 
were injected using a 6 µL injection volume from a 100 µL injection loop (full loop 
injection with loop overfill).  Figure 4.2 shows the liquid chromatogram of AEME, BZE 
and cocaine. 
Figure 4.2 Total ion chromatogram of Anhydroecgonine methyl ester AEME (Segment 1), 
benzoylecgonine BZE (Segment 2) and cocaine COC (Segment 3) obtained after injection of 
standards at 100 ng/mL using an Agilent LC-MS single quadrupole. 
AEME 
BZE 
COC 
Acquisition time (min) 
Co
un
ts
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Detailed method development was conducted to optimise the mass transitions for use 
in SIM. All drugs were run individually as standards to obtain their retention time and 
mass spectra. To do this, reference standards were diluted in mobile phase A to a final 
concentration of 100 ng/mL. Following chromatographic separation, the acquisition was 
split into three stages, based on the elution time. This segment separation was also used 
to increase the response of the ions present in the segment, as less number of ions need 
to be detected in a single segment of time (3-6 ions per segments instead of 16 ions). 
Table 4.4 presents the optimal MS parameters.  
Table 4.4 Compound-specific MS (Agilent LC-MS single quadrupole) parameters used for 
the analysis of cocaine and cocaine derivatives in SOF and tissue. 
Compound St
  
(min) 
Rt  
(min) 
Quantitatio
n ion 
Fragmentor 
Quantifier 
(V) 
Qualifier 
ion 
Fragmentor 
Qualifiers 
(V) 
NP  
(psi) 
AEME 1.5 - 2.5 2.13 182.1 120 91.1 122.1 
220 
170 40 
AEME-d3 1.5 - 2.5 2.13 185.2 120 
94.1 
125.2 
220 
170 40 
BZE 2.5 - 3.5 3.36 290.1 120 168.1 220 40 
BZE-d3 2.5 - 3.5 3.36 293.3 120 171.2 170 40 
COC 3.5 – 4.0 3.88 304.1 120 
82.1 
182.1 
220 
170 40 
COC-d3 3.5 – 4.0 3.88 185,1 170 
85.1 
307.7 
220 
120 40 
AEME: Anhydroecgonine methyl ester, AEME-d3: Deuterated AEME, BZE: Benzoylecgonine, BZE-d3: Deuterated 
BZE, COC: Cocaine, COC-d3: Deuterated COCAINE, St: Segment time, Rt: Retention time. NP: Nebuliser Pressure. 
4.2.11 LC-MS/MS conditions - Method optimisation for buffered oral fluid 
Chromatographic separation was conducted using an adapted version of the in-house 
routine analysis method for cocaine and metabolites used at Alere Toxicology (Abingdon, 
UK). The analysis was conducted at Alere Toxicology (Abingdon, UK) using a Waters 
Aquity instrument. The LC and MS parameters were altered several times to ensure 
chromatographic separation and optimum detection. Mobile phase A was an aqueous 
solution of 0.01% formic acid and mobile phase B was MeOH. The flow rate was 0.4 
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mL/min and the column temperature was 55°C. The gradient was programmed from 5% 
B held for 0.25 min, then raised from 5% to 60% B over 2 min, then to 80% B over 0.25 
min and finally held for 0.75 min. The system was then returned to its original conditions 
and the column was re-equilibrated at 5% B for 1.75 min. The total chromatographic 
cycle time was five minutes. The samples were injected using a 5 µL injection volume. 
Figure 4.3 shows a typical chromatogram of EME, AEME, BZE, COC, CE and NC. 
 
Figure 4.3 Total ion chromatograms of ecgonine methyl ester (EME), anhydroecgonine 
methyl ester (AEME), benzoylecgonine (BZE), cocaine (COC), cocaethylene (CE) and nor-
cocaine (NC) obtained at 100 ng/mL using a Waters LC-MS/MS Xevo TQ.  
Detailed method development was conducted to optimise the mass transitions for use 
in MRM. All drugs were run individually as standards to obtain their individual retention 
times and mass spectra. To do this, reference standards were diluted in mobile phase A 
(0.1% FA) to a final concentration of 100 ng/mL. Following chromatographic separation, 
the acquisition was split into three stages, based on the elution time. Table 4.5 presents 
the optimal MS parameters. 
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Table 4.5 Compound-specific MS (Waters LC-MS/MS Xevo TQ) parameters used for the 
analysis of cocaine and cocaine derivatives in BOF. 
Compound St (min) Rt (min) MRM Transitions (m/z) 
Collision 
energy (V) Corona (V) 
EME 0.2-1 0.59 200.1 à   82.1 200.1 à 182.1 35 
20 
25 
AEME 1 - 2 1.35 182.1 à 118.1 182.1 à 122.1 35 
25 
20 
AEME-d3 1 – 2 1.35 185.1 à 125.1 35 20 
BZE 2 - 5 2.56 290.1 à 105.1 290.1 à 168.1 30 
30 
20 
BZE-d3 2 - 5 2.56 293.1 à 171.1 30 20 
COC 2 - 5 2.81 304.1 à 105.1 304.1 à 182.1 30 
30 
20 
COC-d3 2 - 5 2.81 307.1 à 185.1 30 20 
NC 2 - 5 2.97 290.1 à 136.1 290.1 à 168.1 35 
20 
25 
CE 2 - 5 3.13 318.1 à   82.1 318.1 à 196.1 35 
25 
20 
CE-d3 2 - 5 3.13 321.1 à 199.1 35 25 
AEME: Anhydroecgonine methyl ester, AEME-d3: Deuterated AEME, BZE: Benzoylecgonine, BZE-d3: Deuterated 
BZE, CE: cocaethylene, CE-d3: Deuterated CE, COC: Cocaine, COC-d3: Deuterated COC, NC: Nor-cocaine St: 
Segment time, Rt: Retention time. NP: Nebuliser Pressure. 
4.2.12 Methods validation 
Method validation (SOF, BOF and porcine oral tissue) were conducted in accordance 
with the Scientific Working Group for Forensic Toicology (SWFTOX) standard practices 
for method validation in forensic toxicology (SWGTOX 2013).  The following 
parameters were used to evaluate each of the methods: accuracy; intra-assay precision 
and inter-assay precision; linearity; matrix effect; sensitivity; specificity and recovery.  
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4.2.12.1 Limit of Detection (LOD) and Lower Limit of Quantification (LLOQ) 
The LOD for each compound was assessed by determining the lowest concentration 
at which a drug can be detected with a signal to noise (S/N) ratio greater than three. The 
LLOQ was determined as the lowest concentration with S/N ratio greater than 10 and at 
which accuracy (± 20%) and precision criteria (± 20%) were met. 
4.2.12.2 Linearity 
Calibration standards were prepared by spiking control SOF, tissue or OF as outlined 
in Section 4.2.6 and Section 4.2.7. Calibration lines were plotted using the peak area ratio 
against analyte concentration and at least six calibration points per curve. The peak to 
area ratio was calculated using the respectively deuterated IS, e.g. COC and COC-d3.  
The linear regression with unweighted least assumes that (1) the y-direction errors are 
normally distributed (Gaussian distribution), and (2) that the standard deviation of y-
direction errors is the same for all x values (homoscedastic data) (Motulsky and 
Christopoulos 2005; Miller 1991). However, in some cases, the standard deviation of y-
direction errors often increases as x increases (heteroscedastic data) and a weighted 
regression should be used instead. Linear regression of unweighted and weighted data 
was calculated by the method of least squares and expressed by the correlation coefficient 
(R2), linearity was assessed by F-test and visual evaluation of residual plots. The best 
weighting factor was chosen according to the percentage of deviation from the nominal 
value and expressed as %bias. 
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In addition to the full validation, QC procedures were routinely conducted during batch 
analysis. A maximum deviation of ± 20% of the mean of the nominal QC value was 
considered acceptable to ensure the validity of the calibration (SWGTOX 2013). 
4.2.12.3 Precision and accuracy 
Within-run (n = 6) and between-run (n = 3) precision and accuracy of the method was 
determined by employing n = 6 of QC samples spiked at low (QC1), medium (QC2) and 
high (QC3) concentrations. Within-run precision was calculated using n = 6 replicates 
obtained on the same day and expressed as a percentage relative standard deviation 
(%RSD) (Equation 4.2). Between-run precision was evaluated for n = 6 sets at each QC 
level on three different days and expressed as a percent RSD (Equation 4.3). Accuracy 
was calculated by dividing the mean measured concentration at each QC level (n = 6) 
divided by the theoretical spiked concentration and expressed as a percentage of the 
theoretical spiked concentration (Equation 4.4). A maximum deviation of ± 20% of the 
nominal QC value was considered acceptable (SWGTOX 2013). 
𝑊𝑖𝑡ℎ𝑖𝑛 − 𝑟𝑢𝑛	𝑅𝑆𝐷% = IJ4/<:/2:	:.K5/456<	6L	/	M5<NO.	M.4	6L	M/PQO.MR./<	K/OS.	6L	/	M5<NO.	M.4	6L	M/PQO.M T 𝑥100     (Equation 4.2) 
𝐵𝑒𝑡𝑤𝑒𝑒𝑛 − 𝑟𝑢𝑛	𝑅𝑆𝐷% = IJ4/<:/2:	:.K5/456<	6L	P./<	K/OS.	L62	./9W	96<9.R./<	K/OS.	L62	./9W	96<9. T 𝑥100 (Equation 4.3) 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦	(%) = 	 194S/O	K/OS.[\2S.	K/OS.\2S.	K/OS. 𝑥100            (Equation 4.4) 
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4.2.12.4 Carryover 
Carryover was assessed by injecting blank samples following the injection of three 
independent calibrators at the high calibrant: concentration of 100 ng/mL for SOF and 
homogenate porcine tissue, and 250 ng/mL for BOF. The blank samples were 
subsequently examined for the presence of analytes from each previous injection. 
4.2.12.5 Method selectivity – interference studies 
The selectivity of the method was assessed to determine if there was any interference 
that can cause positive results. Interferences can be caused by endogenous (analytes 
present in the matrix) and exogenous compounds (other analytes present in the sample). 
Single ion monitoring (analysis of SOF and homogenate porcine tissue) and multiple ion 
monitoring (analysis of BOF) were used to ensure selectivity for the analyte of interest, 
even for two co-eluting analytes, e.g. COC and COC-d3 (Ekman et al. 2009). Samples 
prepared in mobile phase A containing all analytes and internal standards at concentration 
10 ng/mL were analysed and compared with samples prepared in each matrix. 
4.2.12.6 Matrix effect – Ion suppression and ion enhancement 
The matrix effect refers to the ion suppression or enhancement of an analyte by the co-
eluting compounds in a biological sample, e.g. SOF, BOF or Tissue (Matuszewski et al. 
2003). This effect was assessed by preparing two sets of samples made up in the mobile 
phase (Set 1) and in extracts of blank matrices spiked with the analyte after extraction 
(Set 2). Set 1 and 2 samples were spiked at low (QC1), medium (QC2) and high (QC3) 
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concentrations. The percentage of the matrix effect was calculated by dividing the mean 
peak area of the extracted samples by the mean of unextracted samples (Equation 4.5). 
𝑀𝑎𝑡𝑟𝑖𝑥	𝐸𝑓𝑓𝑒𝑐𝑡	(%) = 	 -./0	/2./	.842/94.:	M4/<:/2:-./0	/2./	S<.842/94.:	M4/<:/2: 𝑥100                      (Equation 4.5) 
A percentage of matrix effect greater than 100% suggested an ion enhancement and a 
percentage less than 100% suggest an ion suppression. 
4.2.12.7 Auto-sampler stability 
The auto-sampler stability was assessed to determine any variability in the 
concentration of analytes (peak area ratios) from samples that have undergone routine 
preparation after a certain period of time. The concentration of the samples may change 
because of their degradation when samples are not immediately analysed following the 
extraction procedure. Delays in the analysis can be caused by instrument failure (which 
may take from hours to days) and/or sample re-injection. Additionally, batch run times 
may take up to 24 hours depending on the number of samples. 
In order to evaluate the auto-sampler stability, QCs at low (QC1), medium (Q2) and 
high (Q3) concentrations were analysed. The QCs were subsequently left in the auto-
sampler and re-injected after 24 and 96 hours (one and four days). The recovery of each 
analyte was calculated using the Equation 4.6. Analytes were identified as unstable if 
their recovery fell out of the acceptable criteria of ± 20%. 
𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦	(%) = 	 `5</O	-./0	12./	3/456\2S.	-./0	12./	3/456 𝑥100              (Equation 4.6) 
The variation in analyte response can also monitor the stability of the analytes and 
internal standards themselves. Although the peak area ratio may not change over time, 
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the analyte and respectively internal standard can degrade in the same extent and to a 
concentration that cannot longer be detected. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Solid phase extraction – Synthetic oral fluid and porcine oral tissue samples 
The extraction method used for the analysis of cocaine and cocaine derivatives (AEME 
and BZE) from SOF and porcine oral tissue samples was based on previous studies 
developed by Rees et al. (2012). This method was modified to fit the analysis of analytes 
in a LC-MS system, e.g. there was no need for a derivatisation step. Overall recovery of 
the SPE method for SOF and tissue samples were 88% and 88% respectively. Recovery 
values for all analytes in both matrices is presented in Table 4.6.  
Table 4.6 SPE recovery values of cocaine and cocaine derivatives in SOF and porcine oral 
tissue obtained using TELOS® cartridges. 
Concentration 
(ng/mL) 
Recovery (%) 
SOF  TISSUE 
AEME BZE COC  AEME BZE COC 
2 95.5 97.3 98.4  98.6 99.2 99.9 
20 97.0 94.9 99.2  96.3 95.6 99.5 
80 97.0 96.4 99.0  98.2 103 99.6 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine and COC: Cocaine, SOF: synthetic oral fluid; 
Tissue: homogenised porcine oral mucosa 
The results showed mean recovery values of 96, 96 and 99% for AEME, BZE and 
COC in SOF respectively. Mean recovery values of 98, 99, 100% were obtained for 
AEME, BZE and COC in porcine oral tissue. Recovery values for the deuterated analytes 
in SOF (10 n/mL) were 93, 90 and 107% for AEME-d3, BZE-d3 and COC-d3 respectively. 
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The recovery in tissue were 75, 110 and 103% for AEME-d3, BZE-d3 and COC-d3 
respectively. 
4.3.2 Solid phase extraction – Buffered oral fluid samples 
The extraction method used for the analysis of cocaine and cocaine derivatives (EME, 
AEME, BZE, CE and NC) from BOF samples was based on a method used to analyse 
cocaine and metabolites at Alere toxicology. This method was modified to fit the analysis 
of the compounds of interest (EME, AEME, BZE, COC, CE and NC). Additionally, PBS 
(pH 6.0) was assessed as loading solvent because high recoveries (> 95%) were reported 
for the extraction of EME and other analytes in OF samples using this solution (Toennes 
et al. 2005). 
Table 4.7 shows the peak area obtained for all the SPE method evaluated for the 
extraction of cocaine and cocaine derivatives (EME, AEME, BZE, CE and NC).  From 
this table, it can be observed that the extraction of EME could not be achieved using the 
methods 1 to 5. Hence, these methods were discarded. Even though methods 6 to 9 were 
able to extract EME, only the methods 7 and 9 provided more significant peak areas for 
EME and the rest of analytes. The method 9 provided bigger peak areas for the extraction 
of EME in comparison with method 7 but the peak areas of BZE, COC, CE and NC were 
considerably reduced (10, 64, 69 and 82% respectively) using this method 9. As the peak 
area of EME was only reduced by 43% using method 7 compared with method 9, this 
method was used for the extraction of cocaine and cocaine derivative in BOF. 
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Table 4.7 Analyte response from the different SPE extraction methods obtained using Oasis® 
micro-extraction plates. 
Analyte 
Concentration 
(ng/mL) 
SPE Extraction Method  
Peak Area (Response/min) 
1 2 3 4 5 6 7 8 9 
AEME 1 1287 1340 151849 1441 1675 109 2650 182 3956 
 10 11194 2428 160278 16322 20070 148 32657 137 53702 
 50 62920 28377 168197 69520 68547 126 147006 186 224759 
EME 1 ND ND ND ND ND 15 352 40 516 
 10 ND ND ND ND ND 18 638 74 1725 
 50 ND ND ND ND ND 2 1964 521 8514 
BZE 1 1104 13862 3428 163 18 460 21914 338 2669 
 10 8679 19260 31603 2569 110 594 313855 337 22462 
 50 51393 276693 116146 9014 416 545 1214830 366 133342 
COC 1 13023 21922 1632 20725 21356 3199 54274 2606 33229 
 10 102029 43643 4038 193650 204132 3261 529737 2356 370845 
 50 542366.1 455895 13826 848273 897018 2917 2525980 2604 1509470 
CE 1 15115 22442 389 22968 23186 388 56701 787 36900 
 10 117318 44449 343 220887 231460 598 559461 421 429495 
 50 635877 481312 365 954770 1008471 356 2743653 514 1762914 
NC 1 3221 16681 186 4184 4138 445 20480 496 15982 
 10 26719 183626 148 40275 42066 427 195194 374 173931 
 50 134727 917489 227 169780 178313 414 946733 425 753667 
AEME
-d3 
50 16379 51352 53433 22507 28950 84024 79179 122544 118596 
BZE-d3 50 18694 642525 9717 4857 213 786952 673331 103306 71642 
COC-
d3 
50 178190 982177 93590 331148 382832 948417 1034307 726091 813472 
CE-d3 50 256103 1137591 81868 403984 429283 786952 673331 103306 71642 
AEME: Anhydroecgonine methyl ester, AEME-d3: Deuterated AEME, BZE: Benzoylecgonine, BZE-d3: 
Deuterated BZE, CE: cocaethylene, CE-d3: Deuterated CE, COC: Cocaine, COC-d3: Deuterated COC, NC: Nor-
cocaine SPE: Solid phase extraction. 
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The percentage of recovery obtained using the method 7 for the extraction of all 
analytes is described in Table 4.8. The recovery of analytes using this method ranged 
between 49-100% for all analytes. Mean recoveries for AEME, EME, BZE, COC, CE 
and NC were 56.1, 76.7, 57.4, 89.3, 99.9 and 49.0% respectively. These results indicated 
that COC and CE were considerably higher than the other analytes. The differences in 
recovery values were attributed to changes in the recovery of corresponding IS. The mean 
recovery values of AEME-d3 and BZE-d3 were 77% and 109% respectively, compared 
with 52% for COC-d3 and 51% for CE-d3. As indicated in Equation 4.1, the percentage 
of recovery was calculated using values of peak area ratio and this ratio is affected by the 
IS response, e.g. a decrease in IS response will result in a high recovery value. 
Table 4.8 SPE recovery values of cocaine and cocaine derivatives in BOF obtained using 
Oasis® micro-extraction plates and the SPE method 7. 
Concentration 
(ng/mL) 
Recovery (%) 
AEME EME BZE COC CE NC 
0.75 57.2 74.7 54.2 73.2 81.8 47.2 
20 51.9 82.4 45.5 64.1 82.6 42.7 
200 59.2 72.8 72.5 131 135 57.1 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, CE: cocaethylene, COC: Cocaine, NC: Nor-
cocaine. 
These percentage of recoveries were considerably lower in comparison with the 
recoveries obtained using the TELOS multimode cartridges which ranged between 96-
100%. Even though most recovery values using the Oasis® micro-elution plate were 
<90%, the sensitivity of the MRM mode from the MS detection allowed the detection and 
quantification of these analytes at nano-gram levels, as indicated below. 
4.3.3 LC-MS method validation – Synthetic oral fluid and porcine oral tissue 
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Analyte identification was initially evaluated in total ion monitoring (TIM) under low 
fragmentor energy (this allowed the detection of unfragmented analytes). However, no 
detection was obtained due to the low concertation injected (100 ng/mL) and the low 
sensitivity that the scanning mode offered. Since TIM could not be used for the detection 
of analytes, SIM was used instead. SIM allowed the detection of single ions in a longer 
period of time and also the rapid switching between other selected ions resulting in 
reduced noise and increased sensitivity. 
A maximum of three target ions and qualifier ions were obtained using the flow 
injection analysis (FIA) option from the ChemStation software. This option can be used 
to optimise the main MS parameters, such as fragmentor energy. Several fragmentor 
voltages were checked to find the optimum voltage that provided strong molecular ions 
and good relative abundance of fragment ions. To do this, voltages in a range of 0 to 300 
V were set at 20 V intervals. Figure 4.4 illustrates a characteristic FIA results for the 
analysis of AEME (parent ion 182.1 m/z). In this figure, the highest response was 
obtained at fragmentor voltage of 120 V. For the detection of qualifiers ions higher 
fragmentor voltages were used as fragmentation of the parent ion was required, e.g. 220 
V for the detection of qualifier ion 91.1 m/z. Results of the optimum MS parameters 
including the target ions and qualifier ions used for the detection and identification of 
each analyte were mentioned in the methodology section (Table 4.4).  
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Figure 4.4 Optimisation of fragmentor voltage for the pseudo-molecular ion and fragment ion 
of AEME obtained using an Agilent LC-MS single quadrupole. 
An illustration of the final MS spectra obtained for each analyte following optimisation 
is presented in Figure 4.5 Quantitation ions were selected based on the highest response 
as stated in Table 4.4. The quantitation ion for COC-d3 was selected as 185.2 m/z instead 
of 307.7 m/z because this was the higher response obtained at the optimum fragmentor 
voltage. 
 
Figure 4.5 Mass Spectra (Agilent LC-MS single quadrupole) of AEME, AEME-d3, BZE, 
BZE-d3, COC and COC-d3. 
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4.3.3.1 Method selectivity  
No interferences were observed for AEME, BZE or COC (Figure 4.5). Additionally, 
no interferences were seen on any of the peaks of the non-deuterated analytes from the 
deuterated counterparts and vice-versa. The retention time variation for all analytes was 
<0.2% for all analytes (AEME: 0.20%, AEME-d3 0.18%, BZE 0.19%, BZE-d3 0.10%, 
COC 0.12% and COC-d3 0.15%; with n = 53 for each analyte). No interferences were 
seen in any of the blanks of control BOF. This result indicated that there was no 
interference from the matrix in this method. 
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Figure 4.6 Liquid chromatograms (Waters LC-MS/MS Xevo TQ) of AEME, 
AEME-d3, BZE, BZE-d3, COC and COC-d3 including qualifiers.  
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4.3.3.2 Linearity 
Linearity for AEME and BZE was determined over a concentration range of 0.5-100 
ng/mL in SOF or Tissue using six calibration points and six replicates per calibration 
point. Linearity for COC was determined over a concentration range of 1-100 ng/mL in 
SOF or Tissue. The residual plots (Figure 4.7) of unweighted data for all analytes in both 
matrices indicated that the data was heteroscedastic as the scatter of the residuals 
increased with the increase in concentration (Pereira da Silva et al. 2015). 
Figure 4.7 Residual plot for the analysis of anhydroecgonine methyl ester (AEME), 
benzoylecgonine (BZE) and cocaine (COC) in SOF and homogenate porcine tissue. 
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The F-Test at confidence level of 95% indicated that there were significant differences 
(p < 0.05) between the variances at the lowest and highest concentration level in all 
calibration lines (Table 4.9). These significant differences in variances confirmed the 
heteroscedasticity of the data. 
Table 4.9 Results of F-Test. Comparison of the homogeneity of variances.  
Analyte Matrix Concentration calibrant (ng/mL) Mean PAR F-Test
 p 
 SOF 0.5 0.13 1893 3.48x10-8 
AEME  100 10.22   
 Tissue 0.5 0.14 5020 3.04x10-9 
  100 10.21   
 SOF 0.5 0.06 23721 6.27x10-11 
BZE  100 9.81   
 Tissue 0.5 0.063 7947 9.64x10-10 
  100 10.27   
 SOF 1 0.04 1063 1.47x10-7 
COC  100 2.59   
 Tissue 1 0.04 5320 2.63x10-9 
  100 2.70   
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, PAR: Peak area ratio, SOF: Synthetic 
oral fluid, Tissue: homogenised porcine oral tissue. F-Test (5, 5, 0.95 = 5.05, p < 0.05). 
In order to obtain a best linear unbiased relation between the concentration and the 
response of the analytes a weighted least squares linear regression model (1/x) was used. 
Weighed models are commonly used to minimise the influence of higher concentrations 
of the regression. Weights based on the variable x (concentration) can provide a simple 
approximation of the variance (Pereira da Silva et al. 2015). Results of the unweighted 
and weighted (1/x) linear correlation are summarised in Table 4.10. This table shows 
higher correlation coefficients and lower % bias (sum of the absolute % bias across the 
whole concentration range) for the 1/x weighting regression model than the unweighted 
model. The accuracy or % bias values were within ± 20% for all analytes on the weighted 
model. Plotting of the weighted residuals showed random scattering of variances for all 
analytes in both SOF and tissue matrices (Figure 4.8). 
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Table 4.10 Results of unweighted and weighted linear regression model for AEME, BZE and 
cocaine in SOF and homogenate porcine tissue. 
Analyte Matrix Regression model Equation R2 %Bias 
 SOF unweighted y = 0.1019x+0.1112 0.998 679 
AEME  1/x y = 0.1031x+0.0786 0.998 233 
 Tissue unweighted y = 0.1013x+0.1148 0.999 715 
  1/x y = 0.1022x+0.0892 0.999 246 
BZE SOF unweighted y = 0.0981x+0.0168 0.993 377 
  1/x y = 0.0984x+0.0082 0.995 291 
 Tissue unweighted y = 0.1026x-0.0078 0.995 425 
  1/x y = 0.1020x+0.0079 0.996 254 
COC SOF unweighted y = 0.0261x+0.0181 0.993 424 
  1/x y = 0.2639x+0.0077 0.994 263 
 Tissue unweighted y = 0.0269x+0.0102 0.990 233 
  1/x y = 0.0269x+0.0100 0.993 232 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, SOF: Synthetic oral fluid, Tissue: 
homogenised porcine oral tissue. 
 
 
 
  
 
Figure 4.8 Residual plots of 1/x weighted regression model for anhydroecgonine methyl ester 
(AEME), benzoylecgonine (BZE) and cocaine (COC) in SOF and homogenate porcine tissue. 
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4.3.3.3 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
The LOD and LOQ obtained for the detection of AEME, BZE and COC in SOF are 
shown in Table 4.11. The results indicated that AEME and BZE could be detected (0.1 
ng/mL) and quantified (0.5 ng/mL) at a lower concentration than COC (1.0 ng/mL). 
During the development of the method validation, it was observed the presence of a peak 
which corresponded to COC. Even though several washes were injected before and after 
every analytical run and a complete clean-up of the LC-MS system was conducted, this 
interfering peak could not be eliminated. Hence, the LOQ was calculated using the S/N 
response which included the interfering COC peak.  
Table 4.11 LOD, LOQ and linearity for the analysis of cocaine and cocaine derivatives in 
SOF and porcine oral tissue. 
Matrix Analyte LOD (ng/mL) 
LLOQ 
(ng/mL) 
Calibration 
range 
(ng/mL) 
Calibration 
equation R
2 
SOF 
AEME 0.1 0.5 (15.0) 0.5-100 y=0.101x-0.087 0.997 
BZE 0.1 0.5 (9.2) 0.5-100 y=0.099x-0.002 0.999 
COC 0.5 1.0 (7.0) 1.0-100 y=0.029x-0.010 0.999 
TISSUE 
AEME 0.1 0.5 (7.7) 0.5-100 y=0.102x-0.107 0.999 
BZE 0.1 0.5 (11.3) 0.5-100 y=0.101x-0.016 0.999 
COC 0.5 1.0 (8.3) 1.0-100 y=0.029x-0.010 0.999 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, LOD: Limit of detection, LLOQ: Low 
limit of quantification expressed as mean value and percent relative standard deviation (%RSD, n=6). SOF: Synthetic 
oral fluid, Tissue: homogenised porcine oral tissue. 
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4.3.3.4 Precision and Accuracy for synthetic oral fluid 
Within-run precision data for all analytes extracted from SOF are summarised in Table 
4.12. The within-run precision values were within the acceptable range of £ 20% 
(SWGTOX 2013) for the low (2 ng/mL), medium (20 ng/mL) and high (80 ng/mL) 
concentrations.  
Table 4.12 Within-run and between-run data for analysis of AEME, BZE and COC in SOF 
obtained using an Agilent LC-MS single quadrupole 
  
Concentration (ng/mL) 
AEME BZE COC 
2 20 80 2 20 80 2 20 80 
W
ith
in
-r
un
 1
 
(n
=6
)  
Mean 2.01 20.8 80.0 1.96 19.7 80.0 2.00 18.2 80.6 
SD 0.08 0.34 2.28 0.05 0.55 1.40 0.13 0.78 2.57 
SE 0.03 0.14 0.93 0.02 0.22 0.57 0.05 0.32 1.05 
%RSD 4.09 1.63 2.85 2.35 2.77 1.75 6.35 4.28 3.19 
Accuracy 101 104 100 97.8 98.5 100 100 91.2 101 
           
W
ith
in
-r
un
 2
 
(n
=6
) 
Mean 1.92 20.5 80.7 1.93 19.9 79.9 1.79 17.8 78.5 
SD 0.05 0.63 3.45 0.01 0.08 0.59 0.08 0.35 0.67 
SE 0.02 0.26 1.41 0.00 0.03 0.24 0.03 0.14 0.28 
%RSD 2.53 3.09 4.27 0.40 0.40 0.73 4.60 1.94 0.86 
Accuracy 96.1 102 101 96.6 99.3 100 89.6 89.0 98.2 
           
W
ith
in
- r
un
 3
 
(n
=6
) 
Mean 1.83 20.4 81.2 1.96 19.9 80.6 1.85 18.5 79.4 
SD 0.16 0.57 2.83 0.05 0.08 1.16 0.17 0.83 0.74 
SE 0.07 0.23 1.16 0.02 0.03 0.47 0.07 0.34 0.30 
%RSD 8.95 2.79 3.49 2.48 0.40 1.44 9.06 4.51 0.93 
Accuracy 91.7 102 102 97.9 99.4 101 92.5 92.4 99.2 
           
Be
tw
ee
n-
ru
n 
(n
=3
) 
Mean 1.92 20.6 80.6 1.96 19.8 80.32 1.93 18.4 79.9 
SD 0.15 0.46 2.39 0.04 0.36 1.20 0.16 0.73 1.82 
SE 0.06 0.19 0.97 0.02 0.15 0.49 0.06 0.30 0.74 
%RSD 7.89 2.23 2.96 2.16 1.83 1.49 8.14 3.99 2.28 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, SD; standard deviation, SE: Standard 
error, %RSD: Percent relative standard deviation. 
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The within-run mean results were 1.9, 20.6 and 80.6 ng/mL for the low, medium and 
high AEME concentrations respectively. The mean results for BZE were 1.9, 19.8 and 
80.2 ng/mL for the low, medium and high concentrations. The mean results for COC were 
1.9, 18.2 and 79.5 ng/mL for the low, medium and high concentrations. Precision values 
were below 9.1% for all analytes at the three concentrations evaluated. The precision 
values obtained for AEME were within 8.9% (Low), 3.1% (Medium) and 4.3% (High). 
The values for BZE were within 2.5% (Low), 2.8% (Medium) and 1.8% (High). Precision 
values for COC were within 9.1% (Low), 4.5% (Medium) and 3.2% (High). Within-run 
accuracy varied between concentrations and analysis. In general, between-run accuracy 
was less than 9.0% for AEME, 2.8% for BZE and 9.1% for cocaine. 
The between-run precision for cocaine and derivatives in SOF was below the 
acceptable value of ± 20% or ± 30% if the result is close to the LOQ (SWGTOX 2013). 
Imprecision values were below 7.9, 2.2 and 8.1% for AEME, BZE and COC respectively. 
4.3.3.5 Precision and Accuracy for porcine oral tissue 
Within-run precision data for all analytes extracted from porcine oral tissue are 
summarised in Table 4.11. The within-run precision values were within the acceptable 
range of £ 20% (<10.9%) for all analytes at the three concentrations evaluated. The 
within-run mean results were 2.0, 20.5 and 80.4 ng/mL for the low, medium and high 
AEME concentrations respectively. The mean results for BZE were 1.9, 20.1 and 81.6 
ng/mL for the low, medium and high concentrations. The mean results for COC were 1.9, 
19.4 and 83.3 ng/mL for the low, medium and high concentrations. The values obtained 
for AEME were within 5.6%, 6.7% and 3.7% of the main value at the low, medium and 
high concentrations respectively. The values for BZE were within 9.4% (Low), 2.4% 
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(Medium) and 2.2% (High). Precision values for COC were within 10.9% (Low), 5.8% 
(Medium) and 10.1% (High). Within-run accuracy varied between concentrations and 
analysis. In general, between-run accuracy was within 4.3% of the mean value for AEME, 
8.6% for BZE and 8.1% for COC. 
Table 4.13 Within-run and between-run data for the analysis of AEME, BZE and COC in 
Tissue obtained using an Agilent LC-MS single quadrupole. 
  
Concentration (ng/mL) 
AEME BZE COC 
2 20 80 2 20 80 2 20 80 
W
ith
in
-r
un
 1
 
(n
=6
)  
Mean 2.04 19.9 79.6 1.96 19.8 81.9 1.87 18.7 83.8 
SD 0.09 0.25 1.80 0.08 0.48 1.84 0.20 1.08 8.46 
SE 0.04 0.10 0.73 0.03 0.20 0.75 0.08 0.44 3.45 
%RSD 4.28 1.25 2.26 4.15 2.43 2.24 10.9 5.79 10.1 
Accuracy 102 99.6 99.4 97.9 99.1 102.4 93.6 93.7 105 
           
W
ith
in
-r
un
 2
 
(n
=6
) 
Mean 2.06 20.8 81.3 1.83 20.3 81.3 1.94 20.0 82.1 
SD 0.11 1.39 2.98 0.17 0.20 1.34 0.02 0.15 2.74 
SE 0.05 0.57 1.22 0.07 0.08 0.55 0.01 0.06 1.12 
%RSD 5.55 6.68 3.67 9.39 0.97 1.65 1.03 0.76 3.34 
Accuracy 103 104 102 91.4 102 102 96.9 100 103 
           
W
ith
in
-r
un
 3
 
(n
=6
)  
Mean 2.03 20.5 80.2 1.90 20.2 81.6 1.84 19.5 84.0 
SD 0.09 1.19 2.85 0.17 0.25 1.09 0.17 0.91 0.91 
SE 0.04 0.49 1.16 0.07 0.10 0.45 0.07 0.37 0.37 
%RSD 4.67 5.83 3.56 9.15 1.24 1.34 9.37 4.68 1.09 
Accuracy 101 102 100 95.0 101 102 91.9 97.6 105 
           
Be
tw
ee
n-
ru
n 
(n
=3
) 
Mean 2.04 20.4 80.4 1.89 20.1 81.6 1.88 19.4 83.3 
SD 0.01 0.47 0.88 0.07 0.27 0.31 0.05 0.65 1.06 
SE 0.01 0.27 0.51 0.04 0.16 0.18 0.03 0.38 0.61 
%RSD 0.71 2.31 1.10 3.44 1.35 0.38 2.68 3.37 1.27 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, SD; standard deviation, SE: Standard 
error, %RSD: Percent relative standard deviation. 
The between-run imprecision for COC in SOF was within the acceptable range of ± 
20% or ± 30% of mean values if the result is close to the LOQ (SWGTOX 2013). 
Precision values were within 2.3, 3.4 and 3.4% for AEME, BZE and COC respectively. 
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4.3.3.6 Carryover 
No carryover was seen for the analysis of AEME and BZE. However, for the analysis 
of COC some carryover was seen. In order to eliminate this carryover, three washes were 
injected following the injection of high concentrations of COC in both SOF and Tissue 
samples. As mentioned above (Section 4.5.1.1), an interfering peak of COC was seen 
during the development of the analysis, therefore this could have contributed to the 
carryover seen during the method validation. 
4.3.3.7 Matrix effect 
The results of the matrix effect indicated ion suppression or ion enhancement of all 
analytes from samples in SOF or Tissue at the three concentrations evaluated. The matrix 
effect ranged from 16-134% for all the analytes in both matrices. From the results 
presented in Table 4.14, it was evident that ion suppression was higher at the lowest 
concentrations for all analytes in both SOF and tissue matrices. Except from AEME in 
SOF at the low concentration, which presented ion enhancement (109%). Ion 
enhancement was also observed for BZE in both matrices (SOF: 117%; Tissue: 134%) at 
the high concentration and COC in Tissue (101%) at the high concentration. Overall, the 
percentage of ion suppression of COC was greater than the suppression of BZE across all 
the concentrations. Matusewski et al. (2003) suggested that the presence of either an 
absolute or relative matrix effect does not necessarily suggest that a method is not valid. 
As long as the analyte and the internal standard (IS) exhibits the same relative matrix 
effect, the peak area ratio used to calculate the drug concentration should not be affected. 
Ion suppression or enhancement was compensated by the use of deuterated internal 
standards (Matuszewski et al. 2003, Bosker and Huestis 2009). 
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Table 4.14 Matrix effect for the analysis of cocaine and cocaine derivatives in SOF and tissue. 
Concentration 
(ng/mL) 
Matrix Effect (%) 
SOF Tissue 
AEME BZE COC AEME BZE COC 
2 109 55.5 16.0 40.3 61.6 22.5 
20 54.5 73.0 35.2 53.6 80.1 48.6 
80 81.8 117 71.0 86.1 134 101 
SOF: Synthetic oral fluid, AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine. 
The differences in percentages of matrix effect could be attributed to differences in 
chromatographic response of each analyte and to the detection process. Even though the 
extraction process eliminates most interferent compounds in the samples, some 
compounds from the matrix could still be present in the extract. These compounds of the 
matrices could decrease the affinity of the stationary phase for the analyte, therefore 
decreasing the response of the analyte  (De Sousa et al. 2012). Additionally, interferent 
ions could lead to changes in the ionization of the analyte and consequently on their final 
response. Interferent ions can compete with the analyte ions for ejection from the droplet 
during the desolvation process (ESI mechanism) resulting in ion enhancement or 
suppression of the analyte (Particle Sciences 2009).  
4.3.3.8 Auto-sampler stability 
The results of recovery for the auto-sampler stability are presented in Table 4.15. The 
recovery values for all analytes in SOF and tissue were within the acceptable criteria of 
± 20% (ranging 96-108%) during a period of four days. The mean recovery values 
obtained for AEME, BZE and COC in SOF were 102.6±0.9%, 99.8±1.2% and 
101.3±0.7% respectively. Similarly, the mean recovery in tissue was 100.3±1.4%, 
102.0±0.7% and 102.4±1.4% for AEME, BZE and COC. The results presented in this 
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section confirm that samples in SOF and tissue can be analysed or re-injected within four 
days following SPE extraction without any significant sample degradation. The small 
differences in the percentage of recovery were attributed to two factors: (1) The accuracy 
of the method e.g. peak areas was within a ±20% accuracy values. (2) A slight 
concentration of the samples produced by the evaporation of the reconstituted solvent 
over the time of sample preparation and their analysis/re-injection, i.e. evaporation from 
such small volumes (50 µL) could lead to significant concentration of the samples. 
Table 4.15 Recovery values of the auto-sampler stability for the analysis of cocaine and 
cocaine derivatives in SOF and tissue. 
Day Concentration (ng/mL) 
 Recovery (%) 
SOF  Tissue 
AEME BZE COC 
 
AEME BZE COC 
1 
2 98.8 96.3 103  99.1 102 99.6 
20 101 99.1 101  97.9 100 104 
80 103 97.0 99.8  96.1 101 100 
4 
2 104 100 98.9  103 101 108 
20 105 103 101  100 105 101 
80 104 104 103  106 102 102 
SOF: Synthetic oral fluid, AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine. 
4.3.4 LC-MS method validation – Buffered oral fluid 
Analyte identification was evaluated in multiple reaction monitoring (MRM). Suitable 
product ions were chosen from the reference method as indicated in Table 4.5. Maximum 
sensitivity was accomplished by varying the voltage in the collision cell and corona 
needle. 
Several collision and corona voltages were checked to find the optimum voltage that 
provided the selection of the ion transition which produced the highest response. To do 
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this, collision voltages in a range of 10 to 40 V were set at 5 V intervals. Cone voltages 
were set in a range 0 to 60 V at 5 V intervals. Results of the optimum MS parameter 
including the ion transitions used for the detection and identification of each analyte were 
mentioned in the methodology section (Table 4.5). 
4.3.4.1 Method selectivity 
The injection of individual analytes did not show any interfering peaks for EME, 
AEME, COC and CE. For the contrary, some interfering peaks were seen in the detection 
of BZE and NC. However, these interfering peaks did not have any influence on the 
response of the analyte of interest as interfering peaks had a resolution higher than two. 
An illustration of the chromatograms for all analytes is represented in Figure 4.10. No 
interference was seen on the peaks of the non-deuterated analytes from the deuterated 
counterparts and vice-versa. Additionally, no interferences were seen in any of the blanks 
of control BOF. These results indicated that there was no interference from the matrix in 
this method. 
  
Chapter 4 - Validation of liquid chromatography – mass spectrometry for the analysis of cocaine 
and cocaine derivatives in buffered human oral fluid, synthetic oral fluid and porcine oral mucosa 
 
 174 
 
 
 
Figure 4.9 Chromatograms of AEME, AEME-d3, EME, BZE, BZE-d3, COC, COC-d3, CE, CE-
d3 and NC at concentration of 10 ng/mL in OF and obtained using a Waters LC-MS/MS Xevo 
TQ. 
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The retention time variation for all analytes was < 3% (0.30% for AEME, 0.0% for 
AEME-d3, 2.63% for EME, 0.19% for BZE 0.06% for BZE-d3, 0.15% for COC, 0.09% 
for COC-d3, 0.84% for CE and 0.15% for CE-d3 and 0.65 for NC; with n = 130 for each 
analyte).  
An increase in the response of EME was observed when a mixture of analytes (AEME, 
BZE, COC, CE and NC) was analysed. This enhancement was further evaluated as 
discussed next. 
4.3.4.2 EME response 
During method validation, it was observed that the response of EME when it was 
analysed as a mixture (in combination with the other analytes) increased significantly 
than when it was analysed as an independent analyte. In order to evaluate this 
discrepancy, two set of samples (A and B) were prepared and subsequently compared 
based on their EME response. The set of samples A contained EME in BOF at 
concentrations ranging 0.5-250 ng/mL. The set of samples B contained a mixture of 
AEME, BZE, COC, CE and NC in BOF at concentrations ranging 0.5-250 ng/mL of each 
analyte. 
 Table 4.16 shows the EME response obtained for the set of samples A and B. The 
response was reported as mean (n = 6) peak area and mean peak area ratio for the analysis 
of EME in BOF. The results indicated that EME was present in the set of samples B as 
well as for the set of samples A. Furthermore, the mean EME peak area response was 
160% (120 – 230%) higher for the set of samples B than the set of samples A. The peak 
area ratio was 180% (120-280%).  These high responses obtained for B could have been 
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the result of the degradation of the COC stock (Kiszka et al. 2000). Based on the fact that 
stock solutions and working solutions were prepared using the whole ampule of analytical 
standard (as purchased), it was not possible to evaluate whether or not EME was present 
as a result of degradation or as an impurity from any of the other analytes. Analysis of 
independent analytes (AEME, BZE, COC, CE and NC) from a different batch (including 
deuterated ISs) was conducted for detection of EME, but no response was seen in any of 
the analytes. Additionally, all certificates of analysis were checked for EME impurities, 
but then again, no impurities were reported. Since the intrinsic amount of EME present 
in the set of samples B was contributing to the final response of EME and the variation 
in the EME response (%RSD) was higher than 20% over the range of concentrations 
(28% and 33% for PA and PAR respectively) the validation of EME in BOF was 
conducted separately. 
Table 4.16 Variability in peak area and peak area ratio for EME response. 
Concentration 
in BOF 
(ng/mL) 
Response of EME in 
sample A 
Response of EME in 
sample B 
Percentage of 
EME in B 
PA PAR PA PAR PA PAR 
0.5 12 0.003 150 0.037 120 120 
1 19 0.005 311 0.070 160 140 
10 128 0.032 2916 0.921 230 280 
50 643 0.165 12914 3.331 200 200 
125 1631 0.387 22154 6.280 140 160 
250 3624 0.927 41828 14.02 120 150 
A: Set of samples containing EME: ecgonine methyl ester. B: Set of samples conteining AEME (Anhydroecgonine 
methyl ester), BZE (Benzoylecgonine), CE (Cocaethylene), COC (Cocaine) and NC (Nor-cocaine). PA: Peak area. 
PAR: Peak area ratio. Ratio: EME to Mix analytes ratio 
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4.3.4.3 Linearity  
Linearity for all analytes (AEME, BZE, CE, COC and NC) was determined over a 
concentration range of 0.5-250 ng/mL in BOF using six calibration points and six 
replicates per calibration point. Linearity for EME was further evaluated in a larger range 
of 250 – 10000 ng/mL EME in BOF. This range was extended in order to be able to 
quantify the amount of EME present in the mixture of analytes (AEME, BZE, COC, CE 
and NC).The residual plots (Figure 4.10) of unweighted data for all analytes indicated 
that the data was heteroscedastic as the scatter of the residuals increased with the increase 
in concentration (Pereira da Silva et al. 2015). 
   
  
 
Figure 4.10 Residual plot for the analysis of anhydroecgonine methyl ester (AEME), 
benzoylecgonine (BZE) and cocaine (COC) in SOF and homogenate porcine tissue. 
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The F-Test at confidence level of 95% indicated that there were significant differences 
(p < 0.05) between the variances at the lowest and highest concentration level in all 
calibration lines (Table 4.17). These significant differences in variances confirmed the 
heteroscedasticity of the data. 
Table 4.17 Results of F-Test. Comparison of the homogeneity of variances.  
Analyte Concentration calibrant (ng/mL) Mean PAR F-Test
 p 
AEME 0.5 0.35 326685 8.90x10--14 
 250 181.13   
EME 125 0.63 708.7 4.04x10-7 
 10000 36.45   
BZE 0.5 0.24 147419 6.51x10-13 
 250 170.08   
COC 0.5 0.54 5676 2.24x10-9 
 250 154.25   
CE 0.5 0.47 18024 1.24x10-10 
 250 162.36   
NC 0.5 0.23 85767 2.52x10-12 
 250 130.77   
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, PAR: Peak area ratio, SOF: Synthetic 
oral fluid, Tissue: homogenised porcine oral tissue. F-Test (5, 5, 0.95 = 5.05, p < 0.05). 
In order to obtain a best linear unbiased relation between the concentration and the 
response of the analytes a weighted least squares linear regression model (1/x) was used. 
Results of the unweighted and weighted (1/x) linear correlation are summarised in Table 
4.18. This table shows higher correlation coefficients and lower % bias (sum of the 
absolute % bias across the whole concentration range) for the 1/x weighting regression 
model than the unweighted model. The accuracy or % bias values were within ± 20% for 
all analytes on the weighted model. Plotting of the weighted residuals showed random 
scattering of variances for all analytes in BOF (Figure 4.12). An example of the 
calibration lines for all analytes in BOF obtained in this validation are presented in 
Appendix C. 
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Table 4.18 Results of unweighted and weighted linear regression model for AEME, BZE, 
EME, COC, CE and NC in BOF. 
Analyte Regression model Equation R2 %Bias 
AEME unweighted y = 0.7264x+1.0918 0.996 2864 
 1/x y = 0.7414x+0.0004 0.997 198 
EME unweighted y = 0.0036x+0.2497 0.999 190 
 1/x y = 0.0036x+0.1838 0.999 83 
BZE unweighted y = 0.6857x-0.8089 0.986 2005 
 1/x y = 0.6766x-0.1477 0.998 404 
COC unweighted y = 0.6181x-0.0164 0.999 140 
 1/x y = 0.6188x-0.0832 0.999 98 
CE unweighted y = 0.6606x+2.0200 0.993 5398 
 1/x y = 0.6866x+0.1353 0.995 233 
NC unweighted y = 0.5268x+0.2523 0.998 1102 
 1/x y = 0.5308x-0.0426 0.999 172 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, SOF: Synthetic oral fluid, Tissue: 
homogenised porcine oral tissue. 
 
Figure 4.11 Residual plots of 1/x weighted regression model for anhydroecgonine methyl ester 
(AEME), benzoylecgonine (BZE), ecgonine methy ester (EME), cocaine (COC), cocaethylene 
(CE) and nor-cocaine (NC) in BOF. 
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4.3.4.4 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
The LOD and LOQ obtained for the detection of EME, AEME, BZE, COC, CE and 
NC are shown in Table 4.19. The results show that all analytes can be detected up to 
concentrations as low as 0.1 ng/mL (AEME and CE). LOD ranged from 0.1-0.5 ng/mL 
for all analytes. The LOQ, on the other hand, was 0.5 ng/mL for all analytes, except for 
EME that had a LOQ of 1 ng/mL.  
Table 4.19 LOD, LOQ and Linearity for the analysis of cocaine and cocaine derivatives in 
BOF. 
Analyte LOD (ng/mL) 
LLOQ 
(ng/mL) 
Calibration 
range 
(ng/mL) 
Calibration 
equation R
2 
AEME 0.1 0.5 0.5-250 y=0.783x-0.068 0.998 
EME 0.5 1.0 1.0-250 y=0.078x-0.001 0.999 
BZE 0.2 0.5 0.5-250 y=0.786x-0.132 0.999 
COC 0.03 0.5 0.5-250 y=0.790x+0.045 0.994 
CE 0.1 0.5 0.5-250 y=0.775x+0.071 0.992 
NC 0.2 0.5 0.5-250 y=0.601x-0.116 0.990 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, NC: Nor-cocaine. LOD: Limit of 
detection, LLOQ: Low limit of quantification expressed as mean value and %RSD (Percent relative standard deviation) 
(n = 6). 
4.3.4.5 Precision and Accuracy  
Within-run precision data for all analytes extracted from BOF are summarised in Table 
4.20. The within-run precision values were within the acceptable range of £ 20% 
(SWGTOX 2013) concentration value for the low (0.75 ng/mL), medium (20 ng/mL) and 
high (200 ng/mL) concentrations.  
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Table 4.20 Within-run and between-run data for analysis of cocaine and cocaine derivatives 
in BOF. 
  
Concentration (ng/mL) 
AEME EME BZE 
0.75 20 200 0.75 20 200 0.75 20 200 
W
ith
in
-r
un
 
1 
(n
=6
)  Mean 0.88 21.0 206 0.88 20.8 233 0.80 17.3 188 
SD 0.04 1.17 16.01 0.04 2.08 39.7 0.00 1.03 17.2 
SE 0.02 0.48 6.53 0.02 0.85 16.2 0.00 0.42 7.04 
RSD 4.62 5.57 7.77 4.62 10.0 15.1 0.00 5.97 9.18 
           
W
ith
in
- r
un
 
2 
(n
=6
)  Mean 0.87 21.2 208 0.82 17.4 195 0.83 17.9 195 
SD 0.08 1.28 10.3 0.26 2.47 22.9 0.10 0.64 10.2 
SE 0.03 0.52 4.21 0.11 1.01 9.34 0.04 0.26 4.18 
RSD 9.42 6.06 4.96 28.8 14.2 11.7 9.99 4.62 5.25 
           
W
ith
in
-r
un
 
3 
(n
=6
) Mean 0.88 20.7 190 0.92 17.4 195 0.65 16.4 167 
SD 0.04 1.88 16.8 0.26 2.47 22.9 0.05 0.81 14.1 
SE 0.02 0.77 6.87 0.11 1.01 9.34 0.02 0.33 5.75 
RSD 4.62 9.08 8.84 28.8 14.2 11.7 8.43 5.60 8.46 
           
Be
tw
ee
n -
ru
n 
(n
=3
) Mean 0.88 21.0 201 0.87 18.6 208 0.76 17.2 183 
SD 0.01 0.26 9.71 0.05 1.99 21.7 0.10 0.74 14.7 
SE 0.00 0.15 5.61 0.03 1.15 12.5 0.06 0.42 8.50 
RSD 0.66 1.23 4.82 5.76 10.7 10.4 12.7 4.27 8.04 
 Accuracy 117 105 101 116 92.8 104 101 86.1 91.6 
 
  COC CE NC 
  0.75 20 200 0.75 20 200 0.75 20 200 
W
ith
in
-r
un
 
1 
(n
=6
)  Mean 0.82 19.6 185 0.83 19.5 174 0.83 16.9 169 
SD 0.04 1.36 17.8 0.05 1.16 12.7 0.05 0.75 14.7 
SE 0.02 0.56 7.25 0.02 0.47 5.19 0.02 0.30 6.00 
RSD 5.00 7.05 9.59 6.20 5.93 7.29 6.20 5.01 8.67 
           
W
ith
in
-r
un
 
2 
(n
=6
)  Mean 0.88 17.0 160 0.83 17.2 172 0.78 16.6 188 
SD 0.08 1.90 7.79 0.05 1.17 8.87 0.08 0.82 9.30 
SE 0.03 0.78 3.18 0.02 0.48 3.62 0.03 0.34 3.80 
RSD 8.52 11.9 4.84 6.20 6.81 5.82 9.61 6.06 5.89 
           
W
ith
in
- r
un
 
3 
(n
=6
)  Mean 0.82 23.9 196 0.72 22.4 166 0.86 17.5 171 
SD 0.15 2.32 22.6 0.10 1.64 16.8 0.05 1.59 18.1 
SE 0.06 0.95 9.23 0.04 0.67 6.85 0.02 0.65 7.41 
RSD 16.1 8.02 11.55 10.7 6.43 11.5 6.37 9.08 10.6 
           
Be
tw
ee
n -
ru
n 
(n
=3
)  
Mean 0.84 20.1 181 0.79 19.7 171 0.82 17.0 176 
SD 0.03 3.49 17.9 0.06 2.61 4.59 0.04 0.43 10.3 
SE 0.02 2.02 10.4 0.04 1.51 2.65 0.02 0.25 5.93 
RSD 4.12 17.4 9.93 8.01 13.21 2.69 4.91 2.56 5.83 
Accuracy 112 100 90.3 106 98.7 85.4 109 84.9 88.1 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, CE (Cocaethylene), COC: Cocaine, EME: ecgonine 
methyl ester and NC (Nor-cocaine).  SD; standard deviation, SE: Standard error, %RSD: Percent relative standard 
deviation. 
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Precision values were within 15% of the nominal value for all analytes at the three 
concentrations evaluated except EME that had a %RSD of 29% on two of the three days 
at the low concentration. The values obtained for AEME were within 9.4%, 9.1% and 
8.8% at the low, medium and high concentrations respectively. The values for EME were 
within 14.2% and 15.1% at the medium and high concentrations. The values for BZE 
were within 10.0% (Low), 6.0% (Medium) and 9.2% (High). Precision values for COC 
were within 16.1% (Low), 11.9% (Medium) and 11.6% (High). The values for CE were 
within 10.7% (Low), 6.8% (Medium) and 11.5% (High). The values for NC were within 
9.6% (Low), 9.1% (Medium) and 10.6% (High).  Within-run accuracy varied between 
concentrations and analysis. In general, between-run accuracy was within 4.8% of 
nominal value for AEME, 10.7% for EME, 12.7% for BZE, 17.4% for COC, 13.2% for 
CE and 5.8% for NC. 
The between-run precision for cocaine in BOF was within the acceptable value of ± 
20% (SWGTOX 2013). Precision values were below 4.8, 10.7, 12.7, 17.4, 13.2 and 5.8% 
for AEME, EME, BZE COC, CE and NC respectively. 
4.3.4.6 Carryover 
No carryover was detected following the injection of the upper calibrant. 
4.3.4.7 Matrix effect 
The results of the matrix effect indicated ion suppression or ion enhancement of all 
analytes from samples in BOF at the three concentrations evaluated. The matrix effect 
ranged from 78-196 % for all the analytes. The results presented in Table 4.21 showed 
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ion suppression of EME, COC and CE with matrix effects ranging between 101-196%. 
Variations (%RSD) in matrix effect between the three concentrations were 16% for EME, 
29% for COC and 30% for CE. Ion suppression was also seen at low concentrations of 
AEME (2%) and NC (22%) in the biological samples. Ion enhancement was observed in 
AEME and NC at the low and medium concentrations and in BZE at all concentrations 
evaluated. The ion enhancement ranged between 78-100% with variation (%RSD) of 
11% for AEME, 16% for NC and 13% for BZE. 
Table 4.21 Matrix effect for the analysis of cocaine and cocaine derivatives in BOF. 
Concentration 
(ng/mL) 
Analyte Matrix Effect (%) 
AEME EME BZE COC CE NC 
0.75 102 138 100 174 196 122 
20 89 129 78 169 179 89 
200 83 101 82 99 105 100 
 Ratio of analyte to IS (%) 
 AEME/ AEME-d3 
EME/ 
AEME-d3 
BZE/ 
BZE-d3 
COC/ 
COC-d3 
CE/ 
CE-d3 
NC/ 
BZE-d3 
0.75 103 140 98 90 88 120 
20 80 116 101 119 123 112 
200 81 98 101 95 96 123 
AEME: Anhydroecgonine methyl ester; BZE: Benzoylecgonine; CE: Cocaethylene; COC: Cocaine; EME: ecgonine 
methyl ester and NC: Nor-cocaine. 
Even though ion suppression or enhancement was present in all analytes, the use of 
deuterated internal standard compensated the matrix effect and therefore the method was 
not affected by this matrix (Bosker and Huestis 2009). Ratio of analyte to deuterated 
internal standard (Table 4.21) demonstrated that internal standards were in the same way 
enhanced or suppressed in the MS source. Mean ratio values over the concentration range 
were 88, 118, 100, 101, 102 and 118 % for AEME, EME, BZE, COC, CE and NC 
respectively, resulting in a mean analyte to IS ratio of 104%. 
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4.3.4.8 Auto-sampler stability 
The results of recovery for the auto-sampler stability are presented in Table 4.22. The 
recovery values for all analytes in BOF were within the acceptable criteria of ± 20% 
(ranging 96-108%) during a period of four days. The mean recovery values obtained for 
AEME, EME, BZE, COC, CE and NC in BOF were 102.6 ± 0.9%, 99.8 ± 1.2%, 101.3 ± 
0.7%, 100.3 ± 1.4%, 102.0 ± 0.7% and 102.4 ± 1.4% respectively. The results presented 
in this section confirmed that samples in BOF could be analysed or re-injected within 
four days following SPE extraction without any significant sample degradation. 
Table 4.22 Recovery values for the auto-sampler stability for the analysis of cocaine and 
cocaine derivatives in BOF. 
Day Concentration (ng/mL) 
 Recovery (%) 
AEME EME BZE  COC CE NC 
1 
        0.75 98.8 96.3 103.0  99.1 102.5 99.6 
  20 101.4 99.1 101.3  97.9 100.0 103.6 
200 103.0 97.0 99.8  96.1 100.8 100.2 
4 
        0.75 103.8 100.3 98.9  103.2 100.9 108.4 
  20 105.0 102.9 101.4  100.3 105.1 101.4 
200 103.6 103.5 103.4  105.5 102.1 102.1 
AEME: Anhydroecgonine methyl ester; BZE: Benzoylecgonine; CE: Cocaethylene; COC: Cocaine; EME: ecgonine 
methyl ester and NC: Nor-cocaine. 
4.4 CONCLUSIONS 
Three quantitative LC-MS methods were successfully developed and validated 
(according to the SWGTOX) for the analysis of cocaine and cocaine derivatives in BOF, 
porcine oral mucosa and SOF respectively. 
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The results showed that cocaine and cocaine derivatives could be extracted using the 
3 mL TELOS cartridges and the Oasis micro-elution plates with mean recoveries of 98% 
and 71% respectively. Mean recovery values of 96, 96 and 99% were obtained for AEME, 
BZE and COC in SOF. The mean recovery values for samples in tissue were 98% for 
AEME, 99% for BZE and 100% for COC. The mean recovery values for samples in BOF 
were 56% for AEME, 77% for EME, 57% for BZE, 89% for COC, 100% for CE and 
49% for NC. 
Identification of analytes was conducted by monitoring a minimum of two target ions 
for each analyte. Single ion monitoring was used for the detection of analytes (AEME, 
BZE and COC) in SOF and porcine oral tissue samples. Tandem mass spectrometry was 
used for detection of analytes (AEME, EME, BZE, COC, CE and NC) in BOF samples. 
Optimisation of MS parameters allowed the detection of analytes at LOQ of 0.5 ng/mL 
for AEME and BZE in either SOF or tissue samples. The LOQ obtained for cocaine in 
SOF or tissue was 1.0 ng/mL. Concentrations of 0.5 ng/mL were obtained as LOQ for 
AEME, BZE, COC, CE and NC in BOF samples. The LOQ obtained for cocaine in BOF 
or tissue was 1.0 ng/mL 
The results indicated that all methods were robust and sensitive methods for the 
analysis of cocaine and cocaine derivatives in SOF, oral tissue and BOF. Additionally, 
these methods allowed high sample throughput, with time limiting steps being the sample 
preparation, i.e. SPE. The LC-MS methods had run times of eight minutes for SOF and 
tissue and 5 minutes for BOF. Linear ranges were obtained between 0.5/1.0 – 100 ng/mL 
for analytes in SOF and tissue and between 0.5-250 ng/mL for BOF, with R2 > 0.99 for 
all analytes. 
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The validation results demonstrated that all parameters evaluated, e.g. accuracy, 
precision, linearity; were within the acceptable values, according with the Scientific 
Working Group for Forensic Toxicology (SWFTOX) standard practices for method 
validation in forensic toxicology (SWGTOX 2013). Precision values (between-run and 
within-run precision) were below the acceptable value of £ 20% for all analytes in each 
matrix. Precision values (%RSD) for AEME, BZE and COC in SOF were below 9.0, 2.8 
and 9.1% respectively. The mean values for AEME, BZE and COC in tissue were below 
6.7, 9.4 and 10.9% respectively. The mean values for AEME, EME, BZE, COC, CE and 
NC in BOF were below 9.4, 15.1, 10.0, 17.4, 13.2 and 10.6% respectively. Accuracy 
values were within ± 20% of nominal value for all analytes in each matrix. 
Some carryover was seen after the injection of cocaine samples in SOF and Tissue at 
high concentrations (>100 ng/mL). This carryover was eliminated by injecting three 
washes, i.e. blank samples, following the injection of high concentrations of cocaine. No 
carryover was seen for the rest of analytes in any of the matrices. 
Different percentages of matrix effect were obtained for all analytes at different 
concentrations. All analytes presented either ion suppression or ion enhancement. All 
analytes presented mean percentages of matrix effect of ± 100%. Mean values for AEME, 
BZE and COC in SOF were -18, -18 and -59% respectively. Mean values for AEME, 
BZE and COC in Tissue were -40, -8 and -43% respectively. Mean values for AEME, 
BZE, COC, CE and NC in BOF were -40, 97, 27, 10 and -40% respectively. 
Auto-sampler stability (at room temperature) demonstrated that samples could be 
analysed up to four days following the extraction of the samples in any of the studied 
matrices. 
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5.1 INTRODUCTION  
Knowledge of the Stability of a drug and its metabolites is important to assist in the 
interpretation of the results obtained following analysis (Kiszka et al. 2000). Skopp (2004, 
p 91) defined stability as “the capacity of sample material to retain the initial value of a 
measured quantity for a defined period within specific limits when stored under defined 
conditions.” 
 Instability of an analyte affects the reliability of the analysis, especially if the samples 
have been exposed to significant changes in storage temperature or if samples are not 
being analysed immediately after collection (Drummer 2004). In real toxicology 
scenarios the stability of the samples needs to be established in order to correlate the 
results if samples are to be reanalysed (for legal reasons or because of batch failure). 
Changes in storage conditions can produce the degradation of samples decreasing the 
concentration of the sample and increase the concentration of their correspondent 
metabolites (Cone and Menchen 1988). 
Studies on the stability of cocaine and metabolites in OF and other matrices such as 
plasma, blood, phosphate buffer saline and urine have described the degradation of 
cocaine into benzoylecgonine (BZE) and ecgonine methyl ester (EME), with BZE being 
the primary degradation product (McCurdy et al. 1989, Hippenstiel and Gerson 1994, 
Kiszka et al. 2000, 2001, Klingmann et al. 2001). 
Few reports on the stability of cocaine (COC) and metabolites in unadulterated or neat 
oral fluid (OF) have been reported to date (Cone and Menchen 1988, Ventura et al. 2009). 
Cone and Menchen (1988) reported the stability of cocaine in OF under different 
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temperature, container and preservatives conditions. The results of this study showed that 
when cocaine samples were stored in glass or plastic containers and in the fridge, less 
than 20% of the cocaine degraded after four days of storage. Only when samples were 
stored (25 °C) in a tube containing sodium citrate samples containing cocaine were stable 
for seven days. After seven days of storage at 25 °C cocaine degraded in more than 70% 
(Ventura et al. 2009). 
Synthetic OF (SOF) is a good substitute for authentic (neat) OF and it is widely used 
in research for in vitro studies and/or method development (Bosker and Huestis 2009). 
SOF is often used to overcome the limitation of the low volume and availability when OF 
is required (Anizan et al. 2015). Although SOF aims to mimic the composition of neat 
OF, the SOF might contain different constituents or different amounts of constituents than 
the human OF, including preservatives, stabilising salts and surfactants (Lee and Huestis 
2014). These differences in composition between neat OF and SOF could therefore lead 
to significantly differences in stability of drugs in these matrices (Lee et al. 2012). 
The monitoring of stability of cocaine and cocaine derivatives in oral tissue was 
essential in this research because the concentration of these analytes might change while 
deposited in the oral cavity and affect the release of drugs in OF. Furthermore, the 
stability in tissue was evaluated to determine changes in analyte concentration that can 
be produced from the time of storage, e.g. time passed between sample collection and 
sample analysis. Stability of cocaine and cocaine derivatives in oral tissues have not been 
reported to date however, reports have been published relating to cocaine stability in other 
tissues such as brain, femoral muscle, kidney and liver from deer, rabbits and humans 
(Moriya and Hashimoto 1996, Kiszka et al. 2001, Rees et al. 2012). 
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The stability of cocaine and cocaine derivatives reported by these authors showed that 
cocaine in tissues degraded rapidly when stored at 25 °C and stable when samples were 
stored in the freezer (-18/-20 °C). Cocaine in human liver, kidney and brain remained 
stable for 90 days while stored at -20 °C (Kiszka et al. 2001). Samples of homogenised 
skeletal muscle were stable for 13 months when stored at -18 °C with 15% of the initial 
concentration decreasing by month 13 (Rees 2011). In samples of liver and kidney stored 
at 25 °C, the loss in cocaine concentration was significant (35–43%) after one day of 
storage. After one month of storage at 25 °C, the mean loss was 62% and 47% 
respectively. The stability of cocaine in human brain at 25 °C after one day was < 10%, 
after seven days the degradation was about 25% and after one month was about 45%. At 
4 °C, the brain tissue was stable for 144 days (Kiszka et al. 2001). Cocaine in skeletal 
muscle was stable for one month when stored at 25 °C with the NaF (Rees 2011). Cocaine 
was reported to degrade more rapidly than cocaethylene (CE) in liver tissue (Moriya and 
Hashimoto 1996). 
In this chapter, the influence of temperature (37°C, room temperature, -4°C and 20°C) 
and time of storage (0-90 days) were examined to determine the stability of cocaine and 
its metabolites (change in concentration of the analytes) in samples of buffered human 
OF (BOF), SOF and homogenised porcine oral mucosa. The storage conditions and times 
presented in this chapter were designed to represent those likely to be encountered during 
the storage and transportation of biological samples between countries, e.g. Colombia to 
the UK (Chapter 6) and the conditions under which the in vitro studies (Chapter 7) were 
conducted. 
The stability of cocaine and cocaine derivatives in the three matrices was evaluated 
for as long as three months at different temperatures (room temperature, 4 °C and -20 °C 
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and at 37 °C). The results of this study were used to check whether BOF samples would 
be stable during storage and transportation after collection and to aid in the interpretation 
of results from Chapter 6 and 7. 
5.1.1 AIM AND OBJECTIVES 
5.1.1.1 Aim: 
The aim of this chapter was to investigate the stability of cocaine and cocaine 
derivatives in BOF, SOF and porcine oral mucosa samples.  
5.1.1.2 Objectives: 
• To determine the change in concentration of anhydroecgonine methyl ester 
(AEME), BZE and cocaine in SOF over a period of 3 months at room temperature, 
4 °C and -20 °C and at 37 °C (regular body temperature) over a period of four 
hours. 
• To measure the change in concentration of AEME, BZE and cocaine in spiked 
porcine oral mucosa homogenate at 37 °C over four hours and storage temperature 
of -20 °C over a period of 30 days. 
• To evaluate the best storage conditions for samples containing cocaine and 
cocaine derivatives (AEME, BZE, EME, cocaethylene CE and nor-cocaine NC) 
in buffered human oral fluid, i.e. BOF. 
• To quantify the degree of degradation of cocaine and metabolites in BOF over a 
period of two months at room temperature, 4 °C and -20 °C. 
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5.2 METHODS 
5.2.1 Materials 
Porcine cheeks were purchased from L F B Meats, Bournemouth, UK. 
The analytical standards and reagents used for the analysis of BOF, SOF and tissue 
were purchased as described in Section 4.2.1. 
TELOS® H-CX 130mg/3mL mixed-mode SPE columns were purchased from Kinesis 
(Cambridgeshire, UK). Oasis mixed-mode cation exchange (MCX) micro-elution plates 
(Waters, Manchester, UK) were donated by AlereTM Toxicology.  
Concateno Certus® oral fluid collection devices were donated by AlereTM Toxicology. 
5.2.2 Instrumentation 
Analysis of SOF and porcine oral tissue was conducted on an Agilent 1200 Infinity 
Series LC system coupled to an Agilent Singe Quadrupole 6120 series MS system. Details 
on the LC-MS systems were described in Section 4.2.2. The analysis was conducted by 
the researcher at Bournemouth University. 
Analysis of BOF samples was carried out using a LC-MS/MS system consisting of a 
tandem quadrupole mass spectrometer coupled to a Waters Acquity UPLC® system. 
Details on the LC-MS systems were described in Section 4.2.2. The analysis was 
conducted by the researcher at Alere Toxicology (Abingdon, UK). 
5.2.3 Synthetic Oral Fluid Preparation 
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SOF was prepared using the Cozart biosciences protocol (2008) “Production of 
Synthetic Saliva” (Appendix A). SOF was used immediately after preparation or stored 
at -20 °C until further use. 
5.2.4 Homogenised tissue preparation 
Preparation of tissue homogenates was described in Section 4.4.1. 
5.2.5 Collection of human oral fluid 
Samples of control OF were collected from six drug free healthy volunteers (Female 
and male with age ranging 25-35) using the Concateno Certus® devices (Figure 4.1). The 
OF was collected following manufacturer recommendations and under the ethical 
approval granted by Bournemouth University. All collected samples were anonymised by 
giving a unique code to each sample. After the collection, all devices were stored at room 
temperature for 24 hours. A pool of human buffered OF (BOF) was subsequently obtained 
by pooling the collected samples and used to prepare calibration, QCs and stability 
solutions. 
5.2.6 Solution preparation for stability in synthetic oral fluid and porcine oral 
mucosa 
The stability studies were conducted on solutions of SOF or homogenised oral mucosa 
containing cocaine and cocaine derivatives (AEME and BZE) at a low, middle and high 
concentration. Solutions of SOF and tissue containing cocaine were prepared individually 
from AEME and BZE to be able to quantify the degradation of cocaine into BZE. A low 
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concentration (5 ng/mL) was selected as the 10-fold of the LLOQ of the LC-MS method 
(Range 0.5 – 100 ng/mL for SOF/Tissue), a medium concentration (20 ng/mL) was 
selected in the middle of the quantitative range and a high concentration (80 ng/mL) was 
selected as the 80% of HLOQ of the LC-MS method. 
AEME is the pyrolysis product of cocaine and is commonly monitored for the use of 
crack cocaine (Terms 1990). AEME was included in this chapter because the results from 
a pilot study developed during this PhD (also presented in Chapter 6) indicated that 
AEME could be present in OF samples following the consumption/exposure to coca tea. 
Initially, the pool of SOF/tissue was divided into six portions (100 mL each). 
Subsequently, the different portions (portion 1-6) were fortified with the allocated volume 
of working solution A or B, as indicated in Table 5.1 to obtain final concentrations of 5, 
20 and 80 ng/mL analyte in SOF/tissue. The working solution (A) containing cocaine was 
prepared by diluting 100 µL of drug stock solution (1 mg/mL) in 1 mL methanol to obtain 
a concentration of 0.1 mg/mL. The second working solution (B) containing a mixture of 
AEME and BZE was prepared by diluting 100 µL of each drug stock solution (1 mg/mL) 
in 1 mL methanol to obtain a concentration of 0.1 mg/mL. 
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Table 5.1 Preparation of SOF and Tissue stability samples. 
Concentration of analytes 
in SOF/Tissue (ng/mL) 
SOF/Tissue 
Portion 
Working 
solution 
Volume Working 
solution (µL) 
LOW 5 
1 A 5 
2 B 5 
MIDDLE 20 
3 A 20 
4 B 20 
HIGH 80 
5 A 80 
6 B 80 
SOF: Artificial oral Fluid, A: Solution containing cocaine (COC), B: Solution containing anhydroecgonine methyl 
ester (AEME) and benzoylecgonine (BZE), ng/mL: nano-gram per millilitre, µL: microliter, Tissue: porcine oral 
tissue. 
Twenty aliquots (3.5 mL each) containing cocaine or the mixture of drugs were 
obtained for each concentration level.  The volume of the aliquots allowed the analysis 
of analytes in triplicate. All aliquots (20 aliquots x 3 concentrations = 60 aliquots in total) 
were stored in 60 individual 5 mL glass tubes. 
5.2.7 Solution preparation for stability in buffered oral fluid 
The stability studies were conducted on solutions of BOF containing cocaine or 
cocaine derivatives AEME, BZE, EME, CE and NC at a low, middle and high 
concentration. Solutions of BOF containing cocaine were prepared individually from 
cocaine derivatives to be able to quantify the degradation of cocaine into BZE and EME. 
The low concentration (5 ng/mL) was selected as the 10-fold of the LLOQ of the LC-MS 
method (Range 0.5-100 ng/mL for BOF), a medium concentration (50 ng/mL) was 
selected in the middle of the quantitative range and a high concentration (200 ng/mL) was 
selected as the 80% of HLOQ of the LC-MS method. 
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Initially, the pool of BOF was divided into six portions (25 mL each). Subsequently, 
the different portions (portion 1-6) were fortified with the allocated volume of working 
solution A or B, as indicated in Table 5.2 to obtain final concentrations of 5 ng/mL, 50 
ng/mL and 200 ng/mL analyte in BOF. The working solution (A) containing cocaine was 
prepared in methanol to obtain a concentration of 10 µg/mL from a 100 µg /mL stock 
solution. The second working solution (B) containing a mixture of AEME, BZE, EME, 
CE and NC, was prepared in methanol to obtain a final concentration of 10 µg/mL for 
each analyte from a 100 µg /mL independent stock solutions. 
Table 5.2 Preparation of BOF and porcine oral tissue stability samples. 
Concentration of analytes in 
BOF (ng/mL) 
BOF Portion 
Working 
solution 
Volume working 
solution (µL) 
LOW 5  1 A 15 
  2 B 15 
MIDDLE 50 3 A 150 
  4 B 150 
HIGH 200 5 A 600 
  6 B 600 
 BOF: Buffered Oral Fluid, A: Solution containing cocaine (COC), B: Solution containing anhydroecgonine methyl 
ester (AEME), benzoylecgonine (BZE), ecgonine methyl ester (EME), cocaethylene (CE) and nor-cocaine 
(NC), ng/mL,: nano-gram per millilitre, µL: microliter. 
Twenty aliquots (1.3 mL each) containing cocaine or the mixture of drugs were 
obtained for each concentration level.  The volume of the aliquots allowed the analysis 
of analytes in triplicate. All aliquots (20 aliquots x 3 concentrations = 60 aliquots in total) 
were stored in 60 individual 5 mL plastic tubes. 
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5.2.8 Storage conditions and time of storage 
Stability samples prepared in BOF, SOF and homogenised porcine oral mucosa were 
prepared at different conditions. The time of storage varied depending on the conditions 
under which the in vivo (Chapter 6) and in vitro (Chapter 7) studies were developed: 
Samples prepared in SOF were divided into four groups and stored at four different 
temperatures: 37 °C, room temperature (18-20 °C), 4 °C and -20 °C, as shown in Figure 
5.1. The times selected for the analysis of SOF at room temperature, 4 °C and -20 °C 
were 0, 1, 4, 7, 14, 30, 60 and 90 days. The times selected for the analysis at 37 °C were 
0, 0.25, 0.5, 1, 2, 4 and 24 hours. Samples stored at 37 °C were analysed over a period of 
24 hours because the in vitro diffusion studies (Chapter 7) were conducted over this 
period of time. 
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Figure 5.1 Diagram of preparation and storage of SOF, porcine oral tissue and BOF samples 
containing cocaine and cocaine derivatives. (+Coc) Addition of COC. (+ Mix) Addition of AEME 
and BZE. (+ Mix2) Addition of AEME, BZE, CE and NC. (n) Number of samples. *Stability on 
day 11 was only evaluated in samples stored at room temperature. 
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Stability samples prepared in homogenised tissue were divided into two groups and 
stored at two different temperatures: 37 °C and -20 °C (Figure 5.1). The times selected 
for the analysis of tissue at 37 °C were 0, 0.25, 0.5, 1, 2, 4 and 24 hours. The times for 
the analysis of samples stored at -20 °C were 0, 1, 4, 7, 14 and 30 days. Samples stored 
at 37 °C were analysed over a maximum period of 24 hours because the in vitro diffusion 
studies (Chapter 7) were conducted over this period of time. Samples stored at -20 °C 
were analysed for a longer time (30 days) to allow enough time for the analysis. Tissue 
samples were stored for a maximum period of 30 days before being analysed by LC-MS. 
Stability samples prepared in BOF were divided into three groups and stored at three 
different temperatures: room temperature, 4 °C and -20 °C (Figure 5.1). The times 
selected for the analysis were 0, 1, 4, 7, 14, 30 and 60 days. These conditions were 
designed to represent those likely to encounter during transportation between Colombia 
and the UK and to evaluate the storage of samples for a maximum period of two months. 
5.2.9 Sample analysis 
Samples prepared in SOF and homogenised porcine tissue were extracted and analysed 
using the validated methods described in Chapter 4 (Section 4.3.4). All samples were 
analysed using calibrators and QCs prepared on the day of analysis. The analysis was 
conducted in triplicate on the selected days (Section 5.2.8). The samples were thawed at 
room temperature and extracted within the day and left to run on the LC-MS instrument 
overnight. 
Samples in BOF were extracted and analysed using the validated method described in 
Chapter 4 (Section 4.3.4). All samples were analysed using calibrators and QCs prepared 
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on the day of analysis. The analysis was conducted in triplicate on the selected days 
(Section 5.2.8). The samples were thaw at room temperature and extracted within the day 
and left to run on the LC-MS/MS instrument overnight. 
5.2.10 Evaluation of stability of analytes 
Analytes analysed on day 0 were held as baseline or 100% concentrations. Changes in 
concentration were presented as percentage of day 0 (% baseline) and were determined 
as: (mean stored sample concentration) / (mean baseline concentration) x 100, with n = 
3.  Concentration changes < 20% were considered stable (Lee et.al. 2013). 
Stability of cocaine was assessed over time by quantifying the change in concentration 
of the parent compound and its major metabolite, BZE. 
5.2.11 Data analysis 
Non-parametric Spearman’s test was used for correlation analysis (IBM SPSS 
Statistics version 23). Results with 2-tailed ps < 0.05 were considered significant. 
5.3 RESULTS AND DISCUSSION 
5.3.1 Stability of cocaine, AEME and BZE in synthetic oral fluid 
Results of the stability of AEME and BZE in SOF are illustrated in Figure 5.2. These 
results showed that AEME and BZE were stable at -20 ºC (Figure 5.2 a-c) for up to 90 
days at the low, medium and high concentrations in SOF. All concentrations were within 
20% from the original AEME and BZE concentrations, with mean values of 92.6% (82.3-
Chapter 5 – Stability of cocaine and cocaine derivatives in buffered human oral fluid, synthetic 
oral fluid and porcine oral mucosa 
201 
103.4%) for AEME and 90.2% (79.5-95.4%) for BZE. Concentration variability (%RSD) 
of AEME and BZE was < 8.2%. Changes in concentration of less than ± 20% of the 
baseline (Day 0) accounted for analytical imprecision (Lee et al. 2012). Variations in the 
pipetted volumes of samples could have also contributed to the variations in 
concentration. When samples are pipetted at different temperatures, e.g. the liquid 
temperature or the ambient temperature, the volume of the sample dispended varies (an 
increase of temperature might lead to a reduction in the volume dispensed) (Ewald 2015). 
Even though all samples were thawed at room temperature for over one hour, the ambient 
temperature could have varied across the study and therefor the temperature and 
transferred volume of the SOF samples. SOF as well as homogenised tissue and BOF 
contained more than 90% water, which density (mass/volume) decreases with the 
increase in temperature. 
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Figure 5.2 Stability of AEME, BZE and cocaine in SOF. Concentration as percentage of day 
0. Stability at -20°C for the concentrations 5 ng/mL (a), 20 ng/mL (b) and 80 ng/mL (c). Stability 
in the fridge for the concentrations 5 ng/mL (d), 20 ng/mL (e) and 80 ng/mL (f). Stability at room 
temperature for the concentrations 5 ng/mL (g), 20 ng/mL (h) and 80 ng/mL (i). Stability at 37°C 
for the concentrations 5 ng/mL (j), 20 ng/mL (k) and 80 ng/mL (l). Dotted lines at 80% indicate 
the stability limit of 20% variation from day 0. 
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Storage at 4 ºC (Fridge stability) indicated that AEME was stable for up to 60 days at 
the low and middle concentrations (Figure 5.2 d-e) and stable up to 90 days for the high 
concentration (Figure 5.2 f). A decrease in AEME mean concentration of 22.5% and 
30.4% were seen for the low and middle concentration on day 90. The decrease in AEME 
concentration could have been the result of degradation into anhydroecgonine (AE) 
during storage (Fandiño et al. 2002). BZE was stable for up to 30 days at all 
concentrations. Samples of BZE at the high concentration were stable on day 90 (mean 
relative concentration of 82.5%). A decrease in BZE concentration of 22.6% (20.2-
26.4%) and 26.0% (17.5-35.8%) was seen on day 60 and 90 respectively (%RSD: 14.7 
and 35.6% respectively). 
Stability at 18-20 ºC (room temperature) indicated that AEME was stable for up to 15 
days at all of the three concentrations evaluated, with values within ± 20% of day 0. The 
recovery values were 82.6%, 82.6 and 87.0% for the low, medium and high 
concentrations on day 15. The %RSD within the 15 days was < 7.3 for all concentrations. 
A decrease in mean concentration of 26.4% (23.7-31.8%), 39.2% (36.9-40.5%) and 
65.4% (66.0-63.8%) was seen on day 30, 60 and 90 respectively, indicating its 
degradation into AE. BZE was stable up to four days at the middle and high 
concentrations (recovery values of 83.1% and 83.0% respectively). Stability at the low 
concentration (79.4%) indicated that BZE in SOF was stable only for few hours. 
Analytical errors could have produced the small changes in concentration in relation to 
Day 0 (20.6%) indicating that BZE samples were stable up to four days. Stability of BZE 
and AEME could not be obtained on day 1, because of instrument failure, therefore it was 
not possible to confirm that BZE (5 ng/mL) was stable for 24 hours. A decrease in mean 
concentration of 67.8% (67.4-68.1%) was seen for BZE after 90 days of storage at room 
temperature. 
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Stability at 37 ºC (Figure 5.2 j-l) indicated that AEME and BZE were stable for up to 
24 hours in SOF at all concentrations evaluated, with changes below 20% from day 0. All 
concentrations were within 20% of the original AEME and BZE concentrations, with 
mean values of 96.7% (88.9-102.2%) for AEME and 91.7% (81.1-101.3%) for BZE. 
Concentration variability (%RSD) of AEME and BZE was 4.5% and 7.1% respectively. 
The results indicated that the concentration of BZE decreased as the temperature of 
storage increased after few days of storage. This decrease in concentration corresponded 
to the degradation of BZE in the fridge and at room temperature. Chen et al. (2016) 
reported ecgonine (ECG) as the hydrolysis product of BZE following enzymatic 
degradation. ECG was not analysed in this study; therefore, it could not be confirmed as 
the degradation product of BZE. 
BZE is the hydrolysis product of cocaine and concentrations of BZE in SOF samples 
were related to the degree of hydrolysis of cocaine (Klingmann et al. 2001, Cognard et 
al. 2006). The results presented in Figure 5.2 confirmed this statement by showing that 
there was a decrease in cocaine concentration compensated by the appearance of BZE in 
SOF samples over a period of 90 days at different storage conditions. 
Samples of cocaine in SOF stored in the freezer (-20 ºC) were stable for the length of 
the study (90 days) at the three concentrations (Figure 5.2 a-c), with a mean recovery 
value of 100.2% (89.1-114.1%). The variability (%RSD) of cocaine concentration was 
7.3%, 8.5% and 9.1% for the low, middle and high concentrations respectively. The 
variations in cocaine concentration were attributed to analytical imprecision and random 
errors from the volume of the samples analysed as it was previously described (Lee et al. 
2012, Ewald 2015). BZE could not be quantified as it was detected at concentrations 
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below the LOQ of the method. These results indicated that cocaine did not degrade when 
samples of SOF were stored at -20 ºC. 
When samples were stored in the fridge (-4 ºC) (Figure 5.2 d-f), the stability of cocaine 
decreased, and samples were stable up to 15 days (92.7%). A mean decrease in 
concentration of 37.1% (36.2-37.5%), 43.9% (43.2-44.6%) and 70.2% (66.5-72.4%) was 
seen in day 30, 60 and 90 respectively. As can be observed in Figure 5.2 (d-f) when the 
concentration of cocaine decreased, the concentration of BZE increased consequently. 
The concentration of BZE increased up to 54% of the initial cocaine concentration over 
90 days. The percentage of BZE in relation to the cocaine concentration (day 0) ranged 
2.9-48.7%, 2.1-53.9% and 1.3-49.6% for the low, medium and high concentrations 
respectively. The decrease in concentration of cocaine was significantly correlated with 
the increase in concentration of BZE when samples were stored at room temperature at 
the medium and high concentrations (Medium: rs = -0.86, p = 0.01; High: rs = -0.89, p = 
0.007), whereas no significant correlation was obtained for the samples at the low 
concentration (Low: rs = -0.64, p = 0.119). These results indicated that at highest 
temperatures the degradation of cocaine into BZE is more significant that at low 
concentrations. 
Room temperature experiments (Figure 5.2 g-i) demonstrated that cocaine in SOF was 
stable up to four days at the low and high concentrations (80.3% and 80.3% respectively). 
The medium concentration appeared to be instable after four hours of storage (79.2%) 
suggesting that cocaine in SOF was stable for only few hours. Analytical errors could 
have produced the small changes in concentration in relation to Day 0 (20.8%) indicating 
that cocaine samples were stable for up to four days. The stability at day 1 could not be 
obtained because of instrument failure, therefore, it was not possible to confirm that 
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cocaine was stable for al least 24 hours of storage at the medium concentration. On day 
90, a degradation of > 90% was observed for cocaine, with concentrations of cocaine 
decreasing by 89.4%, 92.4% and 95.1% for the low, medium and high concentrations 
respectively. On the contrary, an increase in the concentration of up to 68.4% was seen 
for BZE on this day 90.  Mean concentrations (as percentage of cocaine day 0) ranged 
from 5.1-66.1%, 2.1-68.4% and 1.3-53.4% for the low, medium and high concentrations 
respectively. The concentration of cocaine was significantly correlated with the 
concentration of BZE when samples were stored at room temperature (Low: rs = -0.96, p 
< 0.001; Medium: rs = -0.93, p = 0.003; High: rs = -0.86, p = 0.01). 
The stability at 37ºC (Figure 5.2 j-l) indicated that cocaine in SOF was stable up to 
four hours at the low, medium and high concentrations (94.5%, 94.7% and 97.1% 
respectively). Mean concentrations ranged from 85.1-100.0%, 83.9-100.0% and 86.0-
100.0% for the low, middle and high concentrations respectively. BZE was detected as 
break down product of COCAINE (Klingmann et al. 2001, Cognard et al. 2006) at 
concentrations up to 18.8% (Low), 17.1% (Middle) and 17.9% (High) (as percentage of 
COCAINE day 0). After 24 hours at 37 ºC, the concentration of cocaine decreased in 
more than > 64%, with concentrations of cocaine decreasing by 43.5%, 58.0% and 63.3% 
for the low, medium and high concentrations respectively. The concentration of BZE 
consequently increased up to 57% after 24 hours storage at 37ºC.  Mean concentrations 
of BZE in SOF (as percentage of cocaine day 0) ranged from 6.5-56.3%, 2.8-56.8% and 
2.1-57.1% for the low, medium and high concentrations respectively. 
Overall, the increase in BZE concentration did not correspond to the concentration of 
cocaine decreasing.  Whereas cocaine concentration decreased up to 95% on day 90, BZE 
increased up to 68%. These discrepancies could be attributed to the additional degradation 
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of cocaine into EME and subsequently into ECG (Klingmann et al. 2001). Since EME 
and ECG were not included in the quantitative method used to evaluate the stability of 
analytes in SOF, this result could not be confirmed. 
5.3.2 Stability of cocaine, AEME and BZE in porcine oral mucosa 
In this chapter, the stability of cocaine and metabolites was evaluated in tissue in order 
to aid the interpretation of results from in vitro diffusion studies (Chapter 7). Even though 
the diffusion studies were conducted in pieces of whole tissue, for accuracy purposes, the 
stability of cocaine and cocaine derivatives were conducted in homogenised tissue. This 
procedure was preferred as spiking of individual pieces of tissue resulted in different 
absorption of cocaine and therefore variances in the amount of cocaine present in different 
sections of the tissue (RSD >30%).   The degradation of cocaine in biological tissue has 
been reported for its application in post-mortem analysis (Moriya and Hashimoto 1996, 
Kiszka et al. 2001, Rees et al. 2012). 
Stability studies were conducted at 37 ºC and -20 ºC storage temperature only. These 
conditions were selected as the in vitro studies were conducted at 37ºC for a period of 
time of up to four hours and samples were stored at -20 ºC until quantitative analysis. 
Stability at room temperature and -4 ºC was not evaluated because there were not 
experiments conducted at these temperatures or tissue samples stored under these 
conditions. The results of the stability of AEME, BZE and cocaine at 37 ºC and -20 ºC 
are shown in Figure 5.3. 
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Figure 5.3 Stability of AEME, BZE and cocaine in homogenised porcine oral mucosa. 
Concentration as percentage of day 0. Stability at -20°C for the concentrations 5 ng/mL (a), 20 
ng/mL (b) and 80 ng/mL (c). Stability at 37°C for the concentrations 5 ng/mL (d), 20 ng/mL (e) 
and 80 ng/mL (f). Dotted lines at 80% indicate the stability limit of 20% variation from day 0. 
Stability showed that AEME and BZE analytes were stable at -20 ºC for up to 30 days 
at the low, medium and high concentrations in homogenised tissue (Figure 5.3 a-c). All 
concentrations were within ± 20% from the original AEME and BZE concentrations, with 
mean relative recovery values of 94.2% (86.1-102.5%) for AEME and 94.0% (87.1-
100.0%) for BZE. Concentration variability (RSD%) for AEME and BZE were 5.3% and 
4.4%. This variability could have been the results of analytical imprecision (Lee et al. 
2012) and variations in the pipetted volumes of the samples from the fluctuations in the 
temperature of the samples (Ewald 2015). 
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The Stability at 37 °C (Figure 5.3 d-f) demonstrated that samples of porcine oral tissue 
containing AEME and BZE were stable for four hours at the low, medium and high 
concentrations. All concentrations were within ± 20% from the original AEME and BZE 
concentrations, with mean relative recovery values of 98.3% (88.9-102.2%) for AEME 
and 102.5% (81.1-101.3%) for BZE. The recovery values of AEME were 99.9% (97.0-
103.9%) for the low concentration, 97.5% (93.2-101.8%) for the medium concentration 
and 97.5% (95.4-98.8%) for the high concentration. The recovery values for BZE were 
90.0% (81.1-99.0%), 93.1% (82.7-102.5%) and 92.0% (81.5-99.4%) for the low. Medium 
and high concentrations respectively. Concentration variability (%RSD) of AEME and 
BZE recovery values were 2.8% and 7.3% respectively. 
Samples of cocaine at the three concentrations in homogenised tissue (Figure 5.3 a-c) 
were stable for the length of the study (30 days) when stored in the freezer (-20 ºC). Mean 
values of 96.1%, 92.2% and 94.8% for the low middle and high concentrations were 
obtained respectively (giving an overall mean of 98%). The variability (%RSD) of 
cocaine concentration was 6.8, 5.9 and 5.0% for the low, middle and high concentrations 
respectively. The concentration of BZE as a percentage of cocaine day 0 was below 5% 
and ranged from 0.3-4.8%. These results indicated that no significant degradation of 
cocaine in this study was obtained when samples were stored at -20 ºC. 
The stability at 37 ºC (Figure 5.3 d-f) indicated that cocaine in porcine oral tissue was 
stable for the length of the study (four hours) for the low, medium and high concentrations 
(97.0, 98.1 and 97.9% respectively). The variability (%RSD) of cocaine concentration 
was 4.8%, 2.4% and 2.9% for the low, middle and high concentrations respectively. 
Additionally, an increase in the concentration of up to 6.8% was seen for BZE after four 
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hours. Mean concentrations (as percentage of cocaine day 0) ranged from 4.8-6.8%, 1.7-
2.0% and 0.8-1.8% for the low, medium and high concentrations respectively. 
In contrast with the SOF analysis, the amount of BZE being formed, i.e. appearing in 
the tissue samples containing cocaine agreed to the loss of cocaine concentration, with 
%RSD values < 3%. Hence, indicating that the quantification of BZE could account small 
losses of cocaine. 
5.3.3 Stability of cocaine and cocaine derivatives in buffered oral fluid 
The stability of cocaine derivatives (AEME, BZE, CE, EME and NC) in BOF is 
illustrated in Figure 5.4. Stability showed that AEME, CE and NC analytes were stable 
at -20 ºC (-24.9 ± 0.6 °C) for up to 60 days at the low, medium and high concentrations 
in BOF (Figure 5.4 a-c). Excepting the mean concentration of NC at the medium 
concentration on day 15 that was 23.6% from that of day 0.  Concentration variability 
(RSD%) for all analytes were < 17.7%. These variations could have been the result of 
analytical imprecision (Lee et al. 2012) and variations in the pipetted volumes of the 
samples from the fluctuations in the temperature of the samples (Ewald 2015) as 
discussed in Section 5.3.1.  
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Figure 5.4 Stability of AEME, BZE, EME, CE and NC in BOF. Concentration as percentage 
of day 0. Stability at -20°C for the concentrations 5 ng/mL (a), 50 ng/mL (b) and 200 ng/mL (c). 
Stability in the fridge for the concentrations 5 ng/mL (d), 50 ng/mL (e) and 200 ng/mL (f). 
Stability at room temperature for the concentrations 5 ng/mL (g), 50 ng/mL (h) and 200 ng/mL 
(i). Dotted lines at 80% indicate the stability limit of 20% variation from day 0. 
0%
20%
40%
60%
80%
100%
120%
140%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
140%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
140%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
140%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
140%
0 20 40 60
Time (days)
0%
20%
40%
60%
80%
100%
120%
140%
0 20 40 60
Time (days)
a b c 
d e f 
g h i 
Chapter 5 – Stability of cocaine and cocaine derivatives in buffered human oral fluid, synthetic 
oral fluid and porcine oral mucosa 
 
 212 
Solutions of BZE at low and medium concentration were stable up to 30 days at -20 
°C, and solutions at a high concentration were stable up to 60 days. The stability of EME 
indicated that this compound was only stable for few hours (less than 24 hours) at any of 
the three concentrations. A decrease of 74.4%, 98.5% and 89.4% was seen for the low, 
medium and high concentration respectively on day 60. These results could be the result 
of the breakdown of EME into ECG (Klingmann et al. 2001). 
Samples stored in the fridge (5.2 ± 0.4 °C) (Figure 5.4 d-f) were stable for up to 60 
days for AEME at all concentrations. Concentrations of AEME in BOF presented a 
percentage of recovery of 109.2% (101.4-119.7%) (low), 103.7% (98.1-113.3%) 
(Medium) and 103.2% (99.6-105.6%) (High), over the 60 days. Concentration variability 
(RSD%) was < 2.6%. Samples of BZE at the medium (91.3%, 81.4-107.3%) and high 
(100.9 %, 93.2-116.3%) concentrations were stable up to 60 days. However, samples at 
the low concentration appeared to be stable only up to 15 days (92.0 %, 81.1-110.3%). A 
decrease of BZE concentration of 23.6% and 35.4% was seen for the low concentration 
on days 30 and 60 respectively. Solutions containing CE were stable up to 30 days for the 
low (93.0%, 82.9-103.1%) and medium (97.1%, 80.0-101.8%) concentrations and stable 
up to 60 days for the high concentration (92.5%, 81.5-116.3%). Similarly, to the stability 
at -20 ºC, EME was stable for less than 24 hours at the medium and high concentration 
and stable up to one day at the low concentration. A decrease of up to 99% was seen for 
all concentrations at the time of the study. NC was stable for up to 60 days at all 
concentrations, with mean concentrations of 94.9% (79.6-112.7%) (Low), 99.0% (84.9-
112.8%) (Medium) and 95.5% (84.4- 110.5%). 
Stability at room temperature (Figure 5.4 g-i) indicated that BOF containing AEME 
were stable for up to 11 days at the low concentration (109.4%, 105.9-119.9%) and stable 
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up to 60 days at the medium (104.3%, 100.0-114.9%) and high (103.4%, 96.2-111.4%) 
concentrations. The variation in concentration of AEME on day 15, 30 and 60 ranged 
121-138% from day 0. These high percentages were attributed to the instrument
performance, i.e. ion enhancement in the MS detection, and no to degradation of the 
sample or experimental error (the transference (pipetting) of the sample, SPE process or 
reconstitution volume). This statement can be supported by the fact that the other analytes 
present in the same sample did not show high percentages of variation. Ion enhancement 
is a common disadvantage of ESI and is caused by the competition between ions to be 
expelled from the droplet during the desolvation process (Particle sciences 2009). 
Concentrations of BZE at the low and medium values, on the other hand, were stable 
up to 30 days with percentages of 90.3% (80.5-111.3%) and 93.0% (80.8-108.0%) 
respectively. Excepting day eight (medium concentration) that appeared to be unstable, 
with a loss of concentration of 20.7%. At the high concentration, BZE was stable up to 
60 days (98.2%, 84.4-119.2%). The stability of CE was eight days for the low and 
medium concentrations and 11 days for the high concentration. Percentages of variation 
were 90.8% (82.9-98.4%), 96.0% (88.4-98.0%) and 93.9% (84.1-102.1%) respectively. 
A decrease in mean concentration of up to 60.1%, 52.6% and 36.6% were seen in the low, 
medium and high concentrations on day 60. NC was stable for up to 60 days at all 
concentrations (Low: 92.1%, 80.9-112.6 %; Medium: 93.2%, 84.8-111.4% and High: 
93.1%, 80.3-102.4%). 
The stability of cocaine in BOF is presented in Figure 5.5. This figure illustrates the 
change in concentration of cocaine and BZE which is the main break down product of 
cocaine (Cognard et al. 2006). Samples of cocaine in BOF stored in the freezer (-20 ºC) 
(Figure 5.5 a-c) were stable for the length of the study (60 days) at the three 
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concentrations. Excepting cocaine at the medium concentration on day 30, where the 
percentage of recovery was 126.9%. This high value could have been the result of 
experimental error: (1) pipetting error: a higher volume being analysed could have led to 
the quantification of higher amounts of analyte (Ewald 2015). (2) The volume of the 
solution used in the reconstitution step, which could have affected the final concentration 
(Ewald 2015). (3) Ion enhancement from the MS source (Particle sciences 2009). 
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Figure 5.5 Stability of cocaine and BZE in BOF. Concentration as percentage of cocaine day 
0. Stability at -20°C for the concentrations 5 ng/mL (a), 50 ng/mL (b) and 200 ng/mL (c). Stability 
in the fridge for the concentrations 5 ng/mL (d), 50 ng/mL (e) and 200 ng/mL (f). Stability at 
room temperature for the concentrations 5 ng/mL (g), 50 ng/mL (h) and 200 ng/mL (i). Dotted 
lines at 80% indicate the stability limit of 20% variation from day 0. 
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The mean concentration values of cocaine were 94.7% (79.8-117.5%), 98.4% (84.6-
126.9%) and 96.2% (81.8-107.6%) for the low, middle and high concentrations 
respectively. The mean concentration of BZE as a percentage of cocaine on day 0 was < 
20% and ranged from 13.2-16.4% within the three concentrations. These results indicated 
that cocaine was not significantly hydrolysed into BZE when samples of SOF were stored 
at -20 ºC. The concentration of BZE was not significantly correlated with the 
concentration of cocaine at any of the concentrations (Low: rs = -0.75, p > 0.05; Medium: 
rs = -0.57, p > 0.05 and High: rs = 0 .21, p > 0.05), therefore confirming the low 
degradation of cocaine in the BOF samples. 
When samples were stored in the fridge (Figure 5.5 d-f), the stability of cocaine 
decreased, and samples were stable up to 15 days at the low and medium concentrations 
and up to 30 days at the high concentration. A mean decrease in concentration of 83.1%, 
75.8% and 31.3% were seen on day 60 at the low, medium and high concentrations 
respectively. Even though the concentration of cocaine decreased over time, the 
concentration of BZE did not increase notably (Figure 5.5). The BZE concentration 
increased up to 32% of the initial cocaine concentration over the 60 days. The percentage 
of BZE in relation to the cocaine concentration (day 0) ranged 7.7-29.8%, 12.4-26.1% 
and 14.8-32.3% for the low, medium and high concentrations respectively. No correlation 
between the decrease in the concentration of cocaine with the increase in concentration 
of BZE was seen at any of the three concentrations (Low: rs = -0.39, p > .05; Medium: rs 
= -0.07, p > 0.05; High: rs = -0.29, p > 0.05). These results indicated that the increase of 
BZE was not representative of the decrease in cocaine concentration. 
The stability at room temperature demonstrated that solutions of cocaine in BOF were 
stable up to four days at low (92.9%), medium (97.3%) and high (91.8%) concentrations. 
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On day 60, a cocaine degradation of > 90% was seen, with concentrations of cocaine 
decreasing up to 96.2%, 99.2% and 99.6% at the low, medium and high concentrations 
respectively. On the contrary, an increase in the concentration of up to 72% was seen for 
BZE on this day (Day 60).  Mean concentrations (as percentage of cocaine day 0) ranged 
from 11.1-35.0%, 12.4-44.5% and 14.8-71.6% for the low, medium and high 
concentrations respectively. The decrease in concentration of cocaine was significantly 
correlated with the increase in BZE concentration when samples were stored at room 
temperature (Low: rs = -0.92, p < 0.001; Medium: rs = -0.74, p < 0.05; High: rs = -0.98, 
p < 0.001). 
A decrease of up to 99% in cocaine was accompanied by an increase in BZE 
concentration of up to 72% on day 90, indicating that the amount of BZE formed in the 
BOF samples containing cocaine did not appear at the same degree as cocaine was 
degrading. These discrepancies could be attributed to the additional degradation of 
cocaine into EME and ECG (Klingmann et al. 2001). Even though the amount of EME 
was quantified, the concentrations could not be related to the degradation of cocaine 
(Appendix D), this because the concentrations of EME were considerably higher (6-35 
times) than the initial concentration of cocaine. As mentioned in Chapter 4, EME was 
detected at high concentrations in OF samples that did not contain this analyte. Therefore, 
the amount of EME quantified in BOF samples containing cocaine could have been the 
result of the accumulation of the intrinsic EME and the EME from the degradation of 
cocaine. The accumulation of EME was no clearly seen probably because of its further 
degradation into ECG (Klingmann et al. 2001). 
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5.3.4 Comparison between BOF, SOF and porcine oral mucosa stability 
Few differences were seen for the stability of cocaine and cocaine derivatives in BOF, 
SOF and homogenised oral tissue. Summary of the results obtained for the stability of all 
analytes in SOF, BOF or tissue is shown in Table 5.3. The results presented in this table 
show that samples containing AEME and BZE remained stable for a longer period of time 
in BOF (AEME: two months; BZE: two months) than in SOF (AEME: 15 days; BZE: 
four days) at room temperature. These differences in the stability of analytes in SOF and 
BOF could be attributed to the composition of these two matrices. Even though the 
composition of SOF aims to replace the natural, i.e. neat OF, the SOF may contain 
different constituents or amount of compounds present in human OF. Additionally, the 
buffer from the collection device contains exogenous compounds that may contribute to 
the stability of the analytes in OF, e.g. colourants, preservatives, stabilising salts and 
surfactants (Lee and Huestis 2014). 
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Table 5.3 Summary of the results obtained for the stability of cocaine and derivatives in SOF, 
BOF and porcine oral tissue. 
Analyte Storage 
Temperature 
SOF BOF Tissue 
AEME 
37 ºC Stable for up to 24 hours NA Stable for up to 24 h. 
Room 
temperature 
Stable for up to 15 days. 
Maximum decrease in 
concentration of 65% after three 
months 
Stable for up to two 
months.  
NA 
Fridge  Stable for up to two months 
Stable for up to two 
months 
NA 
-20 ºC Stable for up to three months. 
Stable for up to two 
months. 
Stable for up to one 
month. 
BZE 
37 ºC 
• Stable for up to 24 h. 
• Concentrations increased up to 
57% of COC day 0 in 24 h. 
NA 
• Stable for up to 24 h. 
• Concentrations 
increased up to 11% of 
COC day 0 in 24 h. 
Room 
temperature 
• Stable for up to four days. 
Maximum decrease in 
concentration of 68% after three 
months 
• Concentrations increased up to 
68% of COC day 0 in three 
months. 
• Stable for up to one 
month. 
• Concentrations increased 
up to 72% of COC day 0 
in two months. 
NA 
Fridge  
• Stable for up to two months 
• Concentrations increased up to 
54% of COC day 0 in three 
months. 
• Stable for up to two 
months 
• Concentrations increased 
up to 32% of COC day 0 
in two months 
NA 
-20 ºC 
• Stable for up to three months.  
• Detected at concentrations <10% 
COC day 0 over three months. 
• Stable for up to one 
month. 
• Detected at 
concentrations <20% 
COC day 0 over two 
months 
• Stable for up to one 
month. 
• Detected at 
concentrations <5% 
COC day 0 over one 
month 
COC 
37 ºC 
Stable for up to 4 h. Maximum 
decrease in concentration of 64% 
after 24 h. 
. 
NA 
Stable for up to 24 h. 
 
Room 
temperature 
Stable for up to 4 days. Maximum 
decrease in concentration of 90% 
after 3 months. 
Stable for up to 4 days. 
Maximum decrease in 
concentration of >90% 
after 2 months 
NA 
Fridge  
Stable for up to 15 days. 
Maximum decrease in 
concentration of 70% after 3 
months 
Stable for up to 8 days. 
Maximum decrease in 
concentration of 83% after 
2 months 
NA 
-20 ºC Stable for up to 3 months. Stable for up to 2 months. Stable for up to 1 month. 
CE 
Room 
temperature 
NA 
Stable for up to 8 days. 
Maximum decrease in 
concentration of 60% after 
2 months. 
NA 
Fridge  NA Stable for up to 1 month. NA 
-20 ºC NA Stable for up to 2 months. NA 
NC 
Room 
temperature 
NA Stable for up to 2 months. NA 
Fridge  NA Stable for up to 2 months. NA 
-20 ºC NA Stable for up to 2 months. NA 
EME 
Room 
temperature 
NA Stable less than 24 h. NA 
Fridge  NA Stable less than 24 h. NA 
-20 ºC NA Stable less than 24 h. NA 
SOF: artificial Oral Fluid, BOF: Buffered Oral Fluid, Tissue: Homogenised porcine oral tissue, AEME: 
Anhydroecgonine methyl ester, BZE: benzoylecgonine, EME: ecgonine methyl ester, COC: cocaine, CE: cocaethylene, 
NC: norcocaine, NA: No analysed.  
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A mean decrease in AEME concentration of 65% was observed on day 90 for SOF 
samples stored at room temperature. Similar results were reported by Fandiño et al. 
(2002) where a decrease in concentration of 50% was obtained after 30 days (phosphate 
buffer PBS pH 7) and five days (human plasma) of storage at room temperature. The 
more rapid degradation of AEME into AE was attributed to the presence of esterases in 
the plasma (Fandiño et al. 2002). The increased stability obtained for SOF and BOF 
compared with the stability reported in PBS could have attributed to the presence of 
stabilising agents and butyrylcholine esterase inhibitors such as sodium fluoride. 
As per AEME, the stability of BZE was prolonged in BOF (one month) than in SOF 
(four days). This result can be explained by the impact of preservatives present in the 
BOF as it was previously discussed. Reported stability of BZE in whole blood (McCurdy 
et al. 1989) and PBS (Kiszka et al. 2000) indicated that BZE in blood remained stable up 
to 30 days at room temperature. For BZE in PBS, a decreased in concentration of > 60% 
after 90 days of storage at room temperature was reported. The results presented here for 
BZE in BOF were similar to the results of preserved whole blood reported by McCurdy 
(1989) since the analyte remained stable for one month. Unexpectedly, the stability in 
SOF was shorter (decrease in BZE concentration > 60% after 60 days storage) than the 
stability reported in PBS, which indicated that fluctuations in the storage temperature (18 
°C – 25 °C) influenced the degradation of BZE. 
When samples were stored in the fridge, AEME was stable in both matrices for more 
than two months. This stability was longer than the stability reported in plasma (13 days) 
(Fandiño et al. 2002) and was attributed to the stabilising agents present in the OF 
matrices. BZE in BOF showed extended stability (two months) than in SOF (one month), 
which once again was attributed to the preservatives present in the matrices. The results 
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for BOF were similar to the stability reported for BZE in PBS (90 days) (Kiszka et al. 
2000). However, the stability of BZE in both BOF and SOF was expected to be longer 
than in the PBS buffer as the latest does not contain any preservative that could have 
prevented the degradation of BZE. 
The stability of AEME and BZE in both matrices was similar as they remained stable 
for the length of the study (SOF: 90 days and BOF: 60 days). Although no reports were 
found for the stability of AEME in aqueous solutions, it could be implied from the results 
reported by Fandiño et al. (2002) that the stability of AEME increases as the storage 
temperature decrease. Therefore, confirming the results obtained in this study. The 
stability reported for BZE in PBS (stable up to 90 days at -20 °C) (Kiszka et al. 2000) 
was in agreement with the results of BZE in BOF and SOF. 
Increasing concentrations of BZE as a result of cocaine degradation in OF and other 
aqueous matrices (PBS, urine, plasma) have been reported by various authors (Kiszka et 
al. 2000, Ventura et al. 2009, Gao et al. 2010). This tendency was also observed in the 
present study while evaluating the stability of cocaine in BOF and SOF. Concentrations 
of cocaine in both matrices were stable up to four days, and concentrations decreased 
more than 90% from their initial value over the time of the study (SOF: 90 days and BOF: 
60 days). The decrease in cocaine concentration was accompanied by an increase in BZE 
concentration of 72% over a period of 60 days (BOF) and 68% over a period of 90 days 
(SOF) when samples were stored at room temperature. 
Although the formation of BZE correlated with the decrease of cocaine, the sum of the 
amount of BZE and cocaine was not constant over the time period tested, as it was also 
observed by other authors (Ventura et al. 2009). Degradation of 26% and 41% were 
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reported for cocaine in BOF using two different collector devices (Cozart Drug Detection 
System oral fluid collection device and Intercept oral specimen collection device, 
respectively) after two to three days of storage at room temperature (Ventura et al. 2009). 
A decrease of cocaine concentration (mean value) of 11% was obtained on day four of 
storage using the Concateno Certus collection device. This prolonged stability for the 
BOF using the Concateno Certus devices could be the result of the impact of stabilising 
agents in the buffer composition. 
The stability of the samples in BOF (eight days for the low and medium concentration 
and 15 days for the high concentration) and SOF (15 days) was prolonged when samples 
were stored at 4 °C compared to room temperature. Even though there are no reports of 
stability in BOF or SOF at this temperature, degradation of <10% was reported for 
cocaine in neat OF up to four days of storage at 4 °C (Cone and Menchen 1988). Results 
that were expected as BOF and SOF contained preservatives, e.g. sodium azide (SOF). 
At -20 ºC, the stability of cocaine in both matrices was similar as they remained stable 
for the length of the study (60 days for BOF and 90 days for SOF). This prolonged 
stability at -20 °C  in comparison with stability at 4 °C and room temperature was also 
reported for cocaine in blood, urine and PBS (Kiszka et al. 2000, 2001). Although cocaine 
was reported to be stable in the freezer, a small percentage of BZE was observed in PBS 
and blood samples (< 20%) (Kiszka et al. 2000, 2001). Similarly, a percentage of BZE 
was seen in the samples of BOF (72% increase in two months) and SOF (68% increase 
in three months). 
Moriya and Hashimoto (1996) reported that samples of blood and other tissues (brain, 
liver and muscle) containing CE were more stable than the samples containing cocaine. 
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This result was in agreement with the results obtained in BOF, as CE was stable for up to 
eight days compare with cocaine that was stable for four days at room temperature. NC 
on the other hand has been reported to be stable at -20 °C and have a half-life of 43 min 
at 37 °C in plasma. The reported stability for NC in plasma was in agreement with the 
stability in BOF when samples were stored at -20 °C (Bouis et al. 1990). 
Samples of cocaine and cocaine derivatives (AEME, BZE and cocaine) in 
homogenised tissue and SOF were stable when stored at -20 ºC. The concentrations of 
analytes were within ± 20% of the initial concentration value over the time of the study 
(Tissue: 30 days; SOF:90 days). When samples were kept at 37 ºC, most analytes (AEME 
and BZE) were stable in both matrices for up to 24 hours. Cocaine for the contrary was 
less stable in SOF (four hours) than in tissue (24 hours). The increase in the concentration 
of BZE in homogenised oral tissue as a result of the degradation of cocaine race up to 
11% when samples were stored at room temperature.  Stability in other tissues than 
mucosa or tongue tissue was in agreement with the results presented here, as cocaine was 
stable up to 24 hours of storage at 37 ºC in homogenates of liver, brain and muscle (pH < 
7) (Moriya and Hashimoto 1996). Similarly, the results of this study were in agreement 
with the results reported by various authors (Spiehler and Reed 1985, Kiszka et al. 2001, 
Rees 2011). No significant changes in cocaine concentration were reported after one and 
three months in brain samples stored in the freezer (-16 to -20 ºC) (Spiehler and Reed 
1985, Kiszka et al. 2001). Cocaine was also reported to be stable when samples were 
stored at -20 ºC in samples of kidney and liver (Kiszka et al. 2001). Rees (2011) observed 
changes in cocaine concentration < 15% from day 0 in muscle samples, when samples 
were stored at -20 ºC over a period of 30 days. 
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5.4 CONCLUSIONS 
The results presented in this chapter indicated that the time of storage and storage 
temperature influenced the stability (concentration) of cocaine and cocaine derivatives in 
SOF, BOF and porcine oral tissue. A decrease in drug concentration was seen as the 
storage temperature increased. The results indicated that the concentration of BZE 
increased as a result of the degradation, i.e. hydrolysis of cocaine when samples of SOF 
and BOF were stored at room temperature or in the fridge. This increase in BZE 
concentration could be used, at least in part, to correct for losses of cocaine in the SOF 
and OF samples. 
The results of the stability of solutions of SOF containing cocaine showed that samples 
of cocaine remain stable when stored in the freezer (-20 ºC) for as long as 90 days with 
minimum hydrolysis into BZE (< 10%). When samples were stored in the fridge, the 
stability of cocaine decreased, and samples were stable up to 15 days. A mean decrease 
in concentration of up to 70.2% was seen on day 90. Hydrolysis to BZE was seen with 
concentrations increasing up to 54% of the initial cocaine concentration over the 90 days. 
When samples were kept at room temperature cocaine in SOF was stable for up to four 
days, with further degradation (> 90%) seen on day 90. An increase in the concentration 
of up to 68.4% was seen for BZE on this day (Day 90). Additionally, the stability at 37 
ºC indicated that cocaine was stable up to four hours. 24 hours after, a cocaine degradation 
of > 64% was seen, with an increase in BZE concentration of up to 57%. 
Stability of SOF solution containing cocaine derivatives AEME and BZE indicated 
that the derivatives were stable for up to 90 days when stored at -20 ºC. This stability 
decreased to 60 and 30 days for AEME and BZE respectively, when samples were stored 
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in the fridge. Furthermore, when samples were left at room temperature the stability of 
AEME and BZE was reduced to 15 and four days respectively.  After 90 days of storage 
at room temperature, the AEME mean concentration reduced to 65.4% and the BZE mean 
concentration was reduced to 67.8%. Stability at 37 ºC indicated that AEME and BZE 
were stable for up to 24 hours in SOF at all concentrations evaluated.  
The Stability conducted in homogenised porcine oral tissue showed that samples 
containing cocaine and stored in the freezer (-20 ºC) or at 37 ºC were stable for the length 
of the study (30 days or 24 hours respectively). Maximum BZE concentrations of 11% 
were quantified in samples stored in the freezer and 37 ºC. Also, AEME and BZE were 
stable at -20 ºC for up to one month. The Stability at 37 °C demonstrated that samples 
were stable for up to 24 hours. These results concluded that no changes in concentration 
of cocaine and AEME should be expected while developing the in vitro studies on the 
release of drugs from oral drug depots into SOF (Chapter 7). 
The stability of cocaine in BOF indicated that cocaine degraded into BZE when 
samples were stored at room temperature or fridge. At room temperature solutions of 
COC in BOF were stable up to four days. On day 60, a cocaine degradation of > 90% was 
seen, with an increase in BZE concentration of up to 72%. When samples were stored in 
the fridge, the stability of cocaine samples were eight to 15 days. A mean decrease in 
concentration of 83.1%, 75.8% and 31.3% were seen on day 60 at the low, medium and 
high concentrations respectively. The BZE concentration increased up to 32% of the 
initial cocaine concentration over the 60 days. Samples of cocaine in BOF stored at -20 
ºC were stable for the length of the study (60 days). Cocaine was not significantly 
hydrolysed into BZE when samples of SOF were stored at -20 ºC. The mean concentration 
of BZE as a percentage of cocaine on day 0 was < 20%. 
Chapter 5 – Stability of cocaine and cocaine derivatives in buffered human oral fluid, synthetic 
oral fluid and porcine oral mucosa 
225 
Samples of BOF containing cocaine derivatives (AEME, BZE, CE and NC) proved to 
be stable for at least one month while stored at room temperature, in the fridge or the 
freezer. Stability in the freezer (-20 ºC) produced longer stability results than in the fridge, 
as samples were stable for two months. However, some analytes (AEME: medium and 
high concentrations, BZE: high concentrations and NC all concentrations) remained 
stable on day 60 while stored in the fridge or at room temperature. Solutions of AEME at 
the low concentration (5 ng/mL) were stable for up to 11 days at room temperature.  
Solutions of BZE at the low concentration were stable for 15 to 30 days while stored in 
the fridge or room temperature. 
The stability of EME in BOF at any of the temperatures evaluated indicated that this 
compound was only stable for few hours (less than 24 hours), with a decrease in 
concentration of up to 98.5% by day 60. Even though EME was detected, the EME 
concentrations could not be related to the degradation of cocaine. 
In conclusion, samples of BOF, SOF and tissue should be stored at temperatures of -
20 °C to preserve the stability of the samples and avoid degradation of cocaine and 
derivatives from the time of sample collection until sample analysis. SOF samples stored 
at -20 °C or 4 °C and analysis within two months or 15 days respectively are preferred 
to maximise result accuracy. Similarly, analysis of BOF samples should be conducted 
within two months (stored at -20 °C), eight days (stored at 4 °C) or four days (stored at 
room temperature) from the time of sample collection. Studies using SOF and porcine 
oral tissue should be conducted at 37 °C within 24 hours, however, subsampling of 
SOF are recommended at maximum of four hours because of the degradation of 
cocaine into BZE after this time. Careful consideration should be taken in the 
interpretation of results from BOF samples as extended times of storage 
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(transportation) and changes in temperature of storage could lead to degradation of 
cocaine and cocaine derivatives. The results presented in this chapter aided in the 
design of the in vivo and in vitro studies by identifying the best storage conditions and 
the implications that the length of storage (transportation of samples from Colombia 
to the UK) could have on the concentration of cocaine and derivatives in the samples. 
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CONCENTRATION OF COCAINE AND COCAINE 
DERIVATIVES IN HUMAN ORAL FLUID SAMPLES 
FOLLOWING THE INGESTION AND ORAL EXPOSURE 
TO COCA TEA 
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6.1 INTRODUCTION  
The consumption of coca tea (Mate de Coca) is both legal and socially acceptable in 
South America (Jenkins et al. 1996, Penny et al. 2009, Rubio et al. 2014). In these 
countries, the amount of cocaine consumed via coca tea consumption vary depending 
upon the ethnicity and the reason for consumption, e.g. traditional use or occasional 
drinking for the relieve of altitude sickness (Engelke and Gentner 1991, Casikar et al. 
2010, Biondich and Joslin 2015, Rubio et al. 2015). A common dose of cocaine can vary 
between 1-15 g of coca leaves per day for individuals that traditionally consume coca 
leaves by brewing the leaves (Jenkins et al. 1996, Mazor et al. 2006, Rubio et al. 2013, 
2015). Because cocaine and other alkaloids are present in small quantities in the plant 
material, a high amount of coca leaves is required to be consumed in order to obtain 
psychoactive effects (Rubio et al. 2015). The plant material contains a low amount of 
cocaine which is of approximately 0.5% (Jenkins et al. 1996, Rubio et al. 2015). For 
instance, the consumption of coca tea (approximately one gram of coca leaves per cup) 
produce low oral absorption of alkaloids (< 30%) with no significant stimulant effects 
(Mazor et al. 2006). These advantages of low cocaine dosages and no psychoactive effects 
when coca tea is consumed allow the investigation of the kinetics of release of cocaine in 
oral fluid (OF) using a human in vivo safe model. 
Even though no psychoactive effects are obtained following oral administration of 
coca tea, cocaine and metabolites have been detected at high concentrations in biological 
matrices such as urine, hair and OF following consumption of the coca leaves (ElSohly 
et al. 1986, Jenkins et al. 1996, Jufer et al. 2000, Mazor et al. 2006, Strano-Rossi et al. 
2008, Reichardt 2014, Rubio et al. 2015). Initially, ElSohly et al. (1986) reported the 
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detection of benzoylecgonine (BZE) in urine following the ingestion of a cup of coca tea 
(Health Inca tea) for up to 29 hours post consumption using a cut-off of 100 ng/mL. 
Jenkins et al. (1996) confirmed that cocaine and metabolites (BZE and ecgonine methyl 
ester – EME) could be detected in urine after coca tea had been consumed for up to 20 
hours (cut-off value of 6.25 ng/mL). 
Strano-Rosi et al. (2008) reported peak concentrations for cocaine, BZE and EME in 
OF following the consumption of Peruvian mate de coca (1g coca leaves) of 23, 27 and 
15 ng/mL, with times of last detection of 4.3 hours for cocaine, 11 hours for BZE and one 
hour for EME. In a different study, Jenkins et al. (1995) and Cone et al. (1997) described 
that cocaine and derivatives were detected in OF at concentrations significantly higher 
than in blood (16–505 ng/mL for OF and 0.4–1.9 ng/mL for blood) following smoking of 
crack cocaine and that this initial high concentration was the result of oral contamination. 
Oral contamination was reported to disappear over the first 30–120 minutes after oral 
administration. Furthermore, these drugs were detected over an extended period of time 
following smoking (40 g dose: eight hours and 42 g dose: 12 hours). This excretion of 
cocaine and metabolites in OF was attributed to passive diffusion of analytes from the 
systemic circulation and drug depots. 
Reichardt (2014) also reported the detection of high concentrations of cocaine and 
cocaine metabolites (BZE, anhydroecgonine methyl ester AEME and cocaethylene CE) 
in OF samples collected from volunteers that had ingested coca tea. Maximum 
concentrations of cocaine and BZE were reported at 2729 (14-8595) ng/mL and 174 (11-
452) ng/mL immediately after the ingestion of the tea. This study showed detection of 
both cocaine and BZE in OF over one-hour post consumption of the tea, suggesting that 
cocaine and cocaine derivatives were released from buccal tissues into OF over time. The 
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study also revealed a number of unexplained artefacts relating to the random detection of 
AEME and CE in OF samples collected after coca tea consumption.  
Since there is not a clear understanding on the impact of drug depots in the excretion 
of cocaine into OF, it was important to further enhance our understanding of cocaine 
absorption and elimination from oral/buccal tissues. In order to achieve this, OF samples 
were collected following the consumption or swirling of a cup of coca tea from human 
volunteers in a controlled in vivo study. The study was undertaken in collaboration with 
the National University of Colombia from Bogota - Colombia where consumption of coca 
tea is legal and a regular social custom. Analysis of the coca tea was conducted using a 
validated method (Chapter 4) to evaluate the presence of cocaine, AEME, BZE, CE and 
nor-cocaine (NC) in the plant material and coca tea. These cocaine derivatives have been 
previously reported in OF following administration of cocaine, crack-cocaine and coca 
tea (Jenkins et al. 1995, Cone et al. 1997, Jufer et al. 2000, Lewis et al. 2004, Cardona et 
al. 2006, Reichardt 2014). AEME, NC and CE were also reported to be randomly 
distributed throughout collected OF samples following consumption of coca tea 
(Reichardt 2014). Therefore, it is of great importance to evaluate whether other cocaine 
derivatives than BZE such as AEME could be detected on OF after ingestion of coca tea 
as this could have an impact in OF drug testing. AEME is commonly used as a biomarker 
for detection of “crack” cocaine and detection of this analyte in OF could wrongly 
indicate previous use of “crack” cocaine, resulting in legal prosecution of the individual. 
This study was also used to investigate whether the equivalence in concentration of 
cocaine and cocaine derivatives in OF samples when samples are collected from different 
sides of the mouth using one or two OF collection devices. 
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6.1.1 AIM AND OBJECTIVES 
6.1.1.1 Aim: 
This chapter aimed to contribute to the knowledge of the kinetics of cocaine and its 
metabolites in OF following ingestion or swirling of a cup of coca tea. 
6.1.1.2 Objectives: 
• Measure the amount of cocaine and cocaine derivatives present in a cup of coca tea
prepared with coca tea bags from the Nasa community (Colombian community).
• Determine concentration profiles of cocaine, BZE, AEME, EME, CE and NC in oral
fluid following the ingestion or swirling of a cup of coca tea.
• Evaluate times of last detection for cocaine and cocaine derivatives in OF following
the ingestion or swirling of a cup of coca tea.
• Assess differences in concentration profile and time of last detection between
participants that ingested or swirled a cup of coca tea.
• Calculate significant differences between the concentration of cocaine and cocaine
derivatives from OF samples collected from different sides of the mouth.
• Evaluate population-level differences in the kinetics of cocaine and metabolites from
OF samples from participants that have consumed coca tea.
6.2 METHODS 
6.2.1 Materials 
Drug standards and reagents used for the analysis of buffered oral fluid (BOF) were 
purchased as described in Section 4.2.1. 
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Oasis mixed-mode cation exchange (MCX) micro-elution plates (Waters, Manchester, 
UK) MS and AlereÔ Concateno Certus® OF collection devices were donated by AlereTM 
Toxicology. The Oasis micro-elution plates were used for sample preparation prior to 
quantitative analysis by LC-MS as described in Section 4.2.9. 
The coca tea was prepared using coca leaves from the Nasa community (Colombian 
indigenous tribe), commercialised as tea bags under the name “Coca Nasa Nasa Esh’s – 
Aromatica de Coca”. These coca leaves were grown, recollected and dried using 
traditional procedures, no chemical and/or preservatives were added or used in the 
process; leaves were sun-dried. The coca leaves commercialised by Nasa community 
belong to the Erythroxylum novogranatense var. novogranatense (E. novogranatense var. 
nov). Tea bags from the same batch were used to prepare the tea. The tea bags were 
purchased from Coca Nasa Nasa Esh’s (Cauca – Colombia). 
6.2.2 Instrumentation 
Analysis of BOF samples was carried out using a LC-MS/MS system consisting of a 
tandem quadrupole mass spectrometer coupled to a Waters Acquity UPLC® system. 
Details on the LC-MS systems were described in Section 4.2.2. 
6.2.3 Preparation of coca tea - Dosage 
A cup of coca tea was prepared by infusing two coca tea bags (1.04 ± 0.08 g) in 200 
mL boiling water (91 ºC; 2640 m). The tea was ready to drink after leaving the tea bags 
infusing for eight minutes without any stirring. The coca tea was prepared based on 
customary dosage (approximately one gram) and procedures (Jenkins et al. 1996, Mazor 
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et al. 2006). Two coca tea bags were used as the amount of coca leaves per tea bag present 
in the Coca Nasa Nasa Esh’s was 0.52 ± 0.04 g (measurement based on 30 tea bags). 
Eight minutes were chosen based on the results presented by Jenkins et al. (1996), who 
demonstrated there were not significant differences between the amount of cocaine 
extracted after infusing coca leaves for eight and nine minutes. 
6.2.4 Pilot study 
OF samples were collected from five participants (male and female age ranging 30-
80) over a period of six hours following the ingestion of a cup of coca tea (prepared as
per Section 6.2.4). The results of this study indicated that cocaine and derivatives were 
no longer detected in OF after three hours of ingestion. Thus, a period of four hours was 
selected for the main study as this time would allow the monitoring of cocaine and 
derivatives in OF until no analytes could be detected in the OF and minimising the time 
for the volunteers to participate in the study. 
6.2.5 Study population 
The study was conducted with undergraduate students (male and female with age 
ranging 18-33) from the Department of Pharmacy of the National University of Colombia 
in Bogota – Colombia.  
The number of volunteers (sample size) required in this study was elucidated based on 
the results obtained from a pilot study (as per Section 6.2.4). The sample size for the study 
was 30 participants. This value was calculated using the Equation 6.1 and the following 
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values: mean cocaine concentration of 160 ng/mL, imprecision of ± 20%, standard 
deviation of 16%, significance level of 0.05 and power of 80% (Crawley 2005). 
𝑛 = #.%	×	()*)       Equation 6.1 
Where n is the sample size, s the variance and ¶ the difference that want to be detected with a 
probability of 0.8. 
The inclusion criteria were being healthy volunteers, male and woman with age 18 
years or above, be able to give written inform consent and able to understand and 
complete a questionnaire (Appendix E) and able to provide OF samples after ingestion or 
swirling of a cup of coca tea. The participants were excluded from the study if they did 
not give written consent or if they acknowledge had consumed cocaine, crack-cocaine or 
coca tea in the three days before the study. 
All subjects who met the inclusion and exclusion criteria were invited to participate in 
the study. A questionnaire was obtained from all participants along with informed consent 
for the collection of OF samples. Details of the recruitment process were explained in the 
protocol of the study and the volunteer information form as indicated in Appendix E. 
6.2.6 Ethics 
This study was approved by the ethics committees of Bournemouth University and the 
National University of Colombia - Bogota. The approved questionnaire, protocol, 
participant information form and volunteer information form are shown in Appendix E. 
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6.2.7 Collection of control oral fluid samples 
Samples of control OF used for the preparation of calibrants, QCs and blanks were 
collected from six healthy volunteers (male and female with ager ranging 25-35 years 
old) using the Concateno Certus® devices as described in Section 4.2.5. 
6.2.8 Collection of oral fluid samples 
This study was conducted as described in the protocol of the study (Appendix E). 
Initially, verbal information about the study was given to all participants at the beginning 
of the study. The 30 participants were divided in two groups (Group A and B) using 
randomised allocations. Once consent was received from all participants a single sample 
of OF was collected from each participant (pre-dose sample) by active sample collection 
following manufacture guidance (Section 4.2.5). Subsequent OF samples were collected 
following the ingestion or swirling of a cup of coca tea: 
Group A comprised 15 participants each of whom drank and swallowed one cup of 
coca tea within a maximum period of 10 minutes. Following ingestion, all participants 
provided OF samples at 10, 20, 30, 60, 120, 180 and 240 minutes using one Concanteno 
Certus device at each time point (active sample collection). OF was collected as described 
in the protocol of the study (Appendix E) and Section 4.2.5. 
Group B comprised 15 participants each of whom mimicked the drinking of a cup of 
coca tea by sipping, holding and swirling tea in the mouth for 20-30 seconds and then 
spitting out the content. This process was repeated several times to complete the sipping-
spitting of a cup of coca tea for a maximum period of 10 minutes until all the tea had been 
Chapter 6 – Concentration of cocaine and cocaine derivatives in human oral fluid samples 
following the ingestion and oral exposure to coca tea 
 
 236 
used. Following swirling, all participants provided two simultaneous OF samples at 10, 
20, 30, 60, 120, 180 and 240 minutes using two Concanteno Certus devices at each time 
point to observe whether differences were obtained from different sides of the mouth. 
One device was located on the right side of the mouth (R) and the second device on the 
left side of the mouth (L). The devices were placed between the inner side of the cheek 
and the teeth. OF was collected as described in the protocol of the study (Appendix E) 
and Section 4.2.5. 
The length of the study (240 minutes) was selected based on the results obtained from 
the pilot study (five volunteers). 
6.2.9 Storage of buffered oral fluid samples 
All absorbent pads (containing 1 mL OF) were left at room temperature (10-20 ºC) 
into the respectively labelled tube (which contained the extraction buffer) for 24 hours to 
ensure a complete extraction of the analytes into the buffer (The mean recovery from the 
collection pad into the buffer was 97 ± 1.4% for all analytes). Subsequently, each 
collection pad was centrifuged at 3000 rpm for 5 min to recover all BOF. All samples 
were weighted before and after centrifugation to accurately measure the amount of OF 
collected in each sample. The samples were then split in two and stored at -20 °C (2-8 
days) until shipment to the UK. During transportation from Colombia to the UK (seven 
days) the storage conditions could not be monitored and therefore variations in the 
concentration of analytes in OF were expected. After the samples arrived in the UK, they 
were stored at Alere Toxicology at -20 °C until analysis. 
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6.2.10 Quantitative analysis of buffered oral fluid samples 
All buffered samples were extracted and analysed for AEME, BZE, COC, CE, NC and 
EME at Alere Toxicology using a validated LC-MS/MS method. Details of the SPE 
extraction and LC-MS/MS method were given in Chapter 4. All samples were analysed 
by the researcher using calibrators and QCs prepared on the day of analysis. 
All results were reported as concentration of analyte in original “neat” OF rather than 
in BOF. To obtain the concentration in neat OF, the concentrations of analyte in BOF 
were corrected by the dilution factor of the collection device (multiplying by four). 
6.2.10.1 Quantitation of cocaine and cocaine derivatives in coca tea 
Table 6.1 shows the amount of cocaine and cocaine derivatives present in a cup of 
coca tea Coca Nasa Nasa Esh’s. These values were obtained from the analysis of 30 
separate teacups prepared as mentioned in Section 6.2.3. All samples of coca tea were 
diluted (100x) in control buffered oral fluid before storage. Buffered samples were finally 
extracted and analysed as described previously. 
Table 6.1 Amount of cocaine and cocaine derivatives present in a cup of coca tea (200 mL) 
using Coca Nasa Nasa Esh’s tea bags. 
Analyte 
Amount (mg) with n = 30 
Mean ± SE Range 
AEME 1.2 ± 0.03 0.9-1.5 
BZE 0.8 ± 0.04 0.4-1.2 
COC 6.7 ± 0.20 5.2-9.0 
CE - - 
EME 87.2 ± 5.02 40-134
NC - - 
AEME: Anhydroecgonine methyl ester; BZE: Benzoylecgonine; COC: Cocaine; CE: Cocaethylenene; EME: 
Ecgonine methyl ester; NC: Norcocaine; n: Number of samples; SE: Standard error 
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In order to confirm the presence of AEME in the plant material, a methanolic extract 
of the Colombian coca tea bags (1.05 g coca leaves) was analysed following the method 
described by Jenkins et al. (1996). The extraction (using 200 mL methanol and 
mechanical shaking for 48 hours) was conducted at room temperature to avoid the 
formation of AEME from thermal exposure of cocaine. All methanolic extract were 
diluted (100x) in control buffered oral fluid before storage. Buffered samples were finally 
extracted and analysed as described previously. 
6.2.11 Data analysis 
The data was analysed based on analytical cut-off concentrations in OF (Limit of 
quantification LOQ) and the European Workplace Drug Testing Society (EWDTS) cut-
off. The EWDTS recommend a cut off concentration of 8 ng/mL for confirmation of 
cocaine and BZE in neat OF (EWDTS 2015).  
IBM SPSS Statistics version 23 and Microsoft Excel Version 15.33 were used for 
statistical analysis. Nonparametric Spearman’s test was used for correlation analysis. 
Mann-Witney (U) test and Wilcoxon (W) test were used to compare the data. These tests 
were chosen after verifying the absence of normal distribution (Kolmogorov-Smirnov 
normality test) and homogeneity (Levene’s test) of variance. Results with 2-tailed ps < 
.05 were considered significant. 
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6.3 RESULTS AND DISCUSSION 
6.3.1 Amount of cocaine and cocaine derivatives in a cup of coca tea 
Quantitative analysis of the coca tea prepared with tea bags “Coca Nasa Nasa Esh’s” 
as described in Section 6.2.10.1 (Table 6.1) demonstrated that the principal alkaloid 
present in the coca tea was EME (87.2 mg) followed by cocaine (6.7 g), AEME (1.2 mg) 
and BZE (0.8 mg). These results were different from the amounts reported by other 
authors on the analysis of alkaloids in coca tea prepared with coca leaves from Peru (EME 
2.0 mg, COC 4.8 g, AEME 0.01 mg and BZE 0.8 mg) and Bolivia (EME 2.3 mg, COC 
4.8 g, AEME 0.06 mg and BZE 0.2 mg) (Jenkins et al. 1996). The coca tea prepared by 
Jenkins et al. was prepared under similar conditions as the ones used in this chapter using 
approximately 1 g of coca leaves, 180 mL water (94 °C) and nine minutes infusion time. 
Summary of the results obtained in this chapter and the results reported by Jenkins et al. 
(1996) are shown in Table 6.2. In this table the amount of analyte presented in the coca 
tea was corrected for 200 mL coca tea.  
Table 6.2 Amount of cocaine and cocaine derivatives present in a cup of coca tea prepared 
with coca leaves from Colombia, Peru* and Bolivia*. Coca tea was prepared using approximately 
1g of coca leaves. 
Analyte 
Mean amount of analyte (mg)**
Colombian coca tea 
(n = 30) 
Peruvian coca tea*
(n = 30) 
Bolivian coca tea*
(n = 30) 
AEME 1.24 0.01 0.06 
BZE 0.83 0.78 0.17 
COC 6.75 4.76 4.81 
CE - - - 
EME 87.2 1.98 2.28 
NC - - - 
AEME: Anhydroecgonine methyl ester; BZE: Benzoylecgonine; COC: Cocaine; CE: Cocaethylenene; EME: 
Ecgonine methyl ester; NC: Norcocaine; n: Number of samples. * Data reported by Jenkins et al. (1996). ** mg per 200 
mL coca tea using approximately  
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Comparison between the results presented in Table 6.2 indicated that the amount of 
cocaine and EME were higher (1.2 times for COC and 40 times for EME) in the 
Colombian tea than the Peruvian or Bolivian tea. The amount of BZE was similar (< 4% 
difference) between the Colombian tea and the Peruvian tea. 
The high amount of EME obtained in the coca tea (87±5 mg) could be the result of 
thermal degradation of cocaine in the tea (Klingmann et al. 2001) and/or to its extraction 
from the plant material, i.e. coca leaves. However, based on the results of other authors 
(Jenkins et al. 1996, Casale et al. 2014) it can be suggested that the primary source of 
EME in the tea (Coca Nasa Nasa Esh’s) was the extraction of EME from the plant 
material and not the thermal degradation of cocaine. Jenkins et al. (1996) considered that 
thermal degradation of cocaine into EME was less likely to occur during the preparation 
of the tea than its presence in the plant material. This was explained by the fact that EME 
and BZE were present in the tea bags and were not a product of the hydrolysis of cocaine 
(Jenkins et al. 1996). Casale et al. (2014) reported the presence of EME in extracts of 15 
different species of the coca plant including E. novogranatense var. nov. 
No CE or NC was detected in the coca tea. These results were in accordance with the 
results reported by Jenkins et al. (1996), who did not detect any of these analytes in 
Peruvian or Bolivian coca tea, although Casale et al. (2014) reported the presence of NC 
but not CE in organic extracts (e.g. toluene, methanol and chloroform) of the coca plant 
(E. novogranatense var. nov.). This result was unexpected as NC is an active metabolite 
formed from the enzymatic degradation of cocaine in the liver (Poon et al. 2014).  The 
qualitative analysis described by Casale et al. (2014) indicated that NC was present at 
considerable low amounts (less than ten times the peak high of COC or EME) in organic 
extracts of coca leaves. These results suggested that NC could be extracted during the 
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preparation of a cup of coca tea but the amount of NC could be at undetectable 
concentrations. 
AEME has been detected in coca tea and the coca plant by few authors (Jenkins et al. 
1996, Rubio et al. 2015, 2016) however, all authors attributed its presence as an artefact 
product of the GC-MS analysis or its production from cocaine as a result of thermal 
exposure during extraction. The results presented in Table 6.2 indicated that AEME was 
present in the Colombian tea at high amounts (1.24 mg/g coca leaf) compared with the 
amounts present in coca tea prepared with Peruvian or Bolivian coca tea bags (0.01-0.07 
mg/g coca leaf) (Jenkins et al. 1996). This difference in concentration could be attributed 
to differences in the species of the coca leaf and analytical procedures. Even though the 
authors did not report the species of the coca plant in Peruvian and Bolivian coca tea, it 
has been reported that the predominant species of coca leaf in Peru and Bolivia belong to 
the Erythroxylum coca (Plowman 1979, Casale et al. 2014) differing from the species 
found in the Colombian coca tea that belonged to the E. novogranatense var. nov. 
The presence of AEME in the coca tea as an artefact product of the detection process 
(LC-MS method) was discarded as AEME was not detected when standards of cocaine 
were evaluated during the LC-MS method development and validation (Chapter 4). The 
results of the analysis of AEME from the methanolic extract (extraction conducted at 
room temperature) indicated that 12.2 ± 0.1 mg of AEME was present in one gram of 
coca leaves and that only 38% of the total AEME present in the plant was extracted during 
the preparation of the tea. Further confirmation of AEME concentration in the plant 
material is required as the methanolic extraction of AEME and the other analytes was not 
optimised and higher amounts of AEME could be present in the coca leaves. 
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The high amount of AEME present in the coca leaves indicated that AEME 
concentration in the coca tea was most likely to be the result of extraction from the plant 
material than its formation from thermal exposure during the preparation of the tea. This 
assumption could be supported by the fact that other analytes such as BZE and EME were 
not produced during tea preparation (Jenkins et al. 1996). Nonetheless, more studies need 
to be conducted in order to confirm that AEME was not formed during tea preparation. 
The fact that AEME was detected in coca tea was of great importance as detection of this 
analyte in OF samples could wrongly indicate recent consumption of crack cocaine. This 
outcome could have potential impact on OF drug testing as positive results could be 
obtained for AEME after consumption of coca tea. Although OF is not yet used in 
countries where coca tea is traditionally used, there have been reports that coca tea can 
be purchased in several countries such as the USA where OF testing is implemented and 
where the importation of coca leaves is illegal (Mazor et al. 2006). 
6.3.2 Demographics and user experiences 
A total of 30 participants were screened for cocaine and metabolites following the 
ingestion (Group A; n = 15) or swirling (Group B; n = 15) of a cup of coca tea. Table 6.3 
summarises the demographics obtained for the participants. 29 participants were 
undergraduate students (National University of Colombia) with age ranging 18-25 years. 
Only one participant from the Group B was aged 26-33 years. The majority of participants 
that ingested the coca tea were males (60%), whereas the majority of participants that 
swirl the tea were female (60%). Median values for height, weight and BMI were 1.7 m, 
61.0 Kg and 21.4 Kg/m2 respectively. Most BMI values (83%) within the range 18.5-
24.99 Kg/m2 were considered normal according to the World Health Organisation 
(WHO). Two participants (BMI of 15.7 and 17.1 Kg/m2 of BMI were underweight (WHO 
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Underweight BMI: < 18.5 Kg/m2) and three participants (BMI of 26.1, 26.4 and 26.8 
Kg/m2) were pre-obese (WHO Pre-obese BMI: 25.0-29.9 Kg/m2). A statistical Wilcoxon 
(W) test indicated that there were no significant differences in the height, weight and BMI
between the participants from Group A (Ingestion) and B (Swirling) (Height: W (30) 204, 
p = 0.25; weight: W (30) 216, p = 0.49; BMI: W (30) 231, p = 0.97). Only eight 
participants reported to be smokers (Group A - Ingestion: 20%; Group B - Swirling: 
33%). 
Table 6.3 Demographics of the participants that ingested or swirled a cup of coca tea. 
Characteristic Group A - Ingestion Group B - Swirling 
n 15 15 
Age 18-25 18-33
Gender 
Female  40% (n = 6) 
Male     60% (n = 9) 
Female  60% (n = 9) 
Male     40% (n = 6) 
Height (m)* 1.74 (1.52 – 1.8) 1.65 (1.5 – 1.8) 
Weight (Kg)* 65 (45 – 78) 58 (40 – 74) 
BMI (Kg/m2)* 21.6 (15.7 – 26.4) 21.0 (17.1 – 26.8) 
Smokers 20% (n = 3) 33% (n = 5) 
n: Number of participants; * Mean values and range 
Most participants (67%) were originally from Bogota – Colombia and the remaining 
10 participants (33%) were from the following cities in Colombia: Barrancabermeja, 
Cúcuta, Sogamoso, Villeta, Zipaquirá, Duitama, Garagoa, Ipiales, Tunja and Valencia. 
Eleven (37%) of the 30 participants reported previous consumption of coca tea. the 
aforementioned 11 participants reported consumption of coca tea less than once a month 
in the city of residence. The tea was primarily consumed in the afternoon (n = 6, 55%), 
followed by evening (n = 3, 27%) and morning (n = 1, 9%). The tea was reported to be 
prepared using one bag (n = 7, 64%), two tea bags (n = 3, 27%) or leaves (seven leaves 
per teacup) (n = 3, 27%) and mixed with sugar (n = 9, 80%) or drunk on its own (n = 2, 
20%). From five studies reported on the use of coca tea (Engelke and Gentner 1991, 
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Jenkins et al. 1996, Mazor et al. 2006, Penny et al. 2009, Zavaleta 2015) only two studies 
reported the consumption of coca tea with sugar (Penny et al. 2009, Zavaleta 2015). None 
of these reports mentioned the amount of coca leaves used (dose) or the time at which the 
coca tea was consumed. 
The answers reported by the 30 participants on the questionnaire also allowed the 
evaluation of the clinical and psychological effects of consumption of coca tea, as well 
as the reason for consumption of the tea for the study population. These data were 
summarised in Figure 6.1. Figure 6.1-A shows the reason for consumption of coca tea 
given by the participants that had previously consumed coca tea (n = 11). The reasons 
given were as follow: consumption for traditional reasons (n = 2), altitude sickness (n = 
3), test or flavour (n = 2), interest (n = 1), curiosity (n = 3), to increase energy (n = 1) or 
elevate mood (n = 1). These results were in agreement with few publications that 
associated the consumption of coca tea to tradition, relieve of symptoms for altitude 
sickness or nutritional reasons such as elevated energy (Penny et al. 2009, Casikar et al. 
2010, Biondich and Joslin 2015, Zavaleta 2015).  
    
Figure 6.1 (A) Reason for consumption of coca tea. (B) Clinical and psychological effects 
after consumption of coca tea. 
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On the other hand, Figure 6.1-B, showed the experiences of the participants (n = 30) 
following the consumption of coca tea. Most participants (n = 25, 83%) reported ‘no-
significant effects’ following consumption of coca tea. The remaining five participants 
reported have effects of elevated mood, feeling of relieve from altitude sickness, feeling 
of restlessness, increased energy and stimulant effect. Three of the five participants that 
reported effects following consumption of coca tea were the same participants that 
reported consuming coca tea for the same effects (altitude sickness, increase energy or 
elevate mood). The results obtained were in agreement with previous reports (Penny et 
al. 2009, Biondich and Joslin 2015) which described that coca tea is mostly consumed in 
the Andean region for traditional reasons as well as for the effects that this could offer to 
people including antifatigue effect, suppression of appetite, nutritional factors and relieve 
to altitude sickness. The primary reason for consumption of coca tea was therefore related 
traditional reasons with no significant effects obtained following the ingestion of a cup 
of coca tea, however effects such as those described previously can be obtained for a 
small percentage (17%) of the population. 
The results of the questionnaire also revealed that 80% of the participants did not 
expect to have any effect following consumption of coca and 93% did not considered 
coca tea a psychoactive substance. These results were in agreement with the report of 
83% of the participants not reporting any significant effect after the intake of the tea 
(Figure 6.1-B), confirming that consumption of coca leaves is not considered an addiction 
in regions where it is customarily used as mentioned by Rubio et al. (2014). 
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6.3.3 Concentration of cocaine in oral fluid following the ingestion (Group A) and 
swirling (Group B) of a cup of coca tea 
The concentration of cocaine in OF samples in the control samples (pre-dose samples) 
ranged 1-17 ng/mL for all participants. The concentration range for the group that 
ingested the tea (Group A) was 1-9 ng/mL. The concentration range for the group that 
swirled the tea (Group B) was 1-17 ng/mL. Summary of cocaine concentrations in OF 
following the ingestion or swirling of coca tea is presented in Appendix E Table 3. 
The results showed that two out of 15 participants tested positive (based on the 
EWDTS cut-off) for the presence of cocaine in the control sample even though all 
participants reported not have consumed coca tea or cocaine 72 hours before the study. 
The EWDTS guidelines for cocaine confirmatory testing in OF established a cut-off 
concentration of 8 ng/mL for cocaine (EWDTS 2015). As per most voluntary studies, 
consumption of cocaine or coca tea prior to the study could not be ensured. Table 6.4 
shows the descriptive statistics of cocaine concentration at each collection time. 
Table 6.4 Cocaine concentration in neat OF following the ingestion or swirling of a cup of 
coca tea. 
Collection 
time (min) 
Concentration Group A – Ingested 
(ng/mL) (n = 2)* 
Concentration Group B - Swirled (ng/mL) 
(n = 2)* 
Mean Median SD Min Max Mean Median SD Min Max 
0 2 2 2 1 9 3 2 4 1 17 
10 1248 1215 853 58 2993 2553 2569 1012 274 4643 
20 543 449 564 14 2168 1168 1254 755 68 2855 
30 225 105 283 4 1082 483 206 554 11 2172 
60 61 31 66 3 203 78 45 73 3 276 
120 16 8 35 1 140 9 4 13 1 48 
180 7 4 11 1 42 4 4 2 2 9 
240 6 3 9 1 36 2 2 1 0 6 
Group A: Participants ingested one cup of coca tea (data collected using one collection device at each time point). 
Group B: Participants swirled a cup of coca tea (data collected using two collection devices at each time point). A: OF 
sample collected from the right side of the mouth. B: OF sample collected from the left side of the mouth. SD: Standard 
deviation. LOQ: 0.5 ng/mL cocaine in buffered oral fluid; LOQ in neat OF was 2 ng/mL (the dilution factor from 
collection device was 4) * Each sample was analysed in duplicate and values are presented as mean values. 
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The two participants that tested positive were Participant P3 from Group A with 9 
ng/mL and Participant P29 from Group B with 17 ng/mL. Mean and median values were 
below the EWDTS cut-off for Group A and Group B. After excluding the positive pre-
dose samples, the mean and median values did not change significantly (Group A - 
Ingestion: Mean = 1.7, Median = 1.6; Group B - Swirling: Mean = 1.7, Median = 1.6). 
Maximum cocaine concentrations of negative pre-dose samples were 4.8 and 3.0 ng/mL 
in OF for Group A and B respectively excluding the positive pre-dose samples. 
Figure 6.2 illustrates the concentration profile of cocaine in OF for a period of four 
hours following ingestion (Group A) or swirling (Group B) of coca tea. Furthermore, 
Table 6.5 summarises the maximum concentration (Cmax), times of maximum 
concentration (Tmax), time of last detection (T0-last) and area under the curve (AUC0-last) 
for both groups. Mean maximums cocaine concentration (Cmax) in OF of 1248 and 2534 
ng/mL for Group A (Ingestion) and B (swirling) respectively were observed in the first 
sample collected after 10 minutes following ingestion and swirling of the tea. Based on 
the EWDTS (EWDTS 2015) and LOQ cut-offs all participants reported positive for 
cocaine in the sample collected after 10 minutes of the ingestion or swirling of coca tea.  
Figure 6.2 Mean cocaine concentrations in OF following the ingestion (n = 15, 120 samples) 
or swirling (n = 15, 240 samples) of a cup of coca tea. Bars are standard deviation. Data illustrated 
in full scale and with a zoom into the low concentration region. Dotted lines indicate the following 
cut-off concentrations: Limit of quantification (LOQ) (2 ng/mL), EWDTS (8 ng/mL).  
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Table 6.5 Maximum concentration, time at maximum concentration, detection window and 
area under the curve for cocaine in OF following the ingestion (Group A) or swirling (Group B) 
of a cup of coca tea.  
Group A - Ingested Group B - Swirled 
Participant 
Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
Participant 
Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
P1 1886 10 240 594 P16 2862 10 120 39496 
P2 1317 10 120 399 P17 2533 10 120 27306 
P3 1630 10 180 350 P18 2674 10 180 73463 
P4 1242 10 120 543 P19 2496 10 180 44924 
P5 2137 10 >240 1009 P20 1388 10 120 19249 
P6 737 10 180 207 P21 4609 10 180 164380 
P7 2992 10 120 1245 P22 3420 10 240 92801 
P8 1115 10 120 297 P23 2479 10 60 30241 
P9 1215 10 120 273 P24 2473 10 180 57191 
P10 2359 10 180 510 P25 3667 10 120 52353 
P11 207 10 180 92 P26 1875 10 120 15860 
P12 505 10 180 111 P27 305 10 60 9125 
P13 58 10 60 17 P28 3064 10 120 76494 
P14 1176 10 180 469 P29 2212 10 120 50888 
P15 138 10 60 41 P30 1844 10 120 42024 
Mean 1248 10 158 410  2527 10 137 53053 
Median 1215 10 180 350  2496 10 120 44924 
SD 853 0 55 346  1003 0 48 38704 
Min  58 10.0 60 17  305 10.0 60 9125 
Max  2992 10.0 240 1245  4609 10.0 240 164380 
Cmax: Maximum concentration; Tmax: Time at maximum concentration; Tlast: Time of last detection at EWDTS cut-
off (8 ng/mL); AUC0-last: Area under the curve. SD: standard deviation.  
A rapid decrease in concentration in both groups was observed over the first hour to a 
mean concentration of 61 and 77 ng/mL for Group A - Ingestion and Group B - Swirling 
respectively. After two hours, 47% (Group A-Ingested) and 33% (Group B-Swirling) of 
the population still reported positive at both cut-offs. Mean concentration values at two 
hours were 7.0 ng/mL for Group A and 3.9 ng/mL for Group B. The time of last detection 
at the EWDTS cut-off for Group A was three hours and for Group B - Swirling was two 
hours (Table 6.5). Two participants (13 % of the population) from the Group A - Ingested 
gave positive results for cocaine during the length of the study (four hours). Only one 
participant tested positive in Group B – Swirling three hours after having swirled the tea 
but his concentration in OF decreased below the cut-off after four hours. The time of last 
detection at the assay’s LOQ was longer for both groups. More than 60% of the 
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population (Group A - Ingested: 80%; Group B - Swirling: 60%) had detectable 
concentrations of cocaine in OF after four hours. 
Figure 6.2 shows that higher concentrations in OF were obtained when the coca tea 
was swirled (Group B) than when it was ingested (Group A). A Mann-Whitney (U) test 
confirmed that there were significant differences between the Cmax (U = 33, p = 0.001) 
and AUC0-last (U = 0, p < 0.001) among both groups. Similarly to Cmax, there were 
significant differences in cocaine concentrations between both groups at 20 minutes (U = 
53, p = 0.013 Z = -2.5). After 30 minutes there were no significant differences between 
both groups (p > 0.05).  
Although the statistical analysis indicated that there were not significant differences 
between both groups, it was noticed that concentrations of cocaine in OF in the group that 
ingested the tea (Group A) were greater than the group that swirled the tea (Group B) in 
samples collected at or after 120 minutes of ingestion/swirling. Mean concentration of 
cocaine in OF was 16 ng/mL for Group A and 9 ng/mL for Group B at time point 120 
minutes. This increase in cocaine concentrations for Group B (Swirling) after 120 minutes 
of ingestion/swirling resulted in a higher Tlast (Mean: 158 min; Median: 180 min) than the 
Tlast for Group A (Ingestion) (Mean: 137 min; Median: 120 min). A possible explanation 
for these results could be the idea that during the drinking of the tea (Group A) two 
processes took place: (1) the formation of drug depots in the oral tissues, i.e. absorption 
of cocaine in the oral cavity and its subsequently release into oral fluid and (2) the 
elimination of cocaine from the systemic circulation into oral fluid. Since the participants 
that swirled the tea (Group B) did not swallow the tea, only the elimination of cocaine 
from drug depots could have taken place. For instance, it is possible that the contribution 
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of cocaine from the systemic circulation resulted in an increase in cocaine concentration 
in Group A – Ingestion. 
Elevated concentrations of cocaine in OF were expected to be present in the OF 
immediately after ingestion/swirling of the tea because of the contamination of the oral 
cavity with the excess of coca tea (Jenkins et al. 1995, Cone et al. 1997, Huestis and Cone 
2004). The differences in concentration of cocaine in OF between the two groups during 
the first 20 minutes after ingestion/swirling were attributed to differences in the amount 
cocaine absorbed in oral tissues, i.e. formed oral depots, which were subsequently 
released into the OF. The results implied that cocaine was rapidly absorbed in the oral 
tissues forming drug depots even after a short period of exposure to the coca tea (time 
spent on sipping and swallowing or sipping and spitting out the coca tea). 
During the development of the study, it was noticed that participants that swirled the 
tea (Group B) held it in the mouth for a longer period of time (before spitting it) than the 
participants that sipped the tea and then ingested it (Group A). Hence, it was considered 
that these different times of exposure to the tea could have contributed to the differences 
in the number of drug depots formed in the oral cavity which reflected in the 
concentration of cocaine in OF. In the present study, all participants ingested or swirled 
an equal dose of 1.04 g of coca leaves (6.8 mg COC – see Table 6.2) over a maximum 
period of 10 minutes. 
Similar cocaine concentration profiles in OF were reported by others authors regarding 
the detection of cocaine in OF following oral administration of cocaine: drinking dose of 
3 mg, smoke doses of 40 and 42 mg or intranasal dose of 32 mg (Jenkins et al. 1995, Cone 
et al. 1997, Strano-Rossi et al. 2008). In these studies, the initial high cocaine 
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concentration in OF was reported to rapidly disappeared within a period of 0.5-3 hours 
after oral or intranasal drug administration. The authors suggested that rapid dissolution 
of cocaine in saliva following oral exposure to the drug allowed the effective clearance 
by swallowing and that detection of cocaine in OF after two hours appeared to be 
determined primarily by passive diffusion from the blood into saliva (Jenkins et al. 1995, 
Cone et al. 1997). Huestis and Cone (2004) suggested that prolonged times of detection 
in OF were attributed to the release of drugs from formed depot. 
Furthermore, similar concentration profiles for cocaine in OF as the described in this 
chapter were reported by Reichardt (2014). Reichardt’s study was however conducted 
over a period of one hour with Cmax obtained immediately after ingestion. The Tlast 
reported by Reichardt was one hour, which was in agreement with the Tlast obtained in 
this study as concentrations of cocaine in OF remained positive at the EWDTS cut-off 
after one hour of ingestion of coca tea. Comparison between the study reported by 
Reichardt and the reported in this chapter showed that cocaine concentrations in OF were 
considerably lower in Reichardt’s study to those obtained in the present study. Mean 
cocaine concentrations in OF of 160 ng/mL (30 minutes) and 24 ng/mL (one hour) were 
reported by Reichardt (2014). Mean cocaine concentrations in OF for Group A were 
obtained at 225 ng/mL (30 minutes) and 61 ng/mL (one hour). Variation in dose and type 
of tea used could have been the primary reason for the differences between the studies. 
However, variability between individuals and ways of drinking, i.e. speed, time spent on 
drinking and swirling; could have also contributed to differences in concentration as it 
was mentioned before. 
Significant intra-individual variability was seen in both groups (Table 6.4), especially 
for participants P7 (Group A) and P21 (Group B), who showed extreme OF cocaine 
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contamination, i.e. high cocaine concentration in OF. Participants P13 and P15 (Group 
A) and P27 (Group B) showed low contamination, i.e. low cocaine concentration in OF. 
The differences in participants’ profiles were primarily attributed to inter-individual 
variability of the oral cavity and absorption of cocaine in oral tissues. However, 
differences in metabolising enzymes, enhanced or reduced metabolism and genetic factor 
could have also influence in the inter-individual variability (Scheidweiler et al. 2010, 
Allen 2011). It is probable that changes in the speed of drinking or swirling of coca tea 
could have also contributed to the variations in release profiles, but further studies are 
required to confirm this. No correlation was seen between the five participants (P7, P13, 
P15, P21 and P27) that showed extreme or low contamination and the demographics of 
the participants. Three participants were female (P13, P15 and P27) and two were male 
(P7 and P21). None of these participants reported having medical conditions and their 
BMI values were within the normal range (19.5-22.7 Kg/cm2). From the five participants 
only one participant was a smoker (P27). The high and low concentrations of cocaine in 
OF from these five participants could not be related to previous consumption of cocaine 
as none of them reported previous consumption of coca tea or cocaine. 
6.3.4 Concentration of BZE in oral fluid following the ingestion or swirling of a 
cup of coca tea 
BZE concentrations in OF samples before the consumption of coca tea (pre-dose 
samples) ranged between 1.4–2.0 ng/mL for all participants. The concentration range for 
the group that ingested the tea (Group A) was 1.4–1.8 ng/mL. The mean concentration 
range for the group that swirled the tea (Group B) was 1.5–2.0 ng/mL. Table 6.6 shows 
the descriptive statistics (mean, median, standard deviation, minimum and maximum 
values) of BZE concentration at each collection time following the ingestion or swirling 
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of a cup of coca tea. Summary of BZE concentrations in OF following the ingestion or 
swirling of a cup of coca tea is presented in Appendix E Table 2. 
Table 6.6 BZE concentration in neat OF following the ingestion or swirling of a cup of coca tea. 
Collection 
time 
(min) 
Concentration Group A – Ingested 
(ng/mL) (n = 2)* 
Concentration Group B - Swirled (ng/mL) 
(n = 2)* 
Mean Median SD Min Max Mean Median SD Min Max 
0 1.5 1.4 0.1 1.4 1.8 1.6 1.5 0.2 1.5 2 
10 118 61 161 9 603 448 348 360 5 1404 
20 50 22 75 6 300 93 59 109 4 442 
30 26 21 26 4 114 29 21 32 3 161 
60 29 27 30 4 131 8 8 5 2 25 
120 21 23 17 0 60 3 2 2 2 10 
180 22 11 20 2 63 2 2 1 2 5 
240 20 21 14 2 60 2 2 1 0 4 
Group A: Participants ingested one cup of coca tea (data collected using one collection device at each time point). 
Group B: Participants swirled a cup of coca tea (data collected using two collection devices at each time point). A: OF 
sample collected from the right side of the mouth. B: OF sample collected from the left side of the mouth. SD: Standard 
deviation. n: Each sample was analysed in duplicate and values are presented as mean values. LOQ: 0.5 ng/mL BZE 
in buffered oral fluid; LOQ in neat OF was 2 ng/mL (the dilution factor from collection device was 4) 
The EWDTS guidelines for BZE confirmatory testing in OF suggest a cut-off 
concentration of 8 ng/mL (EWDTS 2015). Based on this cut-off, none of the participants 
from Group A - Ingested or Group B – Swirling tested positive for BZE in the control 
sample (pre-dose sample). Similar results were obtained at the analytical LOQ cut-off (2 
ng/mL) as all participants reported negative for the presence of BZE in OF. 
Figure 6.3 illustrates the concentration profiles of BZE in OF for a period of four hours 
following ingestion or swirling of coca tea. Furthermore, Table 6.7 summarises the 
maximum BZE concentration (Cmax), times of maximum concentration (Tmax), time of 
last detection (T0-last) and area under the curve (AUC0-last) for both groups. Mean 
maximum concentrations of BZE in OF (Cmax) of 118 ng/mL (Group A) and 448 ng/mL 
(Group B) were observed in the first sample collected after 10 minutes following 
ingestion or swirling of the tea. Based on the EWDTS and LOQ cut-offs all participants 
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tested positive for BZE in the sample collected after 10 minutes of the ingestion or 
swirling of the tea. 
 
Figure 6.3 Mean concentrations of BZE in OF following the ingestion or swirling of a cup of 
coca tea. Bars are standard deviation. Data illustrated in full scale and with a zoom into the low 
concentration region. Dotted lines indicate the following cut-off concentrations: Limit of 
quantification (LOQ) (2 ng/mL), EWDTS (8 ng/mL). 
Table 6.7 Maximum concentration, time at maximum concentration, detection window and 
area under the curve for BZE in OF following the ingestion (Group A) or swirling (Group B) of 
a cup of coca tea. 
Group A – Ingested Group B – Swirled 
Participant 
Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
Participant 
Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
P1 174 10 >240 154 P16 539 10 120 7476 
P2 62 20 >240 84 P17 615 10 120 5586 
P3 69 10 >240 123 P18 199 10 60 4447 
P4 34 10 >240 29 P19 348 20 120 6198 
P5 110 180 >240 177 P20 89 10 60 1723 
P6 25 10 >240 80 P21 1289 10 120 26699 
P7 603 10 >240 362 P22 816 10 180 11629 
P8 58 10 >240 103 P23 328 10 60 3794 
P9 55 10 >240 127 P24 212 10 120 3609 
P10 363 10 >240 158 P25 1008 10 60 7662 
P11 31 10 >240 63 P26 146 10 120 1683 
P12 64 10 >240 45 P27 5 10 - 752 
P13 9 10 >240 15 P28 487 10 60 7725 
P14 116 10 >240 63 P29 489 10 60 7199 
P15 16 10 >240 15 P30 223 10 120 4518 
Mean 119 18 - 107  453 11 99 6713 
Median 62 10 - 84  348 10 120 5586 
SD 160 28 - 87  359 3 38 6220 
Min  9 10 >240 15  5 10 60 752 
Max  603 120 >240 362  1289 20 180 26699 
Cmax: Maximum concentration; Tmax: Time at maximum concentration; Tlast: Time of last detection at EWDTS cut-
off (8 ng/mL); AUC0-last: Area under the curve. SD: standard deviation. 
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Similarly to what was observed for cocaine, a rapid decrease in concentration between 
both groups was seen over the first thirty minutes. The mean concentrations of BZE in 
OF were 26 and 29 ng/mL for Group A (Ingested) and Group B (Swirling) respectively. 
After one hour, 56% (Mean 8.0 ng/mL; Median 7.8 ng/mL) of the participants from 
Group B reported positive at both cut-offs. The time of last detection at the EWDTS cut-
off for Group B was two hours (Mean: 99 ng/mL; Median: 120 ng/mL). Only one 
participant (P22) reported positive in Group B after two hours of having swirled the tea 
but his concentration in OF decreased below the cut-off after three hours. The time of last 
detection at the assay’s LOQ was longer for Group B as 60% of the population remained 
positive after four hours. The time of last detection at the EWDTS and LOQ cut-offs for 
Group A could not be determined as all participants had detectable concentrations of BZE 
in OF after four hours (Table 6.7). 
Higher concentrations of BZE in OF were obtained during the first hour after coca tea 
was swirled (Group B) than when it was ingested (Group A) (Figure 6.3), as was observed 
for the analysis of cocaine in OF. A Mann- Whitney (U) test indicated that there were 
significant differences between the Cmax (U = 36, p = 0.002) and AUC0-last (U = 0, p < 
0.001) between Group A - Ingestion and Group B - Swiling. Samples that tested positive 
at the EWDTS cut-off collected at 20 and 30 minutes showed no significant differences 
between the groups (20 minutes: U = 138, p = 0.04; 30 minutes: U = 221, p = 0.92). After 
one hour of ingestion/swirling, significant differences were seen between the groups (p < 
0.001). 
The amount of BZE in OF during the initial 30 minutes post ingestion/swirling of the 
tea was less than 20% the concentration observed for cocaine. This result was in 
agreement with the amount of analytes present in a cup of coca tea as the percentage of 
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BZE in respect to cocaine was < 20% (BZE: 0.8 ± 0.04 mg; COC: 6.7 ± 0.04 mg). The 
fact that BZE was present in the coca tea indicated that detection of BZE immediately 
post-consumption and up to a period of 30 minutes could have reflected the concentration 
of BZE in the coca tea (because of oral contamination, i.e. remaining coca tea in the oral 
cavity) and not its concentration in OF resulting from the excretion of BZE from drug 
depots or systemic circulation. 
After 35 minutes of dosage (ingestion/swirling) the concentration of BZE in OF in the 
group that ingested the tea (Group A) was greater than the group that swirled the tea 
(Group B), as observed for cocaine. This difference in concentration was also seen in the 
Tlast as BZE was detected at concentrations higher than the EWDTS cut-off during the 
length of the study (four hours). The increase in BZE concentration in Group A could 
have been the result of the metabolism of cocaine in the body, which was subsequently 
eliminated from the systemic circulation into the OF. Although, BZE could have also 
been released from drug depots formed in the oral cavity. 
As per cocaine, similar BZE concentration profiles in OF have been reported following 
oral administration (smoke doses of 40 and 42 mg or intranasal dose of 32 mg) (Jenkins 
et al. 1995, Cone et al. 1997). Jenkins et al. (1995) reported Cmax immediately after dosage 
(2-5 minutes). Cone et al. (1997) reported Cmax for BZE in OF slightly delayed with Tmax 
ranging between 0.3-3 hours following intranasal dose of 32 mg and 0-2 hours following 
smoking of 40 mg. Furthermore, the authors reported that the concentration of BZE in 
OF was cleared (below the EWDTS cut-off) after 4-12 hours of dosage. Hence agreeing 
with the time of last detection obtained for Group A – Ingestion. 
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The results for BZE were also in agreement with the results reported by Reichardt 
(2014) as Cmax (Mean: 174 ng/mL BZE in OF) was obtained immediately after ingestion 
of a cup of coca tea. Reichardt reported a rapid decrease in BZE concentration within 15 
minutes of dosage to a mean concentration of 17 ng/mL that did not change over 45 
minutes. These results were also in agreement with the results observed in this study. The 
differences in Cmax and Tlast obtained in this study and those reported by Reichardt were 
attributed to differences in the dosage as mentioned in the previous section (Section 
6.3.3). 
BZE to cocaine ratios (BZE/COC) generally increased with time for both groups as 
indicated in Figure 6.4. The slight increase in BZE/COC ratio seen for Group B - Swirling 
could be attributed to differences in the rate at which BZE and cocaine were released 
from drug depots into OF as BZE could have been released more rapidly from drug depots 
than cocaine thus increasing the BZE/COC ratio. BZE is more hydrophilic than cocaine 
and therefore could be less likely to bond to lipids present in the oral tissues such as the 
connective tissue. 
Figure 6.4 Mean BZE/COC concentration ratio over a period of four hours following the 
ingestion (Group A) or swirling (Group B) of a cup of coca tea. 
BZE/COC ratio could have increased as a result of cocaine degradation. The results of 
stability studies reported in Chapter 5 indicated that the BZE concentration in BOF 
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increased up to 27% of its initial concentration because of cocaine degradation when 
samples were stored at room temperature over a period of eight days. Storage of OF 
samples could not be controlled over the time the samples were shipped from Colombia 
to the UK (seven days) hence the concentration of BZE in OF samples could have 
increased from its initial concentration during the shipping period. The significant 
increase of BZE/COC ratio obtained by Group A denoted that an increased amount of 
BZE or a decreased amount of cocaine was being released into OF over time when the 
tea was ingested rather than swirled. BZE has been reported to have wider window of 
detection and longer half-life in OF than cocaine, which indicates that cocaine is 
eliminated faster than its metabolite (Scheidweiler et al. 2010). Furthermore, it has been 
reported that concentrations of BZE were higher in plasma than in OF and that its 
concentration increased with time because of cocaine degradation. Thus, it is possible to 
suggest that the increased BZE/COC ratio in OF was the result of the metabolism of 
cocaine which increased the BZE blood concentration and consequently elevated the 
concentration of BZE in OF over time. 
Significant intra-individual variability was seen in both groups (Table 6.6) especially 
for participants P7 and P21 who showed extreme OF BZE contamination (high 
concentrations of BZE in OF) and participants P13 and P27 who showed low 
contamination (low concentrations of BZE in OF). After excluding the extreme values, 
the mean and median values for Cmax and AUC0-last did not change significantly and 
significant differences were still obtained between the groups. The Cmax values for Group 
A were Mean: 85 ng/mL and Median: 60 ng/mL, for Group B were Mean: 423 ng/mL 
and 386 ng/mL respectively. The AUC0-last values for Group A were Mean: 88 ng/mL and 
Median: 82 ng/mL, for Group B were Mean: 5286 ng/mL and 5052 ng/mL respectively. 
The differences in concentration between groups were also attributed to the inter-
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individual variability of the oral cavity, absorption of cocaine in oral tissues and the 
differences in drinking or swirling of the tea as discussed previously. 
6.3.5 Concentration of AEME in oral fluid following the ingestion or swirling of a 
cup of coca tea 
AEME was not detected in any of the pre-dose OF samples from participants that 
ingested coca tea (Group A). Only one participant (P29) that swirled the tea (Group B) 
reported concentrations above the LOQ cut-off (2 ng/mL). Summary of AEME 
concentrations in OF following the ingestion or swirling of a cup of coca tea is presented 
in Table 6.8. 
Table 6.8 AEME concentration in neat OF following the ingestion or swirling of a cup of coca 
tea. 
Collection 
time 
(min) 
Concentration Group A – Ingested 
(ng/mL) (n = 2)* 
Concentration Group B - Swirled (ng/mL) 
(n = 2)* 
Mean Median SD Min Max Mean Median SD Min Max 
0 0 0 0 0 0 0 0 0 0 1 
10 207 167 161 37 655 542 504 291 121 1275 
20 92 58 105 12 431 262 220 160 20 665 
30 43 22 51 3 193 139 110 113 0 581 
60 6 1 12 0 46 23 15 27 0 119 
120 0 0 0 0 1 1 0 3 0 12 
180 0 0 0 0 0 0 0 1 0 3 
240 0 0 0 0 0 0 0 0 0 0 
Group A: Participants ingested one cup of coca tea (data collected using one collection device at each time point). 
Group B: Participants swirled a cup of coca tea (data collected using two collection devices at each time point). A: OF 
sample collected from the right side of the mouth. B: OF sample collected from the left side of the mouth. SD: Standard 
deviation. n: Each sample was analysed in duplicate and values are presented as mean values. LOQ: 0.5 ng/mL cocaine 
in buffered oral fluid; LOQ in neat OF was 2 ng/mL (the dilution factor from collection device was 4) 
In this study all participants reported positive for AEME at the LOQ cut-off of 2 ng/mL 
immediately after the ingestion or swirling of a cup of coca tea. Figure 6.5 illustrates the 
concentration profile of AEME in OF for a period of four hours following ingestion or 
swirling of coca tea. Furthermore, Table 6.9 summarises of the maximum AEME 
concentration (Cmax), times of maximum concentration (Tmax), time of last detection (T0-
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last) and area under the curve (AUC0-last) for both groups. Mean maximum concentrations 
of AEME in OF (Cmax) of 207 ng/mL (Group A) and 542 ng/mL (Group B) were observed 
in the first sample collected after 10 minutes following ingestion or swirling of the tea. 
 
Figure 6.5 Mean concentrations of AEME in OF following the ingestion or swirling of a cup 
of coca tea. Bars are standard deviation. Dotted lines indicate the following cut-off 
concentrations: Limit of quantification (LOQ) (2 ng/mL). 
Table 6.9 Maximum concentration, time at maximum concentration, detection window and 
area under the curve for AEME in OF following the ingestion (Group A) or swirling (Group B) 
of a cup of coca tea.  
Group A – Ingested Group B - Swirled 
Participant Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
Participant Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
P1 167 10 60 49 P16 466 10 60 8979 
P2 175 20 60 49 P17 433 10 60 5982 
P3 165 10 30 36 P18 544 10 120 15072 
P4 367 10 60 120 P19 528 20 60 8982 
P5 347 180 60 107 P20 125 10 60 1867 
P6 67 10 30 16 P21 1240 10 120 42708 
P7 655 10 60 245 P22 491 10 120 13226 
P8 253 10 30 56 P23 570 10 60 9860 
P9 141 10 60 38 P24 395 10 60 8670 
P10 275 10 30 51 P25 919 10 60 18111 
P11 37 10 30 10 P26 237 10 60 2495 
P12 132 10 30 31 P27 209 10 60 9048 
P13 58 10 30 11 P28 851 10 60 25478 
P14 221 10 60 75 P29 518 10 60 11724 
P15 54 10 30 22 P30 596 10 60 12517 
Mean 208 18 44 61  542 11 72 13149 
Median 167 10 30 49  518 10 60 10679 
SD 161 28 15 60  286 3 25 8715 
Min 37 10 30 10  125 10 60 2666 
Max 655 120 60 245  1240 20 120 35595 
Cmax: Concentration at maximum concentration; Tmax: Time at maximum concentration; Tlast: Time of last detection 
at LOQ (2 ng/mL); AUC0-last: Area under the curve. SD: standard deviation.  
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Like it was observed for BZE, a rapid decrease in AEME concentration in both groups 
was seen over the first thirty minutes to a mean concentration of 43 and 139 ng/mL 
(Group A- Ingested and Group B - Swirling respectively). Mean concentration values at 
one hour were 5.9 ng/mL for Group A and 23.4 ng/mL for Group B. Mean values for Tlast 
at the assay’s LOQ for Group A was 44 minutes and for Group B was 72 minutes (Table 
6.9). Three participants (P18, P21 and P22) from Group B tested positive at the assay’s 
LOQ two hours post dosage, but the concentration decreased below the LOQ cut-off three 
hours post dosage. 
 Figure 6.5 illustrates that higher concentrations of AEME in OF were obtained during 
the first hour post dosage when the coca tea was swirled than when it was ingested as was 
obtained for the analysis of cocaine and BZE. A Mann-Whitney (U) test indicated that 
there were significant differences between the Cmax (U = 31, p < 0.001) and AUC0-last (U 
= 0, p < 0.001) in the two groups. There were significant differences in AEME 
concentrations between the two groups at 20 minutes (U = 0.67, p < 0.001), 30 minutes 
(U = 0.63, p < 0.001) and 60 minutes (U = 0.2, p = 0.001). After two hours there were no 
significant differences between the groups (p > 0.05). 
Contrary to what was observed for cocaine and BZE, the concentrations of AEME in 
OF in the Group B (Swirling) remained below Group A (Ingested) at all times. This was 
also seen in the Tlast as participants that swirled the tea had longer times (1-2 hours) than 
the participants that ingested the tea (30 minutes).  The fact that higher amounts of cocaine 
BZE and also AEME were detected in the participants during the first hour after swirled 
the tea, strongly suggest that the time spent by the participants swirling the tea increased 
the amount of analyte being absorbed in the oral cavity even when both groups of 
participants had the same dosage. AEME is further metabolised into anhydroecgonine 
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(Kintz et al. 1997, Fandiño et al. 2002), hence it is possible that participants that ingested 
the tea could have metabolised AEME into anhydroecgonine and this was eliminated in 
the OF. However, this result could not be confirmed as anhydroecgonine was not 
monitored in this study. 
The amount of AEME in OF during the first 30 minutes post ingestion/swirling of the 
tea was less than 30% the concentration observed for cocaine. This result was in 
agreement with the amount of analyte present in a cup of coca tea as the percentage of 
AEME in respect to cocaine was 17% (AEME: 1.2 ± 0.03 mg; COC: 6.7 ± 0.04 mg). 
Since AEME was present in the coca tea, it can be suggested that detection of AEME 
could be reflecting the concentration of AEME in the coca tea as a result of oral 
contamination as well as its release from drug depots into OF. 
The concentration profiles of AEME in OF were in agreement to the profiles reported 
by Jenkins et al. (1995) and Cone at al. (1997) who reported AEME concentrations 
following oral administration of cocaine base (smoke doses of 40 and 42 mg 
respectively). These authors reported that AEME was detected in OF at high 
concentrations with Cmax ranging 558-4374 ng/mL (Jenkins et al. 1995) and 51-303 
ng/mL (Cone et al. 1997), within two minutes of smoking. Furthermore, it was reported 
that AEME rapidly decreased with time over a period of 15-30 minutes, which was 
similar to the results presented in this study (30-60 minutes). From the two studies that 
were reported, it was noticed that although the participants smoked similar dosages, there 
were significant differences in AEME concentration in OF (e.g. Cmax) which were cleared 
within the same period of time. These results could indicate that there was a rapid 
dissolution of AEME in the OF which allowed an effective clearance by swallowing 
within 15-30 minutes of drug administration. Based on these results it can be suggested 
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that after 30 minutes of ingestion/swirling of a cup of coca tea, the detection of AEME in 
OF could have been the result of its release from drug depots. The shorter Tlast for AEME 
(30 min for Group A and 60 minutes for Group B) compared with the Tlast for cocaine 
(three hours for Group A and two hours for Group B) could also suggest that AEME 
diffused more rapidly across oral membranes, which could be explained by the lipophilic 
nature of AEME and its potential bonding to lipids present in the oral tissues such as the 
connective tissue. 
The results presented in this Chapter were different from the results reported by 
Reichardt (2014), who reported a random distribution of AEME amongst OF samples 
following ingestion of a cup of coca tea. In Reichardt’s study, nine out of twenty 
volunteers tested positive in at least one OF sample during the one-hour collection period. 
AEME concentrations in OF in Reichardt’s study ranged between 1-322 ng/mL with Cmax 
observed immediately after ingestion. Re-analysed the OF samples one year after sample 
collection, showed similar results as the initial reported. Reichardt reported that positive 
samples could have been obtained from AEME formation in OF following the 
consumption of coca tea and the possible instability of the samples by thermal 
decomposition during storage or during the tea preparation. 
It is unlikely that AEME could have been detected in OF as a result of its formation 
after the collection of the OF samples (chemical reaction during storage or during 
analytical analysis) as mentioned by previous authors (Reichardt 2014). This statement 
can be confirmed by the results presented in Section 6.3.1, which confirmed that AEME 
was present in the coca tea and the plant material (E. novogranatense var. nov). This 
AEME intrinsic to the coca leaves could have subsequently be absorbed into oral tissues 
and released into OF. Since clear AEME profiles were obtained for all the participants 
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that ingested or swirled a cup of coca tea, it can be suggested that the random distribution 
observed by Reichardt could have been the result of poor storage conditions. 
6.3.6 Concentration of EME in oral fluid following the ingestion or swirling of a 
cup of coca tea 
All pre-dose OF samples tested negative for EME from participants than ingested or 
swirled coca tea. Two participants (P21 and P29) that swirled the tea (Group B) showed 
low concentrations of EME but these were below the LOQ cut-off (4 ng/mL). Summary 
of EME concentrations in OF following the ingestion or swirling of a cup of coca tea is 
presented in Table 6.10. 
Table 6.10 EME concentration in neat OF following the ingestion or swirling of a cup of coca 
tea. 
Collection 
time (min) 
Concentration Group A – Ingested 
(ng/mL) (n = 2)* 
Concentration Group B – Swirled 
 (ng/mL) (n = 2)* 
Mean Median SD Min Max Mean Median SD Min Max 
0 0 0 0 0 0 0 0 1 0 2 
10 1723 161 2725 0 8911 12178 9954 9401 196 31823 
20 807 45 1277 0 4181 4594 3056 4736 60 16561 
30 389 33 822 0 3194 2902 2502 2474 52 10308 
60 66 6 126 0 450 653 418 795 0 3239 
120 11 0 22 0 76 88 59 86 0 240 
180 4 0 15 0 58 32 22 33 0 123 
240 1 0 3 0 11 15 2 21 0 77 
Group A: Participants ingested one cup of coca tea (data collected using one collection device at each time point). 
Group B: Participants swirled a cup of coca tea (data collected using two collection devices at each time point). A: OF 
sample collected from the right side of the mouth. B: OF sample collected from the left side of the mouth. SD: Standard 
deviation. n: Each sample was analysed  in duplicate and values are presented as mean values. LOQ: 1.0 ng/mL cocaine 
in buffered oral fluid; LOQ in neat OF was 4 ng/mL (the dilution factor from collection device was 4) 
All participants reported positive for EME at the LOQ cut-off of 4 ng/mL in the first 
sample collected after the ingestion or swirling of a cup of coca tea, except the participant 
P6 (Group A) who reported negative for EME in all OF samples. Like for AEME, there 
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are no proposed EWDTS guidelines for EME confirmatory testing in OF. Therefore, the 
results were presented based on the LOQ cut-off value (4 ng/mL). 
Figure 6.6 illustrates the concentration profile of EME in OF for a period of four hours 
following ingestion or swirling of coca tea. Furthermore, Table 6.11 summarises of the 
maximum EME concentration (Cmax), times of maximum concentration (Tmax), time of 
last detection (T0-last) and area under the curve (AUC0-last) for both groups. EME was the 
analyte that presented the highest concentration after ingestion/swirling of coca tea. In 
general, the concentration of EME was expected to be higher than cocaine as EME was 
present in a cup of coca tea in a higher percentage (13%) than cocaine (COC: 6.7 ± 0.04 
mg; EME: 87.2 ± 5.02 mg). Mean maximum concentrations of EME in OF (Cmax) of 1723 
ng/mL (Group A) and 12178 ng/mL (Group B) were observed in the first sample collected 
after 10 minutes following ingestion or swirling of the tea, as per cocaine, BZE and 
AEME. 
Figure 6.6 Mean concentrations of EME in OF following the ingestion or swirling of a cup of 
coca tea. Bars are standard deviation. Dotted line indicates the limit of quantification (LOQ) (4 
ng/mL). 
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Table 6.11 Maximum concentration, time at maximum concentration, detection window and 
area under the curve for EME in OF following the ingestion (Group A) or swirling (Group B) of 
a cup of coca tea. 
Group A – Ingested Group B – Swirled 
Participant Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
Participant Cmax 
(ng/mL) 
Tmax 
(min) 
Tlast 
(min) 
AUC0-last 
(ng/mL/min) 
P1 42 10 10 4 P16 29244 10 >240 894149 
P2 56 10 60 9 P17 20105 10 180 199898 
P3 118 10 10 10 P18 7514 10 >240 328580 
P4 161 10 30 38 P19 9483 10 180 162613 
P5 160 10 120 35 P20 2903 10 180 131818 
P6 0 0 0 0 P21 28939 10 180 573879 
P7 382 10 30 100 P22 13831 10 >240 233468 
P8 150 10 30 23 P23 14524 10 >240 320898 
P9 65 10 60 11 P24 6723 10 180 43242 
P10 8911 10 120 2207 P25 15481 10 >240 158808 
P11 1354 10 120 519 P26 1812 10 60 33549 
P12 4101 10 120 1094 P27 5009 10 120 718910 
P13 1802 10 60 389 P28 19866 10 >240 597038 
P14 6560 10 120 2844 P29 5179 10 60 165776 
P15 2352 10 240 1127 P30 4394 10 180 259930 
Mean 1748 10 75 561 
 
12334 11 184 321504 
Median 161 10 60 38 
 
9483 10 180 233468 
SD 2730 0 64 892 
 
8969 0 62 256924 
Min 0 10 0 0 
 
1812 10 60 33549 
Max 8911 10 240 2844 
 
29244 10 240 894149 
Cmax: Concentration at maximum concentration; Tmax: Time at maximum concentration; Tlast: Time of last detection 
at LOQ (4 ng/mL); AUC0-last: Area under the curve. SD: standard deviation.  
A rapid decrease in concentration for both groups was observed over the first hour to 
a mean concentration of 66 and 653 ng/mL for Group A and B respectively. After two 
hours, 27% (Group A - Ingested) and 77% (Group B - Swirling) of the population still 
tested positive at the LOQ cut-off. Mean concentration values at two hours were 11 
ng/mL for Group A and 88 ng/mL for Group B.  The time of last detection at the LOQ 
for Group A was one hour and for Group B was three hours (Table 6.11). One participant 
(P15) from the Group A (Ingested) and six participants (P16, P18, P22, P23, P25 and 
P28) from Group B (Swirling) had detectable concentrations of EME in OF after four 
hours. The mean concentration of EME present in the last collected sample (collection 
time of 240 minutes) was 15 ng/mL for Group B (Figure 6.6). 
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Similarly to cocaine, BZE and AEME, higher concentrations of EME in OF samples 
collected during the first hour were obtained when the coca tea was swirled than when it 
was ingested (Figure 6.6). A Mann-Whitney (U) test indicated that there were significant 
differences between the Cmax (U = 0, p < 0.001) and AUC0-last (U = 0, p < 0.001) in the 
two groups. Equally to the Cmax, there were significant differences between EME 
concentrations between the two groups at all times of collection (p < 0.001). EME 
concentrations in OF in the Group A (Ingested) remained below than the Group B 
(Swirling) at all times as was observed for AEME. This was also reflected in the Tlast as 
participants that had swirled the tea exhibited longer times (three hours) than the 
participants that ingested the tea (one hour). The elevated concentrations of EME in OF 
in both groups were primarily attributed to the release of EME from drug depots. High 
concentration of EME in OF were expected as the amount of EME in coca leaves were 
considerable high compared with other constituents like cocaine (87 mg EME per one 
gram of coca leaves). These EME could had formed drug depots in the oral cavity and 
subsequently increase the concentration of EME in OF. It is possible that for Group A – 
Ingested, the concentration of EME in OF could have been the result of the elimination 
of EME from drug depots as well as from the systemic circulation because EME can be 
produced from the metabolism of cocaine. 
Considerable differences were seen between the results obtained for EME in this study 
and the EME concentrations reported in OF by other authors  following smoking of 40-
42 mg cocaine base (Jenkins et al. 1995, Cone et al. 1997) and drinking 3 mg of cocaine 
from mate de coca (Strano-Rossi et al. 2008). These authors reported that EME was 
detected at similar concentrations for BZE in OF and at consistently low concentrations 
compared to cocaine.  The mean Cmax for EME in OF reported by these authors following 
smoking cocaine base (Jenkins: 50 ng/mL; Cone:34 ng/mL; Strano-Rosi: 23 ng/mL) were 
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up to 40 times lower than those reported in this study (Group A – Ingested: 1723 ng/mL; 
Group B – Swirling 12178 ng/mL). Jenkins and Cone suggested that EME was detected 
as a result of the metabolism of cocaine because Cmax was obtained at later times (Tmax 
ranged between 20-120 minutes) than the samples collected immediately after drug 
administration (two minutes). 
Contrary to the results reported following the smoking of cocaine base, Reichardt 
(2014) reported elevated oral contamination following the ingestion of coca tea. Mean 
EME Cmax was reported at 3239 ng/mL (24-16685 ng/mL) in OF immediately after 
ingestion of the tea. Reichardt reported a rapid decreased in EME concentration within 
15 minutes of dosage to a mean concentration of 257 (39-1209 ng/mL) ng/mL that did 
not change over 45 minutes. The results presented in this chapter confirmed the results 
reported by Reichardt as EME were found at high concentrations in OF samples and 
samples tested positive at the LOQ cut-off over a period of one-hour postdose. The 
differences in Cmax, Tmax and Tlast between the studies were attributed to differences in the 
dose as mentioned in the previous section (Section 6.3.3) and the study design. 
The EME to cocaine ratios (EME/COC) for Group A initially increased over time from 
1.4 to 1.7 in the first 30 minutes post-dose and then decreased to 0.1 at four hours. 
Differently, EME/COC ratios for Group B increased from 4.8 to 9.4 during the first three 
hours. The differences between the EME/COC ratios could indicate that a greater amount 
of EME depots were formed in the oral tissue when the tea was swirled and subsequently 
released into OF. 
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6.3.7 Concentration of cocaethylene (CE) and norcocaine (NC) in OF following 
ingestion or swirling of a cup of coca tea. 
The analysis of cocaine and cocaine derivatives in collected OF samples following the 
ingestion or swirling of coca tea showed that only AEME, BZE, COC and EME were 
detected in the OF samples as described above. The analytes NC and CE were not 
detected in any of the OF samples collected from the study participants. The absence of 
CE in OF samples confirmed that none of the participants consumed alcohol in the three 
days prior to the commencement of the study (Laizure et al. 2003, Lewis et al. 2004). The 
absence of NC in the samples indicated that cocaine was not enzymatically metabolised 
by the liver to NC (Poon et al. 2014) or that the concentration of NC in OF was below the 
LOD. Neither CE and NC were detected in the coca tea. 
6.3.8 Comparison of oral fluid samples collected from different sides of the mouth 
OF samples were collected from different sides (left and right) of the mouth using the 
same collection procedure to determine whether there are differences in the concentration 
of analytes when two samples are collected simultaneously. The European guidelines for 
workplace drug testing in OF (EWDTS 2015) suggests the collection of an A and B 
sample which can be generated by the division of one sample from a single collection 
procedure, or by the collection of two separate samples. It is known that some OF 
collection devices cannot collect and generate two separate samples from one single 
sample, because of the limited volume of OF collected. When two samples are to be 
collected, the first aliquot must be labelled A and the second B (EWDTS 2015). In this 
case, the two samples should be simultaneously collected; otherwise, the samples might 
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not be identical. If samples are not collected simultaneously exact times of the generation 
of the sample must be recorded to be able to correlate the results. 
Although  OF samples are collected following standard collection procedures such as 
those described by the European guidelines for workplace drug testing in OF (EWDTS 
2015), there is a lack of evidence on the equivalence of the samples (A and B) when they 
have not been generated from a single collection procedure. 
Mean concentrations ratios for AEME, BZE, COC and EME ranged between 1.01 – 
1.15 indicating that samples collected on the right (A) side of the mouth were equivalent 
to the left (B) side of the mouth (Table 4.12). A Mann-Whitney (U) test confirmed that 
there were no significant differences in concentrations obtained using the two collection 
devices simultaneously. The results for each analyte (A= 240 samples; B = 120 samples) 
were as follow: AEME (U = 6279, p = 0.077), BZE (U = 6485, p = 0.182), COC (U = 
7043, p = 0.771) and EME (U = 6954, p = 0.646).  
Table 6.12 Concentration ratios for samples collected on the right (A) and left (B) side of the 
mouth  
Analyte 
Concentration ratio A/B 
Mean Median SD RSD Min Max 
AEME (n = 62) 1.01 0.91 0.32 29.5 0.56 2.25 
BZE (n = 104) 1.15 1.00 0.63 54.6 0.32 5.63 
COC (n = 119) 1.11 1.00 0.46 41.2 0.23 3.34 
EME (n = 70) 1.04 1.04 0.45 43.2 0.10 2.53 
A: Samples collected on the right side of the mouth; B: Samples collected on the left side of the mouth; AEME: 
Anhydroecgonine methyl ester; BZE: Benzoylecgonine; COC: Cocaine; EME: Ecgonine methyl ester; n: Number of 
samples (A/B)  
Although a general comparison between the concentrations obtained in the right (A) and 
left (B) side of the mouth did not show any significant differences, when the ratio A/B 
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was calculated at each time point (paired samples) high percentages of relative standard 
variation (RSD) of up to 55% (for all analytes) were obtained. This variation can be 
observed in Figure 6.7 which illustrates the concentration ratio A/B for each participant 
(including all seven samples collected per participant) at the corresponding analyte. 
Figure 6.7 shows that most of the samples were distributed within one standard deviation 
(1SD) of the mean but some were within two standard deviation (2SD) or above. For 
AEME, 82% of the samples were within 1SD and 98% within 2SD. For BZE, 85% of the 
samples were within 1SD and 98% within 2SD. For cocaine, 79% of the samples were 
within 1SD and 96% within 2SD. For EME, 76% of the samples were within 1SD and 
93% within 2SD. 
Figure 6.7 Concentration ratio for samples collected on the right (A) and left (B) side of the 
mouth. Red coloured marks correspond to samples collected from each participant over four-hour 
period following the swirling of a cup of coca tea. The different shapes indicate the different 
collection times for each participant. The straight line is the mean value. Dotted lines indicate one 
and two standard deviations. 
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Different factors could have contributed to the variability in A/B ratios including (1) 
the effect of drug depots such as the amount of drug being deposited in the oral cavity 
and the heterogenic formation of these depots among the tissues. (2) The rate at which 
the drug was released from drug depots into OF. (3) Changes in salivation (salivary flow 
rate) could have contributed to an increase or decrease in the dissolution of the drug and 
its transport from oral tissues into OF. Individual salivation can vary from 0.3 to 0.7 
mL/min (Yoshizawa et al. 2013). (4) Swabbing from the surface of the oral cavity could 
have contributed to an increase on analyte adsorbed on the pad and consequently its 
concentration in OF. Although variances in the volume of OF collected using the 
collection swab could have contributed to the differences in concentrations of cocaine 
and its metabolites, this was unlikely to occur because gravimetric correction was 
conducted for all samples. 
The comparison between concentrations obtained from the two sides of the mouth (left 
and right) using two devices (simultaneous collection) showed significant differences for 
all analytes (p > 0.05) except cocaine (U = 0.145, p = 0.075). However, these results were 
not conclusive because the concentrations of cocaine and metabolites following the 
ingestion of a cup of coca tea collected using one device were significantly different from 
the concentrations obtained when the tea was swirled and two devices were used (Section 
6.4 to Section 6.7). Further studies need to be conducted in order to confirm the 
equivalence of results when samples have been collected with one or two collection 
devices as significant differences might be obtained in individual cases. Differences in 
the concentration of analytes from two samples collected simultaneously could have an 
impact on OF drug testing. 
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6.4 CONCLUSIONS 
The initial results presented in this chapter revealed that 1.2 ± 0.2 mg AEME, 0.8 ± 
0.2 mg BZE, 6.7 ± 1.0 mg COC and 87.2 ± 25.1 mg EME were present in a cup of 
Colombian coca tea prepared with tea bags from the Nasa Community (E. 
novogranatense var. nov.). Quantitative analysis of a methanolic extract of coca leaves 
confirmed that AEME was present in the plant material.  This result could have a great 
impact on drug testing as AEME could be detected in OF samples following consumption 
of coca leaves or coca tea and therefore wrongly indicate (giving false positives) previous 
use of crack-cocaine.  
The results obtained from the questionnaire filled by the participants of the study 
(Undergraduate students from the National University of Colombia) confirmed that 
consumption of coca leaves is not considered a psychoactive substance and an addiction 
in regions where it is customarily used as it was previously mentioned by Rubio et al. 
(2014). The results of a questionnaire indicated that coca tea consumption was related to 
traditional reasons, altitude sickness, test or flavour, interest, curiosity, to increase energy 
or elevate mood. 
Positive detection of cocaine, BZE, AEME and EME at the EWDTS (8 ng/mL for 
cocaine and BZE) and LOQ (2-4 ng/mL for all analytes) was obtained following the 
ingestion or swirling of a cup of Colombian coca tea. The concentration profile of all 
analytes in OF was similar for all analytes in both groups. Although, participants that 
swirled coca tea (Group B) showed significantly higher concentrations (Cmax and AUC0-
last) in comparison with the group that ingested the tea (Group A) during the first hour 
after dosage.  
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The time of last detection (median values) for the participants that ingested a cup of 
coca tea (Group A) was 30 minutes (AEME), three hours (cocaine) and one hour (EME). 
The concentration of BZE in OF for Group A (Ingested) remained positive during the 
length of the study. For Group B(Swirling), the time of last detection (median values) 
was 60 minutes for AEME, two hours for cocaine and BZE, and three hours for EME. 
Comparison between both groups showed that time of last detection for cocaine and BZE 
was higher for the drinkers (Group A) than the swirlers (Group B). An increase in cocaine 
and BZE concentration in OF from the participants that ingested the tea (Group A) after 
75 minutes (COC) and 35 minutes (BZE) of ingestion indicated that these analytes were 
released not only from drug depots but from the systemic circulation. Comparison 
between the values obtained for time of last detection for all analytes indicated that the 
analytes could have been released from drug depots into OF at different rates. 
The results of the study suggested that differences in concentration profile and time of 
last detection for all analytes could have been the result of differences in the amount of 
drug depots formed in the oral cavity and its subsequent release into OF. It is possible 
that a greater amount of drug depots was formed in the oral cavity when the tea was 
swirled than when it was ingested as a result of increased time of exposure to the tea.  
This study supported the results reported by Reichardt (2014) for the positive detection 
of cocaine and BZE but demonstrated that AEME was detected in OF samples following 
the ingestion/swirling of coca tea. In this study no random distribution of AEME and CE 
were observed. CE and NC were not detected in any of the collected OF samples. 
The analysis of paired OF samples collected simultaneously from different sides of the 
mouth showed that there were no significant differences between the mean concentration 
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of cocaine and metabolites from OF samples collected on the right (A) and left (B) side 
of the mouth. Analysis of the concentration ratios (A/B) from paired samples across the 
collected samples showed that most concentration ratios (76-85%) were distributed 
within one standard deviation of the mean. Although no significant results were obtained 
when comparing all the samples obtained from the study population, the results also 
indicated that in specific cases there were significant differences (> 50-150%) between 
the A and B samples. Comparison between collection procedures was inconclusive and 
further studies need to be conducted in order to confirm significant differences between 
the procedures. 
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7.1 INTRODUCTION 
Drugs that are consumed orally are delivered into oral tissues and the systemic 
circulation and then subsequently release into oral fluid (OF) via passive diffusion 
through the oral mucosa (Ceschel et al. 2002, Huestis and Cone 2004). This transport (i.e. 
kinetics) of drugs across tissues are widely studied using in vitro permeability or diffusion 
studies (Nicolazzo and Finnin 2008). Permeability studies also allow the evaluation of 
the nature of the biological barrier (tissue). Studies developed in in vitro models offer 
advantages over in vivo models as variables such as temperature, pH and drug 
concentration can be easily controlled. Additionally, in cases where human tissue is not 
available, animal models can be used instead, which reduces cost and ethical 
considerations (Patel et al. 2012). 
In vitro methods commonly involve the use of diffusion cells fitted with suitable 
membranes, e.g. porcine skin, that operate under atmospheric conditions. The most used 
diffusion cells are the static diffusion cells also known as Franz cells (Figure 7.1) 
(Nicolazzo and Finnin 2008, Brodin et al. 2010, Bartosova and Bajgar 2012, Sjögren et 
al. 2014, Castro et al. 2016).  
 
Figure 7.1 Franz type diffusion cell. (Bartosova and Bajgar 2012) 
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Diffusion studies using Franz cells (Figure 7.1) are normally conducted by applying a 
dose on the donor compartment and subsampling the diffused drug from the receptor 
compartment (as described in Section 1.9.2). However, in the in vitro model described in 
this chapter, the diffusion of cocaine and anhydroecgonine methyl ester (AEME) was 
monitored from the membrane into the donor and receptor compartments. Similar to the 
sampling of the process conducted using cell-based in vitro models (e.g. caco-2). In cell 
models, the membrane is initially impregnated with the drug and then the diffused drug 
is subsampled from the apical as well as the basolateral side of the well plate (Teksin et 
al. 2010, Yang et al. 2011, PermeGear Inc. 2014). 
The use of porcine oral mucosa with non-keratinised epithelium, e.g. cheek offer 
higher permeability compared with keratinised epithelium, e.g. tongue tissue (Castro et 
al. 2016). Furthermore, the buccal mucosa which lines inside the cheek is more accessible 
and can be easily removed (Nicolazzo and Finnin 2008). Porcine oral mucosa has a 
similar physiological characteristics to the human oral mucosa such as the structure, 
morphology, composition and permeability (Squier 1991, Squier and Kremer 2001, 
Nicolazzo and Finnin 2008). 
The main mechanism involved in the transfer of molecules across the oral mucosa can 
be described by mathematical models, e.g. zero and first order models (Chapter 1, Section 
1.9.3) and was initially described by Fick’s first law in 1855 (Fick 1855, 1995). Fick’s 
law proposes the concept that a solute will move from a region of high concentration to 
a region of low concentration across a concentration gradient. Mathematical modelling 
can be fitted on experimental data to determine physical parameters, such as the drug 
diffusion coefficient (Dash et al. 2010) and describe the release of drugs at a slow zero or 
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first order rate or the release of an initial high amount of drug followed by a slow release 
of zero or first order. 
This chapter describes the evaluation of the kinetics of release of cocaine and AEME 
into SOF, using an in vitro model that involved the use of Franz diffusion cells, porcine 
oral mucosa and SOF. The model presented in this chapter was developed to mimic the 
in vivo process, where drugs such as cocaine are initially absorbed into the oral mucosa 
following oral exposure (dose) and subsequently release into OF. By using Franz 
diffusion cells it was possible to measure the amount of cocaine/AEME being release 
from drug depots formed in the oral mucosa at controlled conditions of dosage, side of 
drug exposure, side of drug collection, temperature and area of diffusion (Ceschel et al. 
2002, Nicolazzo and Finnin 2008, Bartosova and Bajgar 2012, Castro et al. 2016). 
Cocaine and AEME were used in this study because they form drug depots in the oral 
tissue and are subsequently released into OF (Chapter 3 and 6). Cocaine is the main 
analyte detected in OF following the oral consumption of crack-cocaine, cocaine base or 
coca tea and AEME is used as a biomarker for the consumption of crack cocaine  (Kintz 
et al. 1997, Lewis et al. 2004). AEME is also present in coca tea (Chapter 6). 
7.1.1 AIM AND OBJECTIVES 
7.1.1.1 Aim: 
This chapter aimed to measure the release kinetics of cocaine and AEME from drug 
depots into SOF using an experimental in vitro model. 
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7.1.1.2 Objectives: 
• Assess the release of cocaine and AEME from drug depots formed in porcine oral 
mucosa into SOF using an experimental in vitro model. 
• Evaluate the diffusion of cocaine and AEME from drug depots into OF using an 
experimental in vitro model. 
• Determine the permeability of cocaine and AEME across porcine mucosal 
epithelium. 
7.2 METHODS 
7.2.1 Materials 
Porcine cheeks were purchased from L F B Meats, Bournemouth, UK.  
Synthetic oral fluid (SOF) was prepared using the Cozart biosciences protocol (2008) 
“Production of Synthetic Saliva” (Appendix A). 
Analytical standards and reagents used for the analysis of SOF and tissue were 
purchased as described in Section 4.2.1. 
TELOS® H-CX 130mg/3mL mixed-mode SPE columns were purchased from Kinesis 
(Cambridgeshire, UK). 
ParafilmÒ M roll was purchased from Sigma-Aldrich (Pool, UK). 
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7.2.2 Instrumentation 
Vertical Franz diffusion cell 11.28 mm x 6.5 mL Type B with an area available for 
diffusion of 1.01 cm2 and receiver volume of 6 mL were purchased from Copley 
Scientific Ltd, UK. 
Analysis of SOF samples was conducted using a LC-MS/MS system consisted of a 
tandem quadrupole mass spectrometer coupled to a Waters Acquity UPLC® system. 
Details on the LC-MS systems were described in Chapter 4 - Section 4.3. 
The micrometer (Mitutoyo Series 293) used to measure tissue thickness was purchased 
from Mitutoyo UK Ltd (Liampshire, UK) 
7.2.3 Preparation of homogenised tissue 
Tissue homogenates were prepared as described in Section 4.4.1. 
7.2.4 Solution preparation for transport studies 
Diffusion studies were conducted using solutions of AEME at 5 µg/mL in 1.0M 
phosphate buffer saline solution (PBS) pH 7, AEME at 50 µg/mL in SOF, cocaine at 20 
and 200 µg/mL in SOF and cocaine at 20 µg/mL in 1.0M PBS pH 7. These solutions were 
prepared by spiking SOF or PBS with the required amount of drug from 1 mg/mL stock 
solutions of AEME and cocaine. Concentrations of 5 µg/mL AEME and 20 µg/mL 
cocaine were selected based on the expected concentration of these analytes in a cup of 
coca tea. Concentrations of 6.2 ± 0.2 µg/mL AEME and 33.8 ± 0.8 µg/mL cocaine were 
obtained for a cup of coca tea (200 mL) using two coca tea bags (Table 6.1). Additionally, 
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high concentrations of AEME and cocaine were selected (50 and 200 µg/mL in SOF 
respectively) as ten times the concentration of AEME and cocaine in a cup of coca tea. 
These high concentrations were used to ensure sink conditions at the moment of 
developing the diffusion studies. 
7.2.5 Membrane preparation 
Fresh excised samples of porcine buccal mucosa were removed from pig’s heads 
(Figure 7.2) using surgical scalpel and stored on PBS pH 7 and ice during transportation 
to the laboratory. Porcine buccal mucosa (cheek tissue) was used in this study because 
the buccal mucosa of pigs has similar structure, morphology and composition to the 
human buccal mucosa (Nicolazzo and Finnin 2008). All porcine mucosa tissue was 
cleaned with PBS pH 7 buffer and water to remove impurities such as blood, the residual 
water was immediately dried with a tissue. The mucosa was then cut with scissors to a 
suitable size to fit the Franz cell (pieces of approximately 2 x 2 cm). PBS was used as it 
has been reported that porcine buccal mucosa retained its integrity when stored with a 
preservative (PBS pH 7,  Kreb's bicarbonate ringer solution, HEPES buffer or HBSS – 
Hank’s balanced salt solution) at 4 °C for 24 hours (Kulkarni et al. 2010). Furthermore, 
it can also be stored for a more extended time at -20 °C following sectioning of the tissue 
without losing the tissue integrity (Michaud and Foran 2011). 
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Figure 7.2 Diagram describing the process to obtain buccal mucosa samples. Porcine buccal 
tissue was excised from the cheek area of pig heads, then cut is sections of approximately 2 x 2 
cm. Samples containing epithelium and subcutaneous tissue (A) and epithelium (B) were used 
for the diffusion strudies. Pigs head image from (Franz-Montan et al. 2016) 
Membranes containing epithelium and subcutaneous tissue (A) and membranes 
containing epithelium (B) were used (Figure 7.2). The membranes A were carefully cut 
using a scalpel to obtain sections of 0.45-0.77 cm thickness. This thickness allowed the 
use of the epithelium, underlying connective tissue and some muscle tissue. The muscle 
tissue was included in the diffusion studies because drug depots are likely to be deposited 
within the muscle fibres as presented Section 3.3.2 and Chapters 8 and 9 from Reichardt 
(2014). The membranes B were obtained by removing the subcutaneous tissue (and  most 
of the underlying connective tissue) using a scalpel to isolate the epithelium (Hoogstraate 
and Boddé 1993). Thickness of epithelium ranged from 0.12-0.17 cm. Mucosa thickness 
was measured before the experiment using a microtomer. The mucosa sections were 
immediately mounted on the diffusion cells or stored at -20 ºC until further use. 
Samples B = Epithelium 
Samples A = Epithelium + 
subcutaneous tissue 
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7.2.6 Release studies using the whole mucosa 
7.2.6.1 Conditioning of the diffusion cell 
Before the experiment, the fresh tissue or tissue section was thawed at room 
temperature and then mounted on the cells (Figure 7.2) with a 5 mm magnetic stirrer (600 
rpm) in the receiver compartment. The top of the cell was positioned over the membrane, 
where the epithelium side faced the donor compartment and subcutaneous tissue, or 
submucosa side faced the receptor compartment (Figure 7.3).  
Figure 7.3 Diagram of diffusion using a Franz cell. Red arrows indicate the direction of the 
diffused drug. Drug can diffuse from drug depots formed in the mucosa tissue into SOF (Donor 
compartment) and PBS (receiver compartment). 
The cells were sealed by wrapping parafilm around the two sections (donor and 
receiver compartments). Then, the receiver compartment was filled with pre-warmed 
phosphate buffered saline (1.0M PBS pH 7) (37°C). PBS is a physiological solution 
commonly used in permeability studies and is used to mimic the systemic circulation 
(Squier 1991, Salerno et al. 2010, PermeGear Inc. 2014, Castro et al. 2016). PBS at pH 7 
simulates in vivo plasma pH (Castro et al. 2016). To ensure there was no leakage, the cells 
were inverted and visually inspected. One millilitre of SOF was then added to the donor 
Epithelium 
Donor compartment or apical side 
Receiver compartment or 
basolateral side 
Sampling port 
Muscle 
Membrane 
Drug diffusion 
Stir bar
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compartment. Each cell was submerged in a water bath at 37°C and cells were left to 
equilibrate for 30 minutes (Veuillez et al. 2002). During the experiment, the receptor 
compartment was stirred at a speed of 600 rpm. Stirring was conducted in order to ensure 
that there was no concentration gradient across the barrier (Brodin et al. 2010). 
7.2.6.2 Release studies  
After equilibration, the SOF from the donor compartment was removed and 1 mL SOF 
containing cocaine (20 or 200 µg/mL) at pH 7.3 or 6.3 and AEME (50 µg/mL) at pH 7.3 
was applied for 10 min (Table 7.1). This procedure was conducted to allow the absorption 
of cocaine and AEME into the oral mucosa and therefore the formation of drug depots. 
The time of exposure was equal to the maximum time that participants took to drink a 
cup of coca tea (Chapter 6). The amount of drug absorbed by the mucosa was calculated 
by measuring the concentration of analytes in SOF before and after the dosing by LC-
MS. 
Table 7.1 Conditions evaluated in the release of cocaine and AEME from drug depots formed 
in oral mucosa into SOF. 
Mucosa 
Membrane  
Experiment 
number 
Analyte concentration (ug/mL) SOF pH PBS pH 
A 1 AEME 50 6.3 7 
 2 COC 20 7.3 7 
 3 COC 200 7.3 7 
 4 COC 200 6.3 7 
B 5 AEME 5 7.3 7 
 6 COC 20 7.3 7 
A: Whole porcine oral mucosa that included the epithelium and subcutaneous muscle, B: Porcine oral 
mucosa epithelium. AEME: Anhydroecgonine methyl ester, COC: Cocaine, SOF: Synthetic oral fluid, 
PBS: Phosphate buffer saline. 
Following the dosage, seven washes of 1 mL control SOF were applied sequentially 
on the donor compartment for two minutes each to remove any excess of drug on the 
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epithelium. All washes were then stored at -20ºC for further analysis. Once the washes 
were collected, the PBS from the receiver compartment was removed and replaced with 
fresh pre-warmed PBS. The PBS solutions were later analysed for cocaine, BZE and 
AEME in order to identify if there was any drug being permeated into the receiver 
compartment from the donor compartment and/or drug depots formed in the mucosa. 
Similarly, the washes were analysed to confirm that the donor compartment was free of 
contamination. 
In order to evaluate the release of cocaine and AEME from the drugs depots formed 
in the mucosa into the SOF, serial sampling of SOF was conducted from the donor 
compartment over a period of four hours. Samples of SOF (1 mL) were collected (at 15, 
30, 45, 60, 75, 90, 105, 120, 150, 180, 210 and 240 min) and the equal volume of fresh 
pre-warmed control SOF was replaced after each withdrawal. The SOF was fully replaced 
at any time point to allow sink conditions (Brodin et al. 2010). Diffusion under sink 
conditions occurred when the amount of drug present in the receiver solution did not 
exceed 10% of the donor concentration (concentration of analyte in the mucosa). This 
allowed a concentration gradient where the diffusion per unit time (Jmax) was 
proportional to the thermodynamic activity (αs) of the compound and not its concentration 
(Higuchi 1961). During the experiments, the receiver fluid was stirred with a magnetic 
rotor at a speed of 600 rpm and the cells were placed in a water bath at 37°C. 
After the experiments finished, the mucosa tissues were carefully removed from the 
cells, homogenised and analysed for AEME, BZE and cocaine by LC-MS as described 
next. 
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Power analysis conducted on data (permeability coefficient values) obtained from the 
permeability of lidocaine hydrochloride across porcine oral mucosa (Franz-Montan et al. 
2016) indicated that the sample size for in vitro studies using Franz cells and porcine oral 
mucosa is 1.4. This sample size was calculated using the Equation 6.1 and the following 
values: mean value of 0.96 ± 0.36 (n = 6), imprecision of 10%, significance level of 0.05 
and power of 80% (Crawley 2005). Although a minimum value of one was obtained as 
sample size, it is common that the minimum value of replicates used in in vitro 
permeability studies be set at three or six (Salerno et al. 2010). In this thesis a minimum 
number of six replicates per experiment was used. 
7.2.7 Permeability studies using porcine mucosa epithelium 
This study was conducted to evaluate the effect of the epithelium on the mass transfer 
of cocaine and AEME from the PBS (basolateral side) to the SOF. 
7.2.7.1 Conditioning of the diffusion cell 
All cells were conditioned as mentioned in the section 7.2.7. After equilibration, the 
SOF and PBS were removed from the donor and receiver compartments. 
7.2.7.2 Permeability studies  
To evaluate the permeability of AEME and cocaine through the mucosa epithelium, 
the receiver compartment was filled with PBS pH 7.3 containing AEME and cocaine at 
5 µg/mL and 20 µg/mL respectively. The donor compartment was filled with one 
millilitre pre-warmed SOF. Serial sampling of SOF was collected from the donor 
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compartment over a period of four hours. Samples of SOF were collected at 15, 30, 45, 
60, 75, 90, 105, 120, 150, 180, 210 and 240 min. One millilitre of SOF was collected and 
replaced with one millilitre of fresh pre-warmed control SOF at the specific times.  The 
SOF was fully replaced at any time point to allow sink conditions (Brodin et al. 2010). 
The minimum number of replicates per experiment was n = 3 (Salerno et al. 2010). 
7.2.8 Quantitative analysis of synthetic oral fluid and porcine oral mucosa samples 
All SOF and tissue samples were extracted and analysed for AEME, BZE and cocaine 
using the validated LC-MS method described in Chapter 4. All samples were analysed 
using calibrators and QCs prepared on the day of the analysis. 
7.2.9 Release kinetics 
Franz diffusion cells are practical and robust, but they do not mimic the salivary flow 
as efficiently (Castro et al. 2016). To overcome this drawback the volumes of the donor 
and receiver compartments should continuously be flushed with fresh solutions 
(mimicking a flow-through system), or by treating the obtained data using a set of 
equations that take the changing concentration gradient into account (Brodin et al. 2010). 
To calculate the kinetics of release of cocaine into SOF, the cumulative amount of 
drug (Q) in the donor compartment released from the mucosa per diffusional area (A) was 
plotted against time (t). The profiles of cumulative amount of AEME and cocaine release 
from the drug depots formed in the mucosa at different intervals of time were fitted with 
various kinetic models. Table 7.2 summarise the kinetic models used to characterise the 
mechanism of drug release (Singh et al. 2017): Zero order, First order, Higuchi and 
Chapter 7 - Application of diffusion studies on the in vitro release of cocaine and 
anhydroecgonine methyl ester deposited in oral mucosa into synthetic oral fluid 
 290 
Korsmeyer Papas. The mass transfer coefficient was calculated from the slope of each 
curve. The flux of release (J) was calculated using the best fit with linearity of R2 > 0.95 
over at least five values at steady state. 
Table 7.2 Mathematical models used for the calculation of the mass transfer coefficient. 
Model Equation 
Units of mass transfer 
coefficient (K) 
Zero Order 𝑄" = 𝐾%𝑡 + 𝑄% µg cm-2 h-1 
First Order 𝑙𝑛𝑄 = 𝑙𝑛𝑄% − 𝐾+𝑡 h-1 
Higuchi 𝑄 = 𝑄% + 𝐾,√𝑡 h-0.5 
Korsmeyer - Peppas 𝑄 = 𝑄%𝐾./𝑡0 Related to n value 
Q: Amount of drug released; Q0: initial amount of drug; t: Time; K0: Kinetic coefficient zero -order; K1: Kinetic 
coefficient first-order; KH: Higuchi Kinetic coefficient; KKP: Korsmeyer-Peppas kinetic coefficient; µg: micrograms; 
cm-2: square centimetre; h: hour. 
7.2.10 Statistical analysis 
All data was presented as mean ± standard deviation. Kolmogorov-Smirnov test and 
Levene’s test were used to check the normality and homogeneity of variance. Significant 
differences between experimental groups were evaluated using non-parametric Kruskal-
Wallis H test (multiple comparisons) and Mann-Whitney U-test (two group comparison) 
(IBM SPSS Statistics version 23). Results with 2-tailed ps < 0.05 were considered 
significant. 
7.3 RESULTS AND DISCUSSION 
7.3.1 Release studies 
In order to assess the in vitro release of cocaine and AEME from drug depots into SOF, 
it was necessary to allow the formation of drug depots in the oral mucosa. Oral absorption 
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of cocaine hydrochloride and crack cocaine was reported to be rapid, as mean plasma 
concentrations were obtained immediately after crack smoking (Cone et al. 1994). 
Jenkins et al. (2002) also confirmed the rapid absorption of cocaine by reporting mean 
peak plasma concentrations after two minutes of smoking 40 mg of cocaine base. In this 
study, after ten minutes of exposure 4.8 ± 1.0 % (n = 6) of the cocaine dose (20 or 200 
µg/mL) and 3.9 ± 0.4 % (n = 3) of the AEME dose (50 µg/mL) was absorbed by the 
mucosa. Quantification of the receiver compartment confirmed that no cocaine or AEME 
was permeated during the exposure period as concentrations of cocaine in PBS were < 
2.3 ng/m and AEME was not detected at all times. 
The release profile of cocaine and AEME from formed drug depots in the mucosa is 
illustrated in Figure 7.4. Both release profiles for cocaine and AEME in SOF showed an 
initial rapid release followed by slower release, similar to what was observed for the 
release of cocaine and AEME in OF following the ingestion/swirling of coca tea (Chapter 
6). The initial increased rate seen could be explained if molecules were absorbed at 
different depth of the mucosa. In this scenario, the molecules closer to the epithelium 
would be more rapidly released into the SOF and molecules deeper absorbed move slower 
through the tissue towards the epithelium. This idea could be confirmed by the results 
presented in Chapter 3, where cocaine was detected at higher concentrations in sections 
closer to the epithelium. This gradient in concentration in porcine oral tongue tissue was 
also observed by Reichardt (2014, p 205-309). 
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Figure 7.4 Cocaine (A) and AEME (B) release profile from drug depots in porcine oral 
mucosa (n = 3). Release experiments conducted using 20 and 50 µg/mL cocaine and AEME in 
SOF. Error bars represent the standard deviation of the data. 
Additionally, the initial rapid mass transfer could also be attributed to the desorption 
of the cocaine and AEME molecules from the transcellular spaces of the epithelium, 
which are subsequently dissolved into the SOF. This process was considered to be less 
likely to occur as the surface of the mucosa was washed several times to eliminate any 
excess of compound on the surface of the epithelium. The final concentration of the 
washes were more than five times the concentration at time 15 min in each experiment. 
Mean concentration of cocaine and AEME in the last wash was 33.2 ± 3.8 and 3.4 ± 1.7 
ng/mL respectively. 
The profiles observed in all release studies were similar to the ones presented in Figure 
7.4, with an initial rapid release followed by a slower release. The percentage cumulative 
amount of cocaine and AEME (mean values) obtained for all experiments is shown in 
Table 7.3. The percentage cumulative drug release was calculated using the total amount 
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of drug released into the SOF and the amount of drug that remained in the tissue after the 
experiment. These results showed that the amount of cocaine accumulated in SOF was 
higher for the release studies with higher dose (200 µg/mL) than with a normal dose (20 
µg/mL). More than 20% of the total accumulated cocaine was released during the first 30 
minutes. In comparison, release studies using a normal dose (20 µg/mL) showed that 
more than 20% of the cumulative cocaine was released after 150 minutes. The results 
obtained using AEME at a high dose (50 µg/mL) were similar to the results obtained with 
the high dose of cocaine as more than 20% of the cumulative AEME was released after 
45 min. 
Table 7.3 Percentage cumulative release of cocaine and AEME in SOF. Data expressed as 
mean values ± standard deviation. 
Time (h) 
% COC Cumulative drug release 
% AEME Cumulative 
drug release 
A (n = 6) B (n = 6) C (n = 6) D (n = 3) 
0.25 6.1 ± 1.0 16.3 ± 2.5 11.3 ± 0.6 9.2 ± 1.8 
0.50 9.7 ± 1.8 26.9 ± 3.5 20.3 ± 0.8 15.3± 2.7 
0.75 12.1 ± 2.2 34.2 ± 2.5 29.2 ± 1.2 22.5 ± 3.8 
1.00 14.1 ± 2.6 35.3 ± 2.3 30.8 ± 1.2 23.9 ± 4.0 
1.25 15.8 ± 3.0 36.4 ± 2.2 32.2 ± 1.3 25.3 ± 4.1 
1.50 17.1 ± 3.4 37.3 ± 2.1 33.7 ± 1.3 26.4 ± 4.2 
1.75 18.3 ± 3.6 38.1 ± 2.0 34.7 ± 1.2 27.8 ± 4.3 
2.00 19.4 ± 3.9 39.0 ± 1.9 36.1 ± 1.2 28.9 ± 4.6 
2.50 20.9 ± 4.3 39.9 ± 1.8 37.4 ± 1.1 30.2 ± 5.0 
3.00 22.1 ± 4.6 40.7 ± 1.6 38.4 ± 1.0 31.4 ± 5.1 
3.50 23.2 ± 4.9 41.3 ± 1.5 39.3 ± 0.9 32.3 ± 4.8 
4.00 24.1 ± 5.1 41.9 ± 1.4 40.3 ± 0.5 33.4 ± 4.4 
A: SOF pH 7 and initial dose of 20µg COC; B: SOF pH 7 and initial dose of 200µg COC; C: SOF pH 6 and initial 
dose of 200µg COC, D: SOF pH 6 and initial dose of 50µg AEME; AEME: Anhydroecgonine methyl ester, COC: 
Cocaine, h: hour; n = number of experiments. 
Statistical Kruskal-Wallis test indicated that there were significant differences in 
profiles between the samples within the same experiment (p < 0.001) and between the 
doses 20 and 200 µg/mL (p < 0.001). The significant differences inter-experiment could 
have been the result of the different amount of drug absorbed within the tissue.  
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In a separate experiment conducted on porcine tongue tissue (n = 3) it was observed 
that the concentration of cocaine absorbed or deposited in an individual tissue 
(subsamples n = 20) varied with a %RSD > 40%. Comparison between experiments 
indicated that there were significant differences between the concentration of cocaine in 
the tissue (Kruskal-Wallis test p <0.001) (Appendix G). These differences were attributed 
to the differences inherent to the specific section of the tissue as are the difference in 
thickness of the epithelium, membrane basal, amount of connective tissue and muscle 
fibres, which can vary significantly within the same specimen (Gómez de Ferraris and 
Campos 2002). Even though significant differences (p < 0.001) were obtained between 
the different profiles within the same release experiment and between doses, this appeared 
to not affect the diffusion coefficient of cocaine or AEME as will be discussed next. 
7.3.1.1 Kinetics of release 
Table 7.4 shows the values calculated for the flux and release coefficient for the 
different cocaine and AEME experiments (Experiments 1-4 from Table 7.1). The results 
indicated that the release flux of cocaine increased with the increase of concentration, 
which can be explained by the increased gradient in concentration. Surprisingly, a 
decrease in flux was observed when the pH of the SOF was decreased. At low pH, cocaine 
become more ionisable and therefore more hydrophilic, hence an increase in flux was 
expected at lower pH (Schramm et al. 1992). Nonetheless, the flux is directly related to 
the initial concentration of cocaine in the tissue and the thickness of the mucosa 
(Nicolazzo and Finnin 2008) and the diffusion coefficient obtained at the different pH 
values were similar as will be discussed next. 
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Table 7.4 Results for the release kinetics using various release models for cocaine and AEME. 
Release kinetics 
COC AEME 
Dose 20 
ng/mL 
Dose 200 ng/mL 
Dose 50 
ng/mL 
SOF pH 7.3 SOF pH 7.3 SOF pH 6.3 SOF pH 6.3 
Flux J (ngcm-2h-1) 66.9 107.0 66.8 135 
R2 0.96 0.94 0.96 0.98 
Zero K0 (h-1) 0.0489 0.0992 0.0678 0.0836 
R2 0.64 0.68 0.66 0.76 
First K1 (h-1) 0.280 0.221 0.220 0.24 
R2 0.75 0.54 0.53 0.62 
Higuchi KH (h-1/2) 244 631 378 19.1 
R2 0.97 0.82 0.80 0.88 
Kosmeyer-
Peppas 
n 0.463 0.402 0.403 0.430 
KKP 292 1017 613 27.4 
R2 0.98 0.85 0.84 0.90 
AEME: Anhydroecgonine methyl ester, COC: Cocaine, h: hour; K0: Kinetic coefficient zero -order; K1: Kinetic 
coefficient first-order; KH: Higuchi Kinetic coefficient; KKP: Korsmeyer-Peppas kinetic coefficient; n = release 
exponent indicative of mechanism of release. 
Following the analysis of release profiles with the mathematical models, it was noted 
that the best linearity was obtained using the Korsmeyer-Peppas model (Costa and Sousa 
Lobo 2001) and therefore the results obtained with this model were used for comparison 
of the release coefficient. The diffusion exponent n using the Korsmeyer-Pappas model 
confirmed the Fickian diffusion, e.g. drug release was dependent on concentration since 
n was less than 0.5 (Singh et al. 2017). 
Statistical Kruskal-Wallis H test indicated that there were no significant differences in 
the release coefficient (KH) within the same experiment (Experiment 1: H(5) = 5.0, p = 
0.4 and Experiment 2: H(5) = 5.0, p = 0.4). Additionally, a Mann-Whitney U test 
indicated that there were significant differences between the release coefficient (KH) for 
the two concentrations evaluated (20 and 200 µg/mL), U = 1.00, p = 0.005. These results 
were in agreement with the results obtained for the flux (J). The increase in release 
coefficient indicated that the release of cocaine from drug depots formed in the mucosa 
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into SOF was concentration dependent. This relation between the mass transfer and 
concentration was observed in a different study for the permeability of dexloxiglumide 
using a Caco-2 cell model (Tolle-Sander et al. 2003). Concentrations of 8 and 80 µg/mL 
dexloxiglumide in 10mM HEPES buffer provided permeability values (apical-basolateral 
direction) of 11.7 ± 0.6 cm/s and 17.3 ± 1.5 cm/s respectively. The concentration 
dependency in Tolle-Sander’s study was attributed to the polarisability of the molecule 
and its preference to transport from the basolateral-apical side instead of the apical-
basolateral direction. 
In the present study, the preference in transport of cocaine across the mucosa from the 
apical to basolateral direction was evaluated partially, as sampling from the basolateral 
side of the cell was conducted only twice (before diffusion studies started and after they 
finished). This allowed the measurement of concentrations at the beginning and at the end 
of the experiments. The quantification of the receiver compartment at the end of the study 
indicated that no drug was released from the mucosa into the PBS buffer during the 
release studies at concentrations above the LOD (0.1 ng/mL) of the LC-MS method. 
Changes in K values were finally attributed to differences in concentration gradient 
between the mucosa and SOF as well as between regions of less concentration within the 
tissue (Brodin et al. 2010). It is possible that lower number of cocaine molecules 
deposited in the mucosa tissue (low concentration) could lead to an increase of regions 
with less concentration of cocaine, where the gradient in concentration takes place. The 
results presented in Chapter 3 suggested that cocaine was deposited in specific areas 
within porcine tongue tissue. 
Since a minimum amount of cocaine was detected in the basolateral side, it can be 
implied that cocaine deposited in the mucosa was primarily diffused towards the apical 
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side of the mucosa and therefore towards the SOF. This dynamic suggested that the final 
concentrations of cocaine in OF might get affected as the amount of cocaine in OF could 
be the result of the cocaine transported from the blood circulation as well as the transport 
of cocaine deposited in the oral cavity. Therefore, it can be related to the high 
concentrations of cocaine presented in OF samples that various authors have reported 
(Kato et al. 1993, Kidwell et al. 1998, Bosker and Huestis 2009). The presented results 
also confirmed the slow release of cocaine into OF from drug depots (Chapter 6) and 
implied that the diffusion of cocaine decreased with the amount of cocaine present in the 
oral mucosa. 
Statistical analysis using a Mann-Whitney U test (U = 1.0, p = 0.2) indicated that there 
were no significant differences between the release (KH) of cocaine into SOF at pH 7.3 
or 6.3. The KKP values had n values below 0.5, (pH 7.3: 1017 h-1; pH 6.3: 612 h-1) which 
indicated that the transport of cocaine into SOF was concentration dependent.  This result 
could suggest that variations in the pH of human neat OF (normal OF pH values range 
between 6.0 and 7.0) would not have any effect on the release of cocaine deposited in the 
mucosa tissue (Gjerde et al. 2010). It is important to note that changes in the pH of the 
OF could be related to changes in the production and flow rate of OF (Aps and Martens 
2005), which could affect the diffusion of drugs. 
The flux of AEME (135 ng/cm2/h) was double the flux of cocaine (66.8 ng/cm2/h; dose 
200 µg/mL) at the same SOF pH 6.3 (Table 7.4). This result indicated that AEME was 
being released more rapidly than cocaine from the mucosa. However, a decrease of 20% 
of the total AEME and cocaine concentration was released after 45 and 30 min 
respectively. As per cocaine, the model that best described the release of AEME into SOF 
was the Korsmeyer-Pappas. This model provided an n value of less than 0.5. Therefore 
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the kinetics of AEME followed a Fickian diffusion (Singh et al. 2017). The values of KKP 
obtained for AEME (27.4 h-0.4) was 23 times lower than the value obtained for cocaine 
(612 h-0.4). However, the initial amount of AEME absorbed in the mucosa (58 ng/g 
mucosa) was 26 times lower than the cocaine concentration (1512 ng/g mucosa). 
Therefore, it can be implied that AEME diffused into the mucosa with a similar rate as 
cocaine. Differences in diffusivity could be the result of the more lipophilic properties of 
AEME compared to cocaine since cocaine contain more hydrogen bond donor and 
acceptor (one and five respectively) than AEME (zero and three respectively) (Figure 
1.2). 
7.3.2 Permeability studies 
The permeability across the porcine epithelium of the oral mucosa was measured in 
order to evaluate its influence in the transport of cocaine and AEME from drug depots 
formed in the muscle fibres within the oral mucosa into SOF. The permeability profiles 
for cocaine and AEME are shown in Figure 7.5. The profiles obtained revealed a constant 
release of drug over time. 
 
Figure 7.5 Cocaine (A) and AEME (B) permeability profiles across porcine mucosal 
epithelium. Permeability experiments conducted using 20 and 5 µg/mL cocaine and AEME in 
1M PBS pH 7. 
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Drug permeation across the oral epithelium was described by a zero-order kinetic 
model (Cocaine R2 = 0.99; AEME R2 = 0.99). Since the amount of cocaine/AEME in the 
receiver solution (SOF) did not exceed 10% of the donor solution (PBS pH 7), it was 
assumed that the cumulative rate of drug passing through the epithelium was the steady-
state flux. The results of the permeability studies are presented in Table 7.5. From this 
table, it can be noted that the flux was higher for cocaine than for AEME. This difference 
was the result of the drug concentration from the donor solution (Cocaine: 20 µg/mL in 
PBS pH 7 and AEME: 5 µg/mL in PBS).  
Table 7.5 Permeability results of cocaine and AEME across porcine mucosal epithelium. 
(Mean value ± SD) 
Drug Flux (ng cm-2h-1) Lag time (h) K0 (cm-2h-1) 
COC (n = 3) 305 ± 22 0.80 ± 0.8 0.0153 ± 0.001 
AEME (n = 3) 78.2 ± 2.8 0.77 ± 0.8 0.0156 ± 0.001 
AEME: Anhydroecgonine methyl ester; COC: Cocaine; K0: Diffusion coefficient; n = number of experiments.  
 
The results showed that after 46 and 48 minutes a steady flux could be obtained for 
the release of AEME and cocaine into the SOF respectively. The lag time is the time that 
cocaine/AEME takes to permeate through the membrane and diffuse into the SOF with a 
stable flow rate (Bartosova and Bajgar 2012). A Mann-Whitney U test indicated that there 
were no significant differences between the lag time obtained for AEME and cocaine (U 
= 4.0, p = 1.0). Similarly, diffusion coefficients for AEME and cocaine did not have 
significant differences (U = 4.0, p = 1.0). 
The diffusion coefficient using the flux at steady state was used to compare the 
diffusion coefficient obtained for the release studies and permeability studies. Mean 
diffusion coefficient for the release of cocaine (Experiment 2) was K = 0.036 ± 0.003 cm-
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2h-1. The mean diffusion coefficient for the release of AEME (Experiment 1) was K = 
0.051± 0.008 cm-2h-1. A Mann-Whitney U test indicated that there were no significant 
differences between the diffusion coefficient obtained for cocaine in the release studies 
compared with permeability studies (U = 1.0, p = 0.048). For the contrary, there were 
significant differences for the diffusion coefficient of AEME (U = 0.0, p = 0.1). The 
results obtained for the transport of cocaine across the whole mucosa and the epithelium 
indicated that the main barrier that cocaine has to pass is the epithelium and that other 
sections of the mucosa (such as lamina propria and submucosa; Figure 1.6) did not have 
a significant influence in its diffusion. The results for AEME, on the other hand, indicated 
that AEME diffused more rapidly through the epithelium than on the whole mucosa. This 
result could be attributed to the lipophilic nature of AEME and its potential bonding to 
lipids present in the mucosa such as the connective tissue. 
Even though the stability of cocaine in both SOF and PBS solutions was confirmed in 
Chapter 5, the breakdown product of cocaine (BZE) was monitored in both release and 
permeability studies in order to confirm that no degradation of cocaine took place. The 
percentage of BZE was less than 5% the concentration of cocaine during the length of the 
study, with concentration of BZE in SOF increasing as the cocaine concentration 
increased. Mean percentages of BZE in experiments developed with cocaine 
(Experiments 2, 3, 4 and 6 as indicated in Table 7.1) were 2.8 ± 0.3, 3.4 ± 0.6, 2.21 ±  0.1 
and 4.6 ± 0.7% respectively. The initial concentration of BZE in the solutions of cocaine 
were 1.7% for solutions at 20 and 200 µg/mL in SOF and 7.5% for the solution of 20 
µg/mL cocaine in PBS (Permeability studies). Since the percentages of BZE did not vary 
more than 20% from the initial concentration of cocaine it could be confirmed that 
cocaine did not degraded during the release and permeability studies. 
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During the development of the release and permeability studies the viability of the oral 
mucosa was not monitored because of limitations on the instrumentation required for the 
analysis. However, Kulkarni et al (2010) reported that porcine oral mucosa retained its 
integrity when stored in PBS for up to 24 hours. The fact that the release and permeability 
studies were conducted within 24 hours after excision of the oral mucosa suggested that 
the mucosa retained its integrity during the length of the study.  
The diffusion of cocaine by active transport was considered irrelevant as the principal 
mechanism of diffusion of drugs in the oral mucosa has been reported to be the passive 
diffusion (Squier 1991, Brodin et al. 2010, Bartlett and van der Voort Maarschalk 2012, 
Bartosova and Bajgar 2012, Frank and Hand 2014). Bhat et al. (2001) showed that 
cocaine transported across a T-84 epithelial cell line (an in vitro method to measure 
permeability across the intestinal wall) from luminal to serosal side of the intestine by 
simple diffusion. Bhat’s study also indicated that receptor-mediated transport might not 
take place as there were no significant differences in the diffusion between the time 
periods of exposure (30 and 60 minutes) at different dosages of cocaine (100-800 ng) 
(Bhat et al. 2001). 
7.4 CONCLUSIONS 
The in vitro model evaluated in this chapter allowed the successful measuring of the 
release of cocaine and AEME from drug depots and the evaluation of the permeation of 
cocaine and AEME across oral mucosa. The results indicated that after ten minutes of 
exposure 4.8 ± 1.0 % of the cocaine dose (20 or 200 µg/mL) and 3.9 ± 0.4 % of the AEME 
dose (50 µg/mL) was absorbed by the mucosa. Furthermore, it was observed that cocaine 
and AEME did not permeate the oral mucosa during the exposure period. 
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The release profiles for both cocaine and AEME were similar in all experiments and 
showed an initial rapid release followed by a slower release. The initial increased rate 
was explained if molecules were absorbed at different depth of the mucosa and so 
molecules closer to the epithelium would be more rapidly released into the SOF at the 
same time molecules deeper absorbed into the tissue would move slower through the 
tissue towards the epithelium. 
The Korsmeyer-Peppas model was used to evaluate the kinetics of release because this 
model provided the best correlation coefficient (R2 ranged 0.85-0.99 for all experiments). 
The diffusion exponent n confirmed Fickian diffusion in all cases (Singh et al. 2017).  
Statistical analysis showed no significant differences in the release coefficient (KH) 
within the same experiment KH and between the KH values obtained at pH 7.3 or 6.3. 
However, significant differences were observed between the KH values of the two 
concentrations evaluated (20 and 200 µg/mL; p = 0.005). Additionally, it was observed 
that more than 20% of the total accumulated cocaine was released during the first 30 
minutes (200 µg/mL as initial dose) in comparison to 150 minutes (20 µg/mL as initial 
dose). The increase in release coefficient indicated that the release of cocaine from drug 
depots formed in the mucosa into SOF was concentration dependent. Comparison 
between the release coefficient of AEME and cocaine showed that AEME (K = 0.051± 
0.008 cm-2h-1) diffused into the mucosa with a similar rate as cocaine (K = 0.036 ± 0.003 
cm-2h-1). 
The results obtained in this study suggested that cocaine and AEME deposited in the 
mucosa diffused towards the apical side of the oral mucosa as no drug was detected in 
the receiver solution located on the basolateral side. This was an important finding 
because this factor could have an effect on the final concentrations of cocaine and AEME 
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in OF and therefore in OF cocaine testing. If the molecules of cocaine and AEME 
preferred to transport towards OF, the molecules coming from the blood into the OF 
would further affect this transport. The amount of cocaine released into the OF could 
therefore be the result of the cocaine/AEME transported from the blood circulation as 
well as the transport of the drug deposited in the oral cavity. What is more, cocaine and 
AEME from drug depots would not be transported into the systemic circulation increasing 
the concentration of these drugs in blood.  
Permeability profiles for cocaine and AEME revealed a constant release of drug over 
time. Drug permeation across the oral epithelium was described by a zero-order kinetic 
model (COC R2 = 0.99; AEME R2 = 0.99). The results showed that after 46 and 48 
minutes a steady flux could be obtained for the release of AEME and cocaine into the 
SOF respectively and no significant differences between the lag time were obtained for 
AEME and cocaine (p = 1.0). Similarly, diffusion coefficients for AEME and cocaine did 
not have significant differences (p = 1.0). 
The results obtained for the transport of cocaine across the whole mucosa and the 
epithelium indicated that the main barrier to cocaine was the epithelium and that other 
sections of the mucosa (such as lamina propria and submucosa) did not have a significant 
influence in its diffusion. No significant differences were obtained between the diffusion 
coefficient in the release studies compared with permeability studies for cocaine (p = 
0.048). The results for AEME, on the other hand, indicated that AEME diffused more 
rapidly through the epithelium than on the whole mucosa. This result could be attributed 
to the lipophilic nature of AEME and its potential bonding to lipids present in the mucosa 
such as the connective tissue. This was supported by the significant differences (p = 0.1) 
obtained between the diffusion coefficient in the release study and the permeability study. 
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This differences in release rate suggested that the windows of detection for AEME will 
be shorter than for cocaine in OF, which will therefore have an impact on the times of 
detection of these drugs in OF testing. 
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CONCLUSIONS, RECOMMENDATIONS AND FUTURE 
WORK 
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8.1 CONCLUSIONS 
The correct interpretation of results from the analysis of drugs in oral fluid (OF) is 
essential for the identification of drug abusers in different scenarios such as workplace 
drug-testing programs and driving under the influence of drugs (DUID). Interpretation 
from OF drug testing is generally difficult to achieve because the concentration of drugs 
(e.g. cocaine) can vary significantly in OF compared with blood samples (Wolff et al. 
2017). Since drugs in OF have similar detection times to those found in blood, drug 
detection in OF could indicate recent use and therefore be correlated to the effect that the 
drug might have on the donor at the time of OF sample collection. As such, one of the 
major challenges in OF drug testing is to understand the high concentrations of drugs in 
OF which can be evaluated by studying the kinetics of release of drugs from oral drug 
depots into OF. Drugs consumed orally are likely to form drug depots in the oral cavity 
(Huestis and Cone 2004), and these depots might have the potential to increase the 
concentration of drugs in OF. 
Cocaine was the drug of choice in investigating drug release from drug depots into OF 
because it is one of the most abused drugs worldwide (UNODC 2017), it is commonly 
detected at high concentrations in OF (Jenkins et al. 1995, Strano-Rossi et al. 2010, 
Reichardt 2014) and form oral depots in oral tissues (Reichardt 2014). The European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported cocaine as the 
second most widely used drug of abuse in the UK and Europe (EMCDDA 2017) and the 
United Nations Organisation for Drug Control (UNODC) reported that approximately 17 
million consumed cocaine in 2015 (UNODC 2017). Concentrations of cocaine in OF have 
been reported to be higher than in plasma (S/P > 3) (Jenkins et al. 1995, Scheidweiler et 
al. 2010, Fiorentin et al. 2017). Following crack-cocaine smoking cocaine can be found 
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at concentrations up to 3 µg/mL (Kato et al. 1993, Cone 2012), and after drinking of coca 
tea up to 9 µg/mL (Jenkins et al. 1995, Strano-Rossi et al. 2010, Reichardt 2014). Other 
authors have also reported the detection of cocaine in OF after nasal insufflation of 
cocaine base (Javaid et al. 1983, Cone et al. 1997, Jufer et al. 2006). Furthermore, cocaine 
and cocaine derivatives (cocaine metabolites and other products such as anhydroecgonine 
methyl ester AEME) form oral depots in oral tissues and these depots could subsequently 
be released into OF increasing their concentration in OF (Reichardt 2014). 
The research presented in this thesis enhanced the current knowledge on the release of 
drugs from drug depots into OF and contributed to the interpretation of results from OF 
testing, by evaluating the elimination profile and times of detection of cocaine and 
cocaine derivatives (AEME, benzoylecgonine BZE and ecgonine methyl ester EME) in 
human OF samples. The research also addressed some of the processes surrounding the 
absorption and subsequent release of drugs from oral drug depots into OF, highlighting 
the differences between ingestion and swirling of coca tea (Chapter 6). Furthermore, the 
release kinetics of drugs (cocaine and AEME) from drug depots into OF were predicted 
using an in vitro model by measuring the diffusion and permeability of these drugs across 
porcine oral mucosa (Chapter 7). 
The experiment design and the interpretation of results were aided by monitoring the 
changes in the concentration, i.e. stability of analytes in buffered OF (BOF), synthetic OF 
(SOF) and porcine oral mucosa under different storage temperature and time (Chapter 5). 
Quantitation of cocaine and cocaine derivatives in BOF, SOF and porcine oral mucosa 
was achieved by using two Liquid Chromatography – Mass Spectrometry (LC-MS) 
validated methods (Chapter 4). Analytical approaches were not only evaluated using 
classical techniques such as LC-MS, but also more modern techniques like Raman 
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spectroscopy. Raman spectroscopy and more specifically Surface Enhanced Raman 
Spectroscopy (SERS) was used as an alternative technique to evaluate the detection of 
cocaine in SOF and porcine oral tissue (Chapter 2 and 3). The SERS analysis was 
achieved by using substrates along with handheld Raman spectroscopy (Chapter 2), 
portable Raman spectroscopy and Raman microscopy (Chapter 3). 
Contribution to knowledge was achieved by investigating the presence of cocaine and 
cocaine derivatives from oral drug depots into OF, more specifically analyte 
concentration, release profile and time of last detection. Previous research on the release 
of cocaine from oral depots reported that only cocaine and BZE were detected for up to 
one hour following the consumption of a cup of coca tea (Reichardt 2014). However, the 
present research showed that cocaine, BZE and other cocaine derivatives could be 
detected in OF for up to four hours following ingestion or swirling of coca tea. The 
previous derivatives included AEME which could be detected in OF (LOQ: 2 ng/mL) for 
up to one hour and EME which could be detected up to three hours (LOQ: 4 ng/mL). 
Cocaine and BZE were detected in OF giving positive results at the EWDTS (8 ng/mL 
for cocaine and BZE) for up to a period of three and four hours respectively. The detection 
of AEME in biological samples (OF and urine) has been mentioned in six studies of 
consumption of coca leaves (ElSohly et al. 1986, Engelke and Gentner 1991, Jenkins et 
al. 1996, Mazor et al. 2006, Strano-Rossi et al. 2008, Reichardt 2014), however, only its 
random detection was reported and no release profile had been investigated. 
Comparison of the release profiles of cocaine and its derivatives (AEME, BZE and 
EME) in OF between participants that ingested and swirled coca tea showed differences 
in absorption of these drugs into the oral cavity and their release into OF. Participants that 
swirled coca tea showed peak analyte concentrations two to seven times higher in OF 
Chapter 8 – Conclusions, recommendations and future work 
 309 
compared with the participants that ingested the tea (Tables 6.5, 6.7, 6.9 and 6.11) during 
the first hour following dosage. The higher concentration of cocaine and cocaine 
derivatives in OF among participants that ingested and swirled coca tea suggested that a 
higher amount of drug depots were formed in individuals that swirled the tea because 
they retained coca tea in the mouth for a longer time (30-60 seconds). Participants who 
ingested the tea kept it in the mouth for few seconds before swallowing the tea. These 
drug depots were formed and released over a period of one to three hours. 
The drug release was not consistent for all the evaluated analytes and it also varied 
between analytes depending on the release profile and metabolism (Figure 8.1). AEME 
and EME confirmed being released from oral drug depots because they showed positive 
testing (LOQ 2-4 ng/mL) in participants that swirled a cup of coca tea for a longer period 
of time than the participants that ingested the tea. On the contrary, cocaine and BZE 
showed that they were detected in OF for longer times at the EWDTS cut off (8 ng/mL) 
in the participants that ingested the tea. 
Figure 8.1 Times of last detection for cocaine, AEME, BZE and EME in OF following the 
ingestion or swirling of a cup of coca tea (Chapter 6). Bars are standard deviation. Dotted lines 
indicate the following cut-off concentrations: Limit of quantification (LOQ) of 2 ng/mL for 
cocaine, BZE and AEME, and 4 ng/mL for EME. EWDTS of 8 ng/mL for cocaine and BZE. 
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Taking into account the high BZE to cocaine ratios (BZE/COC) obtained by the 
drinkers, it can be suggested that cocaine and BZE were not only released from drug 
depots but from the systemic circulation when coca tea was ingested. The increase in 
BZE/COC ratio over time (Figure 6.4) was the outcome of the discrepancies observed 
between the last time of detection of drinkers and swirlers. Comparison between the time 
of last detection for all analytes suggested that differences in time were the result of the 
concentration of analytes in the oral depots or that analytes could have been released into 
OF at different rates. 
During the development of the in vivo study the amount of analytes present in a single 
dose of coca tea was determined. Quantitative analysis of a methanolic extract of coca 
leaves and an aqueous infusion of coca leaves, i.e. coca tea demonstrated that as well as 
cocaine, AEME, BZE and EME were present in a cup of coca tea and the plant material 
(Table 6.1). These results suggested that all analytes present in the coca tea including 
cocaine, AEME, BZE and EME could be absorbed into the oral tissues forming drug 
depots in the oral cavity. Hence confirming that cocaine, AEME, BZE and EME could 
be detected in OF samples following the ingestion/swirling of coca tea as a result of oral 
absorption/contamination. 
The presence of AEME in the coca plant material (extraction with methanol at room 
temperature) confirmed that AEME was inherent in the plant (E. novogranatense var. 
nov). For instance, the presence of AEME in the coca tea was the result of the extraction 
of AEME from the coca plant and not the result of thermal degradation of cocaine during 
the tea preparation. These findings are of importance for drug-testing because AEME, 
BZE and/or EME could be detected in biological samples including OF following the 
consumption of coca leaves, wrongly indicating the previous use of crack-cocaine or 
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cocaine base. Furthermore, it is possible that individuals that consume coca products 
could test positive for AEME, BZE and/or EME as well as cocaine. The fact that the 
composition of the coca tea varies depending on the origin of the coca plant (Casale et al. 
2014), implies that the consumption of coca tea from different species of the coca plant 
could impact OF drug testing differently to what was described in this thesis. 
In addition to the in vivo study of the release of cocaine and cocaine derivatives into 
OF, the analysis of paired OF samples collected simultaneously from different sides of 
the mouth (right and left) was studied. The results showed that overall there were no 
significant differences between the mean concentration of cocaine and cocaine 
derivatives from OF samples. However, differences from paired samples across the 
collected samples showed a distribution of more than one standard deviation for 15-24% 
of the samples. This indicated that in specific cases there were significant differences of 
more than 50% between the A and B samples. 
In the absence of blood testing, the results of the in vivo study were confirmed using 
an in vitro model. The in vitro model (Chapter 7) involved using Franz diffusion cells, 
SOF and porcine cheek tissue under controlled conditions of dose, temperature, time of 
exposure and area of exposure (Ceschel et al. 2002, Nicolazzo and Finnin 2008, 
Bartosova and Bajgar 2012, Castro et al. 2016). The results of the in vitro study confirmed 
the outcome of the in vivo study in relation to the release of cocaine and AEME from oral 
drug depots into SOF. In agreement with the in vivo study, the in vitro study demonstrated 
that cocaine and AEME were deposited into the oral mucosa after exposure to the drug 
and subsequently released into OF over a period of four hours. In this respect, the amount 
of drug absorbed into the oral mucosa was proportional to the dose administered. 
Moreover, cocaine and AEME release into OF was dependent on the concentration of the 
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analyte in oral tissues (Singh et al. 2017), which confirmed Fick’s law diffusion (Fick 
1855). 
The release profiles obtained for both cocaine and AEME using the in vitro study were 
similar to those obtained for the release of cocaine and AEME following exposure to coca 
tea. The release profiles showed that cocaine and AEME were released into OF at 
different rates, with molecules of analyte being more rapidly released during the first 
minutes after dosage. Higher concentrations of analytes were obtained in the in vivo study 
immediately after dosage as a result of oral contamination. The differences in release rate 
could have been the result of molecules of cocaine and AEME being absorbed at different 
depth in the oral mucosa. If molecules were absorbed at different depths, it is possible 
that molecules closer to the epithelium would be more rapidly released into the SOF than 
the molecules that were deeper absorbed, which moved slowly through the tissue towards 
the epithelium. This postulation was supported by the fact that cocaine was detected at 
higher concentrations in sections closer to the epithelium using Raman microscopy 
(results presented in Section 3.3.2) and immunohistochemistry staining (Reichardt 2014). 
The higher flux and diffusion coefficient values obtained for cocaine and AEME 
across oral mucosa (Table 7.5) indicated that AEME diffused more rapidly through the 
epithelium than the whole mucosa. The diffusion coefficient for the transport of cocaine 
across whole mucosa (epithelium and muscle) were significantly different from the values 
obtained across mucosal epithelium, which indicated that the main barrier to cocaine 
transport was the oral epithelium. For the contrary, no significant differences were 
obtained between the diffusion coefficient of AEME across whole mucosa and 
epithelium, which indicated that AEME diffused similarly across both barriers. These 
results showed that the diffusion of drugs across oral mucosa was principally driven by 
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the physicochemical properties of the drugs, which confirmed the hypothesis that the 
mechanism of release of drugs from oral tissues into oral fluid was similar to the 
mechanism of action of drugs crossing the BBB (Section 1.10). Johnson et al. (2016) 
reported that the mechanism of diffusion of drugs (cocaine) across BBB depends on the 
structure and the hydration of the molecule.  
The fact that cocaine and AEME were detected in the receiver compartment (and not 
in the donner compartment) indicated that the diffusion of cocaine and AEME deposited 
in the oral mucosa was higher towards the epithelium (apical side of the oral mucosa) 
rather than to the basolateral side (PBS) independently from the pH of the OF. This result 
indicated that higher concentrations of cocaine and AEME could be expected on the 
apical side of the cell (OF) than in the basolateral side (PBS). Since the transport of 
cocaine and AEME across the oral mucosa is higher towards the apical side of the mucosa 
where the OF is, there is a less probability that cocaine gets transported to the systemic 
circulation. This was an important finding as drugs such as cocaine and derivatives from 
drug depots could increase the concentration of drugs in OF and therefore affect OF drug 
testing. Furthermore, drugs (cocaine and derivatives) from drug depots might not be 
transported/released into the systemic circulation indicating that the concentration of 
drugs in blood would not be increased as a result of diffusion of drugs from drug depots. 
If a drug, e.g. cocaine is not transported from drug depots into the systemic circulation, 
this drug is not likely to contribute to the effect of the drug on an individual, e.g. 
psychoactive effect. 
LC-MS was selected as the method to be implemented for the quantitative analysis of 
samples, as this is regarded a golden standard method for analysis of drugs in biological 
samples (Drummer 2006, Cooper et al. 2010, EWDTS 2015). LC-MS methods used in 
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this research were successful in quantifying cocaine and cocaine derivatives in multiple 
matrices (BOF, SOF and porcine oral tissue). These methods were validated according to 
the Scientific Working Group for Forensic Toxicology (SWGTOX 2013) and the 
Forensic Science Regulatory code of practice and conduct (Forensic Science Regulator 
2017). 
The LC-MS methods were also successful in monitoring the release of cocaine and 
derivatives from oral drug depots into OF/SOF and their stability in BOF, SOF and 
porcine oral tissue. The stability studies indicated that the length of storage and the 
storage temperature influenced the stability (concentration) of cocaine and cocaine 
derivatives in BOF, SOF and porcine oral tissue. The concentration of analytes decreased 
(cocaine, CE and EME) or increased (BZE) significantly after few days of storage in 
samples stored at room temperature or up to 37 °C. In particular, concentrations of 
cocaine and BZE in all matrices as the decrease in cocaine concentration increased BZE 
concentration, which is the result of cocaine degradation, i.e. hydrolysis of cocaine. 
Although the concentration of cocaine, CE and EME in BOF decreased as a result of 
degradation into BZE, norcocaethylene and ecgonine respectively, only the increase in 
concentration of BZE was evaluated in this study. The outcome of the stability study 
suggested that samples should be stored at low temperatures (-20 °C) in order to avoid 
degradation of cocaine and derivatives in any of the matrices (BOF, SOF or Tissue). This 
is because long transportation times and changes in ambient temperatures could lead to 
degradation of cocaine and cocaine derivatives in the samples. In conclusion, these results 
aided in the design of the in-vivo and in-vitro studies by identifying the best storage 
conditions of the samples and the implications that the length of storage (transportation 
of samples from Colombia to the UK) could have in the concentration of cocaine and 
derivatives in the samples. 
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Handheld and portable SERS analysis detected and quantified cocaine in SOF at 
concentrations above 100 μg/mL (range 0.1 – 1 mg/mL) using gold and/or silver 
substrates. The data demonstrated that silver nanoparticles (NPs) synthesised by the 
method of hydroxylamine reduction (Lee and Meisel 1982, Feng 2015) provided a more  
reliable SERS method than the commercial substrates. The study demonstrated that 
cocaine could be detected in SOF using SERS, however, the low sensitivity of the SERS 
method did not allow the detection of cocaine in SOF at physiological levels and therefore 
this method could not be applied in the monitoring of drug release in OF. 
The SERS analysis of cocaine using silver NPs obtained by hydroxylamine reduction 
and handheld/portable Raman spectroscopy demonstrated that this technique has 
potential uses in on-site drug testing. However, the sensitivity of the method needs to be 
improved in order to be applied in the practice of human performance forensic toxicology 
and criminal forensic toxicology. For example, the cut-off values of cocaine in OF have 
been reported at concentrations of 8 ng/mL for workplace drug testing (EWDTS 2015). 
In order to increase the sensitivity of the method, more sensitive Raman spectrometers 
should be used along with SERS substrates of higher activity (high number of hot spots).  
Raman microscopy allowed the detection of cocaine in porcine tissue at physiological 
concentrations (0-3 µg/mL) without the use of SERS substrates. The high sensitivity of 
Raman microscopy compared with conventional Raman spectrometers (Turrell and 
Corset 1996) allowed the detection of cocaine in oral tissue in different sections of the 
tissue. The optimisation of the method confirmed that lasers with low energy (532 nm) 
provided higher sensitivity for the detection of cocaine. Variation in the intensity of 
Raman scattering of cocaine at different positions of the tissue supported the idea of 
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formed drug depots and indicated that cocaine was absorbed/deposited in specific areas 
within the tissue. 
In summary, the research findings presented in this thesis contributed to the 
understanding of the release of drugs from drug depots by investigating the kinetics of 
release of cocaine and cocaine derivatives from drug depots using an in vivo and an in 
vitro model. This research confirmed that cocaine and cocaine derivatives formed oral 
depots into the oral tissues and suggested that higher amounts of drug depots can be 
formed when the oral cavity is exposed to the drug for an extended period of time. The 
results presented in this thesis showed that cocaine and derivatives could be released from 
drug depots at different rates over an extended period of time. Diffusion studies of cocaine 
and AEME across oral mucosa confirmed that AEME diffused more rapidly into OF than 
cocaine and indicated that these drugs were more likely to diffuse into OF than the 
systemic circulation. The studies described in this thesis suggested that the mechanism of 
release of drugs from drug depots into OF depend on the physicochemical properties of 
the drug. The higher amount of oral drug depots (cocaine and cocaine derivatives) 
increases the time of detection windows of these drugs in OF which affect OF drug testing 
and its applications to workplace drug-testing programs, driving under the influence of 
drugs (DUID), drug-treatment settings and the prison service where drugs of abuse are 
tested. Further studies need to be conducted with other drugs of abuse to identify the rates 
of elimination of drugs from drug depots and the effect these have in their time of 
detection windows in OF. 
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8.2 RECOMMENDATIONS 
The positive detection of cocaine, BZE, AEME and EME in OF and the time that these 
analytes (30-120 minutes) could be detected in OF suggested a recommendation for 
regulatory agencies about the time of sample collection in countries where coca tea 
drinking is legal (Colombia, Peru, Bolivia and Argentina). The recommendation would 
be to wait at least three hours post administration before OF samples are collected to 
avoid misinterpretation of results from OF cocaine testing as positive testing could be the 
result of oral contamination. 
Careful considerations need to be taken on OF cocaine testing in countries in South 
America where coca tea is frequently consumed because of the higher probability of 
detection of cocaine, AEME, BZE and EME in OF samples as a result of coca tea 
drinking. The positive testing of AEME in OF following ingestion/swirling of coca tea 
wrongly indicated the previous use of “crack” cocaine and showed that coca tea 
consumption has a high impact in OF drug testing. Furthermore, the positive detection of 
cocaine and cocaine derivatives following ingestion and swirling of coca tea present an 
essential finding for local authorities in countries where OF drug testing has been 
implemented (Finland, Sweden, Norway, the UK and the USA) (Wille et al. 2009, Chu 
et al. 2012, Vindenes et al. 2012), and where products of the coca plant are illegal 
consumed. This because positive cocaine drug testing could be the result of coca tea 
exposure and not the consumption of cocaine base or crack cocaine. The increase in the 
importation and illegally purchased from the internet of commercial products of the coca 
plant, e.g. coca tea in European countries and the USA (De la Cal 2016, Transnational 
Institute 2017, SERVINDI 2018), increases the probability of consumption of coca tea 
products, which could affect OF cocaine testing in these places. The research suggested 
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the inclusion of other biomarkers such as cuscohygrine and/or hygrine in OF drug testing 
by regulatory agencies to confirm the presence of AEME from coca tea drinking and to 
discriminate between coca tea/coca products consumption and drug abuse (Rubio et al. 
2013). 
Careful considerations should be taken by regulatory authorities and prosecutors for 
the equivalence of the A and B samples when two samples have been collected 
simultaneously. Significant differences in analyte concentration were obtained from the 
analysis of paired OF samples collected simultaneously from different sides of the mouth 
(right and left) for approximately 20% of the samples collected (n = 119). This indicated 
that in specific cases there were significant differences (> 50-150%) between the A and 
B samples. Which could result in invalidation of results as false positives or negatives 
could be obtained. In cases where the volume of OF collected is not a limitation it could 
be recommendated that sample collection be conducted using a single collection and 
subsequently splitting the sample to obtain the A and B samples. However, if two samples 
need to be collected, it is important that the devices and extraction procedures be 
optimised in order to decrease the discrepancies in results. 
The outcome of the stability study of cocaine and cocaine derivatives in BOF, SOF or 
Tissue suggested that samples should be stored at low temperatures (-20 °C) in order to 
avoid degradation of cocaine and derivatives in any of the matrices. The data from this 
study suggested that caution should be applied to the interpretation of results in samples 
stored at room temperature or up to 37 °C as concentrations of analytes decreased 
(cocaine, CE and EME) or increased (BZE) significantly after few days of storage. In 
particular, concentrations of cocaine and BZE in all matrices as the decrease in cocaine 
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concentration increased BZE concentration, which is the result of cocaine degradation, 
i.e. hydrolysis of cocaine.
The results presented in Chapter 3 proved that Raman microscopy could be used for the 
detection of cocaine in biological tissues at physiological concentrations without the use 
of SERS substrates (Raman enhancers). These results implied that Raman microscopy 
could also be used to detect cocaine in OF samples at concentration in the nanogram level. 
The implementation of alternative techniques, i.e. Raman microscopy in drug testing 
could be beneficial for the accredited laboraties as this could reduce the time and cost of 
analysis. 
8.3 FUTURE WORK 
The in vivo study evaluated the detection window of cocaine and cocaine derivatives 
(AEME, BZE and EME) in OF employing a single dose administration of coca tea. 
However, in the South American countries, coca leaves are consumed multiple times a 
day. It is therefore essential to further assess the windows of detection of cocaine and 
derivatives in OF after multiple dosages of coca tea as the windows of detection are likely 
to vary with the dosage (Coe et al. 2018). 
More research should be conducted for the presence of cocaine and cocaine derivatives 
in biological samples including OF following consumption of coca products. There are 
many products from the coca plant (coca leaves for chewing, coca flour and coca rum) 
that are available in the market and are being consumed as much as the coca tea in the 
South American countries. The consumption of these products could result in positive 
testing for cocaine in OF and therefore interfere in the analysis of drugs in OF. The use 
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of coca products in the investigation of the kinetics of cocaine and cocaine derivatives in 
OF and other biological matrices could reduce the ethical issues associated with the 
administration of drugs of abuse in clinical studies. 
It is suggested that paired OF and blood samples be collected following the exposure 
of coca tea and/or coca products to evaluate S/P ratios (Haeckel and Hänecke 1996). 
Blood samples were not collected while developing the in vivo study because of the 
increase in ethical issues associated to the collection of blood samples and limitations on 
the logistics of sample collection and transport (exportation/importation) of samples from 
Colombia into the UK. The consumption of coca tea and coca products is illegal and not 
socially accepted in the UK which limits the ethical approval of the study if this is to be 
conducted in the UK. Furthermore, a Home Office import licence needs to be obtained to 
import the coca tea (or coca products) to the UK. Hence, further collaborations between 
research groups in South America and the UK is recommended for future studies as this 
could help reduce ethical limitations and cost. Although transportation of biological 
samples between countries could increase the cost of the study if samples need to be 
analysed in the UK. 
Further studies need to be conducted in order to confirm the equivalence between the 
A and B samples when these have been collected simultaneously using two Concateno 
CertusÒ OF collection devices. A large number of samples should be evaluated to 
determine the error in the equivalence of sample concentration and whether any 
significant differences in drug concentration in OF are the result of inaccurate collection 
devices, collection procedure (position of the device in the oral cavity and/or active 
sample collection) or differences in the concentrations of drugs from different sections of 
the oral cavity. 
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In this thesis, the in vitro release of drugs from oral depots into OF and the in vitro 
permeability across oral mucosa were evaluated and conducted using separate studies, 
however, these two processes take place simultaneously. Therefore, more studies need to 
be conducted to determine if there is an increase in the release rate of cocaine in OF when 
cocaine has been transported from the basolateral side across the oral tissue into OF as 
well as being excreted from oral depots into OF. 
Even though the passive transport of drugs across oral mucosa was developed using 
fresh porcine mucosa, the bioavailability of the tissue could not be confirmed because of 
limitations with the instrumentation required to analyse the samples. Evaluation of the 
preservation of the tissue is recommended in the future to verify the release rate obtained 
in this study. To achieve this, the diffusion studies should be conducted under carbogen 
conditions (95% O2 + 5% CO2) and the integrity of the oral mucosa needs to be check 
before and after the diffusion studies (Pather et al. 2008) using any of the methods 
described in Section 1.9.2. 
Cell-based in vitro methods (Hamster check pouch cells (HPBE), epithelial cells of 
Madin-Darby canine kidney (MDCK), TR146 cell line and human oral keratinocytes) are 
also recommended to evaluate the transport of cocaine, cocaine derivatives and other 
drugs across the oral mucosa (Nicolazzo and Finnin 2008, Kolli and Indiran 2015, Castro 
et al. 2016). In particular, the EpiOralTM model offers a buccal 3D tissue model, which is 
widely used for the analysis of barrier function, permeability and toxicity (Castro et al. 
2016). Although these methods require of more controlled conditions (cell cultured 
conditions), they offer the advantage of allowing the evaluation of the passive and active 
diffusion of drugs which could be applied for the study of drug release in OF. 
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The results presented in this thesis showed the potential of Raman microscopy as an 
alternative technique for the quantitative analysis of cocaine in porcine oral tissue and 
OF. It is recommended that further studies be conducted on the quantitation of cocaine in 
OF and oral tissue by more sensitive Raman spectrometers and/or Raman microscopy to 
increase the sensitivity of the method and be able to apply this technique on drug testing. 
Mapping of oral tissue following exposure to cocaine using Raman microscopy should 
be conducted to identify the position of drug depots in the tissue and evaluate whether 
drugs depots are homogeneity distributed or not within the oral tissue. This study could 
further enhance our understanding of how drugs are released from oral depots into OF. 
Although cocaine was the only analyte evaluated by Raman spectroscopy, this technique 
could be further expanded to the detection and quantitation of cocaine metabolites and 
other drugs of abuse such as cannabis and opioids. 
 
References 
323 
REFERENCES 
Adrian, C. L., Olin, H. B. D., Dalhoff, K., and Jacobsen, J., 2006. In vivo human buccal 
permeability of nicotine. International Journal of Pharmaceutics, 311 (1–2), 196–202. 
Agnihotri, S., Mukherji, S., and Mukherji, S., 2014. Size-controlled silver 
nanoparticles synthesized over the range 5–100 nm using the same protocol and their 
antibacterial efficacy. Royal Society of Chemistry Advances, 4 (8), 3974–3983. 
Alere Toxicology, 2018. What is a window of detection? | Alere Toxicology [online]. 
Available from: https://www.aleretoxicology.co.uk/en/home/support/testing-
explained/windows-of-detection.html [Accessed 12 Mar 2018]. 
Ali, E. and Edwards, H., 2010. In situ detection of cocaine hydrochloride in clothing 
impregnated with the drug using benchtop and portable Raman spectroscopy. Raman 
Spectroscopy, 41 (9), 938–943. 
Allen, K. R., 2011. Screening for drugs of abuse: which matrix, oral fluid or urine? 
Annals of Clinical Biochemistry, 48 (6), 531–541. 
Almståhl, A. and Wikström, M., 2003. Electrolytes in stimulated whole saliva in 
individuals with hyposalivation of different origins. Archives of Oral Biology, 48, 337–
344.
References 
 
 324 
Andreou, C., Hoonejani, M. R., Barmi, M. R., Moskovits, M., and Meinhart, C. D., 
2013. Rapid detection of drugs of abuse in saliva using surface enhanced raman 
spectroscopy and microfluidics. ACS Nano, 7 (8), 7157–7164. 
Anizan, S. and Huestis, M. A., 2014. The potential role of oral fluid in antidoping 
testing. Clinical Chemistry, 60 (2), 307–322. 
Anizan, S., Bergamaschi, M. M., Barnes, A. J., Milman, G., Desrosiers, N., Lee, D., 
Gorelick, D. A., and Huestis, M. A., 2015. Impact of oral fluid collection device on 
cannabinoid stability following smoked cannabis. Drug testing and analysis, 7 (2), 114–
20. 
Aps, J. K. M. and Martens, L. C., 2005. Review: The physiology of saliva and transfer 
of drugs into saliva. Forensic Science iIternational, 150, 119–31. 
Bansal, P. and Ajay, D., 2012. Laboratory Dialysis-Past, Present and Future. Recent 
Patents on Biotechnology, 6, 32–44. 
Barnett, N. and Rathmell, C., 2015. Detecting Drugs in Saliva. Optik & Photonik, 10 
(5), 31–34. 
Bartlett, J. A. and van der Voort Maarschalk, K., 2012. Understanding the oral mucosal 
absorption and resulting clinical pharmacokinetics of asenapine. AAPS PharmSciTech, 
13 (4), 1110–5. 
Bartosova, L. and Bajgar, J., 2012. Transdermal Drug Delivery In Vitro Using 
Diffusion Cells. Current Medicinal Chemistry, 19 (27), 4671–4677. 
References 
325 
Baselt, R. C., Yoshikawa, D., Chang, J., and Li, J., 1993. Improved long-term stability 
of blood cocaine in evacuated collection tubes. Journal of Forensic Sciences, 38 (4), 935–
7. 
Beckett, A. H. and Triggs, E. J., 1967. Buccal absorption of basic drugs and its 
application as an in vivo model of passive drug transfer through lipid membranes. The 
Journal of Pharmacy and Pharmacology, 19, Suppl:31S-41S. 
Beule, A. G., 2010. Physiology and pathophysiology of respiratory mucosa of the nose 
and the paranasal sinuses. GMS current topics in otorhinolaryngology, head and neck 
surgery, 9, 1-24. 
Bhat, R., Chari, G., Rao, M., Negrusz, A., and Vidyasagar, D., 2001. Cocaine 
permeability and metabolism in colonic T-84 epithelial cell line. Life Sciences, 70, 549–
556. 
Bhusnure, O. G., Kure, S. R., Deshpande, R. R., and Sachin, B. G., 2017. Challenges 
face by pharmaceutical industry for the development of oral film dosages form. 
International Journal of Pharmacy and Pharmaceutical Research, 10 (1), 118–132. 
Biondich, A. S. and Joslin, J. D., 2015. Coca: High Altitude Remedy of the Ancient 
Incas. Wilderness & Environmental Medicine, 571, 567–571. 
Bolger, M. B., Gilman, T. M., Fraczkiewicz, R., Steere, B., and Walter, W., 2002. 
Predicting drug absorption by computational methods. In: Lehr, C.-M., ed. Cell Culture 
Models of Biological Barriers. London: Taylor & Francis, 353–377. 
References 
 
 326 
Bosker, W. M. and Huestis, M. A., 2009. Oral fluid testing for drugs of abuse. Clinical 
Chemistry, 55 (11), 1910–1931. 
Bouis, P., Taccard, G., and Boelsterli, U. A., 1990. Determination of cocaine and 
norcocaine in plasma and cell cultures using high-performance liquid chromatography. 
Journal of Chromatography, 526 (2), 447–59. 
Brajković, G., Babić, G., Stošić, J. J., Tomašević, G., Rančić, D., and Kilibarda, V., 
2016. Fatal cocaine intoxication in a body packer. Vojnosanit Pregl, 73 (2), 198–201. 
Brodin, B., Steffansen, B., and Nielsen, C. U., 2010. Passive diffusion of drug 
substances: the concepts of flux and permeability. In: Steffansen, B., Brodin, B., and 
Nielsen, C. U., eds. Molecular Biopharmaceutics: Aspects of Drug Characterisation, 
Drug Delivery and Dosage form Evaluation. London: Pharmaceutical Press, 135–152. 
Caballero, L. and Alarcon, A., 2000. Cocaína y cocainomanía en atención primaria. 
In: FCS, ed. Drogas y Drogodependencias en Atención Primaria. Madrid: Fundacion 
Ciencias de la Salud, 207–244. 
Cañamares, M. V., Garcia-Ramos, J. V., Gómez-Varga, J. D., Domingo, C., and 
Sanchez-Cortes, S., 2005. Comparative study of the morphology, aggregation, adherence 
to glass, and surface-enhanced Raman scattering activity of silver nanoparticles prepared 
by chemical reduction of Ag + using citrate and hydroxylamine. Langmuir, 21 (18), 
8546–8553. 
 
References 
327 
Cardona, P. S., Chaturvedi, A. K., Soper, J. W., and Canfield, D. V., 2006. 
Simultaneous analyses of cocaine, cocaethylene, and their possible metabolic and 
pyrolytic products. Forensic Science International, 157 (1), 46–56. 
Casale, J. F., Mallette, J. R., and Jones, L. M., 2014. Chemosystematic identification 
of fifteen new cocaine-bearing Erythroxylum cultigens grown in Colombia for illicit 
cocaine production. Forensic Science International, 237, 30–39. 
Casikar, V., Mujica, E., Mongelli, M., Aliaga, J., Lopez, N., Smith, C., and 
Bartholomew, F., 2010. Does chewing coca leaves influence physiology at high altitude? 
Indian Journal of Clinical Biochemistry, 25 (3), 311–314. 
Castro, P., Madureira, R., Sarmento, B., and Pintado, M., 2016. Tissue-based in vitro 
and ex vivo models for buccal permeability studies. In: Concepts and Models for Drug 
Permeability Studies. Amsterdam: Elsevier Ltd., 189–202. 
Ceschel, G. C., Maffei, P., Sforzini, A., Lombardi Borgia, S., Yasin, A., and Ronchi, 
C., 2002. In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl 
ester (CAPE) from a topical mucoadhesive gel containing propolis. Fitoterapia, 73, S44–
S52. 
Chaki, S. H., Chaudhary, M. D., Deshpande, M. P., Gunawan, P., Xiao, W., Wen, M., 
Chua, H., Chaki, S. H., Malek, T. J., Chaudhary, M. D., Tailor, J. P., and Deshpande, M. 
P., 2015. Magnetite Fe3O4 nanoparticles synthesis by wet chemical reduction and their 
characterization. Advances in Natural Sciences: Nanocience and Nanotechnology, (6), 1–
6.
References 
 
 328 
Chiappin, S., Antonelli, G., Gatti, R., and De Palo, E. F., 2007. Saliva specimen: A 
new laboratory tool for diagnostic and basic investigation. Clinica Chimica Acta, 383 (1–
2), 30–40. 
Chow, M. J., Ambre, J. J., Ruo, T. I., Atkinson,  a J., Bowsher, D. J., and Fischman, 
M. W., 1985. Kinetics of cocaine distribution, elimination, and chronotropic effects. 
Clinical Pharmacology and Therapeutics, 38 (3), 318–24. 
Chu, M., Gerostamoulos, D., Beyer, J., Rodda, L., Boorman, M., and Drummer, O. H., 
2012. The incidence of drugs of impairment in oral fluid from random roadside testing. 
Forensic Science International, 215 (1–3), 28–31. 
Ciurba, A., Todoran, N., Tăurean, A., Antonoaea, P., Hancu, G., Moisei, A., and Sipos, 
E., 2014. Kinetic analysis of in-vitro drug release from valproic acid and sodium valproate 
suppositories. Farmacia, 62 (6), 1143–1156. 
Clemons, K., Kretsch, A., and Verbeck, G., 2014. Parallel artificial membrane 
permeability assay for blood–brain permeability determination of illicit drugs and 
synthetic analogues. Science & Justice, 54 (5), 351–355. 
Coe, M. A., Jufer Phipps, R. A., Cone, E. J., and Walsh, S. L., 2018. Bioavailability 
and Pharmacokinetics of Oral Cocaine in Humans. Journal of Analytical Toxicology, 42 
(5), 285–292. 
Cognard, E., Bouchonnet, S., and Staub, C., 2006. Validation of a gas 
chromatography-Ion trap tandem mass spectrometry for simultaneous analyse of cocaine 
and its metabolites in saliva. Journal of Pharmaceutical and Biomedical Analysis, 41, 
925–934. 
References 
 
 329 
Cone, E. J. and Menchen, S. L., 1988. Stability of Cocaine in Saliva. Clinical 
Chemistry, 34 (7), 1508. 
Cone, E. J., 2012. Oral fluid results compared to self reports of recent cocaine and 
heroin use by methadone maintenance patients. Forensic Science International, 215 (1–
3), 88–91. 
Cone, E. J., Hiilsgrove, M., and Darwin, W. D., 1994. Simultaneous measurement of 
cocaine, cocaethylene, Their Metabolites, and ‘crack’ pyrolysis products by gas 
chromatography-mass spectrometry. Clinical Chemistry, 407 (7 Pt 1), 1299–305. 
Cone, E. J., Oyler, J., and Darwin, W. D., 1997. Cocaine Disposition in Saliva 
Following Intravenous, Intranasal, and Smoked Administration. Journal of Analytical 
Toxicology, 21, 465–475. 
Cooper, G. A. A., Paterson, S., and Osselton, M. D., 2010. The United Kingdom and 
Ireland Association of Forensic Toxicologists. Forensic toxicology laboratory guidelines 
(2010). Science and Justice, 50 (4), 166–176. 
Costa, P. and Sousa Lobo, J. M., 2001. Modeling and comparison of dissolution 
profiles. European Journal of Pharmaceutical Sciences, 13 (2), 123–133. 
Crawley, M. J., 2005. Statistics: An Introduction Using R. London: John Willey & 
Sons, Ltd,1–337  
 
References 
 
 330 
Dana, K., Shende, C., Huang, H., and Farquharson, S., 2015. Rapid Analysis of 
Cocaine in Saliva by Surface-Enhanced Raman Spectroscopy. Journal of Analytical & 
Bioanalytical Techniques, 6 (6), 1–5. 
Dash, S., Murthy, P. N., Nath, L., and Chowdhury, P., 2010. Kinetic modeling on drug 
release from controlled drug delivery systems. Acta Poloniae Pharmaceutica, 67 (3), 
217–223. 
Dawes, C. and Jenkins, G. N., 1964. The Effects of Different Stimuli on the 
Composition of Saliva in Man. The Journal of Physiology, 170, 86–100. 
De la Cal, L., 2016. España ya masca hoja de coca | Sociedad | EL MUNDO [online]. 
Available from: 
http://www.elmundo.es/sociedad/2016/06/14/575ed7a9468aebce0a8b4661.html 
[Accessed 15 Apr 2019]. 
De Sousa, F. A., Guido Costa, A. I., Lopes Ribeiro de Queiroz, M. E., Francisco 
Reinaldo, T., Augusto Antônio, N., and Gevany Paulino,  de P., 2012. Evaluation of 
matrix effect on the GC response of eleven pesticides by PCA. Food Chemistry, 135 (1), 
179–185. 
Dearden, J. C. and Tomlinson, E., 1971. Correction for Effect of Dilution on Diffusion 
Through a Membrane. Journal of Pharmaceutical Sciences, 60 (8), 1278–1279. 
DePriest, A. Z., Puet, B. L., Holt, A. C., Roberts, A., and Cone, E. J., 2015. Metabolism 
and Disposition of Prescription Opioids : A Review. Forensic Science Review, (27), 115–
146. 
References 
 
 331 
Desai, R., Mankad, V., Gupta, S. K., and Jha, P. K., 2012. Size Distribution of Silver 
Naoparticles: UV-Visible Spectroscopic Assessment. Nanoscience and Nanotechnology 
Letters, 4, 30–34. 
Dronova, M., Smolianitski, E., and Lev, O., 2016. Electrooxidation of New Synthetic 
Cannabinoids: Voltammetric Determination of Drugs in Seized Street Samples and 
Artificial Saliva. Analytical Chemistry, 88 (8), 4487–4494. 
Drummer, O. H., 2004. Postmortem toxicology of drugs of abuse. Forensic Science 
International, 142 (2–3), 101–113. 
Drummer, O. H., 2006. Drug testing in oral fluid. The Clinical Biochemist Reviews, 
27, 147–159. 
Egred, M. and Davis, G. K., 2005. Cocaine and the heart. Postgraduate Medical 
Journal, 81, 568–571. 
Ekman, R., Silberring, J., Westman-Brinkmalm, A. M., and Kraj, A., 2009. Mass 
spectrometry : Instrumentation, interpretation, and applications. New Yersey: John 
Wiley & Sons, 1-388. 
Eliasson, L., Birkhed, D., Heyden, G., and Strömberg, N., 1996. Studies on human 
minor salivary gland secretions using the Periotron® method. Archives of Oral Biology, 
41 (12), 1179–1182. 
ElSohly, M. A., Stanford, D. F., and ElSohly, H. N., 1986. Coca tea and urinalysis for 
cocaine metabolites. Journal of Analytical Toxicology, 10 (6), 256. 
References 
 
 332 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2017. 
United Kingdom Country drug report 2017 [Online]. Available 
from: http://www.emcdda.europa.eu/system/files/publications/4529/TD0116925ENN.p
df.  
Engelke, B. F. and Gentner, W. A., 1991. Determination of Cocaine in “Mate de Coca” 
Herbal Tea. Journal of Pharmaceutical Sciences, 80 (1), 96. 
Ewald, K., 2015. Influence of physical parameters on the dispensed volume of air-
cushion pipette. USERGUIDE, (21), 1-4. 
European Worplace Drug Testing Society (EWDTS), 2015. European Guidelines for 
Workplace in Oral Fluid. Version 2.0 [online]. Available from: 
http://www.ewdts.org/data/uploads/documents/ewdts-oral-fluid-2015-11-01-v2.0.pdf. 
Fandiño, A. S., Toennes, S. W., and Kauert, G. F., 2002. Studies on In Vitro 
Degradation of Anhydroecgonine Methyl Ester (Methylecgonidine)in Human Plasma. 
Journal of Analytical Toxicology, 26, 567-570. 
Farquharson, S., Shende, C., Sengupta, A., Huang, H., and Inscore, F., 2011. Rapid 
detection and identification of overdose drugs in saliva by surface-enhanced raman 
scattering using fused gold colloids. Pharmaceutics, 3 (3), 425–439. 
Feng, S., 2015. Surface-enhanced Raman spectroscopy of saliva proteins for the 
noninvasive differentiation of benign and malignant breast tumors. International Journal 
of Nanomedicine, 10, 537–547. 
References 
333 
Ferguson, D. B., 1999. The flow rate and composition of human labial gland saliva. 
Archives of Oral Biology, 44, S11–S14. 
Fernandes de Oliveira, C. A., Silveira, L., and Tavares Pacheco, M. T., 2012. 
Quantification of Binary Mixtures of Cocaine and Adulterants Using Dispersive Raman 
and FT-IR Spectroscopy and Principal Components Regression. Instrumentation Science 
and Technology, 40, 441–456. 
Fick, A., 1995. On liquid diffusion. Journal of Membrane Science, 100 (1), 33–38. 
Fierro-Mercado, P. M., Hernández-Rivera, S. P., and ndez-Rivera, S. P., 2012. Highly 
Sensitive Filter Paper Substrate for SERS Trace Explosives Detection. International 
Journal of Spectroscopy, 2012, 1–7. 
Fineschi, V., Centini, F., Monciotti, F., and Turillazzi, E., 2002. The cocaine 
&quot;body stuffer&quot; syndrome: a fatal case. Forensic Science International, 126 
(1), 7–10. 
Fleming, J. A., Byck, R., and Barash, P. G., 1990. Pharmacology and therapeutic 
applications of cocaine. Anesthesiology, 73 (3), 518–31. 
Forde, M. D., Koka, S., Eckert, S. E., Carr, A. B., and Wong, D. T., 2006. Systemic 
assessments utilizing saliva: Part 1 general considerations and current assessments. The 
International Journal of Prosthodontics, 19 (1), 43–52. 
References 
 
 334 
Forensic Science Regulator, 2017. Codes of Practice and Conduct for forensic science 
providers and practitioners in the Criminal Justice System [online]. Issue 4. Available 
from: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment
_data/file/651966/100_-_2017_10_09_-_The_Codes_of_Practice_and_Conduct_-
_Issue_4_final_web_web_pdf__2_.pdf. 
Fornasaro, S., Marta, S. D., Rabusin, M., Bonifacio, A., and Sergo, V., 2016. Toward 
SERS-based point-of-care approaches for therapeutic drug monitoring: the case of 
methotrexate. Faraday Discuss, 187, 485–499. 
Frank, M. E. and Hand, A. R., 2014. Part IV Mucosal structure and function. In: 
Fundamentals of Oral Hystology and Physiology. Wiley-Blackwell, 163–220. 
Franz-Montan, M., Serpe, L., Martinelli, C. C. M., da Silva, C. B., Santos, C. P. dos, 
Novaes, P. D., Volpato, M. C., de Paula, E., Lopez, R. F. V., and Groppo, F. C., 2016. 
Evaluation of different pig oral mucosa sites as permeability barrier models for drug 
permeation studies. European Journal of Pharmaceutical Sciences, 81, 52–59. 
Freudiger, C. W., Min, W., Saar, B. G., Lu, S., Holtom, G. R., He, C., Tsai, J. C., 
Kang, J. X., and Xie, X. S., 2008. Label-Free Biomedical Imaging with. Science, 322, 
1857–1861. 
Furnari, C., Ottaviano, V., Sacchetti, G., and Mancini, M., 2002. A fatal case of 
cocaine poisoning in a body packer. Journal of Forensic Sciences, 47 (1), 208–10. 
 
References 
 
 335 
Gao, Y., Orson, F. M., Kinsey, B., Kosten, T., and Brimijoin, S., 2010. The concept 
of pharmacologic cocaine interception as a treatment for drug abuse. Chemico-Biological 
Interactions, 187 (1–3), 421–424. 
Geldenhuys, W. J., Allen, D. D., and Bloomquist, J. R., 2012. Novel models for 
assessing blood–brain barrier drug permeation. Expert Opinion on Drug Metabolism & 
Toxicology, 8 (6), 647–653. 
Gjerde, H., Mordal, J., Christophersen, A. S., Bramness, J. G., and Mørland, J., 2010. 
Comparison of drug concentrations in blood and oral fluid collected with the Intercept 
sampling device. Journal of Analytical Toxicology, 34 (4), 204–209. 
Gjerde, H., Sousa, T. R., De Boni, R., Christophersen, A. S., Limberger, R. P., 
Zancanaro, I., Oiestad, E. L., Normann, P. T., Mørland, J., and Pechansky, F., 2014. A 
comparison of alcohol and drug use by random motor vehicle drivers in Brazil and 
Norway. International Journal of Drug Policy, 25 (3), 393–400. 
Gnyba, M., Smulko, J., Kwiatkowski,  a., and Wierzba, P., 2011. Portable Raman 
spectrometer - design rules and applications. Bulletin of the Polish Academy of Sciences: 
Technical Sciences, 59 (3), 325–329. 
Gómez de Ferraris, M. E. and Campos, A., 2002. Capitulo 5. Cavidad bucal. In: 
Histología y embriología bucodental. Editorial Medica Panamericana, 111–150. 
Guzzo, M., Locati, L. D., Prott, F. J., Gatta, G., Mcgurk, M., and Licitra, L., 2010. 
Major and minor salivary gland tumors. Critical Reviews in Oncology Hematology, 74, 
134–148. 
References 
 
 336 
Haeckel, R. and Hänecke, P., 1996. Application of saliva for drug monitoring. An in 
vivo model for transmembrane transport. European Journal of Clinical Chemistry and 
Clinical Biochemistry, 34, 171–191. 
Han, Y., Lan, X., Wei, T., Tsai, H.-L., and Xiao, H., 2009. Surface enhanced Raman 
scattering silica substrate fast fabrication by femtosecond laser pulses. Applied Physics 
A, 97 (3), 721–724. 
Hand, A. R., Pathmanathan, D., and Field, R. B., 1999. Morphological features of the 
minor salivary glands. Archives of Oral Biology, 44, S3–S10. 
He, S., Chua, J., Tan, E. K. M., Kah, J. C. Y., Käll, M., Abrahamsson, J., Abrahamsson, 
K., Feld, M. S., and Whitesides, G. M., 2017. Optimizing the SERS enhancement of a 
facile gold nanostar immobilized paper-based SERS substrate. RSC Adv., 7 (27), 16264–
16272. 
Head and Neck Cancer Guide, 2018. Oral Cancer, Mouth Cancer Anatomy [online]. 
Available from: https://headandneckcancerguide.org/adults/introduction-to-head-and-
neck-cancer/oral-cancers/basics/anatomy/ [Accessed 15 Apr 2019]. 
Herrera, G., Padilla, A., and Hernandez-Rivera, S., 2013. Surface Enhanced Raman 
Scattering (SERS) Studies of Gold and Silver Nanoparticles Prepared by Laser Ablation. 
Nanomaterials, 3 (1), 158–172. 
Higuchi, T., 1961. Rate of Release of Medicaments from Ointment Bases Containing 
Drugs in Suspension. Journal of Pharmaceutical Sciences, 50 (10), 874–875. 
References 
 
 337 
Hippenstiel, M. J. and Gerson, B., 1994. Optimization of storage conditions for 
cocaine and benzoylecgonine in urine: A review. Journal of Analytical Toxicology, 18 
(2), 104–109. 
Holm, R., Meng-Lund, E., Andersen, M. B., Jespersen, M. L., Karlsson, J. J., Garmer, 
M., Jorgensen, E. B., and Jacobsen, J., 2013. In vitro, ex vivo and in vivo examination of 
buccal absorption of metoprolol with varying pH in TR146 cell culture, porcine buccal 
mucosa and Gottingen minipigs. European Journal of Pharmaceutical Sciences, 49 (2), 
117–124. 
Holub, M., Tuschl, K., Ratschmann, R., Strnadová, K. A., Mühl, A., Heinze, G., Sperl, 
W., and Bodamer, O. A., 2006. Influence of hematocrit and localisation of punch in dried 
blood spots on levels of amino acids and acylcarnitines measured by tandem mass 
spectrometry. Clinica Chimica Acta, 373 (1–2), 27–31. 
Hoogstraate, J. A. and Boddé, H. E., 1993. Methods for assessing the buccal mucosa 
as a route of drug delivery. Advanced Drug Delivery Reviews, 12 (1–2), 99–125. 
Howes, D., Guy, R., Hadgraft, J., Heylings, J., Hoeck, U., Kemper, F., Maibach, H., 
Marty, J. P., Merk, H., and Parra, J., 1996. Methods for assessing percutaneous 
absorption: the report and recommendations of ECVAM workshop 13. Atla-Alternatives 
to Laboratory Animals, (24), 81–106. 
Huestis, M. a and Cone, E. J., 2004. Relationship of Delta 9-tetrahydrocannabinol 
concentrations in oral fluid and plasma after controlled administration of smoked 
cannabis. Journal of Analytical Toxicology, 28 (6), 394–399. 
References 
 
 338 
Javaid, J. I., Musa, M. N., Fischman, M., Schuster, C. R., and Davis, J. M., 1983. 
Kinetics of cocaine in humans after intravenous and intranasal administration. 
Biopharmaceutics & Drug Disposition, 4 (1), 9–18. 
Jaworska, A., Fornasaro, S., Sergo, V., and Bonifacio, A., 2016. Potential of Surface 
Enhanced Raman Spectroscopy (SERS) in Therapeutic Drug Monitoring (TDM). A 
Critical Review. Biosensors, 6 (3), 1–17. 
Jeffcoat, A. R., Perez-Reyes, M., Hill, J. M., Sadler, B. M., and Cook, C. E., 1989. 
Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), 
or smoking. Drug Metabolism and Disposition, 17 (2), 153–9. 
Jenkins, A. J., Llosa, T., Montoya, I., and Cone, E. J., 1996. Identification and 
quantitation of alkaloids in coca tea. Forensic Science International, 77 (3), 179–189. 
Jenkins, A. J., Oyler, J. M., and Cone, E. dward J., 1995. Comparison of heroin and 
cocaine concentrations in saliva with concentrations in blood and plasma. Journal of 
Analytical Toxicology, 19 (6), 359–74. 
Johnston, A. J., Busch, S., Pardo, L. C., Callear, S. K., Biggin, P. C., and McLain, S. 
E., 2016. On the atomic structure of cocaine in solution. Physical Chemistry Chemical 
Physics, 18 (2), 991–999. 
Jones, G., 2015. 10 Postmortem Toxicology. In: Moffat, A. C., Osselton, M. D., and 
Widdop, B., eds. Clarke’s Analysis of Drugs and Poisons. 176–191. 
 
References 
 
 339 
Jufer, R. A., Walsh, S. L., Cone, E. J., and Sampson-Cone, A., 2006. Effect of repeated 
cocaine administration on detection times in oral fluid and urine. Journal of Analytical 
Toxicology, 30, 458–462. 
Jufer, R. A., Wstadik, A., Walsh, S. L., Levine, B. arry S., and Cone, E. J., 2000. 
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated 
oral administration to human volunteers. Journal of Analytical Toxicology, 24, 467–477. 
Kacinko, S. L., Barnes, A. J., Schwilke, E. W., Cone, E. J., Moolchan, E. T., and 
Huestis, M. A., 2005. Disposition of cocaine and its metabolites in human sweat after 
controlled cocaine administration. Clinical Chemistry, 51 (11), 2085–2094. 
Karch, S. B., Stephens, B., and Ho, C. H., 1998. Relating cocaine blood concentrations 
to toxicity--an autopsy study of 99 cases. Journal of Forensic Sciences, 43 (1), 41–45. 
Kato, K., Hillsgrove, M., Weinhold, L., Gorelick, D. a, Darwin, W. D., and Cone, E. 
J., 1993. Cocaine and metabolite excretion in saliva under stimulated and nonstimulated 
conditions. Journal of Analytical Toxicology, 17 (6), 338–341. 
Kaufman, E. and Lamster, I., 2002. The Diagnostic Applications of Saliva - A Review. 
Critical Reviews in Oral Biology and Medicine, 13 (2), 197–212. 
Kidwell, D. a., Holland, J. C., and Athanaselis, S., 1998. Testing for drugs of abuse in 
saliva and sweat. Journal of Chromatography B: Biomedical Applications, 713 (1), 111–
135. 
 
References 
 
 340 
Kintz, P., Sengler, C., Cirimele, V., and MANGIN, P., 1997. Evidence of crack use by 
anhydroecgonine methylester identification. Human Experimental Toxicology, 16 (2), 
123–127. 
Kiselev, R., Schie, I. W., Aškrabić, S., Krafft, C., and Popp, J., 2016. Design and first 
applications of a flexible Raman micro-spectroscopic system for biological imaging. 
Biomedical Spectroscopy and Imaging, 5, 115–127. 
Kiszka, M., Buszewicz, G., and Madro, R., 2000. Stability of cocaine in phosphate 
buffer and in urine. Problems of Forensic Sciences, XLIV, 7–23. 
Kiszka, M., Buszewicz, G., and Madro, R., 2001. Stability of Cocaine in Blood and in 
Other Tissues. Problems of Forensic Sciences, XLV, 16–35. 
Klingmann, A., Skopp, G., and Aderjan, R., 2001. Analysis of Cocaine, 
Benzoylecgonine Ecgonine Methyl Ester, and Ecgonine by High-Pressure Liquid 
Chromatography-API Mass Spectrometry and Application to a Short-Term Degradation 
Study of Cocaine in Plasma. Journal of Analytical Toxicology, 25 (6), 425–430. 
Koljenović, S., Schut, T. C. B., Wolthuis, R., Vincent, A. J. P. E., Hendriks-Hagevi, 
G., Santos, L., Kros, J. M., and Puppels, G. J., 2007. Raman spectroscopic 
characterization of porcine brain tissue using a single fiber-optic probe. Analytical 
Chemistry, 79 (2), 557-564. 
 
 
References 
 
 341 
Kolli, C. S. and Indiran, P., 2015. Characterization methods for oral mucosal drug 
delivery. In: Rathbone, M. J., Senel, S., and Pather, I., eds. Oral Mucosal Drug Delivery 
and Therapy. Advances in DElivery Science and Technology. Boston, MA: Springer, 
125–148. 
Kong, K., Kendall, C., Stone, N., and Notingher, I., 2015. Raman spectroscopy for 
medical diagnostics - From in-vitro biofluid assays to in-vivo cancer detection. Advanced 
Drug Delivery Reviews, 89, 121–134. 
Kulkarni, U., Mahalingam, R., Pather, I., Li, X., and Jasti, B., 2010. Porcine buccal 
mucosa as in vitro model: Effect of biological and experimental variables. Journal of 
Pharmaceutical Sciences, 99 (3), 1265–1277. 
Laizure, S. C., Mandrell, T., Gades, N. M., and Parker, R. B., 2003. Cocaethylene 
metabolism and interaction with cocaine and ethanol: Role of carboxylesterases. Drug 
Metabolism and Disposition, 31 (1), 16–20. 
Lee, D. and Huestis, M. a., 2014. Current knowledge on cannabinoids in oral fluid. 
Drug Testing and Analysis, 6 (1–2), 88–111. 
Lee, D., Milman, G., Schwope, D. M., Barnes, A. J., Gorelick, D. A., and Huestis, M. 
A., 2012. Cannabinoid Stability in Authentic Oral Fluid after Controlled Cannabis 
Smoking. Clinical Chemistry, 58 (7). 
Lee, P. C. and Meisel, D., 1982. Adsorption and surface-enhanced Raman of dyes on 
silver and gold sols. Journal of Physical Chemistry, 86, 3391–3395. 
References 
 
 342 
Lenander-Lumikari, M., Laurikainen, K., Kuusisto, P., and Vilja, P., 1998. Stimulated 
salivary flow rate and composition in asthmatic and non-asthmatic adults. Archives of 
Oral Biology, 43, 151–156.  
Lewis, R. J., Johnson, R. D., Angier, M. K., and Ritter, R. M., 2004. Determination of 
cocaine, its metabolites, pyrolysis products, and ethanol adducts in postmortem fluids and 
tissues using Zymark automated solid-phase extraction and gas chromatography-mass 
spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical 
and Life Sciences, 806 (2), 141–150. 
Li, X., Yang, T., and Lin, J., 2012. Spectral analysis of human saliva for detection of 
lung cancer using surface-enhanced Raman spectroscopy. Journal of Biomedical Optics, 
17, 1–5. 
Litti, L., Amendola, V., Toffoli, G., and Meneghetti, M., 2016. Detection of low-
quantity anticancer drugs by surface-enhanced Raman scattering. Analytical and 
Bioanalytical Chemistry, 408 (8), 2123–2131. 
Lizasoain, I., Moro, M. A., and Lorenzo, P., 2002. Cocaina: Aspectos farmacologicos. 
Adicciones, 13 (2), 37–45. 
Loren, A., Engelbrektsson, J., Eliasson, C., Josefson, M., Abrahamsson, J., Johansson, 
M., and Abrahamsson, K., 2004. Internal Standard in Surface-Enhanced Raman 
Spectroscopy. Analytical Chemistry, 76 (24), 7391–7395. 
Mack, A. E. and Long, W. J., 2010. Fast Analysis of Illicit Drug Residues on Currency 
using Agilent Poroshell 120. Wilminton, USA: Agilent Technologies Inc., 1-10. 
References 
 
 343 
Madhav, N. V. S., Shakya, A. K., Shakya, P., and Singh, K., 2009. Orotransmucosal 
drug delivery systems: A review. Journal of Controlled Release, 140 (1), 2–11. 
Mali, N., Karpe, M., and Kadam, V., 2011. A review on biological matrices and 
analytical methods used for determination of drug of abuse. Journal of Applied 
Pharmaceutical Science, 1 (06), 58–65. 
Manoharan, R., Wang, Y., and Feld, M. S., 1996. Histochemical analysis of biological 
tissues using Raman spectroscopy. Spectrochimica Acta Part A: Molecular and 
Biomolecular Spectroscopy, 52 (2), 215–249. 
Mascolo, M. C., Pei, Y., and Ring, T. A., 2013. Room Temperature Co-Precipitation 
Synthesis of Magnetite Nanoparticles in a Large pH Window with Different Bases. 
Materials (Basel, Switzerland), 6 (12), 5549–5567. 
Matthäus, C., Kale, A., Chernenko, T., Torchilin, V., and Diem, M., 2008. New ways 
of imaging uptake and intracellular fate of liposomal drug carrier systems inside 
individual cells, based on Raman microscopy. Molecular Pharmaceutics, 5, 287–293. 
Matuszewski, B. K., Constanzer, M. L., and Chavez-Eng, C. M., 2003. Strategies for 
the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-
MS/MS. Analytical chemistry, 75 (13), 3019–30. 
Mayersohn, M. and Perrier, D., 1978. Kinetics of pharmacologic response to cocaine. 
Research Communications in Chemical Pathology and Pharmacology, 22 (3), 465–74. 
 
References 
 
 344 
Mazor, S. S., Mycyk, M. B., Wills, B. K., Brace, L. D., Gussow, L., and Erickson, T., 
2006. Coca tea consumption causes positive urine cocaine assay. European Journal of 
Emergency Medicine, 13 (13). 
McCurdy, H. H., Callahan, L. S., and Williams, R. D., 1989. Studies on the stability 
and detection of cocaine, benzoylecgonine, and 11-nor-delta-9-tetrahydrocannabinol-9-
carboxylic acid in whole blood using Abuscreen radioimmunoassay. Journal of Forensic 
Sciences, 34 (4), 858–70. 
Michaud, C. L. and Foran, D. R., 2011. Simplified field preservation of tissues for 
subsequent DNA analyses. Journal of Forensic Sciences, 56 (4), 846–852. 
Mie, G., 1908. Beiträge zur Optik trüber Medien, speziell kolloidaler Metallösungen. 
Annalen der Physik Leipzig, (25), 377–445. 
Miljković, M., Chernenko, T., Romeo, M. J., Bird, B., Matthäus, C., and Diem, M., 
2010. Label-free imaging of human cells: algorithms for image reconstruction of Raman 
hyperspectral datasets. The Analyst, 135 (8), 2002–13. 
Ministerio de Sanidad y Consumo, 2007. Cocaína: Informes de la Comisión Clínica. 
Madrid: Ministerio de Sanidad y Consumo Centro de Publicaciones, 1-124. 
Moffat, A., Osselton, D., Widdop, B., and Watts, J., 2011. Volume 2. In: Clarke’s 
Analysis of Drugs and Poisons. London: Pharmaceutical Press, 1152–1155. 
 
References 
 
 345 
Mohammad, M. S., Pin, L. M., Kathawala, M. H., Pratheepan, S., Saini, N. B., Mansor,  
maimanah B., and Xue, C., 2010. Triangular Core-Shell Structure Ag @ AgAu. 
Photonics Global Conference (PGC), 1–3. 
Moore, C. and Lewis, D., 2003. Comment on oral fluid testing for drugs of abuse: 
positive prevalence rates by Intercept immunoassay screening and GC-MS-MS 
confirmation and suggested cutoff concentrations. Journal of Analytical Toxicology, 26, 
561–546. 
Moore, J. M., Casale, J. F., Klein, R. F. X., Cooper, D. A., and Lydon, J., 1994. 
Determination and in-depth chromatographic analyses of alkaloids in South American 
and greenhouse-cultivated coca leaves. Journal of Chromatography A, 659 (1), 163–175. 
Moriya, F. and Hashimoto, Y., 1996. Postmortem stability of cocaine and cocaethylene 
in blood and tissues of humans and rabbits. Journal of Forensic Sciences, 41 (4), 612–6. 
Mosier-Boss, P. A., 2017. Review of SERS Substrates for Chemical Sensing. 
Nanomaterials, 7 (6), 1–30. 
Movasaghi, Z., Rehman, S., and Rehman, I. U., 2007. Raman Spectroscopy of 
Biological Tissues. Applied Spectroscopy Reviews, 42, 493–541. 
Naumova, E. a, Dierkes, T., Sprang, J., and Arnold, W. H., 2013. The oral mucosal 
surface and blood vessels. Head & Face Medicine, 9 (8), 1–5. 
 
References 
 
 346 
Nguyen, B. H., Nguyen, V. H., and Tran, H. N., 2016. Rich variety of substrates for 
surface enhanced Raman spectroscopy. Advances in Natural Sciences: Nanoscience and 
Nanotechnology, 7 (3), 033001-11. 
Nicolazzo, J. and Finnin, B., 2008. In vivo and in vitro models for assessing drug 
absorption across the buccal mucosa. Drug Absorption Studies, 89–111. 
Nielsen, H. M., 2002. In vitro models of the human buccal epithelium: the TR146 cell 
culture model and the porcine in vitro model. In: Lehr, C., ed., Cell Culture Models of 
Biological Barriers. London: Taylor & Francis, 310–326. 
Osselton, M. D., 2012. Personal comunication. 
Othman, A. A., Syed, S. A., Newman, A. H., and Eddington, N. D., 2007. Transport, 
metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, 
a class of compounds extensively evaluated in animal models of drug abuse. The Journal 
of Pharmacology and Experimental Therapeutics, 320 (1), 344–353. 
Particle Sciences, 2009. Mass Spectrometry in Bioanalysis [online]. Technical Brief. 
Available from: http://www.particlesciences.com/docs/technical_briefs/TB_4.pdf. 
Patel, V. F., Liu, F., and Brown, M. B., 2012. Modeling the oral cavity: In vitro and in 
vivo evaluations of buccal drug delivery systems. Journal of Controlled Release, 161 (3), 
746–756. 
Pather, S. I., Rathbone, M. J., and Şenel, S., 2008. Current status and the future of 
buccal drug delivery systems. Expert Opinion on Drug Delivery, 5 (5), 531–542. 
References 
 
 347 
Penny, M. E., Zavaleta, A., Lemay, M., Liria, M. R., Huaylinas, M. L., Alminger, M., 
Mcchesney, J., Alcaraz, F., and Reddy, B. M., 2009. Can Coca leaves contribute to 
improving the nutritional status of the Andean population? Food and Nutrition Bulletin, 
30 (3), 205–216. 
Pereira da Silva, C., Soares Emídio, E., and Rodrigues de Marchi, M. R., 2015. Method 
validation using weighted linear regression models for quantification of UV filters in 
water samples. Talanta, 131, 221–227. 
PermeGear Inc., 2014. Diffusion Testing Fundamentals [online]. Available from: 
www.Permegear.Com. 
Pindel, E. V, Kedishvili, N. Y., Abraham, T. L., Brzezinski, M. R., Zhang, J., Dean, 
R. A., and Bosron, W. F., 1997. Purification and cloning of a broad substrate specificity 
human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. The 
Journal of Biological Chemistry, 272 (23), 14769–75. 
Plowman, T., 1979. Botanical perspectives on Coca. Journal of Psychedelic Drugs, 11 
(1–2), 103–116. 
Poklis, A., Maginn, D., and Barr, J. L., 1987. Tissue disposition of cocaine in man: A 
report of five fatal poisonings. Forensic Science International, 33 (2), 83–88. 
Poon, S., Gareri, J., Walasek, P., and Koren, G., 2014. Norcocaine in human hair as a 
biomarker of heavy cocaine use in a high risk population. Forensic Science International, 
241, 150–154. 
References 
 
 348 
Radzol, A. R. M., Lee, Y. K., Mansor, W., and Yahaya, S. R., 2012. Surface-Enhanced 
Raman Spectral Analysis of Substrates for Salivary based Disease Detection. IEEE 8th 
International Colloquium on Signal Processing and its Applications Surface-Enhanced, 
505–509. 
Rees, K. A., 2011. The Distribution of Opiates , Cocaine and their Metabolites in 
Skeletal Muscle Tissue and Vitreous Humour as an Aid to Post-mortem Toxicological 
Interpretation. Bournemouth University. 
Rees, K. A., McLaughlin, P. A., and David Osselton, M., 2012. Validation of a gas 
chromatography-ion trap-tandem mass spectrometry assay for the simultaneous 
quantification of cocaine, benzoylecgonine, cocaethylene, morphine, codeine, and 6-
acetylmorphine in aqueous solution, blood, and skeletal muscle tissue. Journal of 
Analytical Toxicology, 36, 1–11. 
Reichardt, E. M., 2014. Validation of Oral Fluid as a Matrix for Drug Detection, 
Chapter 4 - Concentrations of cocaine, benzoylecgoniine and ecgonine methyl ester in 
oral fluid following the consumption of coca tea., Chapter 7 – Development of an 
immunohistochemical method for the visualisation of cocaine and heroin in tissues with 
a benzoylecgonine or morphine antibody, Chapter 8 – In vitro investigation of 
concentrations of cocaine and heroin in porcine tongue tissue. Thesis (PhD) Bournemouth 
University. 
Rohn, G. and Gamble, B., 2016. Salivary glands [online]. Otolaryngology Specialist 
of North Texas. Available from: http://entkidsadults.com/minimally-invasive-salivary-
gland-surgery-dr-rohn-dr-gamble/ [Accessed 15 Apr 2019]. 
References 
 
 349 
Rubio, C., Strano-Rossi, S., Tabernero, M. J., Anzillotti, L., Chiarotti, M., and 
Bermejo,  a. M., 2013. Hygrine and cuscohygrine as possible markers to distinguish coca 
chewing from cocaine abuse in workplace drug testing. Forensic Science International, 
227 (1–3), 60–63. 
Rubio, C., Strano-Rossi, S., Tabernero, M. J., Gonzalez, J., Anzillotti, L., Chiarotti, 
M., and Bermejo,  a. M., 2014. Application of hygrine and cuscohygrine as possible 
markers to distinguish coca chewing from cocaine abuse on WDT and forensic. Forensic 
Science International, 243, 30–34. 
Rubio, N. C., Hastedt, M., Gonzalez, J., and Pragst, F., 2015. Possibilities for 
discrimination between chewing of coca leaves and abuse of cocaine by hair analysis 
including hygrine, cuscohygrine, cinnamoylcocaine and cocaine metabolite/cocaine 
ratios. International Journal of Legal Medicine, 129 (1), 69–84. 
Rubio, N. C., Thurmann, D., Krumbiegel, F., and Pragst, F., 2016. Behaviour of 
hygrine and cuscohygrine in illicit cocaine production establishes their use as markers for 
chewing coca leaves in contrast with cocaine abuse. Drug Testing and Analysis, 18–21. 
Saha, A., Barman, I., Dingari, N. C., Galindo, L. H., Sattar, A., Liu, W., Plecha, D., 
Klein, N., Dasari, R. R., and Fitzmaurice, M., 2012. Precision of Raman spectroscopy 
measurements in detection of microcalcifications in breast needle biopsies. Analytical 
Chemistry, 84 (15), 6715–22. 
 
 
References 
 
 350 
Salehi, M., Steinigeweg, D., Ströbel, P., Marx, A., Packeisen, J., and Schlücker, S., 
2013. Rapid immuno-SERS microscopy for tissue imaging with single-nanoparticle 
sensitivity. Journal of Biophotonics, 6 (10), 785–792. 
Salerno, C., Carlucci, A. M., and Bregni, C., 2010. Study of in vitro drug release and 
percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech, 
11 (2), 986–93. 
Scheidweiler, K. B., Kolbrich Spargo, E. A., Kelly, T. L., Cone, E. J., Barnes, A. J., 
and Marilyn A. Huestis, 2010. Pharmacokinetics of Cocaine and Metabolites in Human 
Oral Fluid and Correlation with Plasma Concentrations following Controlled 
Administration. Therapeutic Drug Monitoring, 32 (5), 628–637. 
Schlücker, S., 2014. Surface-enhanced raman spectroscopy: Concepts and chemical 
applications. Angewandte Chemie - International Edition, 53 (19), 4756–4795. 
Schramm, W., Smith, R. H., Craig, P. A., and Kidwell, D. A., 1992. Drugs of abuse in 
saliva: a review. Journal of Analytical Toxicology, 16 (1), 1–9. 
SERVINDI, 2018. Perú: Primera exportación de mate de coca tendrá como destino 
Sudáfrica | Servindi - Servicios de Comunicación Intercultural [online]. Available from: 
https://www.servindi.org/actualidad/278 [Accessed 15 Apr 2019]. 
Sharma, B., Frontiera, R. R., Henry, A.-I., Ringe, E., and Van Duyne, R. P., 2012. 
SERS: Materials, applications, and the future. Materials Today, 15 (1–2), 16–25. 
 
References 
351 
Sheena Mary, Y., Raju, K., Ertan Bolelli, T., Yildiz, I., Nogueira, H. I. S., Granadeiro, 
C. M., and Alseony, C. Van, 2012. FT-IR, FT-Raman, surface enhanced Raman scattering
and computational study of 2-(p-fluorobenzyl)-6-nitrobenzoxazole. Journal of Molecular 
Structure, 1012, 22–30. 
Shrestha, N., Araújo, F., Sarmento, B., Hirvonen, J., and Santos, H. A., 2015. Cell-
based in vitro models for buccal permeability studies. In: Sarmento, B., ed. Concepts and 
Models for Drug Permeability Studies: Cell and Tissue based In Vitro Culture Models. 
Woodhead Publishing, 31–40. 
Simon, G. A. and Maibach, H. I., 2000. The pig as an experimental animal model of 
percutaneous permeation in man: qualitative and quantitative observations. An overview. 
Skin Phatmacology and Applied Skin Physiology, 13 (5), 229–234. 
Singh, S., Singh Kamal, S., Sharma, A., Kaur, D., Kumar Katual, M., and Kumar, R., 
2017. Formulation and In-Vitro Evaluation of Solid Lipid Nanoparticles Containing 
Levosulpiride. The Open Nanomedicine Journal, 04 (17), 17–29. 
Sjögren, E., Abrahamsson, B., Augustijns, P., Becker, D., Bolger, M. B., Brewster, 
M., Brouwers, J., Flanagan, T., Harwood, M., Heinen, C., Holm, R., Juretschke, H. P., 
Kubbinga, M., Lindahl, A., Lukacova, V., Münster, U., Neuhoff, S., Nguyen, M. A., Peer, 
A. Van, Reppas, C., Hodjegan, A. R., Tannergren, C., Weitschies, W., Wilson, C., Zane,
P., Lennernäs, H., and Langguth, P., 2014. In vivo methods for drug absorption - 
Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), 
and applications for formulation/API/excipient characterization including food effects. 
European Journal of Pharmaceutical Sciences, 57 (1), 99–151. 
References 
 
 352 
Sohi, H., Ahuja, A., Ahmad, F. J., and Khar, R. K., 2010. Critical evaluation of 
permeation enhancers for oral mucosal drug delivery. Drug development and Industrial 
Pharmacy, 36 (3), 254–82. 
Sonis, S. T., 2004. The pathobiology of mucositis. Nature Reviews Cancer, 4 (4), 277–
284. 
Spiehler, V. and Cooper, G., 2008. Drugs-of-Abuse Testing in Saliva or Oral Fluid. 
In: Jenkins, A. J., ed. Drug Testing in Alternate Biological Specimens. Humana Press, 
83–99. 
Spiehler, V. R. and Reed, D., 1985. Brain concentrations of cocaine and 
benzoylecgonine in fatal cases. Journal of Forensic Sciences, 30 (4), 1003–1011. 
Spiehler, V., 2011. Drugs in saliva. In: Moffat, A.C., Osselton, M.D., Widdop, B., ed. 
Clarke’s Analysis of Drugs and Poisons. London: Pharmaceutical Press, 308–322. 
Squier, C. a and Kremer, M. J., 2001. Biology of oral mucosa and esophagus. Journal 
of the National Cancer Institute. Monographs, 52242, 7–15. 
Squier, C. A., 1991. The permeability of oral mucosa. Critical reviews in oral biology 
and medicine : an official publication of the American Association of Oral Biologists, 2 
(1), 13–32. 
Squier, C. A., Cox, P., and Wertz, P. W., 1996. Structure and function of the oral 
mucosa and implications for drug delivery. In: Rathbone, M. J., ed. Oral Mucosal Drug 
Delivery. New york: Marcel Dekker, 1–26. 
References 
 
 353 
Steffansen, B., Nielsen, C. U., and Brodin, B., 2010. Physicochemical characterisation 
of drug candidates. In: Steffansen, B., Brodin, B., and Nielsen, C. U., eds. Molecular 
biopharmaceutics : Aspects of drug characterisation, drug delivery, and dosage form 
evaluation. Pharmaceutical Press, 5–35. 
Strano-Rossi, S., Colamonici, C., and Botrè, F., 2008. Parallel analysis of stimulants 
in saliva and urine by gas chromatography/mass spectrometry: Perspectives for ‘in 
competition’ anti-doping analysis. Analytica Chimica Acta, 606 (2), 217–222. 
Strano-Rossi, S., Leone, D., de la Torre, X., and Botrè, F., 2010. Analysis of stimulants 
in oral fluid and urine by gas chromatography-mass spectrometry II: pseudophedrine. 
Journal of Analytical Toxicology, 34, 210–215. 
Scientific Working Group for Forensic Toxicology (SWGTOX), 2013. Standard 
Practices for Method Validation in Forensic Toxicology. Journal of Analytical 
Toxicology, 37 (7), 452–474. 
Synytsya, A., Judexova, M., Hoskovec, D., Miskovicova, M., and Petruzelka, L., 2014. 
Raman spectroscopy at different excitation wavelengths (1064, 785 and 532 nm) as a tool 
for diagnosis of colon cancer. Journal of Raman Spectroscopy, 45 (10), 903–911. 
Teksin, Z. S., Seo, P. R., and Polli, J. E., 2010. Comparison of drug permeabilities and 
BCS classification: three lipid-component PAMPA system method versus Caco-2 
monolayers. The AAPS journal, 12 (2), 238–41. 
Terms, F., 1990. Cocaine smokers excrete a pyrolysis product, anhydroecgonine 
methyl ester. Journal of Toxicology: Clinical Toxicology, 28 (1), 121–125. 
References 
 
 354 
The United States Pharmacopeia. 2011. USP General Chapter 1120, Raman 
spectrometry. The United States Pharmacopeial Convention, Inc., Rockville, MA, US 29. 
Available from: 
https://www.drugfuture.com/pharmacopoeia/usp32/pub/data/v32270/usp32nf27s0_c112
0.html. [Accessed 26 Jan 2019]. 
Thomson, G., 2002. Forensic Applications of Raman Spectroscopy. Thesis (PhD). The 
University of Leeds. 
Toennes, S. W., Steinmeyer, S., Maurer, H.-J., Moeller, M. R., and Kauert, G. F., 2005. 
Screening for drugs of abuse in oral fluid - Correlation of analysis results with serum in 
forensic cases. Journal of Analytical Toxicology, 29, 22–27. 
Tolle-Sander, S., Grill, A., Joshi, H., Kapil, R., Persiani, S., and Polli, J. E., 2003. 
Characterization of Dexloxiglumide in vitro Biopharmaceutical Properties and Active 
Transport. Journal of Pharmaceutical Sciences, 92 (10), 1968–1980. 
Transnational Institute, 2017. Absolución en un caso judicial de hoja de coca en 
España [online]. Available from: https://www.tni.org/es/artículo/absolucion-en-un-caso-
judicial-de-hoja-de-coca-en-espana [Accessed 15 Apr 2019]. 
Trapping, L. and Sorting, C., 2015. Current Uses of Raman Microscopy in Biomedical 
Studies. Spectroscopy, 11, 1–6. 
Tsai, T. H., 2003. Assaying protein unbound drugs using microdialysis techniques. 
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life 
Sciences, 797 (1–2), 161–173. 
References 
355 
Tucker, I. G., 1988. A Method to study the Kinetics of Oral Mucosal Drug Absorption 
from Solutions. Journal of Pharmacy and Pharmacology, 40 (10), 679–683. 
Tunblad, K., Ederoth, P., Gardenfors, A., Hammarlund-Udenaes, M., and Nordstrom, 
C. H., 2004. Altered brain exposure of morpfine in experimental meningitis studied with
microdialysis. Acta Anaesthesiol Scand, 48, 294–301. 
Turrell, G. and Corset, J., 1996. Raman microscopy - developments and applications. 
San Diego: Academic Press, 1–463. 
United Nations Office on Drugs and Crime (UNODC), 2017. Executive Summary 
Conclusions and Policy Implications. In: World Drug Report 2017 [Online]. Available 
from: https://www.unodc.org/wdr2017/field/Booklet_1_EXSUM.pdf [Accessed 15 Apr 
2019]. 
Valente, M. J., Carvalho, F., Bastos, M. L., Carvalho, M., and de Pinho, P. G., 2010. 
Development and validation of a gas chromatography/ion trap-mass spectrometry method 
for simultaneous quantification of cocaine and its metabolites benzoylecgonine and 
norcocaine: Application to the study of cocaine metabolism in human primary cultured 
re. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life 
Sciences, 878, 3083–3088. 
van der Bijl, P. and van Eyk, A. D., 2003. Comparative in vitro permeability of human 
vaginal, small intestinal and colonic mucosa. International Journal of Pharmaceutics, 
261 (1–2), 147–52. 
References 
 
 356 
Ventura, M., Pichini, S., Ventura, R., Leal, S., Zuccaro, P., Pacifici, R., and de la Torre, 
R., 2009. Stability of Drugs of Abuse in Oral Fluid Collection Devices With Purpose of 
External Quality Assessment Schemes. Therapeutic Drug Monitoring, 31 (2), 277–280. 
Veuillez, F., Falson Rieg, F., Guy, R. H., Deshusses, J., and Buri, P., 2002. Permeation 
of a myristoylated dipeptide across the buccal mucosa: topological distribution and 
evaluation of tissue integrity. International Journal of Pharmaceutics, 231, 1–9. 
Vibhooti, P. and Preeti, K., 2018. A newer approach to smart drug delivery system. 
PharmaTutor [online]. Available from: https://www.pharmatutor.org/articles/wafers-
technology-newer-approacah-smart-drug-dilevery-system [Accessed 15 Apr 2019]. 
Vindenes, V., Lund, H. M. E., Andresen, W., Gjerde, H., Ikdahl, S. E., Christophersen, 
A. S., and Øiestad, E. L., 2012. Detection of drugs of abuse in simultaneously collected 
oral fluid, urine and blood from Norwegian drug drivers. Forensic Science International, 
219, 165–171. 
Wang, H., Guo, X., Fu, S., Yang, T., Wen, Y., and Yang, H., 2015. Optimized core–
shell Au@Ag nanoparticles for label-free Raman determination of trace Rhodamine B 
with cancer risk in food product. Food Chemistry, (188), 137–142. 
Wang, J. F., Wu, X. Z., Xiao, R., Dong, P. T., and Wang, C. G., 2014. Performance-
Enhancing Methods for Au Film over Nanosphere Surface-Enhanced Raman Scattering 
Substrate and Melamine Detection Application. PLOS ONE, 9 (6), e97976. 
References 
 
 357 
Warner, A. and Norman, A. B., 2000. Mechanisms of cocaine hydrolysis and 
metabolism in vitro and in vivo: a clarification. Therapeutic Drug Monitoring, 22 (3), 
266–70. 
Wille, S. M. R., Raes, E., Lillsunde, P., Gunnar, T., Laloup, M., Samyn, N., 
Christophersen, A. S., Moeller, M. R., Hammer, K. P., and Verstraete, A. G., 2009. 
Relationship between oral fluid and blood concentrations of drugs of abuse in drivers 
suspected of driving under the influence of drugs. Therapeutic Drug Monitoring, 31 (4), 
511–519. 
Wilkinson, P., Van Dyke, C., Jatlow, P., Barash, P., and Byck, R., 1980. Intranasal 
and oral cocaine kinetics. Clinical Pharmacology and Therapeutics, 27 (3), 386–394. 
Williams, D. and Sebastine, I., 2005. Tissue engineering and regenerative medicine: 
manufacturing challenges. IEEE Proceedings of Nanobiotechnology, 152 (6), 207–211. 
Williams, D., 2015. Measuring & Characterizing Nanoparticle Size – TEM vs SEM 
[online]. Available from: http://www.azonano.com/article.aspx?ArticleID=4118 P 
[Accessed 15 Apr 2019]. 
Wolff, K., Agombar, R., Clatworthy, A., Cowan, D., Forrest, R., Osselton, D., Scott-
Ham, M., and Johnston, A., 2017. Expert panel review of alternative biological matrices 
for use as an evidential sample for drug driving. Goverment UK, Reference RM4825 SB-
2988 [online]. Available from: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment
_data/file/624915/expert-panel-report.pdf. [Accessed 15 Apr 2019]. 
References 
 
 358 
Wolff, K., Brimblecombe, R., Forfar, J. C., Forrest, A. R., Gilvarry, E., Taylor, D., 
Johnston, A., Morgan, J., Osselton, M. D., and Read, L., 2013. Driving under the 
influence of Drugs. Report from the expert panel on drug driving. Government UK 
[Online]. Available from: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment
_data/file/167971/drug-driving-expert-panel-report.pdf. [Accessed 15 Apr 2019]. 
Wrona, M., Salafranca, J., and Nerín, C., 2017. Fast assessment of oxo-biodegradable 
polyethylene film oxidation by surface-enhanced Raman scattering with in situ formation 
of a silver nanoparticle substrate. Journal of Materials Chemistry C, 5 (2), 463–469. 
Wrona, M., Salafranca, J., Rocchia, M., and Nerín, C., 2015. Application of SERS to 
the Determination of Butylated Hydroxyanisole in Edible and Essential Oils. 
Spectroscopy, 30 (7), 40–45. 
Wu, K. P., Ke, J.-Y., Chung, C.-Y., Chen, C.-L., Hwang, T.-L., Chou, M.-Y., Wong, 
A. M. K., Hu, C.-F., and Lee, Y.-C., 2008. Relationship between unstimulated salivary 
flow rate and saliva composition of healthy children in Taiwan. Chang Gung Medical 
Journal, 31, 281–286. 
Yang, J., Deol, G., and Myangar, N., 2011. Retention of o-cymen-5-ol and zinc on 
reconstructed human gingival tissue from a toothpaste formulation. International Dental 
Journal, 61 (Suppl. 3), 41–45. 
Yang, T., Guo, X., Wang, H., Fu, S., Wen, Y., and Yang, H., 2015. Magnetically 
optimized SERS assay for rapid detection of trace drug- related biomarkers in saliva and 
fingerprint. Biosensors and Bioelectronics, 68, 350–357. 
References 
359 
Yang, T., Guo, X., Wang, H., Fu, S., Yu, J., Wen, Y., and Yang, H., 2014. Au dotted 
magnetic network nanostructure and its application for on-site monitoring femtomolar 
level pesticide. Small, 10 (7), 1325–31. 
Yoshizawa, J. M., Schafer, C. A., Schafer, J. J., Farrell, J. J., Paster, B. J., and Wong, 
D. T. W., 2013. Salivary biomarkers: Toward future clinical and diagnostic utilities.
Clinical Microbiology Reviews, 26 (4), 781–791. 
Yu, W. W. and White, I. M., 2013. Chromatographic separation and detection of target 
analytes from complex samples using inkjet printed SERS substrates. The Analyst, 138 
(13), 3679. 
Zavaleta, A., 2015. Mito 1 Verdades y Mitos de la Coca y la alimentación y nutrición 
humana [Online]. Available from: 
http://www.cedro.org.pe/simposio/Ponencia_Alfonso%20Zavaleta.pdf. [Accessed 15 
Apr 2019]. 
Zhang, H., Prisinzano, T. E., and Donovan, M. D., 2012. Permeation and metabolism 
of cocaine in the nasal mucosa. European Journal of Drug Metabolism and 
Pharmacokinetics, 37 (4), 255–262. 
Zhang, H., Zhang, J., and Streisand, J. B., 2002. Oral Mucosal Drug Delivery Clinical 
Pharmacokinetics and Therapeutic Applications. Clinical Pharmacokinetic, 41 (9), 661–
680.
References 
 
 360 
 
 
 
 
 
 
Page intentionally left blank 
Appendices 
 361 
 
APPENDIX A – Protocol for Synthetic Oral Fluid Preparation 
 
 
Table 1. Protocol for the preparation of one litre of synthetic oral fluid (Cozart Bioscience 
2008) 
Materials Quantity Supplier 
De-ionised water 800 mL Fisher Scientific 
Di-sodium hydrogen 
orthophosphate anhydrous 
2.30 g BDH 
Potassium dihydrogen 
orthophosphate 
0.40 g BDH 
Sodium chloride 8.77 g BDH 
Bovine Serum Albumin (BSA) (1.0 
% w/v) 
3.00 g Sigma - Aldrich 
Glucose 0.01 g Fisher Scientific 
Mucin 0.50 g Sigma - Aldrich 
Amylase Type II - A 0.25 g Sigma - Aldrich 
Sodium azide (0.05 %) 0.50 g BDH 
5-Bromo-5-Nitro-1,3 Dioxane 0.10 g 
Sigma - Aldrich 
 
Polyvinyl Alcohol 4.50 g Sigma - Aldrich 
De-ionised water Make up to 1000 mL  Fisher Scientific 
Preparation instructions: 
 
1. Add the above ingredients but allow the BSA to dissolve before adding 
additional ingredients 
2. Mix on a magnetic stirrer until the PVA has dissolved 
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APPENDIX B – Results of peak identification using Raman 
spectroscopy  
 
Table 1. Identification of functional groups obtained from Raman spectra of cocaine 
using the portable iRaman spectrometer equipped with 785 nm laser power. 
Raman shift (cm-1) Assignment 
Coc1 S22 S2+OF3 S2+Coc4 S45 
S4+OF
6 
S4+
Coc7 
S58 
S5+OF
9 
S5 + 
Coc10 
Functional group / 
Compounds 
 413 413 413  393 393    cholesterol 
  530 522 517 520 522    
S-S disulfide stretching 
from proteins 
  637-689 617-687   617   613 
C-C twist aromatic ring 
from proteins 
618 689         (–C–C–) stretch 
784  728 775  727 717   790 
(–C–C–) stretch. 
Symmetric breathing of 
tryptophan (protein 
assignment) 
824   887  890 
860-
887 
   Tropine ring stretch 
868 891   858     895 (–C–C–) stretch 
896 943 914        
Aromatic ring breathing 
mode 
998   1000   1000   1000 
Phenyl aromatic ring 
breathing mode 
1079 1093 
1026-
1089 
1026-
1093 
 1049 1049    
ν(PO2-), ν(CN),  ν(CC) 
Nucleic acids, lipids, 
proteins 
1158 1192 1121 1121  1123 1141   1164 
Amide III (β sheet 
structure). Ν(PO2-), 
nucleic acids. Cellular 
nucleic acids, a 
concentred ring mode 
proteins, including 
collagen. 
1273 1233 1207 1215 
1127
-
1404 
1221 1247   1258 
CH2 bending mode of 
proteins, lipids and 
aliphatic aminoacicds 
 1346 1346 1346        
1452 1406 1450 1452  1474 1478   1445 
C-C stretching. δ(C=C), 
phenylalanine, Oxy-Mb 
(haeme core) 
1596 1540 
1540-
1589 
1540-
1596 
1567
-
1600 
1569 1571   1554 
Aromatic ring (–C=C–) 
stretch and amide I from 
proteins 
1713   1716   1716    
Esters, C=O stretching 
(lipids, tropine ring, 
symmetric and 
asymmetric phenyl ring 
mode) 
Coc: Cocaine hydrochloride (solid), S2: Substrate 2, S2+OF: Substrate 2 with OF, S2+Coc: Substrate 2 
with solution of Coc in OF at 20 mg/mL, S4: Substrate 4, S4+OF: Substrate 4 with OF, S4+Coc: Substrate 
4 with solution of Coc in OF at 20 mg/mL, S5: Substrate 5, S5+OF: Substrate 5 with OF, S5+Coc: Substrate 
5 with solution of Coc in OF at 20 mg/mL. 
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Table 2. Identification of functional groups obtained from Raman spectra using the 
Themo Scientific DXR Raman microscope equipped with 532 nm and 785 nm laser 
power. 
Raman shift (cm-1) Assignment 
Cocaine 
Free 
base 
532 nm 780 nm 
Functional group / Compounds 
CT1 ET2 CT1 ET2
747 748 
Symmetric breathing of tryptophan (protein 
assignment), Mb  (porphyrin core) 
788 Piperidine ring (–C–C–) stretch 
847 Tropine ring stretch 
872 Pyrrolidine ring (–C–C–) stretch 
896 Aromatic ring breathing mode 
1003 1002 1003 Aromatic ring breathing mode from tropine 
1121 1125 1122 
Amide III, Ν(PO2-), nucleic acids. Cellular nucleic 
acids, ring mode proteins, including collagen. 
1298 1309 1294 CH2 Lipids, protein (aliphatic amino acids) 
1439 
1310-
1443 
1439 
1340, 
1450 
CH2 bending mode of proteins & lipids 
δ as (CH3) δ(CH2) of proteins. CH2CH3 deformation 
1580 1583 
C-C stretching. δ(C=C), phenylalanine, Oxy-Mb
(haeme core)
1601 Aromatic ring (–C=C–) stretch 
1638 
Differences in collagen content. Amide I protein 
band 
1655 1644 1657 1657 
(C=C) Amide I/protein amide I absorption lipid
(C=C stretch) 
1713 1744 1709 Esters, C=O stretching (lipids) 
CT: Control tissue, ET: Tissue containing cocaine 
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APPENDIX C – Validation of LC-MS methods for the quantitation of 
cocaine and cocaine derivatives in synthetic oral fluid, 
buffered oral fluid and porcine oral mucosa 
 
 
 SOF TISSUE 
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AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, SOF: Synthetic oral fluid. 
 
Figure 1. Calibration lines obtained for cocaine and cocaine derivatives in synthetic 
oral fluid and homogenised porcine oral tissue.
Appendices 
365 
BOF 
A
E
M
E
 
C
E
 
B
Z
E
 
N
C
 
C
O
C
 
E
M
E
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Figure 2. Calibration lines obtained for cocaine and cocaine derivatives in buffered oral 
fluid. 
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Table 5. Stability data of AEME, EME, BZE, CE and NC in buffered oral fluid stored at 
room temperature 
LOW MED HIGH 
N = 3 DAY 
Mean 
(ng/mL) 
%RSD 
Mean 
(ng/mL) 
%RSD 
Mean 
(ng/mL) 
%RSD 
A
E
M
E
 
0 4.4 3.4 47.5 3.4 189.9 3.4 
1 5.3 2.1 49.4 1.5 192.4 1.6 
4 4.7 4.1 50.0 5.0 198.5 2.5 
8 4.7 4.9 47.9 2.9 193.0 2.6 
11 5.1 14.8 47.9 8.9 205.7 1.1 
15 6.1 2.8 54.6 5.7 211.6 7.4 
30 5.4 7.1 51.4 2.2 197.0 4.7 
60 5.6 10.1 47.7 1.6 182.7 3.8 
E
M
E
 
0 81.3 10.0 1037.9 10.0 3870.6 10.0 
1 71.5 5.1 859.7 15.1 2612.8 3.6 
4 14.9 7.9 165.0 10.2 842.1 13.4 
8 49.1 18.2 634.2 17.2 2303.8 15.7 
11 40.0 22.8 470.7 16.1 2251.6 2.1 
15 34.6 37.7 432.4 8.6 2214.0 32.5 
30 4.1 173.2 66.5 54.5 248.0 43.4 
60 51.3 29.7 208.5 35.4 1720.8 13.9 
B
Z
E
 
0 4.1 4.2 45.2 4.2 170.5 4.2 
1 3.5 11.7 41.7 2.6 156.7 1.6 
4 4.6 1.5 48.8 4.6 185.8 2.9 
8 3.3 1.9 35.8 2.9 149.6 3.4 
11 3.7 13.5 40.5 2.7 167.1 0.6 
15 3.4 5.9 36.5 3.3 162.6 1.8 
30 3.4 14.8 45.7 1.8 203.3 3.4 
60 3.0 22.0 35.5 7.7 144.0 12.8 
C
E
 
0 4.9 3.1 53.0 3.1 182.1 3.1 
1 4.0 2.3 52.0 2.2 171.7 1.5 
4 4.8 3.6 51.6 3.9 153.2 1.7 
8 4.0 5.6 46.9 1.7 185.8 1.2 
11 3.8 14.4 39.6 9.5 161.8 2.5 
15 2.3 2.5 27.8 2.9 135.8 2.7 
30 2.9 10.4 43.5 3.5 137.5 2.7 
60 1.9 5.7 25.1 2.1 115.5 4.1 
N
C
 
0 3.3 13.2 34.7 1.0 154.1 1.0 
1 2.7 0.4 26.1 2.1 123.7 2.7 
4 3.7 3.1 38.7 6.4 157.3 6.6 
8 2.9 4.9 30.6 3.8 136.6 4.9 
11 3.2 13.6 31.1 7.6 141.5 3.3 
15 2.9 4.0 29.5 6.9 124.3 8.8 
30 2.7 10.5 37.5 12.7 157.8 7.3 
60 2.9 4.7 30.8 3.7 153.0 16.0 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, CE: Cocaethylene, EME: 
Ecgonine methyl ester, NC: Norcocaine.
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Table 6. Stability data of AEME, EME, BZE, CE and NC in buffered oral fluid stored in 
the fridge 
LOW MED HIGH 
N = 3 DAY 
Mean 
(ng/mL) 
%RSD 
Mean 
(ng/mL) 
%RSD 
Mean 
(ng/mL) 
%RSD 
A
E
M
E
 
0 4.4 3.1 47.5 3.1 189.9 3.1 
1 5.3 6.8 48.5 11.3 193.2 2.5 
4 4.7 1.1 49.7 1.4 200.5 0.1 
8 4.5 8.8 46.6 6.0 189.7 5.4 
15 5.0 10.4 53.8 6.5 209.4 12.4 
30 5.1 5.4 49.0 0.7 199.3 3.4 
60 4.8 7.9 49.8 2.7 189.2 9.1 
E
M
E
 
0 81.3 4.0 1037.9 4.0 3870.6 4.0 
1 78.1 5.7 700.3 12.6 2741.7 33.2 
4 16.8 6.4 181.9 7.3 748.4 9.7 
8 60.8 10.6 693.7 6.9 3063.8 19.6 
15 45.4 11.4 493.9 10.0 2302.5 65.6 
30 7.0 129.2 90.0 12.6 363.9 126.3 
60 39.4 88.5 13.0 22.9 7.8 34.9 
B
Z
E
 
0 4.1 13.8 45.2 4.0 170.5 13.8 
1 3.4 7.8 41.8 12.6 159.0 6.4 
4 4.5 0.5 48.5 7.3 184.6 3.1 
8 3.3 2.5 36.8 6.9 140.6 2.0 
15 3.5 14.5 35.9 10.0 169.0 17.0 
30 3.1 11.6 41.4 12.6 198.4 12.8 
60 2.6 44.5 39.3 22.9 182.0 10.8 
C
E
 
0 4.9 1.8 53.0 1.8 182.1 1.8 
1 4.2 7.3 51.7 10.8 156.0 12.9 
4 5.0 3.3 54.0 1.5 148.5 4.8 
8 4.7 8.0 52.2 4.0 211.8 4.7 
15 4.0 11.6 42.4 7.6 151.2 4.1 
30 4.3 7.9 55.5 2.1 152.9 1.9 
60 2.5 57.6 41.7 3.3 176.8 6.3 
N
C
 
0 3.3 3.4 34.7 3.4 154.1 3.4 
1 2.7 6.2 32.5 18.8 135.6 16.8 
4 3.7 6.4 39.2 7.1 163.9 6.9 
8 3.0 9.3 29.9 4.8 130.0 6.6 
15 3.0 11.1 34.6 9.1 146.1 17.5 
30 3.6 16.2 40.4 6.2 170.2 9.3 
60 2.6 2.1 29.5 14.0 130.1 8.6 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, CE: Cocaethylene, EME: 
Ecgonine methyl ester, NC: Norcocaine.
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Table 7. Stability data of AEME, EME, BZE, CE and NC in buffered oral fluid stored at 
-20 °C
LOW MED HIGH 
N = 3 DAY 
Mean 
(ng/mL) 
%RSD 
Mean 
(ng/mL) 
%RSD 
Mean 
(ng/mL) 
%RSD 
A
E
M
E
 
0 4.4 6.5 47.5 6.5 189.9 6.5 
1 5.2 2.0 49.7 2.8 191.2 2.0 
4 4.7 0.5 48.7 2.5 198.0 2.0 
8 4.4 5.3 45.9 3.5 195.3 8.1 
15 4.9 2.9 43.7 11.3 204.9 3.0 
30 4.3 0.6 46.4 1.9 186.6 6.8 
60 4.0 8.2 40.4 5.0 184.3 6.7 
E
M
E
 
0 81.3 8.5 1037.9 8.5 3870.6 8.5 
1 61.8 5.0 818.8 2.2 2518.6 46.8 
4 14.5 14.0 188.6 14.7 918.9 11.8 
8 69.2 1.4 648.0 4.8 3054.1 19.0 
15 40.2 20.8 189.1 48.1 2144.2 40.8 
30 7.9 5.7 99.1 5.0 432.5 129.4 
60 20.9 35.6 15.3 20.6 411.5 26.6 
B
Z
E
 
0 4.1 15.1 45.2 15.1 170.5 15.1 
1 3.6 1.7 44.6 14.4 159.0 5.7 
4 4.5 2.1 48.6 1.8 180.4 2.6 
8 3.3 0.6 36.3 1.8 140.3 5.5 
15 3.3 2.5 38.0 7.5 166.1 4.1 
30 3.4 1.0 38.2 2.7 181.0 7.2 
60 2.8 13.2 33.5 5.8 152.0 3.5 
C
E
 
0 4.9 6.8 53.0 6.8 182.1 6.8 
1 4.0 3.3 52.6 2.0 172.6 10.5 
4 5.0 0.6 54.4 1.6 145.8 1.2 
8 5.0 1.1 55.2 3.6 226.7 9.7 
15 4.3 4.7 44.9 17.5 153.9 4.6 
30 5.6 2.3 63.7 1.9 160.2 0.4 
60 4.7 65.4 62.7 3.1 209.6 6.8 
N
C
 
0 3.3 11.1 34.7 11.1 154.1 11.1 
1 3.0 6.7 31.1 17.7 133.1 7.8 
4 3.7 6.5 37.9 2.8 156.0 5.7 
8 2.9 3.7 30.1 3.5 133.8 9.2 
15 3.0 6.1 26.5 6.2 147.7 9.7 
30 3.5 2.5 39.6 4.8 154.8 1.5 
60 2.8 4.6 30.2 9.7 132.8 12.0 
AEME: Anhydroecgonine methyl ester, BZE: Benzoylecgonine, COC: Cocaine, CE: Cocaethylene, EME: 
Ecgonine methyl ester, NC: Norcocaine.
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Title Evaluation of the concentration of cocaine derivatives from collected oral fluid 
samples following consumption of coca tea. 
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Procedures commonly used to collect blood or urine samples in workplace or police 
environments are regarded as invasive either because the subject is subjected to having 
blood collected via a syringe and needle or urine collected under “observed” collection 
conditions. During recent years research has demonstrated that drugs are excreted via the 
saliva into the mouth hence the collection and analysis of saliva (oral fluid) is growing in 
popularity. The initial concept of drug entry into saliva and oral fluid (OF) was based on a 
philosophy that that drugs present in the blood could pass through the cell membranes of 
the salivary glands across a concentration gradient, the extent of which would be 
determined by the lipid solubility of the drug and its pKa value. Whilst this theory holds for 
many medicinal drugs consumed in tablet formulations Osselton et al (2001) demonstrated 
that for heroin and cocaine, which are commonly consumed via nasal insufflation or 
smoking, the detection times are significantly longer that would be expected using 
pharmacokinetic models. This lead to the proposition that cocaine and heroin can form 
depots in the mouth tissues following exposure and are subsequently released from the 
tissue over time. If drugs are accumulated in oral tissue depots and are subsequently 
released over time, this has significant potential implications when oral fluid is used for 
monitoring drug use by an individual. Reichardt (PhD Thesis Bournemouth University) 
demonstrated that following exposure of buccal tissue to coca tea, cocaine derivatives are 
released from buccal tissues over a period of several hours. The study also revealed a 
number of unexplained artefacts relating to the detection of cocaine derivatives in oral fluid 
collected after the consumption of coca tea. This study aims to further our understanding of 
cocaine absorption and elimination from oral/buccal tissues by analysing the oral exudate 
collected from volunteers following the consumption of coca tea. The study will be 
undertaken in collaboration with the National University of Colombia where consumption of 
coca tea is legal and regular social custom The study aims to engage 30 adult volunteers to 
consume a standard cup of tea and subsequently collect oral fluid samples at timed 
intervals over a period of 4 hours using a commercial oral fluid collection device. It is 
proposed to collect oral fluid samples at 10, 20, 30, 60, 120, 180 and 260 minutes post 
consumption. Oral fluid samples will be analysed at Alere Toxicology, Abingdon, UK using a 
validated LC-MS method.Coca tea contains small quantities of cocaine derivatives such that 
at high altitude it eases breathing and reduces the symptoms of altitude sickness. Coca tea 
does not produce any form of “high” or intoxication and is significantly less likely to affect an 
individual than the social use of alcohol. 
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External Ethics Review 
Does your research require external review through the NHS National 
Research Ethics Service (NRES) or through another external Ethics 
Committee? 
No 
Research Literature 
Is your research solely literature based? No
Human Participants 
Will your research project involve interaction with human participants as 
primary sources of data (e.g. interview, observation, original survey)? Yes 
Does your research specifically involve participants who are considered 
vulnerable (i.e. children, those with cognitive impairment, those in unequal 
relationships—such as your own students, prison inmates, etc.)? 
No 
Does the study involve participants age 16 or over who are unable to give 
informed consent (i.e. people with learning disabilities)? NOTE: All 
research that falls under the auspices of the Mental Capacity Act 
2005 must be reviewed by NHS NRES. 
No 
Will the study require the co-operation of a gatekeeper for initial access to 
the groups or individuals to be recruited? (i.e. students at school, members 
of self-help group, residents of Nursing home?) 
No 
Will it be necessary for participants to take part in your study without their 
knowledge and consent at the time (i.e. covert observation of people in non-
public places)? 
No 
Will the study involve discussion of sensitive topics (i.e. sexual activity, drug 
use, criminal activity)? Yes 
Are drugs, placebos or other substances (i.e. food substances, vitamins) to be 
administered to the study participants or will the study involve invasive, 
intrusive or potentially harmful procedures of any kind? 
Yes 
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Please explain why your research project does not require ethical review by a NHS REC. 
 
None of the volunteers participating in this study will be patients or service users within the 
services for which the UK Health Departments are responsible.Only volunteers who 
participate with informed consent will be permitted to enter the study. The experimental 
protocol and reasoning behind the study will be explained in full, samples identity will be 
anonymised and volunteers will be required to sign a consent form agreeing participation in 
the study. The study will be carried out in Colombia where coca tea is widely consumed and 
where its use is both legal and socially acceptable. The quantity of cocaine present in coca 
tea is very low and the oral route of administration of this beverage does not lead to harmful 
or significant side effects. The tea will be prepared using commercial coca tea bags (Nasa 
esh’s) purchased from the Nasa community (indigenous community). This will simply be 
following a local custom of drinking coca tea. 
 
 
Will tissue samples (including blood) be obtained from participants? Note: 
If the answer to this question is ‘yes’ you will need to be aware of 
obligations under the Human Tissue Act 2004. 
No 
 
Could your research induce psychological stress or anxiety, cause harm or 
have negative consequences for the participant or researcher (beyond the 
risks encountered in normal life)? 
 
No 
Will your research involve prolonged or repetitive testing? Yes 
Will the research involve the collection of audio materials? No 
Will your research involve the collection of photographic or video 
materials? 
 
No 
 Will financial or other inducements (other than reasonable expenses and 
compensation for time) be offered to participants? 
 
No 
 
 
 
Please explain below why your research project involves the above mentioned 
criteria (be sure to explain why the sensitive criterion is essential to your project’s 
success). Give a summary of the ethical issues and any action that will be taken to 
address these. Explain how you will obtain informed consent (and from whom) and 
how you will inform the participant(s) about the research project (i.e. participant 
information sheet). A sample consent form and participant information sheet can 
be found on the Research Ethics website. 
The sensitive question will relate to asking whether the volunteer has used drugs for 
either recreational or medical use within a period of 72 hours prior to the consumption of 
coca tea. This will eliminate subjects who may give false positives. Questions relating 
use of medicines will help to eliminate any subjects undergoing medical treatment. Only 
healthy subjects will be allowed to participate in the study and patients undergoing any 
form of medical treatment or suffering from any condition that requires the use of 
medication will be excluded. The research involves collecting eight oral fluid samples 
over a period of 4 hours. This may be regarded as repetitive testing? 
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Final Review 
Will you have access to personal data that allows you to identify individuals 
OR access to confidential corporate or company data (that is not covered by 
confidentiality terms within an agreement or by a separate confidentiality 
agreement)? 
No 
 
Will your research involve experimentation on any of the following: animals, 
animal tissue, genetically modified organisms? 
No 
Will your research take place outside the UK (including any and all 
stages of research: collection, storage, analysis, etc.)? 
Yes 
Does the country in which you are conducting research require that you obtain 
internal ethical approval? 
(i.e. beyond that required by Bournemouth University)?
No 
 
Could conflicts of interest arise between the source of funding and the 
potential outcomes of the research? 
No 
Please use the below text box to highlight any other ethical concerns or risks that 
may arise during your research that have not been covered in this form. 
N/A. We are undertaking the sample collection in Colombia because the consumption 
of coca tea is widely practised social custom. 
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 Volunteer Information Form for Collection of Oral 
Fluid 
 
Title of Project: Evaluation of the concentration of cocaine and other metabolites from 
collected oral fluid samples following consumption of coca tea. 
 
Principal Investigators: 
Aida Merchan, PhD student in Forensic Toxicology, Bournemouth University.  
Professor David Osselton, Head of Department of Archaeology, Anthropology and 
Forensic science, Bournemouth University. 
Dr Sulaf Assi, Lecture in Forensic Science, Bournemouth University.  
Dr Claire George, Alere Toxicology, Abingdon, UK.  
Dr Jorge Ariel Martinez, Lecturer at the Department of Pharmacy, Universidad Nacional 
de Colombia – Bogota. 
 
You are being invited to participate in a research study. Before you decide whether you 
want to participate in this study, it is important that you understand why the research is 
being undertaken and what it will involve. Please read the following information carefully 
and discuss it with others if you wish. Do not hesitate to ask if anything is unclear or if 
you have any questions or concerns. 
 
1. Purpose of the Research 
Detection of abused drugs is a major concern for regulatory agencies worldwide. 
Workplace regulations and Misuse of Drugs Regulations control the production, supply 
or use of abused substances such as cocaine.  Oral fluid drug testing has been 
implemented in several countries for the detection and/or analysis of drugs of abuse. 
Advantages in the procedure of oral fluid sample collection have positioned oral fluid as 
one of the most promising drug testing techniques for use in the future. There are however 
a number of factors related to drug elimination from the body via the saliva and oral fluid 
that we still do not fully understand. This study is aimed at providing information that 
will help us better understand how drugs enter into oral fluid. 
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Coca tea is produced from the leaves of the coca bush which has been planted and 
consumed for centuries in countries such as Colombia, Perú and Bolivia in South 
America. Consumption of coca leaves in these countries is both legal and socially 
acceptable. It is known that after the consumption of coca tea/leaves, cocaine and some 
breakdown products of cocaine can be detected in oral fluid.  
As part of this study volunteers will be invited to drink a cup (200 mL) of coca tea (~1 
mg cocaine) or swill coca tea around their mouths then spit it out without swallowing it. 
An oral fluid sample will be collected prior to administration of coca tea and consecutive 
samples of oral fluid from the inside of the cheek will be taken following administration. 
These samples will be collected for a period of approximately 4 hours. 
A commercial oral fluid collection device (The AlereTM Certus device) will be used for 
collection of oral fluid. Figure 1 shows an image of the collection device. This process is 
non-invasive and will involve a small absorbent pad being kept in the mouth until the 
detector turns blue indicating a sufficient volume has been collected. The pad is then 
inserted into a vial containing buffer. Samples will then be stored and analysed for cocaine 
and its chemical breakdown products.  
You will be requested to fill in a questionnaire providing details of age, sex and whether 
you are taking any drugs or medications. The questionnaire will have your assigned 
identity code. The information you provide and all information provided will be 
anonymised and confidential No impairment is caused by the consumption of coca 
tea/leaves.  
By signing this consent it means that you have not consumed coca tea, cocaine or “crack”, 
within the three days previous to this study. Also, that you do not have any known 
allergies to coca tea. 
Figure 1. AlereTM Concateno Certus oral fluid device. 
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2. Discomforts and Risks 
One risk of giving samples for research may be the release of your name that could be 
linked to the stored samples and/or the results of the tests run on the samples. To prevent 
this, you will be given a unique identification code. Only the research team will know the 
code from your samples. Only authorised members of the research team will have access 
to your assigned code. 
 
There are no reports of any significant side effects after the consumption of coca tea, 
however in South American mountains it is widely common to drink infusions or chew 
coca leaves to relieve the symptoms of Altitude Mountain Sickness. 
 
3. Statement of Confidentiality 
3.1 Privacy and confidentiality measures 
• Each sample will be given a unique code for which the samples will hereby be 
known. 
• Samples are going to be stored and analysed at Alere Toxicology in the UK and 
interpretation of results will take place at Bournemouth University - UK. The 
information provided throughout this study i.e. (sex, health, drug use) will not 
identify you by name. 
• The results of this research study may be presented at scientific/medical meetings or 
in scientific/medical publications. The identity of participants will not be disclosed 
in those presentations. 
• If you agree, samples and results will be stored along with information about yourself 
obtained in the course of this research study (age, sex, health, drug/medication use). 
The information stored will not identify you by name. In the event of any publication 
or presentation resulting from the research, no identifiable information will be 
shared. 
• We will keep participation in this research study confidential to the extent permitted 
by law. However, it is possible that other people may become aware of study 
participation. For example, the following people/groups may inspect and copy 
records pertaining to this research: The Bournemouth University Institutional Ethics 
Review Board (a committee that reviews and approves research studies). 
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• The possibility of identification is very low and every effort will be made to keep
your personal information in the research record private and confidential but absolute
confidentiality cannot be guaranteed. Participants will receive a signed and dated
copy of this consent form for your records.
4. Costs for Participation
4.1 Costs 
There are NO costs for participation in this research 
4.2 Rights: 
Signing this form will lose no legal rights. 
4.3 Compensation 
A small compensation of £10 (equivalent to approximately 40000 Colombian pesos) will 
be given to each participant for participation in this research study. Payment is due to be 
made in form of vouchers for local retailers.  
5. Voluntary Participation / Withdrawal:
Participation in this research study is entirely voluntary. If you choose not to take part, 
you have the right to stop at any time. You can withdraw up to the point of anonymisation 
of data. You are free to withdraw without giving reason and without there being any 
negative consequences. 
6. Contact Information for Questions or Concerns
You have the right to ask any questions you may have about this research. If you have 
questions or concerns about this research please ask the researcher Aida Merchan who is 
conducting the experiment at amerchanotalora@bournemouth.ac.uk or contact Professor 
David Osselton, Head of the Department of Archaeology, Anthropology and Forensic 
science, Bournemouth University, UK at dosselton@bournemouth.ac.uk. 
In case of complaints, please contact Professor Christine Maggs, Executive Dean for the 
Faculty of Science & Technology at cmaggs@bournemouth.ac.uk 
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                       Participant Agreement Form  
 
Title of project: Evaluation of the concentration of cocaine derivatives from collected 
oral fluid samples following consumption of coca tea. 
 
• Aida Merchan, PhD student in Forensic Toxicology, Bournemouth University. 
• Professor David Osselton, Head of Department of Archaeology, Anthropology and 
Forensic science, Bournemouth University. 
• Dr Sulaf Assi, Lecturer in Forensic Science, Bournemouth University.  
• Dr Jorge Ariel Martinez, Lecture at the Department of Pharmacy, Universidad Nacional 
de Colombia – Bogotá 
 
Hereafter you will find a number of statements that you need to read through. Once you 
have read them please mark the statements that you agree with.  
Please 
Initial  or 
           Tick Here 
I have read and understood the participant information sheet for the above 
research project.  
 
 
I confirm that I have had the opportunity to ask questions. 
 
 
I understand that my participation is voluntary. 
 
 
I understand that I am free to withdraw up to the point where the samples 
have been collected and become anonymous, so my identity cannot be 
determined.  
 
 
During the collection of samples, I am free to withdraw without giving 
reason and without there being any negative consequences.   
 
 
Should I not wish to answer any particular question(s) or give a sample, I 
am free to decline.   
 
 
 
I give permission for members of the research team to have access to my 
anonymised samples. I understand that my name will not be linked with the 
research materials and I will not be identified or identifiable in the outputs 
that result from the research.   
 
 
I agree to take part in the above research project.  
 
 
____________________________      _______________      
_________________________ 
Name of Participant                                Date                              Signature 
 
____________________________      _______________      
_________________________ 
Name of Researcher                               Date                              Signature 
 
 
 
This form should be signed and dated by all parties after the participant receives a copy of the participant information 
sheet and any other written information provided to the participants. A copy of the signed and dated participant 
agreement form should be kept with the project’s main documents which must be kept in a secure location. 
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ETHICAL APPROVAL – NATIONAL UNIVERSITY OF COLOMBIA 
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TRANSLATION: ETHICAL APPROVAL – NATIONAL UNIVERSITY OF 
COLOMBIA 
Bogota, 6th February 2017 
Professor 
Jorge Ariel Martinez Ramirez 
Department of Pharmacy 
Dear professor: 
This is to communicate that the Ethics Committee from the Faculty of Science, evaluated 
the ethical aspects of the project presented for you on the meeting that took place on the 
6th of February 2017 (Acta 01-2017). As a result of this revision, the committee 
considered that the project complies with the basic ethical aspects. For the relevant 
purpose, the observations and the final concept are transcribed. 
Project: Evaluation of the concentration of cocaine and other metabolites from collected 
oral fluid samples following consumption of coca tea. 
A joined project between the National University of Colombia and Bournemouth 
University – UK. 
Responsible: Jorge Ariel Martinez (Principal Investigator, National University of 
Colombia, Faculty of Science, Pharmacy Department). Coinvestigators (Faculty of 
Science and Technology – Archaeology, Anthropology and Forensic Science, 
Bournemouth University – UK): Aida Merchan, David Osselton and Sulaf Assi. 
Observations: 
For this research there will be a collection of oral fluid samples from healthy volunteer 
which have consumed coca tea, using a commercial device. The kinetic of cocaine and 
its metabolites in oral fluid will be analysed as an alternative analysis of blood and urine. 
Participants who donate biological fluids will have to sign an informed consent. 
Emphasises should be given to the need of having the required authorisations for sending 
biological samples abroad. 
Concept: Approved 
Luis Fernando Ospina G. 
Coordinator Ethics Committee 
A
pp
en
di
ce
s 
385 
A
P
P
E
N
D
IX
 F
 –
 C
oc
a 
te
a 
da
ta
 
T
ab
le
 1
. A
E
M
E
 c
on
ce
nt
ra
ti
on
 in
 o
ra
l f
lu
id
 f
or
 e
ac
h 
pa
rt
ic
ip
an
t m
ea
su
re
d 
af
te
r 
th
e 
in
ge
st
io
n 
or
 s
w
ir
li
ng
 o
f 
a 
cu
p 
of
 c
oc
a 
te
a.
 
C
on
ce
nt
ra
ti
on
 G
ro
up
 A
 (
ng
/m
L
) 
- 
In
ge
st
ed
 c
oc
a 
te
a 
C
on
ce
nt
ra
ti
on
 G
ro
up
 B
 (
ng
/m
L
) 
- 
Sw
ir
l c
oc
a 
te
a 
C
ol
le
ct
io
n 
ti
m
e 
(m
in
) 
C
ol
le
ct
io
n 
ti
m
e 
- 
R
ig
ht
 s
id
e 
of
 m
ou
th
 (
m
in
) 
C
ol
le
ct
io
n 
ti
m
e 
- 
L
ef
t 
si
de
 o
f 
m
ou
th
 (
m
in
) 
P
ar
ti
ci
pa
nt
 
0 
10
 
20
 
30
 
60
 
12
0 
18
0 
24
0 
0 
10
 
20
 
30
 
60
 
12
0 
18
0 
24
0 
0 
10
 
20
 
30
 
60
 
12
0 
18
0 
24
0 
P
1 
0 
16
7 
65
 
38
 
3 
0 
0 
0 
0 
41
8 
20
5 
67
 
15
 
0 
0 
0 
0 
51
4 
17
2 
73
 
9 
0 
0 
0 
P
2 
0 
17
6 
79
 
29
 
3 
0 
0 
0 
0 
39
6 
17
0 
76
 
14
 
0 
0 
0 
0 
47
1 
21
6 
11
0 
14
 
0 
0 
0 
P
3 
0 
16
5 
36
 
22
 
1 
0 
0 
0 
0 
53
4 
40
8 
18
3 
35
 
6 
0 
0 
0 
55
4 
33
5 
19
8 
46
 
4 
0 
0 
P
4 
0 
36
7 
17
7 
11
1 
8 
0 
0 
0 
0 
61
5 
25
5 
96
 
16
 
0 
0 
0 
0 
44
0 
16
7 
11
4 
12
 
0 
0 
0 
P
5 
0 
34
7 
16
3 
60
 
13
 
1 
0 
0 
0 
13
0 
42
 
16
 
2 
0 
0 
0 
0 
12
1 
20
 
0 
0 
0 
0 
0 
P
6 
0 
67
 
23
 
9 
0 
0 
0 
0 
0 
12
75
 
60
3 
34
0 
10
2 
2 
0 
0 
0 
12
06
 
66
5 
54
9 
11
9 
2 
0 
0 
P
7 
0 
65
5 
43
1 
19
3 
46
 
0 
0 
0 
0 
52
4 
16
9 
13
8 
25
 
12
 
2 
0 
0 
45
9 
22
0 
13
5 
38
 
9 
3 
0 
P
8 
0 
25
3 
58
 
37
 
1 
0 
0 
0 
0 
63
5 
23
5 
10
5 
11
 
0 
0 
0 
0 
50
4 
16
0 
80
 
5 
0 
0 
0 
P
9 
0 
14
1 
58
 
21
 
4 
0 
0 
0 
0 
35
3 
16
7 
10
5 
21
 
0 
0 
0 
0 
39
5 
22
8 
81
 
15
 
0 
0 
0 
P
10
 
0 
27
5 
49
 
13
 
0 
0 
0 
0 
0 
99
7 
31
4 
16
5 
24
 
0 
0 
0 
0 
84
1 
28
5 
21
3 
21
 
0 
0 
0 
P
11
 
0 
37
 
19
 
7 
0 
0 
0 
0 
0 
27
1 
10
1 
33
 
3 
0 
0 
0 
0 
20
3 
59
 
20
 
1 
0 
0 
0 
P
12
 
0 
13
2 
50
 
12
 
0 
0 
0 
0 
0 
23
7 
17
8 
10
7 
6 
0 
0 
0 
0 
18
1 
13
7 
78
 
7 
0 
0 
0 
P
13
 
0 
58
 
12
 
3 
0 
0 
0 
0 
0 
84
5 
55
1 
22
3 
16
 
1 
0 
0 
0 
85
7 
42
9 
21
0 
48
 
1 
0 
0 
P
14
 
0 
22
1 
11
0 
74
 
8 
0 
0 
0 
0 
44
9 
37
7 
12
0 
13
 
0 
0 
0 
0 
58
8 
37
0 
18
8 
22
 
0 
0 
0 
P
15
 
0 
44
 
54
 
15
 
1 
0 
0 
0 
0 
66
8 
35
4 
15
5 
21
 
0 
0 
0 
0 
52
5 
28
6 
12
1 
14
 
0 
0 
0 
M
ea
n 
0 
20
7 
92
 
43
 
6 
0 
0 
0 
0 
55
6 
27
5 
12
8 
21
 
2 
0 
0 
0 
52
4 
25
0 
14
5 
25
 
1 
0 
0 
M
ed
ia
n 
0 
16
7 
58
 
22
 
1 
0 
0 
0 
0 
52
4 
23
5 
10
7 
16
 
0 
0 
0 
0 
50
4 
22
0 
11
4 
14
 
0 
0 
0 
SD
 
0 
16
1 
10
5 
51
 
12
 
0 
0 
0 
0 
30
2 
15
9 
80
 
24
 
3 
0 
0 
0 
28
0 
15
9 
12
9 
30
 
3 
1 
0 
M
in
 
0 
37
 
12
 
3 
0 
0 
0 
0 
0 
13
0 
42
 
16
 
2 
0 
0 
0 
0 
12
1 
20
 
0 
0 
0 
0 
0 
M
ax
 
0 
65
5 
43
1 
19
3 
46
 
1 
0 
0 
0 
12
75
 
60
3 
34
0 
10
2 
12
 
2 
0 
0 
12
06
 
66
5 
54
9 
11
9 
9 
3 
0 
G
ro
up
 A
: P
ar
tic
ip
an
ts
 in
ge
st
ed
 o
ne
 c
up
 o
f 
co
ca
 te
a 
(d
at
a 
co
lle
ct
ed
 u
si
ng
 o
ne
 c
ol
le
ct
io
n 
de
vi
ce
 a
t e
ac
h 
tim
e 
po
in
t)
. G
ro
up
 B
: P
ar
tic
ip
an
ts
 s
w
ir
le
d 
a 
cu
p 
of
 c
oc
a 
te
a 
(d
at
a 
co
lle
ct
ed
 u
si
ng
 tw
o 
co
lle
ct
io
n 
de
vi
ce
s 
at
 e
ac
h 
tim
e 
po
in
t)
. A
: O
F 
sa
m
pl
e 
co
lle
ct
ed
 f
ro
m
 th
e 
ri
gh
t s
id
e 
of
 th
e 
m
ou
th
. B
: O
F 
sa
m
pl
e 
co
lle
ct
ed
 f
ro
m
 th
e 
le
ft
 s
id
e 
of
 th
e 
m
ou
th
. S
D
: S
ta
nd
ar
d 
de
vi
at
io
n.
 L
O
Q
: 0
.5
 n
g/
m
L
 A
E
M
E
 in
 b
uf
fe
re
d 
or
al
 f
lu
id
; L
O
Q
 in
 n
ea
t O
F 
w
as
 2
 n
g/
m
L
 (
th
e 
di
lu
tio
n 
fa
ct
or
 f
ro
m
 c
ol
le
ct
io
n 
de
vi
ce
 w
as
 4
) 
* 
E
ac
h 
sa
m
pl
e 
w
as
 a
na
ly
se
d 
in
 d
up
lic
at
e 
an
d 
va
lu
es
 a
re
 p
re
se
nt
ed
 a
s 
m
ea
n 
va
lu
es
. 
A
ppendices 
 386 
T
able 2. B
Z
E
 concentration in oral fluid for each participant m
easured after the ingestion or sw
irling of a cup of coca tea. 
C
oncentration G
roup A
 (ng/m
L
) - Ingested coca tea 
C
oncentration G
roup B
 (ng/m
L
) - Sw
irl coca tea 
C
ollection tim
e (m
in) 
C
ollection tim
e - R
ight side of m
outh (m
in) 
C
ollection tim
e - L
eft side of m
outh (m
in) 
P
articipant 
0 
10 
20 
30 
60 
120 
180 
240 
0 
10 
20 
30 
60 
120 
180 
240 
0 
10 
20 
30 
60 
120 
180 
240 
P
1 
2 
174 
25 
21 
18 
33 
63 
25 
2 
507 
65 
31 
11 
3 
3 
3 
2 
570 
77 
19 
8 
3 
2 
2 
P
2 
2 
61 
62 
13 
30 
16 
10 
21 
2 
584 
77 
27 
9 
3 
3 
2 
2 
646 
107 
35 
10 
3 
3 
2 
P
3 
2 
69 
11 
28 
28 
25 
43 
28 
2 
171 
60 
47 
8 
7 
2 
3 
2 
226 
63 
25 
7 
4 
2 
4 
P
4 
1 
34 
30 
15 
31 
0 
4 
9 
2 
329 
408 
15 
10 
3 
2 
2 
1 
219 
287 
24 
6 
4 
3 
2 
P
5 
2 
110 
22 
33 
34 
60 
34 
60 
2 
87 
22 
9 
3 
2 
2 
2 
1 
91 
12 
3 
2 
2 
2 
0 
P
6 
1 
13 
18 
16 
24 
25 
18 
18 
2 
1404 
442 
161 
17 
4 
3 
2 
2 
1175 
219 
87 
25 
3 
3 
1 
P
7 
1 
603 
300 
114 
131 
33 
51 
20 
2 
875 
85 
66 
9 
10 
3 
2 
1 
756 
108 
44 
16 
9 
4 
2 
P
8 
1 
58 
43 
22 
27 
23 
25 
23 
2 
290 
33 
9 
4 
2 
2 
2 
1 
366 
34 
7 
2 
2 
2 
1 
P
9 
2 
55 
9 
11 
28 
39 
42 
26 
2 
119 
31 
12 
12 
4 
3 
2 
1 
305 
49 
11 
9 
2 
5 
3 
P
10 
2 
363 
108 
25 
34 
29 
11 
28 
2 
913 
27 
12 
3 
2 
2 
2 
1 
1103 
20 
25 
8 
2 
2 
4 
P
11 
1 
31 
19 
19 
15 
17 
11 
21 
2 
214 
44 
9 
10 
2 
3 
2 
1 
78 
18 
4 
4 
2 
2 
2 
P
12 
1 
64 
22 
21 
7 
6 
11 
7 
2 
8 
5 
4 
2 
2 
2 
2 
2 
5 
4 
5 
2 
2 
2 
1 
P
13 
1 
9 
6 
4 
7 
4 
2 
2 
2 
416 
129 
9 
4 
2 
2 
2 
1 
557 
23 
11 
11 
2 
2 
2 
P
14 
2 
116 
68 
46 
14 
5 
2 
6 
0 
454 
58 
46 
6 
2 
2 
2 
0 
524 
130 
55 
8 
2 
2 
2 
P
15 
1 
16 
8 
7 
4 
2 
2 
2 
2 
152 
97 
43 
9 
2 
3 
3 
2 
294 
56 
24 
7 
2 
3 
3 
M
ean 
2 
118 
50 
26 
29 
21 
22 
20 
2 
435 
106 
33 
8 
3 
2 
2 
2 
461 
80 
25 
8 
3 
3 
2 
M
edian 
1 
61 
22 
21 
27 
23 
11 
21 
2 
329 
60 
15 
9 
2 
2 
2 
2 
366 
56 
24 
8 
2 
2 
2 
SD
 
0 
161 
75 
26 
30 
17 
20 
14 
0 
380 
134 
40 
4 
2 
1 
0 
0 
352 
81 
23 
6 
2 
1 
1 
M
in 
1 
9 
6 
4 
4 
0 
2 
2 
0 
8 
5 
4 
2 
2 
2 
2 
0 
5 
4 
3 
2 
2 
2 
0 
M
ax 
2 
603 
300 
114 
131 
60 
63 
60 
2 
1404 
442 
161 
17 
10 
3 
3 
2 
1175 
287 
87 
25 
9 
5 
4 
G
roup A
: Participants ingested one cup of coca tea (data collected using one collection device at each tim
e point). G
roup B
: Participants sw
irled a cup of coca tea (data collected using tw
o collection 
devices at each tim
e point). A
: O
F sam
ple collected from
 the right side of the m
outh. B
: O
F sam
ple collected from
 the left side of the m
outh. SD
: Standard deviation. L
O
Q
: 0.5 ng/m
L
 B
Z
E
 in buffered 
oral fluid; L
O
Q
 in neat O
F w
as 2 ng/m
L
 (the dilution factor from
 collection device w
as 4) * E
ach sam
ple w
as analysed in duplicate and values are presented as m
ean values. 
A
pp
en
di
ce
s 
387 
T
ab
le
 3
. C
oc
ai
ne
 c
on
ce
nt
ra
ti
on
 in
 o
ra
l f
lu
id
 f
or
 e
ac
h 
pa
rt
ic
ip
an
t m
ea
su
re
d 
af
te
r 
th
e 
in
ge
st
io
n 
or
 s
w
ir
li
ng
 o
f 
a 
cu
p 
of
 c
oc
a 
te
a.
 
C
on
ce
nt
ra
ti
on
 G
ro
up
 A
 (
ng
/m
L
) 
- 
In
ge
st
ed
 c
oc
a 
te
a 
C
on
ce
nt
ra
ti
on
 G
ro
up
 B
 (
ng
/m
L
) 
- 
Sw
ir
l c
oc
a 
te
a 
C
ol
le
ct
io
n 
ti
m
e 
(m
in
) 
C
ol
le
ct
io
n 
ti
m
e 
- 
R
ig
ht
 s
id
e 
of
 m
ou
th
 (
m
in
) 
C
ol
le
ct
io
n 
ti
m
e 
- 
L
ef
t 
si
de
 o
f 
m
ou
th
 (
m
in
) 
P
ar
ti
ci
pa
nt
 
0 
10
 
20
 
30
 
60
 
12
0 
18
0 
24
0 
0 
10
 
20
 
30
 
60
 
12
0 
18
0 
24
0 
0 
10
 
20
 
30
 
60
 
12
0 
18
0 
24
0 
P
1 
2 
18
86
 
73
2 
30
6 
53
 
32
 
21
 
6 
2 
27
03
 
59
2 
16
6 
35
 
6 
6 
6 
2 
30
22
 
52
1 
12
0 
23
 
4 
4 
3 
P
2 
5 
13
17
 
78
0 
12
0 
35
 
7 
3 
3 
2 
24
37
 
73
3 
20
6 
40
 
3 
3 
2 
2 
26
29
 
91
7 
23
7 
28
 
3 
4 
2 
P
3 
9 
16
30
 
18
1 
19
5 
31
 
9 
6 
3 
2 
26
83
 
17
72
 
13
20
 
17
9 
48
 
5 
3 
2 
28
70
 
16
56
 
84
4 
11
2 
22
 
2 
3 
P
4 
2 
12
42
 
91
2 
39
7 
14
5 
2 
2 
3 
1 
25
69
 
20
73
 
14
6 
68
 
10
 
3 
3 
1 
24
23
 
18
22
 
20
6 
39
 
9 
9 
3 
P
5 
2 
21
37
 
10
31
 
50
7 
20
3 
14
0 
42
 
36
 
2 
15
54
 
32
4 
12
2 
24
 
4 
4 
3 
2 
12
23
 
12
2 
11
 
4 
4 
3 
0 
P
6 
1 
73
7 
23
6 
56
 
31
 
10
 
6 
3 
2 
45
75
 
28
37
 
18
82
 
16
5 
17
 
4 
2 
2 
46
43
 
28
55
 
21
72
 
20
5 
10
 
4 
1 
P
7 
1 
29
93
 
21
68
 
10
82
 
18
4 
5 
4 
2 
2 
35
50
 
13
01
 
99
9 
16
6 
45
 
7 
3 
1 
32
89
 
19
00
 
87
4 
27
6 
37
 
9 
2 
P
8 
2 
11
15
 
44
9 
89
 
26
 
4 
4 
3 
2 
24
99
 
54
6 
74
 
16
 
2 
2 
1 
2 
24
58
 
56
6 
39
 
6 
1 
2 
1 
P
9 
2 
12
15
 
15
8 
10
5 
41
 
8 
4 
3 
1 
21
27
 
12
92
 
44
2 
19
8 
12
 
3 
2 
1 
28
19
 
15
10
 
50
9 
13
3 
6 
5 
2 
P
10
 
2 
23
59
 
62
7 
74
 
30
 
8 
3 
15
 
1 
34
07
 
11
95
 
15
0 
15
 
2 
2 
3 
1 
39
27
 
90
8 
43
3 
10
9 
2 
2 
5 
P
11
 
2 
20
7 
80
 
43
 
22
 
10
 
4 
4 
1 
21
22
 
59
7 
52
 
34
 
4 
4 
2 
1 
16
28
 
19
1 
19
 
23
 
4 
3 
2 
P
12
 
1 
50
5 
97
 
39
 
5 
3 
3 
2 
3 
33
6 
21
5 
30
 
3 
2 
2 
2 
3 
27
4 
68
 
22
 
3 
2 
2 
1 
P
13
 
1 
58
 
14
 
4 
3 
2 
1 
1 
1 
32
11
 
19
33
 
15
6 
45
 
5 
2 
2 
1 
29
17
 
14
21
 
66
6 
10
9 
2 
4 
2 
P
14
 
3 
11
76
 
64
1 
34
6 
10
3 
8 
2 
4 
17
 
21
32
 
12
59
 
72
3 
66
 
2 
4 
2 
17
 
22
92
 
14
88
 
80
3 
73
 
2 
4 
2 
P
15
 
1 
13
8 
40
 
13
 
5 
1 
1 
2 
3 
17
30
 
12
54
 
59
3 
59
 
3 
4 
4 
3 
19
58
 
11
07
 
28
7 
62
 
3 
7 
4 
M
ea
n 
2 
12
48
 
54
3 
22
5 
61
 
17
 
7 
6 
3 
25
09
 
11
95
 
47
1 
74
 
11
 
4 
3 
3 
25
58
 
11
37
 
48
3 
80
 
7 
4 
2 
M
ed
ia
n 
2 
12
15
 
44
9 
10
5 
31
 
8 
4 
3 
2 
24
99
 
12
54
 
16
6 
45
 
4 
4 
2 
2 
26
29
 
11
07
 
28
7 
62
 
4 
4 
2 
SD
 
2 
85
3 
56
4 
28
3 
66
 
35
 
11
 
9 
4 
97
9 
72
9 
54
7 
67
 
15
 
2 
1 
4 
10
55
 
77
9 
56
3 
79
 
10
 
2 
1 
M
in
 
1 
58
 
14
 
4 
3 
1 
1 
1 
1 
33
6 
21
5 
30
 
3 
2 
2 
1 
1 
27
4 
68
 
11
 
3 
1 
2 
0 
M
ax
 
9 
29
93
 
21
68
 
10
82
 
20
3 
14
0 
42
 
36
 
17
 
45
75
 
28
37
 
18
82
 
19
8 
48
 
7 
6 
17
 
46
43
 
28
55
 
21
72
 
27
6 
37
 
9 
5 
G
ro
up
 A
: P
ar
tic
ip
an
ts
 in
ge
st
ed
 o
ne
 c
up
 o
f 
co
ca
 te
a 
(d
at
a 
co
lle
ct
ed
 u
si
ng
 o
ne
 c
ol
le
ct
io
n 
de
vi
ce
 a
t e
ac
h 
tim
e 
po
in
t)
. G
ro
up
 B
: P
ar
tic
ip
an
ts
 s
w
ir
le
d 
a 
cu
p 
of
 c
oc
a 
te
a 
(d
at
a 
co
lle
ct
ed
 u
si
ng
 tw
o 
co
lle
ct
io
n 
de
vi
ce
s 
at
 e
ac
h 
tim
e 
po
in
t)
. A
: O
F 
sa
m
pl
e 
co
lle
ct
ed
 f
ro
m
 th
e 
ri
gh
t s
id
e 
of
 th
e 
m
ou
th
. B
: O
F 
sa
m
pl
e 
co
lle
ct
ed
 f
ro
m
 th
e 
le
ft
 s
id
e 
of
 th
e 
m
ou
th
. S
D
: S
ta
nd
ar
d 
de
vi
at
io
n.
 L
O
Q
: 0
.5
 n
g/
m
L
 c
oc
ai
ne
 in
 
bu
ff
er
ed
 o
ra
l f
lu
id
; L
O
Q
 in
 n
ea
t O
F 
w
as
 2
 n
g/
m
L
 (
th
e 
di
lu
tio
n 
fa
ct
or
 f
ro
m
 c
ol
le
ct
io
n 
de
vi
ce
 w
as
 4
) 
* 
E
ac
h 
sa
m
pl
e 
w
as
 a
na
ly
se
d 
in
 d
up
lic
at
e 
an
d 
va
lu
es
 a
re
 p
re
se
nt
ed
 a
s 
m
ea
n 
va
lu
es
. 
A
ppendices 
 388 
T
able 4. E
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irling of a cup of coca tea. 
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e point). G
roup B
: Participants sw
irled a cup of coca tea (data collected using tw
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 in buffered 
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Q
 in neat O
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 (the dilution factor from
 collection device w
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ean values.
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APPENDIX G - Absorption of cocaine in tongue tissue 
Table 1. Amount of cocaine absorbed in porcine tongue tissue following exposure to 200 
mg crack cocaine.  
Experiment 
Site of 
tongue 
COC concentration (ng/mL) 
SD %RDS 
Mean Min Max 
TONGUE 1 Top (n = 7) 53.1 26.0 94.6 25.4 47.7 
Middle (n = 8) 107.2 58.2 231.4 55.7 51.9 
Low (n = 5) 140.3 71.3 206.8 59.7 42.5 
TONGUE 2 Top (n = 6) 7.3 6.1 9.6 1.3 17.2 
Middle (n = 6) 7.2 3.4 9.0 2.6 36.6 
Low (n = 5) 12.7 3.5 26.0 9.5 75.2 
TONGUE 3 Top (n = 6) 12.6 8.2 24.1 5.9 47.2 
Middle (n = 9) 15.2 7.4 21.6 5.3 34.8 
Low (n = 5) 10.5 7.9 15.5 3.0 29.0 
COC: Cocaine; SD: standard deviation; %RSD: Percentage standard deviation, n = number of subsamples 
analysed.
